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ABSTRACT 
 Urinary tract infections (UTIs) are among the most common bacterial infections in 
humans, accounting for $3.5 billion in health care expenditures yearly in the United States alone. 
Yet, treatments for UTI have seen little innovation over the past decade. As demonstrated in 
other body sites, such as the vagina and gastrointestinal (GI) tract, acute and infectious diseases 
often have indirect microbial contributions which serve as intriguing new targets for therapies. 
The recent discovery of the existence of a resident community of bacteria (i.e., microbiota) in the 
bladders of both women and men, represents a novel avenue for targeting UTIs. However, before 
targeted approaches aimed at modulating the urinary microbiota can be thoroughly investigated, 
it is first necessary to understand the normal modulations of these bacteria in the context of the 
host. 
Temporal dynamics in the vaginal and GI microbiota have been well described, and often 
linked to lifestyle factors or behaviors. Rigorous, longitudinal studies are required to study these 
trends. To date, few studies have assessed the urinary microbiota in such a manner – none were 
comprehensive, and all were in the context of lower urinary tract symptoms. This is primarily due 
to the impracticality of collecting repeated transurethral catheterized urine specimens for 
analysis.  
I sought an extensive and in-depth analysis of the temporal dynamics of the lower urinary 
tract (LUT) microbiota in individuals without confounding urinary symptoms or disorders. 
xx 
 
Moreover, I intend to determine if any observed changes have correlations to participant-
reported lifestyle factors. Through these analyses, I will aim to achieve three things. First, these 
data will provide the first description of the normal dynamics of the LUT microbiota. Second, our 
study design will serve as a framework for future research on this topic. Finally, our findings will 
increase our understanding of the development, risk, and prevention of UTIs by identifying 
patterns and potential causes of fluctuations within the LUT microbiota. 
In this thesis, I performed a clinical survey study as well as traditional mechanistic 
investigations to describe and understand the relationship between urinary microbiota dynamics 
and lifestyle. In the primary clinical study, I used next-generation sequencing and bacterial 
culture, as previously described and validated, to identify and taxonomically characterize the 
bacteria present in mid-stream voided urine (MSU) and peri-urethral swab specimens obtained 
daily from healthy, pre-menopausal women, for three months. Measures of microbiota temporal 
stability as well as changes in microbiota composition and alpha-diversity were obtained. I 
assessed for relationships between these values and various participant-reported lifestyle 
factors.  Ultimately, I found that reporting of menstruation and sexual activity had significant 
impact on the microbiota of the MSU specimens in particular. The microbiota variability was 
observed across participants, while specific trends were very individualized but were consistent 
over time.  
I then sought to determine if the lifestyle factors were directly responsible for the 
observed microbiota changes. I chose to investigate sexual intercourse in particular because of 
the literature-documented epidemiological association with UTI risk in women. I first 
xxi 
 
investigated the biological mechanism of these changes by analyzing specimens from male and 
female sexual partners. I determined that urinary Streptococcus isolates, which appear in 
elevated abundance in the MSU specimens of the female following sexual intercourse, are 
genomically related to isolates from the male’s oral flora. These data suggest that direct 
movement of bacteria between sexual partners results in altered female LUT microbiota 
following sexual intercourse. I then asked what the clinical significance of these changes were by 
studying the in vitro phenotypes of isolates from the normal LUT flora (i.e., Lactobacillus) as well 
as isolates from MSU specimens following sexual intercourse (i.e., Streptococcus). In relation to 
UTI risk, I found that urinary Lactobacillus isolates were bacteriostatic against strains of 
uropathogenic Escherichia coli (UPEC) while urinary Streptococcus isolates were not. These 
findings may directly relate to sexual intercourse and UTI risk, in which the normal LUT flora are 
protective against UTI, while the flora following sexual intercourse are not. 
Altogether, these data show that the LUT microbiota are dynamic and directly respond to 
lifestyle. Large clinical studies should be performed to further investigate the clinical significance 
of these findings. 
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CHAPTER I 
INTRODUCTION AND LITERATURE REVIEW 
The Human Microbiota 
 Bacteria and archaea evolved about 3 billion years ago and have since adapted to every 
conceivable niche on Earth, including the human body. Much as the soil of a tropical rainforest 
harbors a unique but specific community of microorganisms, so do our bodies. These 
microorganisms are highly adapted to each of our organs and provide us with a range of vital 
functions that have yet to be fully appreciated or understood. Considering that these 
microorganisms are equal in number to our somatic cells1, the extent of their influence is 
seemingly infinite. 
 The microorganisms that colonize our bodies are collectively known as the human 
microbiota. These microbes, which include bacteria, bacteriophage, fungi, protozoa, and viruses, 
when defined by their genomes, are referred to as the human microbiome. From a medical 
perspective, microbes have traditionally been associated with disease and, as such, our primary 
focus has been on eliminating and preventing their colonization of the human body. The Human 
Microbiome Project (HMP) represents the first major shift from studying microbes in relation to 
disease to exploring them in the context of health. The HMP used culture-independent methods 
to characterize the populations of microorganisms that naturally colonize humans (i.e., not in the 
context of disease). The project sampled a cohort of 300 individuals at five different body sites: 
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the gastrointestinal (GI) tract, oral cavity, vaginal/urogenital tract, skin, and nasal cavity2. Besides 
providing an in-depth comprehensive description of the microbiome at each body niche, the 
project generated two important conclusions. The first was that, although the diversity and 
abundance of microbes varied dramatically, each body niche sampled showed a level of 
specificity that was consistent within and between subjects. This means that the microbiome of 
a particular body niche is more similar amongst people than it is amongst other body niches2. The 
second conclusion was that the human microbiome has a degree of plasticity; the abundance and 
diversity of microorganisms within a person is not constant2. Recent research shows that this 
plasticity is largely determined by our lifestyle choices and behaviors - a topic that will serve as 
the main focus of this thesis. 
The Role of the Human Microbiota 
 The human microbiota play essential roles in a variety of processes throughout the body. 
These include priming the immune system to recognize “self” versus “non-self” antigens, 
breaking down indigestible food using fermentation, synthesizing several key vitamins, and 
inhibiting colonization of pathogenic microorganisms.  In return, our bodies provide protection, 
energy sources, and ideal growth conditions for the microbes. The symbiotic nature of this 
relationship leads to the opportunity for disease should an imbalance arise. Therefore, the 
balance of benefit versus harm depends largely on the overall state of the microbiota in terms of 
its distribution, diversity, and composition3. As a result, the microbiota are also associated with 
numerous diseases, including inflammatory bowel disease (IBD)4 5, cancer6, and depression7. 
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 The associations with both health and disease make the human microbiota an innovative 
clinical target. Modulating the microbiota for preventative or therapeutic means is a novel 
approach to targeting disease. These approaches, while still in their infancy, can generally be 
classified into three models: additive, subtractive, or modulatory therapies. Additive therapy 
involves introducing natural or engineered strains or consortia of microorganisms to supplement 
the existing microbiota. Subtractive therapy is the targeted elimination of harmful members of 
the microbiota. Modulatory therapy is the addition of non-living matter, such as prebiotics, which 
are used to alter the composition or activity of the microbiota8. In recent years, a massive amount 
of research has gone into studying these approaches, which ultimately have the potential to 
revolutionize and personalize clinical treatments. Early data show incredibly promising results; 
for example, the use of fecal microbiota transplantation for treatment of Clostridium difficile 
infection9. 
Measuring the Microbiome 
 Targeting the genomes of microorganisms in a given population provides a less biased 
means of classifying and characterizing the microbiota, than do approaches that first require 
culturing of the microorganisms. Next Generation Sequencing (NGS) is a culture-independent 
method for analyzing a population of microorganisms from a particular specimen. NGS uses 
massively parallel sequencing methods to generate large numbers of relatively short sequence 
reads. NGS can be performed on a clonal bacterial isolate [e.g., Whole Genome Sequencing 
(WGS)] or on a patient or environmental specimen containing a complex population of microbes 
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(i.e., metagenomics). Both approaches can be used to understand the gene content of a bacterial 
isolate or specimen; they can also be used to taxonomically classify microbes. 
 The most widely used method to taxonomically classify bacteria makes use of the 16S 
rRNA gene. When transcribed, this ~1500 base gene forms an RNA molecule that serves as a key 
component of the cell’s ribosomes by acting as a binding scaffold for ribosomal proteins. As such, 
the 16S rRNA gene is essential to the cell and is highly conserved throughout the bacterial 
domain9 10. The 16S rRNA gene contains some regions that are highly conserved and others that 
are highly variable. The nine variable regions of the 16S rRNA gene (i.e., V1-V9) contain 
polymorphisms that provide the means for measuring evolutionary and phylogenetic 
relatedness9 10. The 16S rRNA gene sequence can be determined using shotgun amplicon 
sequencing. This approach uses universal primers to amplify and thus sequence the gene from a 
mixed population of bacteria (e.g., a patient specimen). However, NGS generates short sequence 
reads; thus, only one to three of the variable regions can be targeted at once. The full sequence 
of the 16S rRNA gene is generally necessary to obtain species-level taxonomic classifications. 
Therefore, shotgun amplicon sequencing of the 16S rRNA gene usually only provides adequate 
data for family and/or genus-level taxonomic classifications. However, a recently developed 
probabilistic-based approach to evaluate taxonomic classifications [i.e. Bayesian LCA-based 
Taxonomic Classification Method (BLCA)] can attain accurate species-level identifications for 
some partial 16S rRNA gene sequences11.  
 Studies employing 16S rRNA gene sequencing assess differences in observed communities 
of bacteria amongst samples to obtain statistically significant correlations between sample type 
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and either bacterial composition or biodiversity12. These studies have provided key data 
describing microbiome differences among specimens and environments, over time, between 
individuals, and between health and disease states. However, these studies are also limited to 
providing only bacterial identifications. Shotgun metagenomics goes beyond identification and 
provides functional potential of the genomic content. In this approach, the genomes within a 
patient sample are fragmented, sequenced, and aligned to reference genomes or assembled de 
novo using overlapping reads. Not only does this approach offer further insight into phylogenetic 
relatedness of the microbes, it also provides knowledge of the potential role of the microbial 
community.  
Analyzing Microbiome Data 
 16S rRNA amplicon sequencing relies on polymerase chain reaction (PCR) amplification to 
isolate and amplify the gene, or variable region of the gene. This approach does not supply 
quantitative data for several reasons, including biases in the amplification process, differential 
amplification rates of sequences, and the presence of multiple copies of the 16S rRNA gene in 
most bacterial strains. Therefore, data regarding the number of sequence reads obtained in a 
given sample cannot be directly compared to other samples. Because of this limitation, 
microbiome data are typically represented in terms of relative abundance. Relative abundance 
values are the percent composition of a taxon relative to the total number of taxa in the 
community. For sequencing data, this refers to the percent of sequence reads for a taxa relative 
to the total number of sequence reads in that sample. When presented in this manner, relative 
abundance plots show how common or rare a taxon is relative to other taxa in the sample. 
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Statistical measures can be performed comparing these percentages between specimens. 
Relative abundance data can also be used to make generalized groupings of samples based on 
the dominant taxa present. These are referred to as enterotypes in the context of the GI 
microbiome13, community state types (CSTs) in the vagina14, and urotypes in urine15. These 
groupings are determined by clustering samples based on taxonomic similarities (e.g., Bray-Curtis 
dissimilarity measurements). 
 Early studies assessing the microbiome were largely exploratory. As such, methods to 
investigate differences between and among groups were also exploratory. Principal coordinate 
analysis (PCoA) is a common method used to assess and emphasize similarities and differences 
within a population. Data are transformed into principal components, where the first principal 
component has the largest possible variance and each succeeding orthogonal component has the 
next highest variance. When plotted, data points with distinct variance patterns will appear far 
apart, while data points with similar variance will cluster together. Various metadata can then be 
applied to determine qualitatively if trends exist. For example, PCoA of microbiome data 
collected from the HMP showed distinct clusters that corresponded well to specimen type, 
despite there being no individual taxa that alone could discriminate specimen types2. 
 The complexity of microbiome data can also be expressed through biodiversity measures. 
The diversity of species within a population (i.e., alpha-diversity) is a measure of both species 
richness and species evenness. Richness refers to the number of unique species, while evenness 
is how the species are distributed in the population. Various alpha-diversity calculations rely on 
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one or both of these measures. Mean alpha-diversity can be calculated for a group and statistical 
measures can be used to determine significance between or among groups. 
 The microbiome can be assessed between subjects or within subjects over time. Temporal 
measurements of the microbiome within a subject include assessments of both stability and 
resiliency. Stability refers to the level of change over time, while resiliency refers to the 
permanence of the change. These metrics can be assessed using measures of similarity, such as 
Bray-Curtis Dissimilarity or Jensen-Shannon Divergence. Measuring the rate of change in these 
values or variability within the means provides information regarding stability and resiliency. 
These measures often serve as exploratory analyses that generate testable hypotheses. 
“Urine Denial”: The Concept of Bladder Sterility 
 The human urinary bladder is a muscular organ that collects and stores urine from the 
kidneys. The kidneys function to filter and eliminate waste from the blood and maintain overall 
fluid balance. Waste, in the form of urine, exits the kidneys and passes into the bladder via the 
ureters. A typical urinary bladder can hold 300 to 500 milliliters (mL) of urine before a sensation 
of urge is experienced. When urine is being stored, the detrusor muscle surrounding the bladder 
is relaxed, and the internal urethral sphincter remains tense preventing urine from exiting the 
bladder. During urination, the detrusor muscle is voluntarily contracted, and the internal urethral 
sphincter relaxes allowing urine to exit the bladder, pass through the urethra, and out of the 
body16. 
 Urine is an aqueous solution of mostly (>95%) water, but also includes various 
nitrogenous molecules, such as urea and creatinine, ions such as chloride, sodium, and 
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potassium, and other metabolic waste components including proteins and hormones. The exact 
proportions of the various constituents of urine vary among individuals and also with factors such 
as diet and health17. 
 Traditionally, bladder urine has been considered sterile in the absence of clinical infection. 
This concept is largely grounded by work done in the mid-twentieth century by Dr. Edward Kass, 
who sought to establish a diagnostic means to determine risk of pyelonephritis (i.e., kidney 
infection) in patients undergoing pelvic surgeries18. To identify a valid diagnostic, Kass assessed 
urine from symptomatic and asymptomatic women and determined that bacterial levels greater 
than 105 colony forming units per milliliter (CFU/mL) urine could distinguish between infection 
and contamination in these patients19. Using this technique, patients who screened positive were 
given antibiotic treatments prior to surgery, which ultimately improved outcomes and lowered 
incidence of pyelonephritis19. Because of the dramatic clinical improvement and effectiveness of 
this diagnostic measure, the medical field slowly adopted it as a means to also diagnose acute 
bladder infections. 
 The misconceptions surrounding bladder sterility were further entrenched by the notion 
that potential urinary pathogens originate from the bowel and colonize the bladder and urinary 
system by ascension through the urethra20. Such a notion supports the idea that acute bladder 
infections are solely the result of enteric organisms, like Escherichia coli. As such, a culture-
dependent method specifically designed to cultivate these organisms was used in conjunction 
with Kass’s diagnostic threshold. These assumptions, together with the fact that acute bladder 
infections rarely progress to pyelonephritis, and the observation that a large percentage of 
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bladder infections resolve spontaneously (25-45% of women)21 22, created a situation whereby 
the re-evaluation of knowledge was considered unnecessary and medically unimportant.  
 It remained understood that the bladder was sterile until a decade into the twenty-first 
century, though earlier attempts to overturn this idea were reported. For example, Rosalind 
Maskell and co-workers showed that patients with symptoms of bladder infection had slow-
growing, non-enteric organisms present at lower than acceptable thresholds23 24. Stamm et al. 
collected midstream voided urine (MSU) specimens from symptomatic women (n=187) and 
found that only 51% would have been diagnosed with a urinary tract infection (UTI) by standard 
definitions25. They found that use of 102 CFU/mL would be a more appropriate diagnostic as this 
had high sensitivity and specificity values25. Furthermore, Stark et al. collected transurethral 
catheter (TUC) urine specimens from 110 symptomatic patients, 34 of which had >105 CFU/mL of 
bacteria26. However, in 41 patients who had bacteria at <105 CFU/mL, 96% had subsequent urine 
cultures, usually within three days of the original, that reached >105 CFU/mL26. This shows that 
failure to treat at lower thresholds in symptomatic patients usually develops into higher bacterial 
counts. Despite all of these data, which clearly showed that standard approaches to diagnosing 
acute bladder infections were not clinically appropriate, it was not until the advent of DNA-based 
evidence in the 2010s that a re-interpretation of these methods was generally accepted. 
The Discovery of the Female Urinary Microbiota and Microbiome 
 In part, due to the circumstances described above, the HMP did not publish a description 
of the microbiome of the bladder or lower urinary tract. However, Nelson et al. assessed voided 
urines (i.e., non-catheterized), using 16S rRNA gene sequencing to show that diverse bacteria 
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colonized the urogenital tract of the adult male28. They also showed that these bacterial 
communities differed between men with and without sexually transmitted infections (STIs), and 
that those with STI had predominantly anaerobic and previously uncultivated bacteria27. Another 
study by the same authors demonstrated similarities between the bacterial communities of 
paired voided urine specimens and urethral swabs28. These data show that previously undetected 
bacteria colonize the male urogenital tract and may relate to urinary symptoms. A detailed 
discussion of the findings in men is located in the section, Description of the Male Urinary 
Microbiota. 
 In an effort to determine if the findings in men were applicable to women, Wolfe et al. 
used 16S rRNA gene sequencing to assess the microbiome of voided urine specimens from 
women who did not meet the clinical and microbiologic criteria for a UTI (i.e., symptomatic and 
>105 CFU/mL of non-vaginal or skin flora on blood or MacConkey agar incubated in ambient 
atmosphere at 35°C for 24 hours)29. Additional specimens were collected from study patients to 
distinguish vulvo-vaginal contamination from true inhabitants of the bladder. Suprapubic 
aspirates (SPA) (i.e., collection of urine directly through the lower abdomen using a needle) and 
TUC urine samples were collected, analyzed, and compared to the voided urine, a vaginal swab, 
and a skin swab from the SPA needle insertion site29. Bacterial composition and diversity were 
similar between SPA and TUC urine, but different from the vaginal and skin swabs, as well as the 
voided urine, which contained a mixture of urinary (i.e., SPA and TUC) and genital (i.e., vulvo-
vaginal) flora29. Because SPA and TUC specimens sample bladder urine, Wolfe et al. concluded 
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that the bladders of women contain a unique microbiome that, similarly to men27 28, contain 
bacterial genera not cultivated by the standard urine culture (SUC) method29. 
 The findings in females by Wolfe et al. have since been verified by others30 31 32 33. 
Unsurprisingly, the data using 16S rRNA gene sequencing were in stark contrast to data obtained 
from SUC-dependent methods, even from the same urine specimen. Data for Patient 18 from the 
Wolfe et al. study clearly show these discrepancies (Figure 1). This figure shows the 16S rRNA 
gene sequencing data for the various specimen types (left panels), the SUC culture results for the 
TUC specimen (right), and the Gram-stain results for the TUC specimen (bottom) from a single 
patient29. The left panels are an example of the difference in bacterial composition and 
Figure 1. Bacterial Abundance, Culture, and Gram-Stain Results for Patient 18. Pie charts (left) 
of the most abundant bacterial genera of TUC (A), SPA (B), sham-needle stick (C), and skin swab 
(D) using 16S rRNA gene sequencing from Patient 18, a culture-positive patient. Pie chart of SUC 
culture data (right) from TUC urine. Gram-stain assessment (bottom) of TUC urine showing 
Gram-positive cocci (A & B) and Gram-negative rods (C) (Wolfe et al, 2012). 
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abundance amongst the specimen types; similarities exist between TUC and SPA urine. However, 
the data between 16S rRNA gene sequencing and bacterial culture for the TUC urine specimen 
differ dramatically. The SUC method showed the presence of 105 CFU/mL of E. coli, which 
accounted for 100% of detected bacteria using this approach. However, the sequencing data 
showed that E. coli comprised less than 1% of the total bacteria sequences. The TUC urine had 
50 times greater relative abundance of Aerococcus and 17 times more Actinobaculum (now called 
Actinotignum). Furthermore, Gram-stain assessment (bottom) of the TUC urine showed that the 
non-E. coli bacterial DNA is not entirely exogenous (e.g., from dead and lysed cells), as Gram-
positive cocci (possibly indicative of Aerococcus and Actinobaculum) are clearly visible in panels 
A and B. The discrepancy between the results lies in limitations associated with the SUC method. 
In a clinical laboratory, a urine specimen will undergo the SUC protocol for the detection of 
urinary infections. This protocol involves plating 0.001 mL of urine spread quantitatively onto 5% 
sheep blood (BAP) and MacConkey agars (BD BBL™ Prepared Plated Media, Cockeysville, MD) 
and incubated aerobically at 35°C for 24 hours. The SUC protocol would not be appropriate for 
growth of many of the organisms detected by 16S rRNA gene sequencing, as most are facultative 
or strict, slow-growing anaerobes. To invesitgate this, Hilt et al. designed a more appropriate 
protocol [i.e., the Expanded Quantitative Urine Culture (EQUC) protocol]34. EQUC uses 0.1 mL of 
urine spread quantitatively onto BAP, Chocolate, and Colistin Naladixic Acid (CNA) agars (BD 
BBL™ Prepared Plated Media) and incubated in 5% CO2 at 35°C for 48 hours; BAP incubated 
aerobically at 35°C for 48 hours; CDC Anaerobic 5% sheep blood (Anaerobic BAP) agar (BD BBL™ 
Prepared Plated Media) incubated anaerobically at 35°C for 48 hours. Each distinct colony 
13 
 
 
 
morphology was sub-cultured at 48 hours to obtain pure culture for microbial identification34. 
Comparatively, EQUC uses 100 times more urine, allowing for detection of microbes at the lower 
threshold of 10 CFU/mL urine, two times longer incubation times to allow for growth of fastidious 
and slow growing organisms, non-aerobic incubation conditions for the growth of facultative and 
strict anaerobes, and selective media for Gram-positives (i.e. CNA) and fastidious organisms 
(Chocolate agar). Hilt et al. used EQUC to examine the microbiota of 65 TUC urine specimens and 
compared the results to SUC. 80% (52/65) of the TUC urine specimens had bacterial growth 
detected by EQUC; 92% (48/52) of those specimens were reported as no growth (< 103 CFU/mL 
urine) by SUC34. Microbial identification was determined using a Matrix-Assisted Laser 
Desorption/Ionization-Time-of-Flight Mass Spectrometer (MALDI-TOF MS, Bruker Daltonics, 
Billerica, MA). Genera detected by EQUC largely matched those observed by 16S rRNA gene 
sequencing. 
 Together, Wolfe et al. and Hilt et al. showed that both bacterial DNA and live cultivatable 
bacteria exist in catheterized (i.e., TUC) urine specimens in women, effectively showing that 
bladder urine is not sterile29 34.  
Urine is Not Sterile: Now What? 
 The finding that communities of bacteria exist in an environment previously thought to 
be sterile raises numerous clinical and basic science questions. These questions can be 
appropriately grouped into the canonical problem-solving questions. “Who”: Which 
microorganisms are present normally, and does this differ by demographic and clinical measures? 
“What”: What is the role of the microbiota? Do they interact with the urothelium and immune 
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system? Do they interact with each other?  “When”: When is the microbiota established - at birth 
or beyond? “Where”: Where do the bacteria reside? Are they associated with the uroepithelial 
tissue of the bladder? Do they transit between pelvic floor sites? “Why”: Does the microbiota 
contribute in previously undescribed ways to the etiologies of any lower urinary tract diseases or 
disorders? is it protective against colonization of pathogenic microbes? “How”: How do the 
microbiota change over time and, if so, does this relate to environment and lifestyle? At the time 
of writing this thesis, some of these questions have begun to be explored. The final question (i.e. 
“How”) will be addressed here. In this section, we provide an up-to-date description of data 
relating to each of these questions in relation to the female urinary microbiota. For a description 
of the male urinary microbiota and a comparison to female, see the section Description of the 
Male Urinary Microbiota. 
 Since the discovery of the female urinary microbiome and microbiota in 2012, several 
research groups have published descriptive studies on this topic. Because these groups employed 
a variety of methods and techniques to study the bacterial communities, it is difficult to directly 
compare data. In general, however, these studies detected similar populations of bacteria [e.g., 
microorganisms typically found in the vagina, such as Lactobacillus and Gardnerella, but also a 
distinct set of mainly Gram-positive bacteria, including Streptococcus, Staphylococcus, and 
Corynebacterium (see Figure 2)] and thus came to comparable conclusions. The techniques 
varied by urine specimen type (e.g., MSU, TUC, SPA), whether culture-dependent or DNA–
dependent approaches were used, the volume of urine used for DNA extraction (ranged from 
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0.1mL to 30mL), the DNA extraction method (e.g., magnetic-bead extraction, phenol-chloroform 
extraction), and which hypervariable region(s) was (were) amplified. A discussion of data 
collected entirely from MSU specimens is located in the section, Longitudinal Assessment of the 
Lower Urinary Tract Microbiota – What Specimen to Collect? 
Figure 2. Phylogenetic tree representing diversity of bacteria cultured from the female 
bladder. A representation of the full bacterial diversity (n=149 isolates) that can be isolated 
using the EQUC method from TUC urine specimens. Visualization was done in iTOL (Thomas-
White et al, 2018). 
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Correlations with Health and Disease 
 A comprehensive analysis of the urinary microbiota of TUC specimens in healthy women 
of varying demographics has yet to be published. However, several studies used small cohorts of 
healthy women as controls for comparison to particular disease populations15 31 35 36. I compiled 
EQUC and 16S rRNA gene sequencing data on TUC urine specimens from 224 healthy female 
patients and compared the data across demographics and clinical variables. These patients were 
recruited from various studies15 34 35 performed at Loyola University Chicago from 2013-2018. In 
summation, I found that the urinary microbiota profiles are highly stratified by dominant taxa. 
For these participants, I determined the urotype (classified by a genus with >50% relative 
abundance; if no genus has ≤50% relative abundance, the specimen is designated as ‘mixed’) and 
found that women with a Gardnerella urotype were likely to be younger, have a higher body 
mass index (BMI), and a low median vaginal parity score (i.e., number of vaginal deliveries). 
Women with an Escherichia urotype were likely to be older and post-menopausal, and unlikely 
to engage in vaginal intercourse. 
 Correlations between the female urinary microbiota and various lower urinary tract 
diseases and disorders have been described, including: urinary incontinence (UI)15 35 37 38 39 40 41, 
interstitial cystitis/painful bladder syndrome (IC/PBS)33 36 42, UTI and UTI symptoms43 44 45 46, 
overactive bladder (OAB)34 47 48, and neuropathic bladder30 49. These are described below. 
 UI is described in more detail in Appendix B, where I correlate symptom severity, as 
defined by urinary distress inventory (UDI) questionnaire scores, to the urinary microbiota and 
microbiome using EQUC and 16S rRNA gene sequencing. Pearce et al. collected TUC specimens 
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from 182 women with urgency urinary incontinence (UUI), a form of UI combining leakage of 
urine (incontinence) with feelings of urgency37. Using 16S rRNA gene sequencing of the V4 
hypervariable region to analyze 1mL TUC specimen, 51% (93/182) had a detectable urinary 
microbiome (i.e., “sequence-positive”)37. The sequence-positive patients tended to be 
dominated by Lactobacillus or Gardnerella (i.e., urotypes)37. Thomas-White et al. also used 16S 
rRNA gene sequencing of the V4 hypervariable region to assess 1 mL TUC specimens from women 
with UUI (n=74)35. These data were compared to a non-UI cohort (n=60). They found that UUI 
patients have higher alpha diversity levels, and similarly to Pearce et al. the majority of the 
specimens were dominated by Lactobacillus and Gardnerella35. This finding contrasts with data 
from Karstens et al., who also used 30 ml TUC specimens and 16S rRNA gene sequencing of the 
V4 hypervariable region but recruited a smaller sample size [UUI (n=10); non-UI (n=10)]31. They 
found lower diversity levels in the UUI cohort31. Brubaker et al. recruited 155 women with UUI as 
part of a clinical trial to assess cystoscopic onabotulinum toxin A infection and oral placebo 
medication versus cystoscopic placebo injection and active oral medication for UUI treatment50. 
Using 16S rRNA gene sequencing of the V4 hypervariable region to assess 1mL TUC specimens, 
39% (60/155) had a detectable urinary microbiome, with similar composition to previous 
studies50. These patients (n=60) had a significantly higher mean number of UUI episodes per 
day50. Finally, Komesu et al. recruited women with (n=123) and without (n=84) mixed urinary 
incontinence, a form of UI encompassing symptoms of both UUI and SUI (stress urinary 
incontinence)40. 16S rRNA gene sequencing of the V4-V6 hypervariable regions were performed 
on 0.28 mL of urine collected from TUC specimens40. Post-hoc analyses found more Lactobacillus 
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and Mixed urotypes in younger (<51 years old) women40. Collectively, these data show that 
trends exist between the female urinary microbiota and UI, as well as UI subtypes (i.e., UUI and 
MUI). 
 IC/PBS is described in detail in Appendix C and Appendix D. I saw no difference in 
composition or diversity between the urinary microbiota (using EQUC) or microbiome (using 16S 
rRNA gene sequencing of the V4 hypervariable region) in MSU specimens of women with IC/PBS 
(n=21) and demographically similar non-IC/PBS women (n=20) in a small case-controlled study 
described in Appendix C. Using EQUC on TUC specimens, however, I saw a higher frequency of 
the Streptococcus urotype in women with IC/PBS (n=49) compared to women without (n=40); 
this is described in more detail in Appendix D. Other groups have also sought a relationship 
between the urinary microbiota and IC/PBS. Abernathy et al. collected TUC specimens from 40 
women, half with IC/PBS and half without. 16S rRNA gene sequencing (hypervariable region was 
not specified) showed lower richness and lower abundance of Lactobacillus (particularly 
Lactobacillus acidophilus) in the IC/PBS cohort36. Using 16S rRNA gene sequencing on clean catch 
voided urine, Siddiqui et al. observed the opposite trend with Lactobacillus having an overall 
higher abundance in women with IC/PBS (n=8)33. The data were not compared to a control 
population33. Finally, Nickel et al. analyzed initial void and MSU specimens from 213 patients with 
IC/PBS42. Some patients were currently experiencing symptom flares (n=86), while others were 
not (n=127)42. DNA sequencing was done on 3 mL of urine using taxa-specific primer pairs, 
including a pair for fungi. No taxa other than the yeast genera Candida and Saccharomyces were 
significantly different between groups; the fungal taxa were more prevalent in the flare group42. 
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Altogether, these data show somewhat conflicting results for associations between the female 
urinary microbiota and IC/PBS, making it difficult to reach a definitive conclusion regarding a 
microbiologic etiology for IC/PBS. More research on this topic should be done. 
 UTI diagnosis, etiologies, and symptom presentation are further described below (see UTI 
Risk and Lifestyle) and in Appendix E. Using EQUC, Price et al. showed differences in the urinary 
microbiota of TUC urine specimens between women who do (n=75) and do not (n=75) self-report 
UTI44. These differences included higher frequency of the Escherichia urotype and lower alpha 
diversity in the self-report UTI cohort44. A more detailed explanation of this study and related 
studies are found in Appendix F and Appendix G. 
 OAB manifests as frequent feelings of urgency. If involuntary leakage of urine also occurs, 
the patient is diagnosed with UUI. OAB is conventionally considered a neurological disorder. Hilt 
et al. and Thomas-White et al. found differences between both the urinary microbiota and 
microbiome of TUC urine specimens from OAB (n=60) and non-OAB (n=60) patients. Patients with 
OAB had higher alpha diversity values by both EQUC and 16S rRNA gene sequencing (V4 
hypervariable region), as well as fewer Lactobacillus urotypes34 35. However, by EQUC, Pearce et 
al. found that, within the Lactobacillus genus, the species Lactobacillus crispatus was significantly 
associated with the non-OAB patients, while Lactobacillus gasseri was associated with OAB15. 
 Neuropathic bladder syndrome is also a neurological disorder that causes difficulty or the 
full inability to pass urine without the use of a catheter. Fouts et al. and Groah et al. both found 
that patients with neuropathic bladder diagnosis had lower abundances of detectable 
Lactobacillus in TUC urine specimens30 49. 
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 Microbiota correlations to other urologic-related diseases and disorders exist. For 
example, several groups have detected the presence of bacteria and bacterial communities in 
kidney stones, suggesting a novel microbial etiology for stone formation51 52. Using MSU 
specimens, Kramer et al. found that higher microbial diversity was associated with higher 
estimated glomerular filtration rate (eGFR) in patients with non-dialysis-dependent chronic 
kidney disease (CKD)53. Assessing specimens collected by a modified MSU collection protocol, Liu 
et al. and Ling et al. found lower bacterial richness and differences in various taxa, between 
patients with and without type 2 diabetes mellitus (T2DM) 55 54.  
 Whether the urinary microbiota directly or indirectly contribute to the etiologies of the 
diseases and disorders described above remain unclear. However, Thomas-White et al. provided 
data showing that the bladder bacterial communities in patients with OAB could be predictive of 
treatment response, suggesting a possible bacterial etiology35. In this study, patients with OAB 
were given the anticholinergic drug, Solifenacin (Vesicare), which is a competitive antagonist of 
the cholinergic muscarinic receptor, meaning that it prevents the binding of acetylcholine 
thereby reducing muscle tone in the bladder. Thomas-White et al. found that a less diverse 
urinary microbiota (i.e., a mean of three unique microorganisms detected by EQUC) correlated 
with a more robust treatment response, whereas patients with a more diverse urinary microbiota 
(i.e., a mean of five unique microorganisms detected by EQUC) did not respond, or required a 
dosage increase35. These data provide evidence that the urinary microbiota may be directly 
involved in disease etiologies. 
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 Some evidence exists showing a positive or beneficial role for the urinary microbiota. For 
example, in patients undergoing pelvic organ prolapse and urinary incontinence (POP-UI) 
surgery, Thomas-White et al. and Fok et al. found that 32% of women whose day of surgery TUC 
urine specimens had bacteria detected by SUC developed a post-operative UTI. By 16S rRNA gene 
sequencing, these specimens were dominated by the family Enterobacteriaceae (which includes 
the species E. coli). By contrast, in those who did not have SUC-detectable bacteria on the day of 
surgery, only 4% developed a post-operative UTI; by 16S rRNA gene sequencing, these latter 
specimens were dominated primarily by Lactobacillus55. Furthermore, Thomas-White et al. found 
that in this same patient population, UTI risk was associated with a depletion of Lactobacillus 
iners specifically56. These data suggest that some populations of urinary microorganisms may pre-
dispose the bladder to infection, while others may be beneficial or protective.  
Description of Urinary Bacterial Isolates 
 Even unique bacterial isolates of the same species may have contrasting roles; WGS 
analysis of bacterial isolates obtained by EQUC show varied genotypes. These are described in 
more detail in Appendix H. In 2018, Thomas-White et al. used WGS to investigate the genetic 
diversity of the urinary microbiota by analyzing the genomic content of 149 bacterial strains 
obtained from TUC specimens from 77 patients of varying health and disease status57. 
Phylogenetic analysis (Figure 2) showed that the EQUC-measured urinary microbiota are mainly 
composed of members of the Gram-positive phyla Firmicutes (47.4%) and Actinobacteria 
(38.5%). Furthermore, the degree of phylogenetic variation among isolates of the same species 
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varied dramatically (Figure 2), again suggesting somewhat individualized roles for the urinary 
microbiota. 
 To better understand the association between the urinary microbiota and health and 
disease, it is necessary to understand the anatomical location of the bacteria and whether they 
transit among pelvic floor sites. The bladder epithelium, or uroepithelium, is a type of transitional 
epithelial cell coated with uroplakin, a family of proteins that associate with each other and form 
plaques58. These plaques are highly glycosylated and act to create a permeability barrier to 
separate the tissue from the urine58. To prevent bacterial attachment, a negatively charged 
glycosaminoglycan layer also covers the uroepithelium59 60. Some bacteria can bypass these 
defenses with the use of specific virulence factors. E. coli, for example, can bind to mannose on 
the uroplakin through the expression of a FimH-containing type-1 pilus61. This process allows E. 
coli to successfully adhere to and colonize the uroepithelium. Whether similar mechanisms exist 
for the commensal urinary microbiota are currently unclear, but possible. Using shed 
uroepithelial cells from the urine of patients, as well as in vitro work using patient-derived 
bacterial strains, Khasriya et al. found that members of the urinary microbiota are within or 
closely associated with the shed cells32. In unpublished work, we found both uropathogens and 
commensal flora associated with bladder biopsies; the bacterial communities were similar to 
those identified in the corresponding patients’ TUC and SPA specimens. Together, these data 
provide initial evidence to support bacterial colonization of the bladder in vivo. 
 Tissue-unattached microbes would potentially exist as planktonic, or free-floating cells in 
the urine, and therefore could leave the bladder during urination. Transit of microbes in the 
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opposite direction is more complicated. In unpublished work, we tested the in vitro motility of 
representative bacterial isolates from the urinary microbiota (isolated from TUC specimens) to 
determine if transit into the bladder is biologically possible. Other than some Gram-negative 
uropathogens (e.g., Escherichia, Proteus and Pseudomonas), we found that the bacterial isolates 
were not motile; this suggests that self-propelled transit into the bladder and thus against the 
flow of urine is unlikely. However, the in vitro conditions were not set to mimic the appropriate 
Figure 3. Functional diversity between genomes of bacterial strains isolated from the bladder, 
vagina, and intestine. Discriminant analysis of principal components using conserved protein 
domains (CDD). Each color dot represents a strain from 3 different niches: blue (vagina; n = 92), 
red (bladder; n = 67), and green (gut; n = 152). (Thomas-White et al, 2018). 
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in vivo environment, making the conclusions somewhat tenuous. However, a scan of the 
genomes of these isolates does not reveal genes associated with the most common motility 
mechanisms, flagella and type IV pili.  
 Regardless, it is likely that strain similarities exist between bladder organisms and 
urethral, peri-urethral, vaginal, and possibly GI tract organisms. Thomas-White et al. compared 
genomes of urinary bacterial isolates (see Figure 2) with 67 publicly available vaginal and 120 GI 
species cultivated from unrelated women57. Using whole-genome pairwise average nucleotide 
identity (ANI), 23 species were found at ANI > 95% in both the bladder and vaginal microbiota57. 
This contrasts to just the one species (Bifidobacterium bifidum) that was found at ANI > 95% in 
all three sites57. Together, these data suggest that transit of microbes between the vaginal and 
urinary tract likely occurs. A comparison using discriminant analysis of principle components of 
conserved protein domains in a subset of the analyzed genomes is seen in Figure 357. This 
comparison shows clear overlapping potential protein functions within the vaginal and urinary 
strains, and separation from GI strains (Figure 3). Furthermore, Thomas-White et al. used ANI to 
assess the relatedness between species (i.e., Streptococcus anginosus, E. coli, L. iners, L. 
crispatus) isolated from the vagina and urine of the same woman. All isolate pairs had ANI > 
99%57. Altogether, these data provide strong evidence for the movement of microbiota between 
the vaginal and urinary tracts. However, these data alone are not enough to provide an 
explanation of directionality of movement. 
 
 
25 
 
 
 
Other Urinary Microorganisms 
 In addition to bacteria, viruses and fungi have also been detected in the urinary bladder. 
Miller-Ensminger et al. found several hundred phage-like sequences in the genomes of urinary 
bacterial species isolated from females, some of which can be cultivated from the bacterial 
isolate62. Some of these phage populations varied between women with and without OAB, which 
suggests that they may play a role in urinary health. A description of phage populations found in 
Gardnerella isolates is found in Appendix I. Fungi have also been detected in urine specimens by 
several groups. Nickel et al. observed an increase in the number of patients with detectable fungi 
(i.e., the genera Candida and Saccharomyces) during IC/PBS symptomatic flares42. Ackerman et 
al. describe the detection of numerous fungal taxa in TUC urine specimens using NGS63. 
 In conclusion, the field of the female urinary microbiota is still very much in its infancy. 
Much work has been done to provide descriptive analyses of the composition and diversity of 
the communities of bacteria, viruses, and fungi, as well as the relationship to health and disease. 
Several questions still remain: How do these communities become established? How stable are 
these communities over time and does our lifestyle determine this? How do the microorganisms 
interact with one another and with the immune system? And ultimately, what can we do clinically 
to transform these findings into meaningful patient care? 
Description of the Male Urinary Microbiota 
 Though the majority of the work presented in this thesis is done in females, some data 
shown in Chapter VI comes from males. Considerably less research has focused on the microbial 
communities of the male lower urinary tract. This may be due to the lower incidence of 
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moderate-to-severe lower urinary tract symptoms (LUTS) in men (8.5%) than women (13.9%)64, 
thereby prompting less of an interest to explore novel etiologies of LUTS in men. Initial work by 
Nelson et al. used 16S rRNA gene sequencing of voided urine specimens (1.5mL) obtained from 
a small cohort of young men (n=19), revealing high abundances of the following genera: 
Lactobacillus, Corynebacterium, Streptococcus, Sneathia, Aerococcus, Anaerococcus, Prevotella, 
Gemella, and Veillonella27. Several of these taxa include strict anaerobic microorganisms. 
Interestingly, some of these taxa (especially Prevotella, Sneathia, Dialister, Atopobium) were 
found more frequently in men who had a sexually transmitted infection (STI) (8/10)27. In men 
who did not have an STI (n=9), facultative anaerobes such as Lactobacillus, Corynebacterium, 
Staphylococcus, Propionibacterium and Streptococcus were commonly found27. These data 
suggest that urinary microbes in men may play a role in urinary health, specifically STI risk. 
 Male and female lower urinary tract anatomies are considerably different; thus, 
interpretation of urine specimens also differs. An in-depth discussion of the difference in urine 
specimens collected from a female and what these may tell us about the urinary microbiota, are 
discussed in the section Longitudinal Assessment of the Lower Urinary Tract Microbiota – What 
Specimen to Collect? In males, the urethra is about eight inches long and opens at the end of the 
external urethral meatus at the distal portion of the penis65. The distal male urethra (i.e., pre-
prostatic and prostatic urethra) is lined with transitional epithelial tissue, which is similar to the 
bladder uroepithelium; pseudostratified columnar epithelial tissue is found in the membranous 
urethra and proximal spongy urethra; stratified squamous tissue is found in the distal spongy 
urethra (i.e., penile urethra)65. In males, both urine and semen pass through the urethra. In 
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females, where only urine passes, the urethra is considerably shorter (about 2 inches) and exits 
between the clitoris and the vagina66. The proximal half of the female urethra is lined with 
transitional epithelial tissue, while stratified squamous tissue is found in the distal half66. 
Therefore, a voided urine specimen from a female may be sampling the microbial content of the 
bladder, urethra, peri-urethra, and vagina; whereas in a male, a voided specimen is primarily 
sampling the urethra. The latter was confirmed by Dong et al., who recruited 32 men (median 28 
years of age) to collect urethral swabs (swabs inserted 1-3 centimeters into the urethra and 
rotated) and voided urine (5mL)28. Using 16S rRNA gene sequencing of the V1-V3 hypervariable 
regions and the Kolmogrorov-Smirnov test for similarity, they found that paired urine and swab 
specimens were statistically similar for most (30/32) patients28. The contribution of the coronal 
sulcus (CS) of the penis to the voided urine specimen was negligible, as assessed by Nelson et al. 
in 201267. These authors recruited 18 young men and collected CS swabs and voided urine 
specimens. Using 16S rRNA gene sequencing of the V1-V3 hypervariable regions, they found that 
59.1% of taxa identified in the urine specimens belonged to Streptococcus, Lactobacillus, 
Gardnerella, and Veillonella; only 1.3% of taxa identified in the CS specimens belonged to these 
genera (the 1.3% was primarily Streptococcus)67. These data show that the microbiota of voided 
urine and the CS are highly dissimilar. The microbiologic difference between a voided urine and 
TUC specimen was recently assessed by Bajic et al68. They recruited 49 male participants (range 
40-85 years of age) to collect MSU and TUC specimens prior to surgery. Using EQUC and 16S rRNA 
gene sequencing of the V4 hypervariable region, they found that when combined, the two 
methods detected bacteria in 98% (48/49) of voided urine specimens, but only 39% (19/49) of 
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TUC specimens68. Patients with and without detectable microbiota did not differ with respect to 
age, race, ethnicity, BMI, tobacco use, hypertension, diabetes status, or circumcision status, 
suggesting that the microbiologic differences between specimen types indicate that separate 
niches were sampled (i.e., voided urine does not primarily sample the male bladder)68. 
Correlations with Health and Disease 
 Very little work has been done to determine the contribution of the male urinary 
microbiota to urinary health and disease. Lewis et al. collected MSU specimens from six 
asymptomatic healthy males (range 39-83 years of age) and performed 16S rRNA gene 
sequencing on the V1-V3 hypervariable regions (2mL urine)69. Most of the specimens had greater 
than 50% abundance of bacteria belonging to the phylum Firmicutes. An assessment of 
demographics showed a slight trend with increasing alpha diversity (i.e. richness) and age69; this 
was not significant, likely due to the low sample size. Bajic et al. recruited 28 male participants 
with benign prostate enlargement (BPE)-related LUTS, and 21 controls without68. Analysis of TUC 
specimens using EQUC and 16S rRNA gene sequencing showed a trend between detection of a 
microbiota and increasing BPE/LUTS symptoms as assessed by the International Prostate 
Symptom Scores68. In addition to BPE/LUTS, Shrestha et al. showed a relationship to prostate 
cancer. Voided urine specimens from 129 men with benign tumors (n=63) or prostate cancer 
(n=66) (as assessed by tissue biopsies) were collected and 16S rRNA gene sequencing was 
performed on the V6 hypervariable region70. No significant differences in alpha diversity were 
seen between cohorts, but abundance of pathogenic taxa (e.g., Ureaplasma, Gardnerella) were 
higher in the prostate cancer group70. The inclusion of Gardnerella, which is associated with 
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Bacterial Vaginosis (BV) in women, as a pathogenic taxa was not explained. Finally, Wu et al. 
assessed the relationship to bladder cancer by recruiting 31 male patients with histologically 
confirmed urothelial carcinoma and 18 patients with non-neoplastic conditions71. 16S rRNA gene 
sequencing of the V4 hypervariable region was performed on voided urine specimens of various 
volumes. The authors observed increased alpha diversity (richness), higher abundance of 
Acinetobacter and Anaerococcus, and lower abundance of Serratia and Proteus in the cancer 
cohort71. Collectively, these data suggest that the male urinary microbiota may be involved in 
urinary health and/or the development or progression of certain urinary diseases, such as 
BPE/LUTS and both prostate and bladder cancers; the microbiota could also serve as biomarkers 
for these conditions. 
 When the male urinary microbiota becomes established remains unclear. However, data 
from Lee et al. show that some bacterial communities exist in infants (< one year old)72. Urine 
specimens were collected by urination into a sterile bag (this specimen type is described in 
further detail in the section, Longitudinal Assessment of the Lower Urinary Tract Microbiota – 
What Specimen to Collect?). Specimens from 66 male infants were collected: 41 with UTI 
(defined as presences of a single uropathogen at >103 CFU/mL in a SPA specimen) and 25 
without72. Routine SUC was performed on the urine specimens; in addition, 0.001mL of urine was 
cultured anaerobically in Lactobacillus-Selective DifcoTM Rogosa agar (Becton, Dickinson and Co, 
Franklin Lakes, NJ) at 37°C for 48 hours72. Lactobacillus sp. were identified in some urine 
specimens, and the mean CFU/mL was higher (i.e. >103 CFU/mL) in the non-UTI cohort72. Though 
other taxa were not assessed, and this method of urine specimen collection is prone to 
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contamination, these data provide some evidence that a male urinary microbiota might be 
established very early in life. 
Correlations with Lifestyle and Preliminary Measures of Stability 
 In relation to lifestyle factors, the effect of sexual intercourse has been assessed by one 
group. The 18 male participants in the Nelson et al. study were queried regarding prior sexual 
behavior67. Interestingly, detection of BV-associated anaerobic taxa (e.g. Atopobium, 
Megasphera, Mobiluncus, Prevotella, Gemella, Gardnerella) as well as non-BV taxa that are 
common in the vaginal tract (e.g., Lactobacillus, Staphylococcus) did not differ between those 
who reported prior vaginal intercourse and those who did not67. Though the cohort was small, 
and information regarding recent behavior was not specified, these data provide evidence that 
sexual intercourse does not alter the male urinary microbiota. 
 An assessment of microbial stability was also determined by Nelson et al. (2012). The 18 
male participants collected voided urine specimens at one-month intervals for three months (i.e., 
four specimens collected)67. Using Sørensen’s similarity index, they determined that urine 
specimens from the same participants were significantly more similar to one another over time 
than urine specimens from other participants67. Some bacterial taxa (i.e., Propionibacterium and 
Lactobacillus) had long durations of colonization, while others (i.e., Corynebacterium, 
Anaerococcus, Staphylococcus, and Prevotella) were more infrequent67. Despite the use of non-
daily longitudinal specimens, these data show that that the male urinary microbiota are relatively 
stable over a three-month period of time. Some taxa seem to be less stable, but whether lifestyle 
can explain these differences is currently unclear.  
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Differences between the Male and Female Urinary Microbiota 
 Differences exist between the male and female urinary microbiota. Lewis et al. found that 
the phylum Firmicutes dominate the urinary microbiome of MSU specimens in both men (n=6) 
and women (n=10), but the phyla Actinobacteria and Bacteroidetes were significantly more 
abundant in women69. Furthermore, the association between increased alpha diversity and age 
was stronger in women69. Gottshick et al. compared 16S rRNA gene sequencing data on MSU 
specimens from healthy men (n=31), and women with (n=43) and without (n=49) BV73. Using 
PCoA, they observed significant overlap between the male and non-BV female microbiome 
composition data73. However, there were some bacterial taxa that were not found in the male 
specimens [e.g., Gardnerella, Atopobium, and several Lactobacillus operational taxonomic units 
(OTUs)]73. These data show that, generally, the male and female urinary microbiota are similar, 
but certain differences exist.  
The Microbiome is Shaped by Environment 
 The HMP showed massive differences in the composition of the microbiome between 
subjects2. However, at the time, it was unclear whether these differences were driven primarily 
by “nature” or “nurture”. In other words, is the microbiome determined by our genetics or by 
our environment? 
 The GI microbiome is believed to be established at birth. Microbes from the mother and 
the environment colonize the infant’s gut74 75. The initial composition of the GI microbiome is 
affected by mode of delivery and undergoes rapid and dramatic changes for the first year of life74. 
After this point, the GI microbiome remains largely stable74. Initial studies investigating how this 
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stable population of microbes is determined, pointed largely to genetics. It was observed that 
family members and twins often had more similar microbiome characteristics than unrelated 
individuals76 77 78. Some studies identified heritable bacterial taxa79 80, while others found 
associations between certain host single nucleotide polymorphisms (SNPs) and the microbiome81 
82. However, the extent of the microbiome impacted by these findings, as well as the influence of 
shared environment, were unclear from these studies. 
 Recently, Rothschild et al. examined the microbiome and genotypes of more than 1,000 
healthy individuals with several distinct ancestral origins, but a relatively common environment83. 
Blood and stool samples were collected from healthy adults. Metagenomic and 16S rRNA gene 
sequencing were performed on the stool specimens. The cohort consisted of a variety of Israeli 
ancestries (i.e., Ashkenazi, North African, Middle Eastern, Sephardi, Yemenite, other) that 
showed clear separation based on genetics. However, the microbiome showed no significant 
variation across ancestral types assessed by PCoA, alpha-diversity measures, or abundance of 
specific taxa for ancestral types or shared ancestry. Furthermore, relatives with no history of 
household sharing showed microbiome characteristics that were less similar than relatives with 
a history of household sharing83. Other studies have shown similar impactful roles for 
environment in shaping the microbiome84 85 13, though these did not consider host genetics. 
Together, these data show that environment largely influences the GI microbiome, likely more 
than genetics. 
 Environment, unlike genetics, can be manipulated and changed. Therefore, it is plausible 
to hypothesize that our microbiota can also change, and these changes should correlate to 
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particular environmental and lifestyle factors. The next sections will discuss how environment 
and lifestyle influence the microbiota of the GI tract and vagina as a framework for understanding 
how these factors may influence the microbiota of novel sites, such as the bladder and lower 
urinary tract. 
The GI Microbiota and Lifestyle 
Description of GI Tract Physiology 
 The environment of the GI tract differs by physiology, digestive content, pH, oxygen 
tension, host secretions, and immune system interface among each anatomic compartment86. As 
such, the microbial content differs as well. Sampling feces from a subject provides insight into 
only the distal potion of the GI tract (i.e., the large intestine). The large intestine and colon are 
characterized by slow flow rates, low oxygen tension, and mildly acidic pH. It harbors the greatest 
microbial content (approximately 1011 cells per gram of feces) and species diversity (between 100 
and 1000 unique species) consisting of mainly obligate anaerobes, such as Prevotella2 87. By 
comparison, the small intestine has rapid flow rates and high bile concentrations. However, 
studying the microbiome of the small intestine requires more invasive approaches, such as an 
ileostomy. Such studies have concluded that this site consists of mainly facultative anaerobes, 
such as Lactobacillus, Enterococcus, and Bacteroides. 
 The primary function of the GI microbiota is metabolism. The majority of microbial 
metabolism within the colon is fermentative88. Saccharolytic fermentation pathways result in the 
large concentration of short-chain fatty acids (SCFAs) associated with the colon (especially 
acetate, propionate, and butyrate)89. SCFAs support the growth of other microbial species90, 
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promote down-regulation of proinflammatory cytokines91, and induction of FOXP3-expressing 
regulatory T-cells92, resulting in an anti-inflammatory gut environment. 
 The species composition of the GI microbiota differs substantially between individuals93. 
Subtle trends in composition and diversity exist among demographics, including age, nationality, 
race, gender, and BMI87 93 94 9596 . However, metagenomic analysis shows that the predicted 
functionality of the microbial gene content is similar among individuals, suggesting that the 
differences in species composition may not be biologically meaningful2. 
Correlations between the GI Microbiota and Lifestyle 
 The GI microbiota has a high degree of variability within an individual during the first three 
years of life followed by a more stable state during adulthood94 . The initial composition of the GI 
microbiota resembles the body niche of the method of child delivery (i.e., skin microbiota for 
cesarean section, or vaginal microbiota for vaginal delivery)2. From adolescence to adulthood, 
levels of Bacteroides tend to decrease, while levels of Proteobacteria increase97 98. This results in 
a greater tendency towards a pro-inflammatory gut phenotype with age. 
 Besides age, lifestyle and environmental factors can dramatically impact the GI 
microbiota. Generally, these changes occur rapidly and are inherently reversible. However, the 
biological consequences of these changes can be long lasting and thus justify the continued 
research in this area - research aimed at understanding these trends from both a therapeutic and 
preventative standpoint. For example, diet has been extensively studied in relation to the GI 
microbiota. Modulating one’s diet is an ideal opportunity for a low-risk intervention or 
preventative measure for conditions in which the GI microbiota and its metabolic products have 
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been shown to be causative of disease99. Data show that long-term diet largely impacts GI 
microbiota composition13. However, extreme alterations to diet can cause dramatic shifts in the  
microbiota within days100 84. This can be visualized from work done by David et al., where two 
subjects sampled the GI microbiome (i.e., colon microbiome) from self-collected stool samples. 
Samples were collected daily, or near daily, for 8-12 months100 . David et al. found that the time 
spent living abroad rapidly altered the composition and diversity of Subject A’s microbiome, likely 
attributable to a substantial change in the diet100. Other researchers have found that certain types 
of diets correlate to various GI microbiota characteristics. In general, a high fat diet correlates 
with higher microbial diversity84, higher relative composition of Bacteroides and Clostridiales, and 
lower relative composition of Bifidobacterium13 85 101. A protein-rich diet correlates with higher 
alpha-diversity84 but lower microbial richness102, higher relative composition of Bacteroides13, and 
lower relative composition of Lactobacillus and Bifidobacterium102 103. In contrast, diets high in 
fiber show trends opposite those of protein-rich diets13 104. These associations are summarized in 
Table 1A. 
 Besides diet, other lifestyle factors correlate to particular GI microbiota states. 
Smoking105, alcohol consumption106 107 108, and antibiotic use109 are all correlated with decreased 
alpha-diversity. Correlation to particular GI microbiota states vary with antibiotic use. However, 
unlike other lifestyle factors discussed, repeated use of antibiotics does not show resiliency of 
the GI microbiota110. This means that over time the GI microbiota fail to return to a baseline state 
following antibiotic use – a finding that does not seem to apply to any other studied lifestyle 
factor in this context. Furthermore, the same antibiotic can affect certain microbes differently 
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depending on the rest of the microbiota111. Other lifestyle factors that can impact the GI 
microbiota include probiotic use, which generally correlates to higher alpha-diversity values and 
species richness112 113 114 115, and sleep deprivation and stress, which correlate to lower relative 
composition of Bacteroidetes116 117. 
Temporal Dynamics of the GI Microbiota 
 In general, the GI microbiota are stable throughout life, other than the first year of life, 
during which there is dramatic variation and lack of microbial stability94 118 119. With age, comes a 
decrease in the ratio of Bacteroides to Proteobacteria97 98. 
 Because lifestyle factors are, in large part, controlled by the host, day-to-day variation 
exist in their usage. As a result, the short-term temporal dynamics of the GI microbiota are 
affected. The GI microbiota are remarkably stable when viewed across months or years100 120 121, 
but short-term variations exist is response to the lifestyle factors described in Table 1100 120 121. 
Observable changes in the microbiota in response to the lifestyle factors are seen on a rapid 
timescale. For example, dietary changes result in microbiota changes within a few days13 122. For 
most lifestyle factors, the microbial changes are reversed almost immediately following cessation 
of use123. These data show that the GI microbiota are both stable and resilient. The notable 
exception is antibiotic use, where compositional changes and antibiotic resistance genes persist 
for years124 125. 
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Table 1A. Impact of Extrinsic Lifestyle Factors on Microbiota and Risk for BV and UTI. 
 
Lifestyle 
Factors Impact on GI Microbiota Impact on Vaginal Microbiota and BV Risk UTI Risk 
Diet 
High Fat: 
↑ Diversity 
↑ Bacteroides, Clostridiales 
↓ Bifidobacteria 
[13 84 85 101] 
 
 
Iron-Deficiency: 
↑ BV Risk  
↑ Candida 
↓ Lactobacillus 
[126 127] 
 
Cranberry Juice: 
↓ UTI Risk9 
↓ Biofilms 
[128 129 130 131] 
 
Protein-rich: 
↑ Diversity, ↓ Richness 
↑ Bacteroides 
↓ Bifidobacteria 
[13 101 102 
103] 
Vitamin E-Deficiency: 
↑ BV Risk  
↑ Coccobacilli4 
[127 132] Fluid Intake: 
No Effect 
[133 134] 
High Fiber: 
↑ Richness 
↑ Bifidobacteria, Firmicutes 
[13 104] 
 
Calcium-Deficiency: 
↑ BV Risk  
↑ Coccobacilli4 
[132] Carbonated Drinks: 
↑ UTI Risk10 
↑ Hematuria 
[135 136 137] 
Sugar-Free: 
↑ Bacteroides 
↓ Bifidobacteria 
[138 139] 
 
High Fat: 
↑ BV Risk  
↑ Coccobacilli4 
[132] Vitamin C: 
↓ UTI Risk 
[136] 
Gluten-Free: 
↑ Richness 
↑ Bifidobacteria 
[140 141] High Glycemic Load: 
↓ BV Risk 
[142] Vegetarian Diet: 
↓ UTI Risk 
[131] 
Smoking 
↓ Diversity 
↑ Firmicutes 
↓ Proteobacteria 
[105] 
↑ BV Risk 
↑ Gardnerella, Mycoplasma 
↓ Lactobacillus 
[143 144] 
No Effect 
[145] 
Alcohol Use 
↓ Diversity 
↑ Proteobacteria 
↓ Bacteroidetes 
[106 107 108] 
↓ BV Risk 
↓ Anaerobic bacteria [146] 
↕ UTI Risk11 
 [131 147] 
Antibiotic 
Use 
↓ Diversity 
↓ Richness 
↕ Composition1 
[109 124 148] 
↑ BV Risk 
↓ Lactobacillus restoration5 [149] 
↕ UTI Risk12,13 
 [150 151 152 153] 
Probiotic Use 
Oral: 
↑ Diversity 
↑ Richness 
↕ Composition2 
[112 113 114 
115] 
Oral: 
↓ BV Risk 
↑ Lactobacillus6 
[154 155 156 157] Oral: 
↕ UTI Risk14 
[158 159] 
Intra-vaginal: 
↕ UTI Risk14 
[160 161 162] 
Hygiene 
Oral Hygiene: 
No Impact3 
[163] Menstrual Protection
7: 
No Impact 
[164 165 166] Menstrual Protection
7: 
↕ UTI Risk15 
[131 136] 
Douching: 
↕ BV Risk8 
↕ Lactobacillus8 
[166 167 168 169] Douching: 
No Effect 
[131  136] 
  Bathing: 
↕ UTI Risk15 
[131  136] 
Birth Control N/A 
Oral Contraceptives: 
↓ BV Risk  
↑ Lactobacillus 
↓ Candida 
[170 171 172] Oral Contraceptives: 
No Effect 
[136  173] 
Intrauterine Device (IUD): 
↑ BV Risk  
↓ Lactobacillus 
↑ Candida, Mycoplasma 
[174 175] Condom Use: 
↕ UTI Risk16 
[153 176 177] 
Sex N/A 
Vaginal Intercourse: 
Condom Use: 
↓ BV Risk  
[178] Vaginal Intercourse: 
↕ UTI Risk17 
 
[179 180 181 182] 
High Frequency: 
↑ BV Risk  
↓ Lactobacillus 
[178 183 184] 
Female Partner: 
↑ BV Risk  
[185 186] 
Oral Sex: 
No Impact 
[178 187] 
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Table 1B. Impact of Intrinsic Lifestyle Factors on Microbiota and Risk for BV and UTI. 
 
Lifestyle 
Factors 
Impact on GI 
Microbiota Impact on Vaginal Microbiota and BV Risk UTI Risk 
Menstruation N/A No Impact on BV Risk Compositional changes18 [
188 189 190 191] N/A 
Pregnancy N/A 
Full-Term: 
↑ Lactobacillus 
↓ Prevotella, anaerobes 
[192 193] 
N/A Pre-Term: 
↓ Lactobacillus 
↑ Gardnerella, Ureaplasma 
↑ BV Prevalence19 
[193 194 195] 
Menopause N/A 
↑ BV Risk 
↓ Lactobacillus 
↓ Diversity 
[196 197 198 199] 
↑ UTI Risk 
 [158 200 201 202] 
Sex Hormones N/A ↑ Lactobacillus [203 204] 
Oral/Vaginal Estrogen: 
↓ or No Effect on UTI Risk 
[205 206 207 208] 
Urine Properties & 
Constituents N/A N/A 
Glucose: 
↑ UTI Risk/Presence 
[209] 
Bilirubin: 
↑ UTI Risk/Presence20 
[210] 
Ketones: 
No Effect 
[211] 
Specific Gravity: 
No Effect 
[211] 
Blood/Hematuria: 
↑ UTI Risk/Presence 
[211 212 213 214] 
pH (Alkaline): 
↑ UTI Risk/Presence 
[211] 
Protein: 
↑ UTI Risk/Presence 
[211 212] 
Urobilirubin: 
No Effect 
[210 211] 
Nitrites: 
↑ UTI Risk/Presence 
[211 212 213 214 215] 
Leukocyte esterase: 
↑ UTI Risk/Presence 
[211 212 213 214 215] 
 
 
1 Varies with antibiotic, 2 Varies with species of probiotic, 3 Assessed impact of Triclosan 
(toothpaste component) on GI microbiome, 4 Presence of Coccobacilli by Gram strain is highly 
indicative of Gardnerella vaginalis, 5 Assessed Metronidazole treatment, 6 All used a 
Lactobacillus probiotic, 7 Tampon or Pad use, 8 Data conflict, 9 Some data show no effect, 10 
Some data show no effect, 11 Data conflict, 12 Antibiotics used as prophylaxis, 13 Varies with 
antibiotic, 14 All used a Lactobacillus probiotic; data conflict, 15 Data conflict, 16 Data conflict, 
17 Increased in pre-menopausal, 18 Compositional changes vary greatly among individuals, 19 
Women with BV at the start of pregnancy are at greater risk for Pre-term birth, 20 Increased UTI 
Risk in neonates 
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The Vaginal Microbiota and Lifestyle 
Description of Vaginal Tract Physiology 
 The vaginal mucosa is comprised of stratified squamous epithelium overlaid by a mucosal 
layer covered by cervicovaginal fluid216. Besides providing both physical and biochemical 
protection from invading microorganisms, the vaginal environment has additional layers of 
defense to inhibit microbial colonization; these include acid pH, production of antimicrobial 
peptides (e.g., β-defensins and mucins) and surfactant proteins216. Nevertheless, an intrinsic 
population of bacteria colonize the vagina. This vaginal microbiota can generally be classified into 
five groups (i.e., CSTs), though some research suggests otherwise. CSTI-IV are dominated by 
species of the genus Lactobacillus (i.e. L. iners, L. crispatus, L. gasseri, and Lactobacillus jensenii), 
while CST-V is dominated by a diverse group of anaerobic bacteria (e.g. Gardnerella, Prevotella, 
Anaerococcus)14 217. CST may correlate to demographics, particularly race and ethnicity; typically, 
African American/Blacks and Hispanics harbor CST-V, as well as displaying higher vaginal pH 
regardless of clinical infection14 217. 
 Colonization by Lactobacillus (i.e., CSTI-IV) reportedly protects against infection via 
several different mechanisms. They exclude pathogens by competing for epithelial binding sites 
and inhibit pathogen proliferation by producing lactic acid, hydrogen peroxide, and/or 
bacteriocins218 219 220. Lactobacilli also can modulate the host immune response by inducing pro-
inflammatory or anti-inflammatory cytokines or by intermittently translocating across the 
mucosa, inducing systemic immune events, in the gastrointestinal tract221. These mechanisms 
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may relate to data showing that lactobacilli are commonly non-dominant in women with vaginal 
disorders222. 
 The vaginal microbiota has been greatly studied in the context of BV. The putative cause 
of BV is thought to be microbiologic in nature. BV presents clinically as vaginal malodor and 
discharge, vulvar irritation, dysuria, and abdominal pain223. Microscopically, BV is characterized 
by increased vaginal pH, presence of clue cells in the discharge (i.e., vaginal epithelial cells 
covered with coccobacilli), and detection of anaerobic bacteria223. BV is characterized using 
Nugent scores, which range from 0-10 – a score of 0-3 is considered normal, 4-6 is designated 
intermediate, and 7-10 is considered BV224. The values are determined from a Gram stain of a 
vaginal smear specimen at 1000x oil immersion. Values are based on the presence of 
Lactobacillus, Gardnerella/Bacteroides morphotypes, and curved Gram-variable rods224. 
Correlations between the Vaginal Microbiota, BV Risk, and Lifestyle 
 Numerous lifestyle factors are correlated to BV risk and subsequently vaginal microbiota 
composition and diversity characteristics (Table 1). Dietary characteristics, such as iron, vitamin 
E, and calcium-deficiencies, are linked to BV risk, lower Lactobacillus levels, higher microscopic 
detection of coccobacilli (i.e. Gardnerella), and higher levels of Candida126 127 132 142. High glycemic 
diets are correlated with lower BV risk142. Smoking143 144, antibiotic use149, use of an intrauterine 
device (IUD)170 174 175, high frequency of vaginal sex178 183 184, and vaginal sex with a female 
partner185 186 are associated with higher BV risk, lower Lactobacillus, and higher levels of 
anaerobes, such as Gardnerella and Mycoplasma (Table 1). Factors associated with lower BV risk 
and the corresponding microbiota characteristics include alcohol consumption146, probiotic use154 
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155 156 157, use of oral contraceptives170 171 172, and condom use during vaginal sex178 (Table 1). 
Menstrual protection, such as tampon or pad use164 165 166, and oral sex178 187 are not associated 
with BV risk or microbiota changes. Menstruation is associated with individualized compositional 
changes and greater diversity, but not BV risk188 171 190 191 (Table 1B).  
Temporal Dynamics of the Vaginal Microbiota 
 The temporal dynamics of the vaginal microbiota have also been studied primarily in the 
context of BV. Early work by Brotman et al. recruited 39 women to self-collect vaginal swabs 
twice weekly for 16 weeks225. Participants completed a behavioral diary consisting of yes/no 
questions regarding vaginal-related factors (e.g., vaginal douching, menstrual bleeding, sexual 
activity, tampon use, medications). Nugent scores were calculated from the vaginal smears to 
determine BV status, and Gram-strain results were recorded. Brotman et al. found that most 
women (73%) experienced spontaneous and frequent fluctuations between normal and BV 
states225. Lubricant use and rectal intercourse were associated with BV onset225. The vaginal swab 
specimens from the participants in this study were later used for 16S rRNA gene sequencing. As 
reported by Gajer et al., the vaginal communities, in general, showed low constancy and high 
levels of species turnover, but overall the dynamics varied widely among women, even those 
within the same CST188. By calculating the rate of change of the log of Jensen-Shannon divergence 
values between time points, Gajer et al. found that menses correlated to low levels of constancy 
or stability. Sexual activity was correlated to low constancy and was independent of the 
menstrual cycle188. Diversity indices did not show significant correlations to menses or sexual 
activity, indicating that the low levels of stability were due to compositional changes. Despite 
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these general associations, various trends were seen across participants. The vaginal 
communities of some women were resilient and showed predictable changes, while others were 
invariant or continuously variant. For example, when the taxonomic data were compared to 
participant-reported menstruation, four unique trends were seen. One participant’s specimens 
(Subject 24) normally contained high abundance of L. crispatus, except during menstruation 
when Gardnerella repeatedly dominated the microbiome. This trend was reproducible over four 
menses. Subject 12 had high levels of L. iners and during menstruation a disruption was also 
observed, but unlike Subject 24, the pattern differed at each instance. Subject 29 was invariant, 
except for one instance where the L. crispatus was replaced by L. iners, but this did not 
correspond to menstruation. Finally, Subject 6 was continuously variant despite menstruation. 
No recorded metadata can explain the differences in microbial response to menstruation seen in 
these four participants188. Collectively, these data show that, unlike the GI microbiota, the vaginal 
microbiota do not consistently show long-term stability; intrapersonal variation in temporal 
dynamics exist and do not always correlate to lifestyle factors or behaviors.  
 A possible explanation for the participant disparities reported by Brotman and Gajer and 
co-workers is that the data are not representative of long-term trends. Without more clinical 
measures, it remains unclear whether the participants were sampled during an “atypical” time. 
Ravel et al.’s approach to measuring the dynamics of the vaginal microbiota took this into account 
by sampling participants who were currently experiencing BV symptoms (N=15), had 
asymptomatic BV (N=6), or did not have BV or symptoms (N=4)226. Despite these clear clinical 
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distinctions in the participants, Ravel et al. found similar findings, where community dynamics 
were again highly individualized226.  
 An additional finding of Ravel et al. was that women with symptomatic BV who were given 
antibiotic treatment experienced initial changes towards a less BV-associated microbiota (i.e., 
Lactobacillus-dominant). However, the effect was short-lived; in most individuals, the community 
returned to its pretreatment state within 4 weeks226. Another group has observed similar 
trends227. 
 Besides BV, vaginal microbiota dynamics have also been studied in the context of 
pregnancy. Romero et al. recruited 22 pregnant women who delivered at term (38 to 42 weeks). 
Vaginal swabs were collected every four weeks until 24 weeks of gestation, and every 2 weeks 
until the last prenatal visit193. The microbial data were compared to the participant data from the 
work of Brotman and Gajer and co-workers. Romero et al. calculated the Jensen-Shannon 
divergence values between each timepoint and the mean community state for each participant 
as a measure of overall instability193. The mean within-subject values were significantly lower for 
non-pregnant women, showing that the vaginal communities are more stable during 
pregnancy193. 
 In conclusion, the vaginal microbiota of some women are very dynamic, while others are 
very stable. Menstruation and sexual activity generally result in reduced stability, while 
pregnancy shows the opposite trend. 
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UTI Risk and Lifestyle 
 Not only is it unknown if lifestyle factors and behaviors can affect the urinary microbiota, 
but it is also unclear whether temporal dynamics even exist in these bacterial communities. I 
hypothesize that dynamics do exist in the urinary microbiota due to evidence presented above 
showing the existence of dynamics in the GI tract and vaginal microbiota. These microbiota, 
especially those of the vagina, contain bacterial constituents similar to those of the urinary 
microbiota. And, like the bladder, the bacterial communities of the GI tract and vagina exist in a 
confined organ that is susceptible to outside influence and associated with a highly specialized 
tissue. Furthermore, I hypothesize that lifestyle factors and behaviors associated with UTI risk 
(Table 1) will correlate to observed temporal dynamics. 
Current Understand of UTI and an Overview of Risk Factors 
 UTIs are described in more detail in Appendix E. In brief, UTIs are the most common 
bacterial infections and amongst the most common reasons for antibiotic treatment228 229. Almost 
half of women experience at least one UTI in their lifetime, and 10% have one annually230. UTIs 
typically present as one or more of the following symptoms or characteristics: urine odor, painful 
urination, frequent urination, nocturia (urination at night), urgency of urination, hematuria 
(blood in the urine), unexplained lower back pain or pelvic pain, and feelings of urinary retention. 
In healthy pre-menopausal, non-pregnant women with no prior history of urogenital 
abnormalities, presence of acute cystitis and/or pyelonephritis is classified as an uncomplicated 
UTI20. To provide a rapid diagnosis of bacteriuria (i.e., presence of a uropathogenic bacterial 
species in the urine) and pyuria (i.e., presence of white blood cells in the urine), dipstick tests are 
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commonly used. These test for leukocyte esterase, nitrates, and red blood cells. However, SUC is 
the definitive test for UTI, and it can also provide appropriate antibiotic susceptibilities. Typically, 
a positive SUC result is the presence of a single organism (typically E. coli) isolated at ≥ 105 CFU/mL 
urine231. A positive SUC with or without pyuria, in the absence of urinary symptoms, is commonly 
referred to as asymptomatic bacteriuria (ABU or ASB)231 232. The high morbidity of cystitis typically 
prompts prescription of antibiotics228.  
 Risk factors for UTI are detailed in Table 1, and include factors related to diet, medication 
use, hygiene, sexual activity, menstruation, and several others. Components of diet, including 
cranberry juice (results vary among studies) and Vitamin C225 227 198 199 131, have been shown to 
decrease risk for UTI. Carbonated drinks have an increased UTI risk131  133, while total fluid intake 
has no effect129 130. Oral and intra-vaginal probiotic use158 159 160 161 162 and estrogen use203 205 206 207 
208 have decreased UTI risk. Vaginal sex without condom use is correlated with increased UTI risk, 
particularly within five days of intercourse131 173 176 177 179. Post-menopausal women are more at 
risk for UTI than pre-menopausal women, likely due to decreased vaginal estrogen158 200 201 202. 
Alcohol consumption, antibiotic use, bathing, and menstrual protection have been shown to 
impact UTI risk in some studies, but not others128 131 135 136 137 145 147. There is no evidence that 
smoking, oral contraceptives, or douching have an effect on UTI risk128 131 134 159. 
Probiotics and UTI Risk 
 Probiotics are microorganisms that have beneficial effects, such as the restoration or 
maintenance of bacterial communities in the body. They are usually taken orally, but can be given 
through alternate routes, such as vaginally. It has been shown that use of probiotics (oral and 
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vaginal), particularly Lactobacillus sp., can alter the vaginal microbiome and reduce BV risk (Table 
1)154 155 156 157. There are also data relating probiotics to UTI risk. Reid et al. recruited 41 post-
menopausal women with acute UTIs161. All were treated with antibiotics (norfloxacin or 
trimethoprim/sulfamethoxazole) for three days, resulting in the eradication of the infection in all 
women. Half of the women were given post-therapy vaginal administration of Lactobacillus 
suppositories. In these patients, the recurrence rate of UTI within 6 months was 21%; this was 
compared to 41% recurrence in the patients not given the post-therapy161. Further research 
showed that weekly use of the suppository reduced UTI recurrence from 6 to 1.6 per year160. 
Conflicting data were reported in a randomized controlled trial of 252 post-menopausal women 
with recurrent UTIs. In this trial, Beerepoot et al. compared the effects of 12 months of 
prophylaxis of trimethoprim/sulfamethoxazole (480mg once/day) to an oral Lactobacillus 
probiotic (twice/day)158. The probiotic capsule contained 109 CFU/mL of Lactobacillus rhamnosus 
GR-1 and Lactobacillus reuteri RC-14. Patients who received the antibiotic prophylaxis (n=126) 
reported an average incidence of 2.9 UTIs during the 12 months, while patients who received the 
probiotic (n=126) reported 3.3 UTIs, which did not significantly differ158. However, strains of E. 
coli isolated from the prophylaxis cohort showed increasing resistance (20% at baseline to 80% 
by one month) to trimethoprim/sulfamethoxazole, trimethoprim, and amoxicillin; this trend was 
not observed in the probiotic cohort158. These data show that probiotic use may lower risk for 
UTI. 
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Correlations between UTI Risk and Lifestyle 
 Several comprehensive studies assessing UTI risk and lifestyle have been performed. 
Foxman and co-workers have provided several of these studies. An in-depth assessment of UTI 
risk factors in young women was published in the 1980s as a series of reports. Foxman et al. 
collected MSU specimens from 225 pre-menopausal college-aged women [mean age of 21.5 
(range of 16-39)] at a student health clinic and assessed for UTI using the following criteria: 
>50,000 CFU/mL of a single bacterial species detected using SUC and presence of one or more 
symptoms of a UTI233 131. All participants completed a self-administered lifestyle questionnaire 
prior to diagnosis. The questionnaire queried information relating to diet, urination habits, 
clothing worn, sexual habits, and birth control method used in the preceding four weeks233 131. 44 
participants were diagnosed with a UTI; 181 served as non-UTI controls. 100% (44/44) of the UTI 
participants reported that they engaged in sexual intercourse at least once in the previous four 
weeks, while only 47% (85/181) of the controls had done so233. Similarly, engaging in sexual 
intercourse with more than one partner and starting a new sexual relationship were more 
commonly reported in the UTI cohort233. Among the women who reported being sexually active, 
the birth control method of diaphragm use was also associated with the UTI cohort233. Oral 
contraceptive had no association. These findings were independent of the frequency of sexual 
intercourse233. Because of the strong correlation between sexual intercourse and UTI, Foxman et 
al. statistically corrected for these data in their remaining assessments of the lifestyle 
questionnaire. An assessment of diet showed a positive correlation to the UTI population for 
consumption of tea, soft drinks, cranberry juice, vitamin C, citrus juice, coffee, and milk within 
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the past four weeks131. A vegetarian diet and consumption of garlic, ginger, chile peppers, and 
alcohol beverages were negatively correlated to the UTI cohort131. In relation to hygiene, Foxman 
et al. found a positive correlation between UTI and tampon use, as well as reporting of douching, 
but bathing habits (e.g., frequency of showing, taking a bath) did not131. Frequency of urination 
was not correlated to UTI; in sexually active women, reporting of urination before sexual 
intercourse was positively correlated with UTI, while urinating afterwards was negatively 
correlated131. Altogether, Foxman et al. found associations between UTI risk and diet, sexual 
habits, and urination habits233 131. 
 In follow-up work, Foxman et al. recruited a much larger cohort of college-aged women 
(n=1641) through a similar recruitment process as described in their previous work233 131. The 
population had a mean age of 21.9 years [standard deviation (SD) = 4.4] and was comprised of 
women with (n=237) and without (n=1404) UTI, as defined previously233 131 136. All participants 
completed a lifestyle questionnaire regarding the preceding four weeks. In agreement with their 
previous work, Foxman et al. found that women with UTI were more likely to have engaged in 
sexual intercourse, but they also found a positive relationship between the frequency of sexual 
intercourse and UTI136. Additionally, women with UTI were more likely to use a diaphragm than 
oral contraceptives for birth control methods136. Urination habits also showed similar trends. 
Urinating after intercourse was associated with increased overall fluid intake. By controlling for 
this confounding variable, Foxman et al. found that always urinating after sexual intercourse was 
protective (i.e., associated with the non-UTI cohort)136. The association was so strong that in 
those women who report always urinating after sexual intercourse, the association between 
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diaphragm use and UTI was lower136. Toileting habits like frequency of urination, delaying or 
hesitating to urinate, direction of toilet tissue wiping, and use of laxatives and stool softeners 
showed no correlation to UTI136. Use of feminine hygiene products and type of product used also 
showed no correlation to UTI136. Dietary factors also provided similar results as previously 
described233 131, except cranberry juice consumption was not associated with a protective 
effect136. Total fluid intake and cigarette smoking showed no correlation136. Foxman et al. also 
queried measures of stress including getting enough sleep, feeling alone, and a self-perceived 
measure of stress level. Interestingly, women in the UTI cohort were likely to report the lowest 
levels of self-perceived stress136. 
 Foxman also assessed UTI risk factors in post-menopausal women. Foxman et al. recruited 
222 women aged 40-65, who did (n=63) and did not (n=159) have a UTI; the clinical and 
microbiologic measures used to determine UTI were not described182. Consistent with previous 
work, the participants completed a lifestyle questionnaire; however, the questionnaire used in 
the present study queried behaviors of the preceding two weeks, rather than four182. Contrary to 
data in pre-menopausal women, Foxman et al. found that UTI participants were less likely to 
report sexual activity in the past two weeks, but individual types of sexual activity were not 
associated with either cohort182. No other factors contradicted those reported previously in pre-
menopausal women, but most showed no association with either cohort182; it must be considered 
that the sample size of this present study was considerably smaller. Women in the UTI cohort 
were more likely to report incontinence or urine loss182, but UTIs can cause urinary incontinence-
like symptoms in older women234, so the significance of this finding is unclear. Foxman et al. also 
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found that non-UTI women were considerably more likely to use estrogen replacement 
therapies182. 
 The work of Foxman and co-workers provided a foundation for modern clinical 
understandings of UTI risk and lifestyle. In general, subsequent work has supported the 
conclusions made (Table 1). An example of an exception includes work by Fihn et al. showing that 
in women with acute UTI caused by E. coli (n=604), use of spermicide-coated condoms conferred 
a significantly higher risk of UTI compared to demographically matched controls (n=629)177. Also, 
several studies have shown significant reduction in UTI risk, bacteriuria, and pyuria following 
consumption of cranberry juice128 129 130 contrary to Foxman’s work136. Antibiotic use was not 
assessed as a UTI risk factor in Foxman’s work (it was an exclusion factor), but others have, in the 
context of prophylaxis. Harding et al. recruited 40 women with a history of recurrent UTI (rUTI) 
(as defined as ≥3 incidences of UTI in one year) to complete three consecutive three-month long 
regimens of various prophylactic antibiotics150. While taking sulfamethoxazole (500mg/day) UTI 
incidence (per patient/year) was 2.5, methenamine mandelate (2g/day) with ascorbic acid 
(2g/day) was 1.6, and trimethoprim (40mg/day) with sulfamethoxazole (200mg/day) was 0.1, 
compared to 3.6 using no drug therapy150. Nicolle et al. found similar data when assessing UTI 
incidence over five years (mean=32 months) in a small cohort of women (n=11) with a history of 
rUTI using trimethoprim-sulfamethoxazole prophylaxis151. Other studies have shown that 
antibiotic prophylaxis, when compared to vaginal oestrogens (n=150), oral Lactobacillus probiotic 
(n=238), and D-mannose supplement (n=94), results in an average of 24% lowered risk of UTI 
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recurrence in women with history of rUTI235. These data show that prophylactic antibiotic use 
reduces UTI risk, at least in populations of women with rUTI.  
 Antibiotic use is also the only lifestyle factor, to my knowledge, that has been studied in 
the context of the urinary microbiota. Gottschick et al. compared data collected from MSU and 
vaginal swab specimens of primarily pre-menopausal women with (n=42) and without (n=49) 
BV73. Patients with BV were treated with oral metronidazole (2g; single dose) and specimens were 
collected before (day of) and after (7-28 days) treatment73. They observed significant changes in 
the urinary microbiota composition following antibiotic treatment. Urotype frequencies of L. 
iners and Enterobacteriaceae increased following treatment, while Gardnerella and anaerobic 
taxa decreased, as well as overall alpha diversity levels73. The antibiotic treatment also lowered 
the proportion of women with significant correlations between the urinary and vaginal 
microbiota (9%)73. These data show that antibiotic treatment of vagina-related diseases (i.e., BV) 
can alter the urinary microbiota. A caveat of these data is the length of time between the first 
and second specimen collection and also lack of patient lifestyle data. 
 Considering that dynamics in the GI and vaginal microbiota occur rapidly (i.e., within a 
few days) in response to or following certain lifestyle factors, the use of questionnaires regarding 
behaviors across several weeks in Foxman’s work, represents a major limitation to the 
conclusions made about UTI risk. To my knowledge, none of the lifestyle factors described above 
have been assessed for UTI risk on a daily timescale, with the exception of sexual intercourse. 
Nicolle et al. recruited 27 sexually active pre-menopausal women, 14 with history of UTI and 13 
without (i.e., none within two years)180. MSU specimens were collected each morning over 
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several months (17-95 days; mean=66 days) and Dipslide cultures were performed (these consist 
of a sterile culture medium on a plastic carrier that is dipped into the urine specimen and then 
incubated). Dipslide tests were kept at room temperature until being submitted to the laboratory 
for incubation on a weekly basis180. UTI diagnosis was determined as ≥105 CFU/mL of a single 
bacterial species. Participants maintained a calendar where they recorded the date and time of 
sexual intercourse episodes, menstruation days, menstrual protection used, contraceptives used, 
and urinary symptoms. The mean intercourse frequency for both cohorts was 2/week180. 
Regardless of cohort, this value was significantly (p<0.02) higher in those who developed a UTI(s) 
(n=13) compared to those who did not (n=14)180. 75% of all UTI episodes occurred within 24 hours 
of sexual intercourse180; differences were not seen between cohorts. UTI incidence did not 
correlate to any other lifestyle factor assessed. Buckley et al. found supporting data from a 
microbiologic rather than symptomatic perspective. They recruited 20 pre-menopausal females 
to provide urine specimens (type of specimen was not specified) before, 1 hour after, 6-10 hours 
after, and 30-48 hours after sexual intercourse for assessment of bacterial counts (type of 
microbiologic culture/technique was not specified)181. Of the 76 intercourse episodes assessed, 
46 had colony counts that started and remained below 104 CFU/mL, 7 had counts above 105 
CFU/mL before and after, and 23 had an increase of more than one log after intercourse181. None 
of the 23 episodes resulted in reporting of urinary symptoms. In 7/23 episodes, counts after 
intercourse were >105 CFU/mL; these were commonly identified as E. coli181. In the remaining 16 
episodes, colony counts were between 104 and 105 CFU/mL after intercourse. Interestingly, these 
organisms were frequently identified as non-pathogens such as Corynebacterium and non-Group 
53 
 
 
 
D Streptococcus (i.e., not Enterococcus)181. The rise in bacterial counts in these 23 episodes was 
transient; counts were less than 104 in 16/23 by the 30-48-hour timepoint181. In an unrelated 
study from Buckley et al., half of the participants were instructed to urinate immediately 
following intercourse, while the other half were told to not urinate. This did not have an impact 
on the data181. Collectively, these data show that, in general, sexual intercourse results in a rapid 
(i.e., with 24 hours) increase in UTI risk and urinary bacterial counts. These trends are discussed 
again in Chapter V. 
Correlations between UTI Risk and Urine Properties 
 Traditionally, it has been understood that risk factors result in UTI by altering the urinary 
and urogenital environment to be more susceptible to infection. As such, various properties and 
constituents of urine have also been studied in relation to UTI (Table 1B). Typically, these are 
measured by urinalysis. The simplest approach is a urine dipstick test, which is a urine test strip 
comprised of several chemical pads that react, via color changes, when exposed to a urine 
sample. This approach is in contrast to a microscopic urinalysis where a urine specimen is 
centrifuged, resuspended and added to a glass slide for microscopic analysis and enumeration of 
eukaryotic cells (e.g., leukocytes and erythrocytes), urinary crystals (e.g., calcium oxalate), and 
bacterial cells211.  
 Urine dipsticks can test for a variety of urine characteristics and properties, some of which 
are correlated to UTI risk. Specific gravity is the urine osmolality and provides information 
regarding the hydration of the person. These values range from 1.000 to 1.030, where values 
above 1.020 indicate dehydration211. The pH of the urine ranges from 4.5 to 8.0 but is usually 
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slight acidic (i.e., 6.0)211. Diets that are high in protein and acidic fruits can cause more acidic 
urine, while foods high in citrate, like oranges, can lead to more alkaline urine236. Urine with an 
alkaline pH is considered indicative of a UTI211 212 213 214 215. Hematuria, or blood in the urine, can 
be detected visually, but microscopic hematuria is determined by detection of peroxidase activity 
of the urine, which is indicative of the presence of erythrocytes. Urologic hematuria is not 
typically considered indicative of UTI, but rather more serious urologic conditions211. In healthy 
individuals, levels of protein in the urine (proteinuria) should be minimal to none, as these should 
be reabsorbed and metabolized by the proximal tubules of the kidney. Significant proteinuria, 
defined as greater than 150 mg per day, is considered indicative of renal disease. Proteinuria is 
not related to UTI. Glucose in the urine (glycosuria) is found in those with diabetes mellitus, liver 
disease, and several other diseases. Glycosuria is associated with higher UTI risk209 211. Ketones, 
from fat metabolism, are also not normally found in urine, but are associated with higher UTI 
risk209 211. Starvation and diets low in carbohydrates can lead to detection of ketones in the urine. 
Bilirubin and/or urobilirubin in the urine are signs of liver disease and are considered a risk factor 
for UTI in neonates210 211. Nitrates are common in urine from the breakdown of amino acids, but 
nitrites will only be found if bacteria capable of reducing the nitrates are present211. Both Gram-
negative and Gram-positive are capable of this conversion and it has not been assessed in the 
context of the urinary microbiota. Despite this, presence of nitrites is considered indicative of a 
UTI211 212 213 214 215. Finally, leukocyte esterase is produced by neutrophils and is considered 
indicative of an immune response to a UTI211 212 213 214 215. However, detection of leukocyte esterase 
can occur following exercise, or with non-UTI diseases, such as viral infections and bladder 
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tumors. In some cases, the dipstick-measured urine property (e.g., presence of leukocyte 
esterase and nitrites) is likely a direct result of the UTI, rather than a risk factor for it. But, in other 
cases, like the presence of ketones or certain pH levels, which can be altered by diet, it is unclear 
what the relationship is between the risk factor and the urine property, and furthermore how 
these relate to the urinary microbiota. I assess this complicated relationship in Chapter IV. 
Longitudinal Assessment of the Lower Urinary Tract Microbiota 
Rationale and Problems 
 I have cited evidence that temporal dynamics exist in the GI and vaginal microbiota and 
that, in large part, these dynamics correlate to lifestyle factors, behaviors, or events. 
Furthermore, I have described how lifestyle impacts UTI risk. Collectively, these data prompted 
us to hypothesize that temporal dynamics exist in the female urinary microbiota and correlate to 
lifestyle. To date, few studies have assessed the urinary microbiota longitudinally. Thomas-White 
et al. assessed the microbiota of TUC specimens in women with OAB at three timepoints (several 
weeks apart) as a measure of treatment (i.e., Solifenacin) efficacy35. Changes in the microbiota 
and microbiome were observed, but conclusions cannot be made regarding dynamics because of 
the influence of the drug, the disease state of the patients, the varying demographic and clinical 
measures, and lack of lifestyle data. Ideally, a study assessing the temporal dynamics of the 
urinary microbiota should involve a cohort of demographically similar women who provide 
detailed lifestyle information and biological specimens on a daily timescale for several months. 
While certainly difficult to coordinate, this is a relatively straightforward study design. The 
challenge exists in the collection and interpretation of the biological specimens. Differences exist 
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in the urinary microbiome between voided (i.e., non-catheterized) and catheterized urine 
specimens29. These differences, and how they relate to surrounding niches (e.g., urethral, peri-
urethral, vaginal), have yet to be studied in great detail. Furthermore, intermittent and Foley 
catheterization are associated with an elevated UTI risk237  and these have yet to be studied in 
relation to the urinary microbiota. Therefore, daily collection of catheterized specimens to study 
the urinary microbiota is impractical and possibly harmful. A voided urine specimen must be 
used, but proper interpretation of the resultant microbiologic data is complicated. 
What Specimen to Collect? 
 Various urine collection methods exist. The gold standard for urine collection to diagnose 
bladder infections is a SPA specimen. This procedure involves the use of a needle to aspirate urine 
directly from the bladder through the abdomen, thus eliminating the possibility of contamination 
from the skin and urethra. SPA specimens are only collected from patients that are fully hydrated, 
have a palpable bladder, and no indication of intestinal obstruction or abdominal scarring238. 
Collection of these specimens is considered invasive and proper collection involves the use of 
ultrasound guidance. Altogether, these considerations make daily collection of SPA specimens 
for longitudinal research a non-viable option.  
 Urethral catheterization, or TUC, specimens are the next most accurate specimen in 
capturing bladder-specific urine. In the context of the female urinary microbiota, Wolfe et al. 
showed similarities between TUC and SPA specimens29, suggesting that the process of 
catheterization does not introduce urethral contaminants, or alter the bladder urine microbiota, 
a finding confirmed by others63. However, catheterization is still an invasive procedure that 
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requires some technical skill to perform. Repeated, or intermittent catheterization, is associated 
with an increased risk of symptomatic urinary infections237. Indwelling, or Foley catheterization, 
does not require frequent removal and insertion, but can result in high infection rates. Bacteria 
can migrate along the inside and outside of the catheter to enter the bladder. Infection rates 
increase for each day of use, with almost 95% incidence past one month of use239. Therefore, TUC 
specimens, either intermittent or indwelling, are also not a viable or safe option to study the 
longitudinal urinary microbiota. 
 Clean catch voided urine is much less invasive compared to TUC or SPA techniques for 
obtaining a urine specimen. This requires the collection of voided urine in a sterile manner. 
Although it is less invasive, there is a higher opportunity for contamination, both environmental 
and from unintended body sites. There is also significant variability in the actual practice of the 
techniques, making interpretation of the results even harder. Initial void versus mid-stream void, 
use or no use of a genital cleansing wipe prior to urination, and type of urine collection cup are 
examples of the variability seen among protocols. Recently, Aisen et al. examined clean catch 
voided urine specimens (the explanation of collection technique was not shown) and paired TUC 
urine specimens from 107 mostly post-menopausal women presenting UTI-like symptoms240. 
Using SUC, a positive clean catch urine specimen was defined as having >104 CFU/mL of a single 
bacterial species or a culture with multiple bacterial species and an abnormal urinalysis (UA); a 
positive TUC specimen was defined as having any bacterial growth (i.e. >103 CFU/mL)240. All 
patients had a positive clean catch voided urine specimen, but only 53 (49.5%) had a positive 
paired TUC specimen240. Despite the differences in defining a positive culture, a clear distinction 
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was observed in the microbiologic data from clean catch voided urine and TUC specimens. An 
additional caveat of this study, however, was that the paired specimens were not collected at 
the same visit; it is unclear how this affected the data.  
 Urine collection bags are used to obtain urine specimens primarily from children and the 
elderly. This involves a collection bag applied to the perineum after cleansing the skin. The patient 
urinates, the bag fills with urine, and then pulls away from the skin. This specimen type is at 
significant risk for contamination with perineal and fecal bacteria. False positive cultures (i.e., 
SUC) are frequently obtained241.  
 Considering all of the data, I conclude that clean catch voided urine specimens are the 
optimal collection type needed to study the urinary microbiota longitudinally due to the less 
invasive nature, minimal risk for infection or complications with its use, and lower likelihood of 
contamination compared to other non-invasive approaches. 
 MSU specimens are a type of clean catch voided urine specimen and are commonly used 
to diagnose UTI. MSU specimens consist of voided urine collected after discarding the initial void, 
typically the first 10 mL. These are commonly collected after use of a vaginal cleansing wipe242, 
although not always. The cleansing wipe has no difference on the ability to properly interpret the 
specimen243. Urine collected from an MSU specimen potentially contains bladder organisms, 
urethral, peri-urethral, and possibly even vaginal. Therefore, from this point, I will refer to 
microbiologic data collected using MSU specimens as the lower urinary tract (LUT) microbiota. 
Additionally, it is difficult to standardize collection of an MSU specimen, although attempts have 
been made. Recently, I studied the urinary microbiota collected from women using the Peezy® 
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system, a self-contained device that collects a standardized MSU specimen and likely reduces 
skin and environmental contamination244. The results from this study are described in detail in 
Appendix J. But, all in all, the bacterial composition of MSU specimens relative to their starting 
niche (e.g., bladder, urethra, peri-urethra, vagina) has not been extensively investigated. 
 Several groups have studied the differences between MSU and catheterized urine 
specimens in the context of UTIs but present the differences as “contamination rates”. 
Unfortunately, the “contamination” is typically regarded as any bacterial growth other than usual 
Gram-negative uropathogens (e.g., E. coli, Klebsiella); this approach considers the normal flora 
of the bladder as part of the “contamination”. Using data from 105 patients, Walter et al. found 
that the concordance rates between MSU and catheterized urine specimens for urine cultures 
(i.e., SUC), nitrites (using urine dipstick), leukocyte esterase (using urine dipstick), microscopic 
bacteriuria (Gram-stain), and pyuria were 96%, 94%, 93%, 90%, and 90%, respectively245. 
Therefore, they concluded that with proper technique, MSU and catheterized urine specimens 
did not provide significantly different laboratory results or result in differences in UTI diagnosis. 
This, of course, is potentially in contrast to work done by Aisen et al. described above, which 
showed a 50% discrepancy between paired clean catch voided urine and TUC specimens in 
women with UTI-like symtoms240. However, it is unclear from the manuscript if these were MSU 
specimens. Ultimately, what I can conclude is that new research, done with the understanding of 
the existence of the urinary microbiota, and using modern laboratory techniques (e.g., EQUC and 
16S rRNA gene sequencing) is required to fully understand the data provided by MSU specimens. 
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 Some data exist that show that microorganisms obtained through MSU specimens are 
mostly free from vaginal and peri-urethral contaminants. Recently, Gottschick et al. analyzed the 
LUT microbiota of MSU and vaginal swab specimens collected from health women and women 
with BV. 16S rRNA gene sequencing data showed that, in most patients, the correlation between 
the microbiome identified in the two specimen types was not significant. The exception was in 
women with BV who had an anaerobic urotype (e.g., Gardnerella vaginalis, Atopobium vaginae, 
Sneathia amnii) in the MSU specimen (59%)73. These data show that, in healthy women, MSU 
specimens do not sample the vagina.  
 I can also speculate that peri-urethral contamination in MSU specimens is low. Typically, 
peri-urethral swabs from females are collected by separating the labia without prior cleansing 
and swabbing the area around the external urethral orifice with a sterile swab. In a small cohort 
of 19 female patients hospitalized for various diseases, Munir et al. collected MSU specimens and 
assessed for bacterial content using a modified culture approach in which a non-standardized 
quantity of urine was inoculated onto cystine-lactose-electrolyte-deficient (CLED) agar and 
incubated under aerobic conditions for 48 hours246. Peri-urethral swabs specimens were also 
collected on these patients and plated onto BAP and MacConkey agar and incubated under the 
same conditions246. The MSU specimens contained primarily Gram-Negative bacteria, while the 
peri-urethral swab had primarily Gram-Positive organisms246, showing that the two sites are 
distinct, at least in this particular patient population. Cattell et al. collected MSU and peri-urethral 
swab specimens weekly for six weeks from a variety of female patients: healthy women, patients 
with symptomatic bacteriuria, patients with urethral syndrome (inflammation or swelling of the 
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urethra), and patients with asymptomatic bacteriuria247. Peri-urethral swabs were cultured on 
MacConkey agar and incubated aerobically for 24 hours. Though they only reported on 
enterobacteria values, Cattell et al. found that there was no correlation in any of the cohorts 
between detection of enterobacteria in the peri-urethral swab and the development of a UTI (as 
defined by >104 CFU/mL of bacterial growth in the MSU specimen and UTI symptoms) during the 
six-week study247. These data suggest that the peri-urethral area and MSU specimens sample 
separate niches. 
 From these limited data, I conclude that MSU specimens primarily sample the bladder 
and urethral bacterial communities. To my knowledge, however, no work has been done to 
understand the precise contribution of either site in MSU specimens. Despite this lack of 
knowledge, several groups have used MSU specimens to study the urinary microbiota (i.e., LUT 
microbiota). In 2011, Siddiqui et al. used 16S rRNA gene sequencing of the V1-V2 and V6 
hypervariable regions (similar results were obtained) to assess the microbiome of MSU 
specimens (30mL) from eight culture-negative (<105 CFU/mL using SUC) healthy females248. 
Demographics were not provided. Common genera detected included Lactobacillus, Prevotella, 
and Gardnerella, as well as taxa with known pathogenic potential. But, overall, significant 
variation among individuals was observed248. Lewis et al. also sampled a small cohort of female 
participants, with a range in ages from 26 to 9069. MSU specimens were collected (2 mL) and using 
16S rRNA gene sequencing of the V1-V3 hypervariable regions, as well as quantitative PCR to 
provide relative enumerations of the bacteria, they found high diversity of bacterial genera 
generally belonging to the Actinobacteria and Bacteroidetes phyla69. Additionally, higher 
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abundance of anaerobic bacterial taxa were found to be associated with age69. Gottschick et al. 
compared data collected from MSU and vaginal swab specimens of primarily pre-menopausal 
women with (n=42) and without (n=49) BV73. DNA was extracted from 15 mL of urine and 16S 
rRNA gene sequencing of the V1-V2 hypervariable regions was performed. They observed several 
distinct urotypes (based on hierarchical clustering) in the MSU specimens including Lactobacillus, 
Escherichia, Streptococcus, Enterococcus, Mixed/Diverse, and Anaerobic73. The anaerobic 
urotype was more prevalent in the BV cohort of women, while the Lactobacillus urotype was 
more prevalent in the non-BV cohort73. Curtiss et al. also performed a case-controlled study using 
MSU specimens. They assessed the LUT microbiota between women with (n=63) and without 
(n=35) OAB48. 5 mL of urine was centrifuged and resuspended in 50 µl of the supernatant; then 5 
µl was plated onto two Chocolate agar plates and incubated in 5% CO2 and anaerobically for 48 
hours; morphologically distinct colonies were selected, purified, lysed, and then the V9 
hypervariable region of the 16S rRNA gene was amplified using PCR and sequenced48. Curtiss et 
al. observed lower abundance of Lactobacillus in OAB patients, and higher abundance of Proteus. 
But the mean number of distinct bacterial genera did not differ between cohorts48. Willner et al. 
collected MSU specimens from women with acute UTI symptoms (n=38)43. Using 1 mL of urine, 
they performed 16S rRNA gene sequencing of the V5-V8 hypervariable regions and found high 
abundance of Escherichia, low abundance of anaerobic taxa, and overall low bacterial diversity43. 
Additionally, they reported a correlation between Escherichia urotype and age43. Kramer et al. 
assessed a cohort of 41 women with non-dialysis-dependent CKD53. 1 mL of MSU was analyzed 
using 16S rRNA gene sequencing of the V4 hypervariable region. They found overall high bacterial 
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diversity in these specimens, and these levels generally correlated to higher eGFR values 
independent of demographics53. Finally, Coorevits et al. analyzed MSU specimens from 86 
healthy females using a modified urine culture protocol [i.e., Expanded Urine Culture (EUC)]249. 
This EUC method used a BAP and a Schaedler agar plate (commonly used for growth of anaerobic 
GI tract bacteria) inoculated with 0.01 mL of urine and incubated at 35°C for seven days in aerobic 
and anaerobic atmosphere, respectively249. Using MALDI-TOF MS for identification, EUC revealed 
a total of 98 unique species including several in the Lactobacillus, Staphylococcus, Streptococcus, 
and Corynebacterium genera249; these organisms are commonly identified as part of the 
microbiota of TUC urine specimens.  
 All in all, data assessing the microbiota of the LUT using MSU specimens provides similar 
results to those seen in the assessment of the urinary microbiota using TUC specimens. Though 
a proper cross-sectional analysis has not been performed, similar taxa are identified and similar 
patterns with various demographics and disease states can be seen. For example, in patients with 
acute UTI, Willner et al. (using MSU) and Price et al. (using TUC) both found high abundance of 
Escherichia and overall low diversity43 44. In patients with OAB, Curtiss et al. (using MSU) and 
Pearce et al. (using TUC) both found lower abundance of Lactobacillus, higher abundance of 
pathogenic taxa, and overall higher diversity48 15. And, in healthy patients, Siddiqui et al., 
Gottschick et al., and Lewis et al. (all using MSU) found distinct urotypes including Lactobacillus, 
Gardnerella, and Anaerobic, as well as trends with age248 73 69. I find similar trends using TUC 
specimens. These data suggest that use of MSU specimens are an appropriate alternative to TUC 
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specimens when catheterization is not possible or is unsafe. This further supports the use of MSU 
specimens for longitudinal microbiologic analysis. 
Preliminary Findings 
 To my knowledge, no one has assessed the urinary or MSU microbiota for stability in 
females. In a recent abstract, Forster et al. sampled voided urine specimens from six C57BL/6 
mice month over a five-month period (mice started at 9 weeks of age)250. 16S rRNA gene 
sequencing showed that the proportion of specific bacteria did not change in individual mice over 
the five months250. Alpha diversity measures (i.e., Shannon Diversity) also did not change over 
time. Mice were co-housed and fed identical diets over the five months250. These data show that, 
in mice, the microbiota of the LUT are stable over a five-month period. The strength of these data 
is that the mice are in an entirely controlled environment and, therefore, the influence of lifestyle 
factors is negligible. Caveats include non-daily specimen collection and lack of information 
describing the method of urine collection. Also, using non-daily specimen collection, Gottschick 
et al. demonstrated that antibiotic use in women BV resulted in changes to the microbiome of 
the LUT73. 
 In 2017, primarily as an assessment of feasibility, I recruited seven pre-menopausal 
women who were instructed to collect MSU and peri-urethral swab specimens daily for about 
two weeks. These data are described in Chapter III. I observed rapid temporal variation in the 
microbiota of both specimen types in all participants. Some showed consistent variations over 
time, while others were more random. These variations were in both composition and diversity. 
Whether the variations relate to lifestyle factors is unclear from these data.  
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Summary 
 At the time of writing this thesis, it has been almost a decade since the discovery of the 
urinary microbiota. In that short amount of time, we have learned a lot about these communities 
of microbes from the perspective of both health and disease. But, we have yet to implement 
these findings into clinical patient care, largely because there is still so much that we do not know. 
This thesis will serve to provide another piece of the puzzle - that is, how do these communities 
of microbes change over time? Researching this question will not only provide insight into the 
bladder and LUT environment at a microscopic level, but at a clinical level as well. By exploring 
this question in relation to lifestyle factors that have associations with UTI risk, the hope is that 
we will obtain a richer and more complete understanding of UTIs. We can no longer define a UTI 
as a microbe entering and colonizing an otherwise sterile environment. The UTI-causing 
organism(s) has(have) to compete with the normal flora to establish colonization and ultimately 
infection. And, if the normal flora is subject to change over time, then it may be that certain 
populations are better or worse at combating UTI-causing organisms. My data provide evidence 
to support this claim. What this ultimately means is that it may be possible to alter the urinary 
microbiota, possibly through lifestyle changes, to generate a more protective state. This is an 
entirely novel approach to UTI therapies. 
 In the forthcoming chapters, I will describe a longitudinal study in which eight pre-
menopausal female participants were recruited to self-collect urine and other biological 
specimens on a daily timescale for approximately three months. Using daily lifestyle 
questionnaires, I show that some factors are associated with temporal changes in the microbiota 
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of the LUT. These are described in Chapters IV & V. One of the most interesting findings from this 
work was an association between vaginal intercourse and microbiota alterations, particularly 
because the changes were consistent within participants and similar among participants. Chapter 
VI describes a follow-up study where one of the original participants and her male sexual partner 
provided additional daily specimens to determine the biological and clinical significance of these 
findings. I found evidence that the intercourse-associated microbiota originate from outside the 
urogenital tract. I further found that these microbiota, in vitro, are not protective against UTI-
causing organisms, which contrasts with the normal flora. Taken together, these data provide 
evidence that the etiology of UTI risk factors, like sexual intercourse, may be grounded in the 
microbiota. This creates a new avenue to provide therapeutic and preventative measures for 
patients that are at risk of developing UTIs.
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CHAPTER II 
MATERIALS AND METHODS 
Overview of Clinical Studies 
 In this thesis, I present data for three clinical studies used to assess the temporal dynamics 
of the microbiota of the female LUT. In Chapter III, I describe data obtained from my 
pilot/feasibility project, the MAGnUM Study (Measuring the effects of Alcohol on the Genito-
urinary Microbiota). This work was done in collaboration with Danielle Johansen, MS, a former 
Master’s student in the lab. The primary goals of the MAGnUM study were to assess the 
feasibility of longitudinal urine specimen collection in community women, to determine the 
short-term temporal dynamics of the microbiota of the LUT, and to determine the effects of one 
lifestyle factor, alcohol consumption, on the temporal dynamics. 
 In Chapters IV and V, I describe data obtained from the primary project, the ProFUM 
Study (Probiotics and the Female Urinary Microbiome). This work was done in collaboration with 
Birte Wolff, MD, a urogynecology fellow at Loyola University Medical Center (Maywood, IL). The 
primary goals of the ProFUM study were to measure the long-term temporal dynamics of the 
microbiota of the LUT in pre-menopausal non-symptomatic women, to assess the relationship 
between lifestyle factors and behaviors, as well as urine properties and constituents, on the 
temporal dynamics, and to determine the effect of oral probiotic use on the microbiota 
composition and diversity and temporal dynamics. 
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 Data obtained from the ProFUM study led us to perform a follow-up project, the PARTNER 
Study (Effect of Sexual Activity on the Urinary Microbiota of Sexual Partners), data from which is 
described in Chapter VI. This work was also done in collaboration with Dr. Birte Wolff. The 
primary goals of the PARTNER study were to further assess the effect of sexual intercourse on 
microbiota temporal dynamics, and to determine whether compositional changes in the 
microbiota were introduced from the male sexual partner. 
MAGnUM Study 
 From October 2016 to March 2017, following Institutional Review Board (IRB) approval, I 
recruited 10 community participants from the Loyola University Medical Center campus to 
provide daily self-collected biological specimens for 18 days. This included both male (n=3) and 
female (n=7) participants, with a mean age of 23. Recruitment was done by presenting the 
research opportunity to the Department of Microbiology & Immunology. Interested participants 
contacted a third-party study nurse to complete the recruitment process, which included 
determining eligibility, providing instructions on the study design and proper specimen 
collection, and supplying study materials. Demographics were collected including age, 
race/ethnicity, and frequency of alcohol consumption. Participants currently taking antibiotics 
were excluded. Eligible participants were assigned unique study ID numbers. As this was a study 
to assess the feasibility of longitudinal urine specimen collection in community participants, no 
power calculation was performed to determine appropriate sample size. 
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 The clinical design for the MAGnUM study is described in Figure 4. MSU urine specimens 
and peri-urethral/meatal swabs were self-collected each morning and delivered to the laboratory 
for analysis (described below). Participants were given written instructions regarding proper 
specimen collection. Contrary to some clinical protocols, the participants were instructed not to 
use the genital cleansing wipe provided in the collection kits prior to specimen collection. The 
purpose of this was to allow us to study the differences between the peri-urethral area and MSU 
specimens to understand the microbial contributions of both. I was concerned that use of the 
cleansing wipe would disrupt the bacterial communities and provide us with biases and 
inaccurate data. Specimens collected on weekends, or on days when the participant was not at 
the campus, were stored at room temperature until they could be turned in. Labels with the 
participants’ unique study ID number, type of specimen, day of specimen collection (relative to 
the study), and a place for the participant to record the date of specimen collection were given 
Figure 4. MAGnUM Clinical Study Design Outline. Midstream Voided Urine (MSU) and peri-
urethral swab specimens were self-collected daily from 10 participants (male: n=3; female n=7). 
Total collection time was 17 or 18 days. Two female participants withdrew (Day 11 and Day 13). 
Participants were instructed not to consume alcoholic beverages on weekdays (Monday-Friday) 
as a measure of the effect on the LUT microbiota. 
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to each participant prior to the start of the study. The participants were instructed to attach the 
appropriate filled-out label to each specimen prior to drop off. 
 The three male participants completed 17 days of specimen collection. Two female 
participants (i.e., MAG03 and MAG08) completed 17 days, while three (i.e., MAG09, MAG10, 
MAG11) completed 18 days of specimen collection. I did not receive specimens from MAG08 on 
Day 10. Two female participants withdrew prior to study completion. MAG02 completed 11 
consecutive days, while MAG05 completed 13 consecutive days of specimen collection. 
 As a preliminary assessment of lifestyle factors and behaviors on microbiota stability and 
dynamics, the participants were instructed not to consume alcoholic beverages on weekdays 
(i.e., Monday – Friday). It was the choice of the participant to consume alcohol on weekends (i.e., 
Saturday – Sunday). Participants completed a daily diary documenting alcoholic beverages 
consumed. According to the diaries, no participants deviated from the given instructions. 
 Prior to study completion, I was notified that on the final day of specimen collection (Day 
18), female participant, MAG09, reported to the third-party study nurse that she was 
experiencing UTI symptoms. She was instructed to contact her clinical care physician to receive 
medical care. Outside the context of this study, follow-up conversation with this participant 
revealed that she was diagnosed with a laboratory-confirmed E. coli UTI. 
ProFUM Study 
 From September 2017 to July 2018, following IRB approval, I recruited eight pre-
menopausal female community participants from the Loyola University Medical Center campus 
to provide daily self-collected biological specimens over 95 days. This is a registered clinical trial 
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(NCT03250208): https://clinicaltrials.gov/ct2/show/NCT03250208. Recruitment was done by 
presenting the research opportunity to the Department of Microbiology & Immunology, and by 
word of mouth. Interested participants contacted a third-party study nurse. The study nurse then 
informed the clinical team (i.e., Dr. Birte Wolff), who then coordinated a one-on-one meeting to 
complete the recruitment process.  
 Potential participants completed an inclusion/exclusion questionnaire. Eligible 
participants were female, over 18 years of age, not currently pregnant, taking antibiotics, or 
taking probiotics, not planning a vacation for more than seven days during the time of specimen 
collection (i.e., three months), and could read English and sign a consent form detailing the 
requirements and voluntary nature of the study. Eligible participants were given a unique study 
ID number and then completed a demographics questionnaire, which included the following: age, 
race/ethnicity, height/weight, blood pressure, vaginal parity, birth control method, condom use, 
typical length of menstrual cycles, use of menstrual hygiene products, prior urogynecologic 
surgery, sexual activity (frequency, type, partners), dietary preferences, alcohol consumption, 
number of bowel movements in an average week, use of cigarettes, frequency of bathing, current 
medications, and history of UTI, kidney stones, urinary incontinence, and fecal incontinence. 
Participants were then instructed on proper specimen collection by the clinical team. This was 
done by having each participant watch a standardized video detailing proper collection of an MSU 
specimen, a peri-urethral swab, and a combination vaginal and perineal swab. The clinical team 
provided further explanation if the participant had questions. Consistent with the MAGnUM 
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study, participants were instructed not to use the genital cleansing wipe provided in the urine 
collection kits. 
 At the recruitment meeting, participants were given supplies and instructed on where to 
leave the specimens. A locked drop-box was placed in an accessible room in the Center for 
Translational Research and Education building at Loyola University Medical Center. Only the 
research team had access to the drop-box. All participants had or were given access to this 
building prior to the start of the study. Specimens were collected each morning and participants 
were instructed to turn in the specimens by noon of that day. Specimens collected on weekends, 
or on days when the participant was not at the campus, were stored at room temperature until 
they could be turned in. Labels with the participants’ unique study ID number, type of specimen, 
day of specimen collection (relative to the study), and a place for the participant to record the 
date of specimen collection were given to each participant prior to the start of the study. The 
participants were instructed to attach the appropriate filled-out label to each specimen prior to 
drop off. Daily labeled specimens were put in a biohazard bag along with a daily questionnaire 
(described below) and turned in to the drop-box. 
 A daily lifestyle questionnaire was completed and turned in with each day of specimen 
collection. In reference to the previous day (i.e., previous 24 hours), primarily as yes/no-style 
questions, the questionnaire queries alcohol consumption, menstruation, menstrual hygiene, 
bathing, swimming, sexual activity (oral, vaginal, other), number of bowel movements, and diet 
presented as 26 broad food categories. There was also a section to record any medical-related 
comments including medications used. In reference to the current day (i.e., since waking up and 
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before specimen collection), the questionnaire includes two yes/no-style questions regarding 
urination and bowel movements. The final three participants completed a slightly modified 
lifestyle questionnaire that included two additional questions regarding condom use with vaginal 
intercourse and whether the partner was the same as the previous episode. 
 Participants first completed a three-day screening period to determine final study 
eligibility. The purpose of this screening period was to assess proper specimen collection. As 
described in Chapter I, MSU specimens should be sampling the microbial contents of the bladder 
and urethra. Contribution of the peri-urethra should be minimal. Therefore, I excluded 
participants who provided MSU and peri-urethral specimens with similar microbial contents. 
Similarity was determined using the Bray-Curtis Dissimilarity test with a value of 0.8 as a cut-off 
for eligibility. Eligible participants had to provide paired specimens with scores > 0.8 for two out 
of the three collection days in the screening period. The rationale and determination of this cutoff 
are explained in Chapter III using data from the MAGnUM study. 
 Eleven eligible participants were screened for final study eligibility using the three-day 
screening period. Using the exclusion criteria described above, three participants were excluded 
from the final study. These data are provided in Chapter IV. The remaining eight participants 
were informed of their results and a second one-on-one meeting with the clinical team was 
arranged in which the ProFUM study design was described and a W2-form was completed to 
provide the participant with compensation following successful study completion. Participants 
were compensated $800 for their time; this was prorated to $6 per day of completion if the 
participant withdrew (none withdrew). To receive full compensation, the participant could not 
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miss more than seven collection days (all participants received full compensation). Participants 
were not compensated for the three-day screening period. 
 The clinical design for the ProFUM study is described in Figure 5. MSU urine specimens 
and peri-urethral swabs were self-collected each morning for 74 consecutive days followed by 
weekly collection through Day 95. A combination vaginal and perineal swab was collected weekly 
from Days 25 – 95. These were delivered each morning (as described above) for laboratory 
analysis (described below). As this was an exploratory study to understand the temporal 
dynamics and the influence of lifestyle on the microbiota of the LUT, no power calculation was 
performed to determine appropriate sample size. The goal was to recruit nine participants into 
the final study (I recruited eight). 
Figure 5. ProFUM Clinical Study Design Outline. Midstream Voided Urine (MSU) and peri-
urethral swab specimens were self-collected daily from 8 participants from Days 1 – 74, followed 
by weekly collection through Day 95. Daily lifestyle questionnaires were completed on each of 
these days. Vaginal/perineal swabs were collected weekly from Days 25 – 95. The study design 
was divided into three phases: Phase I (Days 1 – 20), Phase II (Days 21 – 60), and Phase III (Days 
61-95). During Phase II, the participants were randomized (2:1) to take an oral probiotic or 
placebo twice daily. This assignment was double-blinded. 
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 The study design (Figure 5) was divided into three phases. Phases I and III flanked an 
experimental or treatment phase (i.e., Phase II) in which the participants were randomized in a 
2:1 ratio to take an oral probiotic or placebo. The probiotic used was L. rhamnosus GR-1 and L. 
reuteri RC-14 at a sum of 109 viable organisms (collectively known as Fem-Dophilus®) to be taken 
twice daily. The probiotic capsules were purchased from www.iherb.com and were sent directly 
to the Loyola University Medical Center inpatient pharmacy department where a randomization 
scheme at a 2:1 ratio was chosen in a double-blinded manner. The capsules were stored at room 
temperature as per the manufacturer recommendations. The probiotic was re-packaged in 
capsules that were identical to the placebo capsules which contained a carbohydrate placebo. 
Pill bottles were labelled with the participant’s name, date of packaging, and “Placebo/Probiotic”. 
As an evaluation of the success of blinding, at the completion of the study, participants were 
asked which study group they thought they were in. Following study completion, it was 
determined that five participants were in the probiotic cohort, and three were in the placebo 
cohort.  
 During Phase I, which was from Days 1 – 20, all participants collected daily MSU (n=20) 
and peri-urethral (n=20) specimens as well as completed the daily lifestyle questionnaire (n=20). 
During Phase II, which was from Days 21 – 60, all participants collected daily MSU (n=40) and 
peri-urethral (n=40) specimens, provided weekly vaginal/perineal specimens (n=6), and 
completed the daily lifestyle questionnaire (n=40). Probiotic/placebo pills were taken twice daily 
during Phase II. As a measure of compliance, they turned in the pill bottle following Phase II 
completion; the number of remaining pills was documented. During Phase III, which was from 
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Days 61 – 95, all participants collected MSU (n=17) and peri-urethral (n=17) specimens as well as 
completed the daily lifestyle questionnaire (n=17) on a daily-basis from Days 61 – 74, followed 
by weekly collection from Days 74 – 95. Vaginal/perineal specimens (n=5) were collected weekly. 
Necessary study materials were provided prior to each phase. Prior to Phase II, the participants 
received their assigned pill bottles along with a description of the use and risks of taking the 
probiotic, which was provided by the manufacturer. 
PARTNER Study 
 From September 2018 to October 2018, following IRB approval, I enrolled one female 
participant and her male sexual partner in a follow-up study to further investigate the effects of 
sexual intercourse on the microbiota of the female LUT. The female participant was previously 
enrolled in the ProFUM Study as participant ProFUM05. The clinical team (i.e., Dr. Birte Wolff) 
coordinated a one-on-one meeting to complete the recruitment process. As part of the study 
design (Figure 6), the male sexual partner of the female participant (PARTNER01) was also 
enrolled in the study (PARNTER02), following consent. 
 Prior to study enrollment, the male participant completed an inclusion/exclusion 
questionnaire. Eligible participants were in a sexual relationship with a female participant of the 
ProFUM study, male, over 18 years of age, not currently taking antibiotics, not planning a 
vacation for more than seven days during the time of specimen collection (i.e., three weeks), and 
could read English and sign a consent form detailing the requirements and voluntary nature of 
the study. Eligible participants then completed a demographics questionnaire, which included 
the following: age, race/ethnicity, height/weight, blood pressure, circumcision status, condom 
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use, prior urologic surgery, sexual activity (frequency, type, partners), dietary preferences, 
alcohol consumption, number of bowel movements in an average week, use of cigarettes, 
frequency of bathing, current medications, and history of UTI, and kidney stones. The female 
participant completed these forms as part of the ProFUM study and therefore was not required 
to do so for the PARTNER study.  
 The male and female participants were then instructed on proper specimen collection by 
the clinical team. This was done by having each participant watch a standardized video detailing 
proper collection of an MSU specimen, a peri-urethral swab, a vaginal swab, and an oral/buccal 
swab for the female, and an MSU specimen, a meatal swab, a penile swab, and an oral/buccal 
swab for the male. The clinical team provided further explanation if the participant had 
Figure 6. PARTNER Clinical Study Design Outline. The female participant (PARTNER01) (i.e. 
ProFUM05) self-collected Midstream Voided Urine (MSU) and peri-urethral and vaginal swab 
specimens daily for 3 weeks (Days 1 – 21). The male participant (PARTNER02) self-collected MSU 
and meatal and penile swab specimens before and after (within 30 minutes of) sexual 
intercourse for 3 weeks. Additionally, both participants self-collected an oral/buccal swab once 
per week for 3 weeks. The participants were instructed to engage in sexual intercourse once per 
week for the duration of the study. Daily lifestyle questionnaires were completed for all 21 days 
by both participants. 
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questions. Consistent with the MAGnUM and ProFUM studies, participants were instructed not 
to use the genital cleansing wipe provided in the urine collection kits. 
 At the recruitment meeting, participants were given supplies and instructed on where to 
leave the specimens. A locked drop-box was placed in an accessible room in the Center for 
Translational Research and Education building at Loyola University Medical Center. Only the 
research team had access to the drop-box. All participants had or were given access to this 
building prior to the start of the study. Specimens collected on weekends or on days when the 
participant was not at the campus, were stored at room temperature until they could be turned 
in. Labels with the participants’ unique study ID number, type of specimen, day of specimen 
collection (relative to the study), and a place for the participant to record the date of specimen 
collection were given to each participant prior to the start of the study. The participants were 
instructed to attach the appropriate filled-out label to each specimen prior to drop off. Daily 
labeled specimens were put in a biohazard bag along with a daily questionnaire (described below) 
and turned in to the drop-box. 
 A daily lifestyle questionnaire was completed and turned in with each day of specimen 
collection. The questionnaire was identical to the one used in the ProFUM study, but included 
the following additional questions regarding sexual activity: type of sexual activity (oral, vaginal, 
anal, manual), products used (condom and lubricant), brand of products used (if applicable), time 
of day (morning, afternoon, evening), and habits immediately following the sexual activity (i.e. 
within 30 minutes) (bathing and urination). The male and female participants completed 
separate questionnaires. The questionnaires were identical except for questions regarding 
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menstruation and menstrual hygiene, which were included in the female’s questionnaire only. 
Responses to the questions regarding sexual activity were consistent between the participants 
for each occasion (i.e., no discrepancies were noted). 
 Four female participants from the ProFUM study were eligible for enrollment in the 
PARTNER study. These participants showed significant alterations to the microbiota of the LUT 
following sexual intercourse in the ProFUM study (see Chapter V). Participant ProFUM05 was the 
first of the four that the clinical team approached to determine her interest in the PARTNER 
study. ProFUM05 and her male sexual partner agreed to participate in the PARTNER study. The 
participants completed W2-forms to provide them with compensation following successful study 
completion. Participants were each compensated $200 for their time; this was prorated to $6 per 
day of completion if the participant withdrew (none withdrew). 
 The clinical design for the PARTNER study is described in Figure 6. The female participant 
(PARTNER01) self-collected MSU specimens, and peri-urethral and vaginal swabs each morning 
for 21 consecutive days. The male participant (PARTNER02) self-collected MSU specimens, and 
meatal and penile swabs before and after sexual intercourse (i.e., within 30 minutes). Both 
participants self-collected an oral/buccal swab once per week. The participants were instructed 
to engage in sexual intercourse once per week (i.e., during Days 1-7, 8-14, and 15-21). Responses 
to the lifestyle questionnaire showed compliance. 
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Bacterial Identification Methods 
Specimen Collection 
 For all clinical studies described above, appropriate specimen collection materials for at-
home collection by the participants were given at one time in bulk. Written (MAGnUM study) 
and video (ProFUM and PARTNER studies) instructions were given to participants regarding 
proper specimen collection.  
 MSU specimens were collected by voiding into a toilet to discard the initial void (i.e., 
approximately the first 10 mL of urine). The remaining specimen was then collected into a sterile 
blue cap collection cup. A portion of each urine sample was placed in a sterile manner into a BD 
Vacutainer® Plus C&S Preservative Tube for culturing. The tube contained a lyophilized boric acid 
preservative to prevent bacterial overgrowth without causing cell death. Thus, specimens could 
be held at room temperature for up to 72 hours without altering specimen integrity. Specimens 
that were collected more than 72 hours prior to receipt were excluded from analyses. 
Participants were instructed not to use the genital cleansing wipe included in each kit.  
 All swab specimens were collected using a BD ESwab® Liquid Amies Collection and 
Transport System. The flocked swabs allow for optimal elution of the specimen into the medium. 
Specimens stored at room temperature generally show bacterial viability up to 48 hours. 
However, no preservative to prevent bacterial overgrowth was included in the collection tubes. 
Therefore, specimens that were collected more than 48 hours prior to receipt were excluded 
from analyses due to the possibility of bacterial overgrowth and thus inaccurate data. Peri-
urethral swabs were collected by swabbing approximately 1 cm around the urethral opening. 
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This was referred to as a meatal swab for the male participant in the PARTNER study. Vaginal 
swabs were collected by inserting the swab approximately 2 cm into the vaginal opening and 
rotating. Perineal/vaginal swabs (ProFUM study) were collected in the same manner as the 
vaginal swabs but following removal from the vagina the swab was then moved down the 
perineum towards the anus. Penile swabs were collected by swabbing the shaft of the penis. 
Oral/buccal swabs were collected by swabbing the inner cheeks of the mouth. 
Expanded Culture Protocol 
 I used a modified version of the Expanded Quantitative Urine Culture (EQUC) protocol to 
identify the microbiota of the specimens34. For the MSU specimens, 0.01 mL (female specimens) 
or 0.1 mL (male specimens) of urine was spread quantitatively onto diverse media types [BAP, 
CNA agar, and CDC anaerobe 5% BAP (ABAP)] and incubated in appropriate environments at 
appropriate temperatures (5% CO2 at 35°C for 48 hours or anaerobic conditions at 35°C for 48 
hours). CNA agar contains approximately 10 mg/L colistin and 15 mg/L nalidixic acid for the 
growth inhibition of Gram-negative organisms. ABAP contains additional growth factors required 
by common obligate anaerobes including hemin (5 mg/L), L-cystine (400 mg/L), and vitamin K1 
(10 mg/L). Each morphologically distinct colony type was counted and isolated on a different 
plate of the same media to prepare a pure culture for identification by MALDI-TOF MS, using the 
Bruker MALDI Biotyper Research (RUO) System. All swab specimens underwent the same 
protocol using 0.01 mL of the liquid elution media after the swab was vortexed in the collection 
tube for 10 seconds. The anaerobic condition was not used for the oral/buccal swabs. An 
82 
 
 
 
overview of the specimen volumes used, and specimen types collected for each clinical study is 
described in Table 2. 
16S Sequencing Protocol 
 The remaining volumes of the MSU and swab specimen elution media after bacterial 
culture were aliquoted for 16S rRNA gene sequencing. 10% (of the specimen volume) 
AssayAssure (Sierra Molecular, Incline Village, NV) was added before storage at -80°C. Specimens 
were assigned a unique Wolfe Lab identifier. Volume, color, turbidity, and pH were recorded for 
all MSU specimens. 
 Each specimen was processed under a negative pressure laminar flow hood to prevent 
environmental contamination. This is particularly relevant for low biomass samples such as 
bladder specimens. All materials were bleached, and the hood was subjected to ultraviolet (UV) 
light for 30 minutes prior to use. 70% ethanol was periodically used to sterilize gloves during the 
early stages of the DNA extraction where exogenous bacteria could contaminate specimens. 
DNA-away was used later in the extraction where exogenous DNA could contaminate specimens. 
 
MAGnUM Study ProFUM Study PARTNER Study 
Female (n=7) Male (n=3) Female (n=8) Female (n=1) Male (n=1) 
Midstream Urine (MSU) 0.01 mL 0.1 mL 0.01 mL 0.01 mL 0.1 mL 
Peri-urethral/Meatal 
swab 0.01 mL 0.01 mL 0.01 mL 0.01 mL 0.01 mL 
Perineal/Vaginal swab - - 0.01 mL - - 
Vaginal swab - - - 0.01 mL - 
Penile swab - - - - 0.01 mL 
Oral/Buccal swab* - - - 0.01 mL 0.01 mL 
All specimens were assessed using a modified EQUC protocol described above. 
* Oral/Buccal swabs were not cultured under anaerobic conditions. 
 
Table 2. Overview of specimens collected, and volumes assessed for bacterial culture. 
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Despite these precautions, I estimate from previous work that the detection threshold is about 
1000 CFU/mL15 35, meaning that specimens with <1000 CFU/mL of bacteria cannot be 
distinguished from background contamination and are thus classified as “negative”.  
 Genomic DNA was extracted from the MSU and swab elution media with the Qiagen 
DNeasy Blood and Tissue kit. 1 mL of urine or 0.5 mL of swab elution media were used. Briefly, 1 
mL of urine was centrifuged at 13,500 rpm for 10 minutes, and the resulting pellet was 
resuspended in 200 µl of a filter-sterilized DNA Extraction Buffer consisting of 20 mM Tris-Cl (pH 
8), 2 mM EDTA, 1.2% Triton X-100, and 20 µg/ml lysozyme and supplemented with 30 µl of filter-
sterilized mutanolysin (5,000 U/ml; Sigma-Aldrich, St. Louis, MO). The addition of mutanolysin 
and lysozyme ensures robust lysis of Gram-positive and Gram-negative species251. The mixture 
was incubated for 1 hour at 37°C, and the lysates were processed through the DNeasy blood and 
tissue kit (Qiagen, Valencia, CA), according to the manufacturer’s protocol. The DNA was eluted 
into 50 µl of buffer AE (10 mM Tris-Cl, 0.5 mM EDTA), pH 8, and stored at -20°C. Negative controls 
(no urine or swab elution media) were included in each extraction performed as an assessment 
of contamination introduced during the protocol. 
 The hyper-variable region 4 (i.e., V4) of the bacterial 16S rRNA gene was amplified via a 
two-step PCR protocol. In the first amplification, the V4 region was amplified using Illumina 
MiSeq modified universal primers 515F and 806R. The extraction negative controls, as well as a 
PCR-negative control (no template), were included to assess the contribution of extraneous DNA 
from reagents. 10 µL aliquots of each reaction mixture were run on a 1% agarose gel. Samples 
containing a band of approximately 360 base pairs were considered PCR-positive and subjected 
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to further library preparation. Samples with no visible amplified product were considered PCR-
negative and not processed further. The PCR-positive reaction mixtures were diluted 1:50 and 
amplified for an additional 10 cycles, using primers encoding the required adapter sequences for 
Illumina MiSeq sequencing and an 8-nucleotide sample index. The PCR reaction was purified, and 
size selected using Agencourt® AMPure XP-PCR magnetic beads (Beckman Coulter, Pasadena, 
CA). Each sample was quantified using the Qubit 2.0 Fluorometeric Bioanalyzer system (Thermo-
Fisher, Waltham, MA). The samples were pooled, quantified to a standard volume, and placed in 
the 2 X 250 bp sequencing reagent cartridge, according to the manufacturer’s instructions 
(Illumina, San Diego, CA).  
 Sample barcodes and sequencing primers were removed using the Illumina proprietary 
MiSeq post-sequencing software. The mothur program (v1.41.3) was used to process the raw 
sequences by following the recommended MiSeq standard operating procedure252. Briefly, 
mothur produced 16S contigs by combining the paired end reads based on overlapping 
nucleotides in the sequence reads; contigs of incorrect length for the V4 region (<290 bp, >300 
bp) and/or contigs containing ambiguous bases were removed. Chimeric sequences were 
removed using UCHIME within the mothur package253. Subsampling at a depth of 5000 sequences 
was performed to correct for different sequencing depth of each sample. The sequences were 
clustered into species-level OTUs with identity cutoff at 97%254. The OTUs were classified using 
RDP classifier (v2.11) at the genus level254 and BLCA11 at the species level. 
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Dipstick Urinalysis 
 Each MSU specimen was characterized using a urine dipstick prior to being aliquoted and 
stored. Approximately 1 mL of urine was pipetted onto a Siemens Multistix® 10 SG Reagent Strip. 
Results were read and interpreted according to the manufacturer’s instructions. The reagent strip 
tests for the presence and quantity (or relative quantity) of glucose, bilirubin, ketones, 
hemoglobin (i.e., blood), protein, urobilinogen, nitrites, and leukocytes. pH and specific gravity 
are also provided. A more detailed explanation of these tests is provided in Chapter I. 
Storage of Bacterial Isolates 
 Several experiments described in Chapter VI rely on the use of bacterial strains isolated 
from participants of the various clinical studies described. In particular, strains of L. jensenii and 
Streptococcus mitis isolated from a female participant (ProFUM05 and PARTNER01) were used in 
both genomic and in vitro assays (see Chapter VI). Following identification using MALDI-TOF MS, 
certain bacterial strains were isolated for purity, stored in CryoSavr tubes pre-filled with Brucella 
medium and glycerol (Hardy Diagnostics CS100BNB), and kept at -80°C. In some cases, multiple 
isolates of the same species were stored. 
Statistical Analyses 
 Statistical analyses of microbiota data were performed using SAS software version 9.4 
(Cary, NC). Microbiota stability measures were calculated using Jensen-Shannon Divergence 
(JSD). Wilcoxon rank sum tests and Mann-Whitney U tests were used to compare mean or 
median JSD values with participant-reported lifestyle data. Frequency of bacterial detection was 
compared to lifestyle data using either Pearson chi-square or Fisher’s exact tests, depending on 
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assumption validity. Chi-square testing was used to compare categorical variables. One-way 
analysis of variance (ANOVA) was used to compare continuous variables. Student t-tests were 
performed to evaluate the association between microbial ratios and probiotic or placebo use, as 
well as differences in average optical density (OD) and CFU values between groups. Correlations 
between variables were determined using the Pearson Correlation test. All test results were 
considered significant using a p-value of <0.05. Relative abundance graphs, alpha diversity 
measures, PCoA, dendrograms, heatmaps, and dot plots were generated in RStudio. 
Whole Genome Sequencing 
DNA Extraction and Library Prep 
 In Chapter VI, I describe the rationale for sequencing the genomes of several isolates of 
S. mitis. In brief, I sought to determine the origin of S. mitis isolates found in MSU specimens of 
a female participant following sexual intercourse with her male sexual partner. To do this, I must 
determine if MSU-isolated strains are clonally related to strains from other specimens (female or 
male). 
 S. mitis isolates were grown in their preferred medium (described below) and pelleted. 
Genomic DNA was extracted from pellets using a phenol-chloroform method. Briefly, pellets 
were resuspended in 0.5 mL of a DNA Extraction Buffer (described above). 50 µL lysozyme (20 
mg/mL), 30 µL mutanolysin, and 5 µL RNase (10 mg/mL) were then added, followed by a 1-hour 
incubation at 37°C. Next, 80 µL of 10% sodium dodecyl sulfate (SDS) and 10 µL proteinase K were 
added, followed by a 2-hour incubation at 55°C. Then, 210 µL 6M NaCl and 700 µL phenol-
chloroform were added for density separation. Following room temperature incubation and 
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constant rotation for 1 hour, the samples were centrifuged at 13,500 rpm for 10 minutes. The 
aqueous phase was aliquoted to a new tube and an equal volume of isopropanol was added 
followed by an additional 10 min centrifugation. The supernatants were decanted and washed 
with 600 µL of 70% ethanol. The DNA was pelleted, the supernatants were decanted, and the 
tubes were left at room temperature to dry before being resuspended in 50 µL of TE buffer and 
stored at -20°C.  
 The Illumina Nextera kit was used for whole genome library preparation255. Briefly, the 
bacterial genome was fragmented and tagged using a transposon system. Illumina sequencing 
adapters and dual-index barcodes were added to allow for multiplexing of samples. The resulting 
fragments were purified and size-selected using AMPure XP beads, quantified via the Qubit 2.0 
Fluorometer and Agilent Bioanalyzer, normalized to equimolar concentrations, and sequenced 
using the Illumina MiSeq System. The concentrations of DNA loaded onto the sequencer were 
calculated based on the expected genome size and average fragment size to achieve 100X 
coverage of the entire genome. The Illumina MiSeq can cover 7500 mega base pairs (mbp) per 
sequence run. Because the genome of S. mitis is approximately 2.5 Mbp, to achieve 100X 
coverage 30 isolates were sequenced at once. Quality control and de-multiplexing of sequence 
data was done with onboard MiSeq Control software and MiSeq Reporter (current version: 3.1). 
Assembly and Annotation 
 Annotated assemblies were produced using the pipeline described previously256. For each 
sample, sequence reads were used to create multiple assemblies using Velvet v1.2257 and 
VelvetOptimiser v2.2.5. An assembly improvement step was applied to the assembly with the 
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best N50 and contigs were scaffolded using SSPACE258 and sequence gaps filled using GapFiller259. 
Assembly was repeated using the SPAdes assembler260. Automated annotation was performed 
using PROKKA v1.11261. 
 To confirm accurate speciation, the 16S rRNA gene was extracted from the annotation 
using Artemis262, and BLASTed for classification263. For phylogenetic analysis of the 16S gene, 
alignments were generated using MAFFT264 in Galaxy, RAxML265 for bootstrapping and tree 
generation, and Figtree and ITOL266  for tree visualization. 
Bacterial Assays: Experimental Procedures 
Bacterial Strains and Growth Conditions 
 Bacterial isolates from the ProFUM and PARTNER studies were isolated and stored for 
future genomic and phenotypic assessments (see Chapter VI). A total of 135 isolates were 
collected. The origins of these strains are summarized in Table 3. Briefly, 81 isolates were 
collected from the ProFUM study from MSU specimens of participant ProFUM05 during 
collection days 31-70. These isolates included one representative isolate of each collection day 
for the following species: L. jensenii (n=34), G. vaginalis (n=28), S. mitis (n=16), and Streptococcus 
agalactiae (n=3). The remaining 54 isolates were collected from the PARTNER study from both 
the male and female participants. These strains included 1-3 representative isolates of each 
collection day and specimen type. All 54 isolates were identified as S. mitis. 
 L. jensenii and S. mitis isolates were grown on CNA media incubated under 5% CO2 
conditions at 37°C for 48 hours. G. vaginalis isolates were grown on ABAP media incubated 
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anaerobically at 37°C for 48 hours. S. agalactiae isolates were grown on BAP media incubated 
aerobically at 37°C for 48 hours. E. coli strains were grown on BAP media incubated aerobically 
  
 
Collection # Isolate # Species Participant ID Specimen Type Collection Day 
1 LJ31 LJ ProFUM05 MSU 31 
2 GV31 GV ProFUM05 MSU 31 
3 LJ32 LJ ProFUM05 MSU 32 
4 GV32 GV ProFUM05 MSU 32 
5 LJ33 LJ ProFUM05 MSU 33 
6 GV33 GV ProFUM05 MSU 33 
7 SM34 SM ProFUM05 MSU 34 
8 LJ35 LJ ProFUM05 MSU 35 
9 GV35 GV ProFUM05 MSU 35 
10 LJ36 LJ ProFUM05 MSU 36 
11 LJ37 LJ ProFUM05 MSU 37 
12 GV37 GV ProFUM05 MSU 37 
13 LJ38 LJ ProFUM05 MSU 38 
14 GV38 GV ProFUM05 MSU 38 
15 SM38 SM ProFUM05 MSU 38 
16 LJ39 LJ ProFUM05 MSU 39 
17 GV39 GV ProFUM05 MSU 39 
18 LJ40 LJ ProFUM05 MSU 40 
19 GV40 GV ProFUM05 MSU 40 
20 LJ41 LJ ProFUM05 MSU 41 
21 GV41 GV ProFUM05 MSU 41 
22 LJ42 LJ ProFUM05 MSU 42 
23 GV42 GV ProFUM05 MSU 42 
24 SM42 SM ProFUM05 MSU 42 
25 LJ43 LJ ProFUM05 MSU 43 
Table 3. Overview of bacterial isolates used. 
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26 GV43 GV ProFUM05 MSU 43 
27 SM43 SM ProFUM05 MSU 43 
28 LJ44 LJ ProFUM05 MSU 44 
29 GV44 GV ProFUM05 MSU 44 
30 SM44 SM ProFUM05 MSU 44 
31 LJ46 LJ ProFUM05 MSU 46 
32 LJ47 LJ ProFUM05 MSU 47 
33 SM47 SM ProFUM05 MSU 47 
34 LJ48 LJ ProFUM05 MSU 48 
35 GV48 GV ProFUM05 MSU 48 
36 SM48 SM ProFUM05 MSU 48 
37 LJ49 LJ ProFUM05 MSU 49 
38 GV49 GV ProFUM05 MSU 49 
39 SM49 SM ProFUM05 MSU 49 
40 LJ50 LJ ProFUM05 MSU 50 
41 GV50 GV ProFUM05 MSU 50 
42 LJ51 LJ ProFUM05 MSU 51 
43 GV51 GV ProFUM05 MSU 51 
44 LJ53 LJ ProFUM05 MSU 53 
45 GV53 GV ProFUM05 MSU 53 
46 SA53 SA ProFUM05 MSU 53 
47 LJ54 LJ ProFUM05 MSU 54 
48 GV54 GV ProFUM05 MSU 54 
49 SM54 SM ProFUM05 MSU 54 
50 SA54 SA ProFUM05 MSU 54 
51 LJ55 LJ ProFUM05 MSU 55 
52 GV55 GV ProFUM05 MSU 55 
53 SA55 SA ProFUM05 MSU 55 
54 LJ59 LJ ProFUM05 MSU 59 
55 GV59 GV ProFUM05 MSU 59 
56 LJ60 LJ ProFUM05 MSU 60 
57 GV60 GV ProFUM05 MSU 60 
58 LJ61 LJ ProFUM05 MSU 61 
59 SM61 SM ProFUM05 MSU 61 
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60 LJ62 LJ ProFUM05 MSU 62 
61 GV62 GV ProFUM05 MSU 62 
62 SM62 SM ProFUM05 MSU 62 
63 LJ63 LJ ProFUM05 MSU 63 
64 GV63 GV ProFUM05 MSU 63 
65 SM63 SM ProFUM05 MSU 63 
66 LJ64 LJ ProFUM05 MSU 64 
67 GV64 GV ProFUM05 MSU 64 
68 LJ65 LJ ProFUM05 MSU 65 
69 GV65 GV ProFUM05 MSU 65 
70 SM65 SM ProFUM05 MSU 65 
71 LJ66 LJ ProFUM05 MSU 66 
72 LJ67 LJ ProFUM05 MSU 67 
73 LJ68 LJ ProFUM05 MSU 68 
74 GV68 GV ProFUM05 MSU 68 
75 SM68 SM ProFUM05 MSU 68 
76 LJ69 LJ ProFUM05 MSU 69 
77 GV69 GV ProFUM05 MSU 69 
78 SM69 SM ProFUM05 MSU 69 
79 LJ70 LJ ProFUM05 MSU 70 
80 GV70 GV ProFUM05 MSU 70 
81 SM70 SM ProFUM05 MSU 70 
82 SM01 SM PARTNER01 MSU 1 
83 SM02 SM PARTNER01 MSU 1 
84 SM03 SM PARTNER01 MSU 1 
85 SM04 SM PARTNER01 MSU 2 
86 SM05 SM PARTNER01 MSU 2 
87 SM06 SM PARTNER01 MSU 2 
88 SM07 SM PARTNER01 PU 2 
89 SM08 SM PARTNER01 PU 2 
90 SM09 SM PARTNER01 OS 2 
91 SM10 SM PARTNER01 OS 2 
92 SM11 SM PARTNER01 OS 2 
93 SM12 SM PARTNER02 OS WK1-B 
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94 SM13 SM PARTNER02 OS WK1-B 
95 SM14 SM PARTNER02 OS WK1-B 
96 SM15 SM PARTNER02 PS WK1-A 
97 SM16 SM PARTNER02 PS WK1-A 
98 SM17 SM PARTNER01 MSU 3 
99 SM18 SM PARTNER01 MSU 3 
100 SM19 SM PARTNER01 MSU 3 
101 SM20 SM PARTNER01 VS 3 
102 SM21 SM PARTNER01 MSU 4 
103 SM22 SM PARTNER01 MSU 5 
104 SM25 SM PARTNER01 MSU 7 
105 SM26 SM PARTNER01 OS 8 
106 SM27 SM PARTNER01 MSU 9 
107 SM28 SM PARTNER01 MSU 9 
108 SM29 SM PARTNER01 MSU 9 
109 SM30 SM PARTNER01 PU 9 
110 SM31 SM PARTNER01 PU 9 
111 SM32 SM PARTNER01 PU 9 
112 SM33 SM PARTNER02 OS WK2-B 
113 SM34 SM PARTNER02 OS WK2-B 
114 SM35 SM PARTNER01 MSU 10 
115 SM36 SM PARTNER01 MSU 10 
116 SM37 SM PARTNER01 MSU 10 
117 SM38 SM PARTNER01 MSU 15 
118 SM39 SM PARTNER01 OS 15 
119 SM40 SM PARTNER01 OS 15 
120 SM41 SM PARTNER01 OS 15 
121 SM42 SM PARTNER01 MSU 16 
122 SM43 SM PARTNER01 MSU 16 
123 SM44 SM PARTNER01 MSU 16 
124 SM45 SM PARTNER01 MSU 17 
125 SM46 SM PARTNER01 MSU 17 
126 SM47 SM PARTNER01 MSU 17 
127 SM48 SM PARTNER02 OS WK3-B 
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128 SM49 SM PARTNER02 OS WK3-B 
129 SM50 SM PARTNER02 OS WK3-B 
130 SM51 SM PARTNER01 MSU 18 
131 SM52 SM PARTNER01 MSU 18 
132 SM53 SM PARTNER01 MSU 18 
133 SM54 SM PARTNER01 MSU 19 
134 SM55 SM PARTNER01 MSU 19 
135 SM56 SM PARTNER01 MSU 19 
at 37°C for 24 hours. Pure cultures of L. jensenii were transferred to De Man, Rogosa and Sharpe 
(MRS) broth and incubated under 5% CO2 conditions at 37°C for 48 hours. Pure cultures of S. mitis 
were transferred to Brain Heart Infusion (BHI) broth with 10% Fetal Bovine Serum (FBS) and 
incubated under 5% CO2 conditions at 37°C for 48 hours. Pure cultures of E. coli were transferred 
to Tryptic Soy Broth (TSB) and incubated aerobically at 37°C for 24 hours. 
Urothelial Cell Adherence Assays 
 A non-malignant urothelial cell line (HURO23A) established by Dr. Phong Le267 was used 
to assess the ability of bacterial strains to adhere to bladder tissue in vitro. Urothelial cells were 
grown in Dulbecco’s Modified Eagle Medium/Nutrient Mixture F-12 (DMEM/F-12) with 5% FBS 
in 5% CO2 conditions at 37°C. Cells were enumerated using a hemocytometer and approximately 
105 cells/mL tissue culture media (i.e., DMEM/F-12 with 5% FBS) were seeded into 24 well 
microtiter plates in triplicate. Cells were incubated overnight to promote adherence. 
 Urinary bacterial strains and uropathogenic E. coli (UPEC) strains were grown accordingly, 
pelleted, washed twice with peptone buffered saline (PBS) and resuspended in PBS. Cell-free 
Abbreviations: L. jensenii (LJ), S. mitis (SM), G. vaginalis (GV), S. agalactiae (SA), Peri-urethral 
swab (PU), Oral swab (OS), Vaginal swab (VS), Penile swab (PS) 
 
         
 
94 
 
 
 
supernatants were collected from some strains using a 0.2-micron filter. Depending on the 
experimental question, bacterial cells were either resuspended in tissue culture media and added 
in a 1:1 volume ratio to the urothelial cells, or the bacterial cells were first pre-treated with 
supernatants of other strains for 1 hour in a 1:1 volume ratio prior to adding the bacterial cells 
to the urothelial cells. As negative controls, bacterial cells were also pre-treated with media 
controls. Between 107 and 108 CFU/mL of bacterial cells were used. 
 The co-cultures of bacterial and urothelial cells were incubated at 5% CO2 in 37°C for 3 
hours. Empty wells (i.e., no urothelial cells) were used as negative controls to determine the level 
of bacterial adherence to the plastic surface of the 24 well microtiter plates. After 3 hours, the 
wells were washed with PBS three times and 500 µL of 0.1% Triton-X was added to each well. The 
contents of each well were then serially diluted and plated on BAP media and incubated in 5% 
CO2 conditions at 37°C for 24-48 hours. CFUs were enumerated and average values obtained 
from the negative controls were subtracted from the experimental conditions (i.e., wells with 
urothelial cells). 
Biofilm Assays 
 Urinary bacterial strains were grown accordingly, pelleted, and the cell-free supernatants 
were collected using a 0.2-micron filter. Strains of UPEC were grown accordingly for overnight 
cultures. UPEC clinical strains isolated from patients with cystitis (i.e., bladder infection) NU14268 
and UTI89269 were used, as well as a mutant strain NU14∆fimH (also known as NU14-1)270, which 
has a deletion of the fimH gene. The FimH protein forms part of the fimbriae that E. coli uses for 
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surface attachment. Therefore, the fimH mutant strain adheres poorly to surfaces, cannot form 
a biofilm, and was therefore used as a negative control270.  
 E. coli strains were diluted and 100 µL were placed into a 96 well microtiter plate. At 
various timepoints (0, 0.5, 1, 2, 4, and 6 hours) after addition of E. coli, an equal volume of urinary 
bacterial supernatants were added. Media controls and PBS were included as negative controls. 
Plates were incubated aerobically for 24 hours total. E. coli biofilm formation was assessed using 
a standard crystal violet assay. Wells were decanted and washed with PBS three times. 200 µL of 
crystal violet stain was added to each well and left for 10 minutes. The crystal violet stain was 
then decanted, and the plates were left to dry for 30 minutes before adding 200 µL of 70% 
ethanol to each well. OD600 measurements were taken. Measurements were divided by two to 
reflect the starting volume of E. coli. 
Growth Competition Assays 
 Urinary bacterial strains and UPEC strains were grown accordingly for overnight cultures. 
Separately, some strains were grown, pelleted, and the cell-free supernatants were collected 
using a 0.2-micron filter. Depending on the experimental question, various combinations of 
cultures and cell-free supernatants were combined in a 1:1 volume ratio, and bacterial cell 
growth was periodically measured by optical density (i.e., OD600) and plated for viable CFUs. 
These experiments assayed bacterial growth over 24 to 48 hours in the presence or absence of 
bacterial cell-free supernatants with or without the addition of various chemicals.
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CHAPTER III 
FEASIBILITY PROJECT: MAGnUM STUDY 
Overview of MAGnUM Study 
 The MAGnUM Study (Measuring the effects of Alcohol on the Genito-urinary Microbiota) 
was conducted from October 2016 to March 2017 as a pilot/feasibility project. The primary goals 
of the MAGnUM study were to assess the feasibility of longitudinal urine specimen collection in 
community women and men, to determine if short-term temporal dynamics of the microbiota of 
the LUT exist, and to determine the effects of one lifestyle factor, alcohol consumption, on the 
temporal dynamics. The study design is described in Figure 4. Three males and seven females 
participated in the study. MSU and peri-urethral swab specimens were collected each day for 
approximately 2.5 weeks. A modified EQUC protocol was used to determine the microbiota of 
the specimens. 16S rRNA gene sequencing was not performed due to cost. Alcohol consumption 
by the participants was self-reported. 
Longitudinal Assessment of the Microbiota of the Male LUT 
 All three male participants completed 17 days of specimen collection. The median age of 
the male participants was 23. All three participants identified as White/Caucasian. I identified 19, 
26, and 30 unique species in the MSU specimens of MAG01, MAG04, and MAG06, respectively. 
The predominant genera that I identified were Corynebacterium, Staphylococcus, and 
Streptococcus. 
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 Participant MAG01 
Participant MAG04 
Participant MAG06 
Figure 7. Microbiota Profiles of MSU Specimens of Male Participants MAG01, MAG04, and 
MAG06 as determined by EQUC. Microbiota profiles are shown as stacked bar graphs depicting 
the relative abundance of various genera (the 12 most abundance genera are described in key 
above graphs) over time in chronological order. Bars that appear “black” refer to days where no 
bacteria were identified by EQUC. Bars that appear “grey” refer to unclassified taxa. Bars that 
appear “white” refer to days where no specimen was collected. MSU microbiota of all three 
male participants of the MAGnUM study are shown. Total bacterial counts (i.e., CFU/mL) are 
shown on the secondary y-axes and are depicted by the black line graphs. 
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 Figure 7 shows the microbiota of the MSU specimens for all three male participants over 
the 17 days. The y-axes depict the relative abundance, as percentage of CFUs, of the various taxa 
identified within each specimen. The secondary y-axes show the total CFUs. When viewed 
longitudinally, the data show a level of instability. Qualitatively, the MSU specimens of MAG01 
vary in the abundance of Staphylococcus (light blue) and Corynebacterium (orange). The MSU 
specimens of MAG04 are typically predominated by Corynebacterium, but various other genera, 
primarily anaerobes, are found each day. The MSU specimens of MAG06 vary in their levels of 
Corynebacterium, Staphylococcus, and Streptococcus (green). 
 Alcohol consumption was recorded by the participants throughout the study. The 
rationale for studying alcohol consumption was that it is a relatively impersonal factor to report 
and would likely be reported frequently by the particular participant population used in the 
study. Alcohol consumption has varying effects on UTI risk in women, as described in Table 1A. 
In men, little research has been done relating alcohol consumption and UTI risk, but one recent 
study also showed varying effects on UTI risk and LUT symptoms regardless of the amount or 
type of alcohol consumed271. 
 MAG01 and MAG04 reported alcohol consumption on only 1/17 days, thus making an 
analysis of the effects on LUT microbiota stability difficult. MAG06 reported alcohol consumption 
of 6/17 days. To determine the effects of alcohol consumption on microbiota stability, JSD values 
were calculated on the MSU microbiota data for MAG06 and compared between alcohol 
consumption and non-alcohol consumption days. Because specimens were collected in the early 
morning, they reflect lifestyle factors of the previous day rather than the current day (this applies 
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to all future data as well). Therefore, I compared JSD values between non-alcohol consumption 
days and the days after alcohol consumption. For example, MAG06 reported alcohol 
consumption on Days 6, 7, 11, 12, 13, and 14. The ‘alcohol-positive’ days for the analysis were 
Days 7, 8, 12, 13, 14, and 15. Using a Mann-Whitney U test, I determined that the median JSD 
values were not significantly different between alcohol and non-alcohol consumption days 
(p=0.96). Consistent with these data, PCoA showed no separation of the microbiota by alcohol 
consumption (Figure 8). There was also no significant difference in alpha-diversity scores 
[Shannon (p=0.86); Simpson’s (p=0.99)]. Together, these data show that, in the male participant 
Figure 8. Principal Coordinate Analysis of Microbiota of MSU Specimens from Participant 
MAG06. Analysis was done using MSU microbiota data collected from male participant MAG06. 
Graph plots the 1st and 2nd principal coordinates of the data. Percent of total variance explained 
by each principal coordinate is shown in the parentheses. Open circles represent the microbiota 
on days when the participant reported “no alcohol consumption” and closed circles represent 
“alcohol consumption”. 
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MAG06, alcohol consumption is not correlated with significant changes in MSU microbiota 
stability, composition, or alpha diversity, respectively. 
 A secondary aim of the MAGnUM study was to determine if longitudinal assessment of 
the LUT microbiota was feasible. A large component of this assessment concerned specimen 
integrity. I sought to determine the level of microbiota similarity between MSU and peri-urethral 
swab specimens. In the three male participants, the level of microbiota similarity between paired 
specimens varied greatly. Using Bray-Curtis Dissimilarity measures between microbiota of 
specimens collected on the same day, I found that the median value of all collection days was 
vastly different among the male participants. For example, the median Bray-Curtis Dissimilarity 
value for MAG01 was 0.38, but for MAG04 the value was 0.71. For this assessment, values closer 
to 1 indicate dissimilarity between specimen types, while values closer to 0 indicate similarity. 
Therefore, the microbiota of MSU and peri-urethral specimens were, in general, similar in MAG01 
but distinct in MAG04. This trend is further verified by PCoA which shows clear separation of 
microbiota between specimen types for MAG04 but not MAG01 (Figure 9). 
Longitudinal Assessment of the Microbiota of the Female LUT 
 Two female participants (i.e., MAG03 and MAG08) completed 17 days, while three (i.e., 
MAG09, MAG10, MAG11) completed 18 days of specimen collection. I did not receive specimens 
from MAG08 on Day 10. Two female participants withdrew prior to study completion. MAG02 
completed 11 consecutive days, while MAG05 completed 13 consecutive days of specimen 
collection. 
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 The median age of the female participants was 25. Five participants identified as 
White/Caucasian, one as African American/Black (MAG02), and one as Asian (MAG03). All 
participants were pre-menopausal. I identified 26, 15, 13, 18, 28, 31, and 19 unique species in 
the MSU specimens of MAG02, MAG03, MAG05, MAG08, MAG09, MAG10 and MAG11, 
respectively. The predominant genera identified were Lactobacillus and Gardnerella. 
 Similar to the male participants’ data, when viewed longitudinally, the microbiota of the 
MSU specimens from the female participants show a level of instability. Figure 10 shows the 
microbiota of the MSU specimens for three of the seven female participants over time. 
Qualitatively, the MSU specimens vary in the abundance of Lactobacillus (blue) and Gardnerella 
(red) and have rapid and brief disruptions consisting of Streptococcus (green), Staphylococcus 
(light blue), Escherichia (yellow), Alloscardovia (dark orange), and/or Actinomyces (brown). Some  
Figure 9. Principal Coordinate Analyses of Microbiota of Specimens from Participants MAG01 
and MAG04. Analysis was done using MSU (closed circles) and peri-urethral (open circles) 
microbiota data collected from two male participants: MAG01 (left) and MAG04 (right). Graphs 
plot the 1st and 2nd principal coordinates of the data. Percent of total variance explained by each 
principal coordinate is shown in the parentheses. 
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Figure 10. Microbiota Profiles of MSU Specimens of Female Participants MAG03, MAG08, and 
MAG10 as determined by EQUC. Microbiota profiles are shown as stacked bar graphs depicting 
the relative abundance of various genera (the 12 most abundance genera are described in key 
above graphs) over time in chronological order. Bars that appear “black” refer to days where no 
bacteria were identified by EQUC. Bars that appear “grey” refer to unclassified taxa. Bars that 
appear “white” refer to days where no specimen was collected. MSU microbiota of all three 
male participants of the MAGnUM study are shown. Total bacterial counts (i.e., CFU/mL) are 
shown on the secondary y-axes and are depicted by the black line graphs. 
 Participant MAG03 
Participant MAG08 
Participant MAG10 
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microbiota show very little variability over time (e.g., MAG08). Because the participants of the 
MAGnUM study did not record lifestyle factors, it is unclear if the variability, or lack thereof, 
relates to lifestyle.  
 Alcohol consumption, the only lifestyle factor recorded in the MAGnUM study, was 
reported by several of the female participants. In those who reported alcohol consumption at 
least three days during the study (i.e., MAG02, MAG03, MAG08), I compared JSD values between 
non-alcohol consumption days and the days after alcohol consumption to determine if alcohol 
consumption altered the stability of the microbiota. Consistent with the male data described 
above, the JSD values were not significantly different between alcohol and non-alcohol 
consumption days. Furthermore, there was no significant difference in alpha-diversity scores 
(i.e., Shannon and Simpson’s indices). 
 Besides alcohol consumption, illness was inadvertently reported by one of the 
participants. On Day 18, participant MAG09 reported to the study nurse coordinator that she was 
experiencing UTI-like symptoms. Because this was the final day of specimen collection, the 
participant was not withdrawn from the study. She was instructed to contact her primary care 
physician as standard of care. The clinical team was later anecdotally notified that the participant 
had a culture-confirmed UTI of E. coli. Microbiota data of the specimens from MAG09 show that 
E. coli was found at 105 CFU/mL on Days 13, 14, 15, and 18 in the peri-urethra, and Days 15, 16, 
17, and 18 in the MSU (Figure 11). Interestingly, E. coli was first detected on Day 8 in both 
specimens in very low amounts, suggesting that a UTI may be a gradual process. However, it is 
  
104 
 
 
 
  
 MSU Specimens 
Peri-urethral Specimens 
Figure 11. Microbiota Profiles of MSU and Peri-Urethral Specimens of Participant MAG09 as 
determined by EQUC. Microbiota profiles are shown as stacked bar graphs depicting the relative 
abundance of various genera (the 12 most abundant genera are described in key above graphs) 
over time in chronological order. MSU (top) and peri-urethral (bottom) microbiota of three of 
the seven female participants of the MAGnUM study are shown. Bars that appear “black” refer 
to days where no bacteria were identified by EQUC. Bars that appear “grey” refer to unclassified 
taxa. Bars that appear “white” refer to days where no specimen was collected. Total bacterial 
counts (i.e., CFU/mL) are shown on the secondary y-axes and are depicted by the black line 
graphs. The participant reported UTI-like symptoms on Day 18. 
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unclear if the strain of E. coli found on Day 8 was the same as the strain that was responsible for 
the infection on Day 18. It is also unclear whether the participant had UTI-like symptoms prior to 
Day 18. Nevertheless, the data show that the appearance of E. coli coincided with an altered 
composition of the MSU and peri-urethral microbiota, in which there were lower abundances of 
Lactobacillus, Corynebacterium, and Staphylococcus. 
 Like the male participants, I sought to determine the level of microbiota similarity 
between MSU and peri-urethral swab specimens in the female participants. In the seven female 
participants, the level of microbiota similarity between paired specimens was generally very low. 
Using Bray-Curtis Dissimilarity measures between microbiota of specimens collected on the same 
Figure 12. Bray-Curtis Dissimilarity Scores between MSU and Peri-urethral Specimens from 
Female MAGnUM Participants. Box plots depict the range of Bray-Curtis Dissimilarity scores for 
microbiota data of paired MSU and peri-urethral specimens from each of the seven female 
participants. Mean scores are depicted by the dashed line. Median scores are solid lines. Outliers 
appear as dots. 
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day, I found that the median value of all collection days was above 0.8 for all seven female 
participants. The median values ranged from 0.83 (MAG10) to 0.98 (MAG08). The range of values 
is shown in Figure 12. These data indicate that the microbiota of MSU and peri-urethral 
specimens are distinct. This trend is further verified by PCoA, which shows clear separation of 
microbiota between specimen types. Two representative plots, for MAG02 and MAG08, are 
shown in Figure 13. 
Summary 
 These data show that longitudinal urine and genital specimen collection in community 
participants is feasible. Only two participants withdrew from the study and these participants 
cited personal reasons as the cause rather than complications or difficulties with the study.  
Figure 13. Principal Coordinate Analyses of Microbiota of Specimens from Participants MAG02 
and MAG08. Analysis was done using MSU (closed circles) and peri-urethral (open circles) 
microbiota data collected from two female participants: MAG02 (left) and MAG08 (right). 
Graphs plot the 1st and 2nd principal coordinates of the data. Percent of total variance explained 
by each principal coordinate is shown in the parentheses. 
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 I also identified a method to determine specimen accuracy, which is vital for descriptive 
longitudinal studies. I determined that, following clinical instruction, collection of MSU and peri-
urethral specimens with distinct microbiota is possible in some pre-menopausal community 
women. This finding allows us to make conclusions exclusive to the MSU microbiota. The median 
Bray-Curtis Dissimilarity values of the microbiota of paired specimens for all seven women was 
above 0.8 (Figure 12). Therefore, in future studies (e.g., ProFUM study), I will use 0.8 as a 
threshold for determining whether a properly collected MSU specimen was obtained. This 
protocol will be used to screen participants and ensure that only quality specimens are used for 
longitudinal analyses. This is important because physiologically, the LUT is very different from the 
peri-urethral area. Therefore, to properly study the effects of the microbiota on the health and 
disease of the LUT, it’s vital to be sampling the microbiota of the LUT specifically. 
 Additionally, I found that daily variation in the microbiota exists, but a level of constancy 
is also maintained (Figures 7&10). Several participants had MSU specimens where the microbiota 
of a particular day did not resemble the microbiota of any of the other specimens collected during 
the study. The changes I observed in the MSU microbiota may be due to the introduction and 
subsequent decline of exogenous microorganisms, or due to a temporary change in the bladder 
or LUT environment that allows for differentially adapted microorganisms to thrive. 
 I also determined that alcohol consumption does not correlate to changes in microbiota 
stability, composition, or diversity, but whether other lifestyle factors, such as menstruation or 
sexual activity, show correlations to microbiota changes remain unclear from these data.  
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 From a research perspective, these data show that single timepoint sampling of the LUT 
microbiota may not be reflective of the average composition. This is an important conclusion 
because most research on the urinary and LUT microbiota and microbiome has been performed 
using single timepoint specimens. Should lifestyle factors correlate to these unrepresentative 
microbiota, it may be possible to use lifestyle questionnaires as a screening tool to determine the 
representativeness of patient urine specimens in a clinical setting. 
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CHAPTER IV 
EFFECT OF INTRINSIC LIFESTYLE FACTORS ON LUT MICROBIOTA 
Overview of ProFUM Study 
 The ProFUM study (Probiotics and the Female Urinary Microbiome) was conducted from 
September 2017 to July 2018. The primary goals of the ProFUM study were to measure the long-
term temporal dynamics of the LUT microbiota in pre-menopausal non-symptomatic women, to 
assess the relationship between lifestyle factors and behaviors, as well as urine properties and 
constituents, on the temporal dynamics, and to determine the effect of oral probiotic use on the 
LUT microbiota composition and diversity and temporal dynamics. The study design is described 
in Figure 5. Eight pre-menopausal females participated in the study. Daily MSU and peri-urethral 
swab specimens, as well as weekly perineal/vaginal swabs (not assessed in this thesis), were 
collected by each participant for approximately three months. A modified EQUC protocol was 
used to determine the microbiota of the specimens. 16S rRNA gene sequencing was performed 
only on a subset of participants due to cost. Various intrinsic (Chapter IV) and extrinsic (Chapter 
V) lifestyle factors were recorded by the participants each day. During collection Days 21-60, 
participants were randomized, using a 2:1 randomization scheme, to taking an oral probiotic (or 
placebo) as part of a registered clinical trial (NCT03250208) (Chapter V). 
Screening Eligible Participants 
 Literature246 247 and data collected from the MAGnUM study show that the composition  
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of the peri-urethral microbiota can be distinct from MSU microbiota. Therefore, a properly 
collected MSU specimen could differ from a peri-urethral swab specimen in terms of microbiota 
composition. To assess for this difference, eligible participants were instructed, via oral and video 
instruction, to collect MSU and peri-urethral specimens for three consecutive days as part of a 
Screening Phase. Using Bray-Curtis Dissimilarity, I measured the level of dissimilarity between the 
microbiota of the paired specimens. A value of 0.8, as determined from the MAGnUM study, was 
used as a threshold to determine specimen collection compliance. Participants enrolled in the 
ProFUM study provided paired specimens with Bray-Curtis Dissimilarity values above 0.8 for at 
least two of the three collection days. 
 12 participants were screened for eligibility. Four did not meet eligibility criteria by failing 
to supply distinct MSU and peri-urethral specimens, as described above. Eight participants were 
ultimately enrolled in the ProFUM study. The Bray-Curtis Dissimilarity values for the Screening 
Phase are summarized in Table 4. 
Screen ID Day 1 Day 2 Day 3 Result Screen ID Day 1 Day 2 Day 3 Result 
SCREEN01 0.94 0.86 0.80 ✓ SCREEN07 0.57 0.92 0.89 ✓ 
SCREEN02 0.01 0.22 0.38 X SCREEN08 0.35 0.94 0.81 ✓ 
SCREEN03 0.96 0.94 0.82 ✓ SCREEN09 0.33 0.30 0.70 X 
SCREEN04 0.28 0.44 0.41 X SCREEN10 0.44 0.46 0.28 X 
SCREEN05 0.89 0.99 0.51 ✓ SCREEN11 0.91 0.83 0.79 ✓ 
SCREEN06 0.87 0.67 0.85 ✓ SCREEN12 0.93 0.96 0.97 ✓ 
Table 4. Bray-Curtis Dissimilarity Values for Paired Specimens during Screening Phase. 
✓ indicates that the participant was eligible for the ProFUM study; X indicates that the 
participant was not eligible for the ProFUM study; Bray-Curtis Dissimilarity values < 0.80 are 
highlighted in grey 
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  ProFUM Participant Demographics Total cohort (n=8) 
Age (years), mean (SD) 29 (± 5) 
Race/Ethnicity 
   Caucasian/White 
   Asian 
   Black/African American 
 
5 (62.5%) 
2 (25%) 
1 (12.5%) 
BMI, mean (SD) 24.6 (± 6.2) 
Prior pregnancy 
   Vaginal delivery 
1 (12.5%) 
1 (12.5%) 
Menstrual cycle 
   Regular (every 20-40 days) 
   Irregular 
   None 
 
5 (62.5%) 
3 (37.5%) 
0 (0%) 
Menstrual hygiene product use: 
   -Tampons 
   -Pads 
   -Menstrual cups 
   -None 
 
5 (62.5%) 
4 (50%) 
2 (25%) 
0 (0%) 
Sexually active 
   Frequency of sexual activity 
      Daily 
      Weekly 
      Monthly 
      Not in past year 
   Type of sexual activity (in past year): (N=6) 
      -Vaginal (penetrative with penis) 
      -Vaginal (penetrative with toy/fingers) 
      -External stimulation 
      -Cunnilingus (receiving) 
      -Anal (penetrative) 
   Current sexual partners 
      One male partner 
      Multiple male partners 
      No current partners 
   Method of birth control: 
      -Condom use 
      -Intrauterine device (IUD) 
      -Oral contraceptive 
8 (100%) 
 
1 (12.5%) 
2 (25%) 
3 (37.5%) 
2 (25%) 
 
6 (100%) 
6 (100%) 
2 (33.3%) 
6 (100%) 
0 (0%) 
 
6 (75%) 
1 (12.5%) 
1 (12.5%) 
 
2 (25%) 
4 (50%) 
2 (25%) 
Hygiene 
   Showers (weekly), mean (SD) 
   Baths (weekly), mean (SD) 
 
6 (± 1) 
1 (± 1) 
Bowel movements (weekly), mean (SD) 8 (± 3) 
Diet 
   Follows a special diet 
   Alcohol consumption 
 
1 (12.5%) 
8 (100%) 
Table 5. Demographics and Clinical Characteristics of the ProFUM Participants. 
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 Median Interquartile Range (IQR) 
ProFUM01 0.98 0.97-1.00 
ProFUM02 0.91 0.73-0.99 
ProFUM03 0.80 0.69-0.84 
ProFUM04 0.86 0.66-0.96 
ProFUM05 0.86 0.68-0.99 
ProFUM06 - - 
ProFUM07 0.85 0.62-0.96 
ProFUM08 0.80 0.52-0.92 
  The demographics and clinical characteristics of the eight eligible participants are 
described in Table 5. None of the participants had a prior history of gynecological surgery, kidney 
stones, rUTI, or symptoms of UI. 
ProFUM Specimen Integrity 
 The microbiota of the MSU and peri-urethral specimens were assessed using a modified 
EQUC protocol for seven of the eight participants. Due to time constraints, the specimens of 
participant ProFUM06 were not cultured. Instead, the MSU specimens of participant ProFUM06 
were analyzed using 16S rRNA gene sequencing. The MSU specimens of participant ProFUM07 
also were analyzed using 16S rRNA gene sequencing in addition to culture. 
 I continued to assess the integrity of the specimens collected during the ProFUM study in 
a similar manner to the Screening Phase. Bray-Curtis Dissimilarity values were calculated for all 
paired specimens of the seven applicable (cultured) participants. The median values for all 
participants was ≥ 0.80. These data show that the participants deemed eligible by the Screening 
Table 6. Overview of Bray-Curtis Dissimilarity Values Comparing MSU and Peri-urethral 
Microbiota of the ProFUM Participants based on EQUC data. 
 
Specimens of participant ProFUM06 were not cultured. 
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Phase continued to provide quality specimens during the ProFUM study; participants remained 
compliant throughout the study. Bray-Curtis Dissimilarity scores are summarized in Table 6. 
 Though median Bray-Curtis Dissimilarity scores were above 0.8, the scores varied 
throughout the course of specimen collection for each participant. The data for some participants 
varied more than others. Figure 14 shows representative data for two participants. The Bray-
Figure 14. Bray-Curtis Dissimilarity Values Comparing MSU and Peri-urethral Microbiota of 
Participants ProFUM01 and ProFUM08. Bray-Curtis Dissimilarity values were calculated for 
paired MSU and peri-urethral microbiota data for each participant. Two representative plots are 
shown: one showing little variation in the values over time (top) and one showing a lot of 
variation (bottom). These data come from participants ProFUM01 and ProFUM08, respectively. 
The median values are represented by the overlaid grey dotted lines. 
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Curtis Dissimilarity values for some participants (e.g., ProFUM01) showed little variation over 
time, while values for other participants (e.g., ProFUM08) varied quite a bit (Figure 14). Whether 
these variations can be explained by lifestyle factors is explored later in this chapter and in 
Chapter V. Nevertheless, these data show that, when provided with clinical instruction, obtaining 
Figure 15. Principal Coordinate Analyses of Microbiota of Specimens from Participants 
ProFUM01, ProFUM03, and ProFUM04. Analysis was done using MSU (closed circles) and peri-
urethral (open circles) microbiota data collected from three participants: ProFUM01 (top left), 
ProFUM03 (top right), and ProFUM04 (bottom). Graphs plot the 1st and 2nd principal coordinates 
of the data. Percent of total variance explained by each principal coordinate is shown in the 
parentheses. 
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repeated and properly collected MSU and peri-urethral specimens is possible. PCoA also shows 
that, in general, the microbiota composition of the specimen types represent two distinct 
microbial populations with very little overlap. Three representative plots are shown in Figure 15. 
Qualitative Description of the Longitudinal LUT Microbiota and Microbiome 
 Figure 16 shows the relative abundance of the microbiota or microbiome over time for 
all participants. The MSU microbiota data are presented as stacked bar graphs (see description 
of graphs in Chapter III). Figures 16F and 16H represent the longitudinal MSU microbiome, as 
assessed by 16S rRNA gene sequencing, of participants ProFUM06 and ProFUM07, respectively. 
Figure 16J shows the legend for each graph and describes the genus-color correspondence. All 
other panels of Figure 16 represent data as assessed by modified EQUC. Below is a brief 
qualitative description of the longitudinal MSU microbiota/microbiome data for each participant. 
 Participant ProFUM01 identified as White/Caucasian, with regular menses, and cited 
condom use as the only form of birth control. Her data (Figure 16A) alternated between 
Lactobacillus (blue) and Gardnerella (red) dominant MSU specimens with short periods of 
elevated Streptococcus (green) and Corynebacterium (orange) abundance. The Lactobacillus 
were exclusively identified as L. crispatus, while the Gardnerella were a mixture of G. vaginalis 
and Gardnerella species.  
 Participant ProFUM02 identified as White/Caucasian, with irregular menses, and used an 
IUD for birth control. Her data (Figure 16B) had primarily Lactobacillus-dominant MSU 
specimens. The Lactobacillus species were a mix of L. jensenii and L. crispatus, with generally 
higher abundances of L. crispatus. The primary exception to the Lactobacillus dominance was a 
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roughly two-week period during the first month of specimen collection, where specimens were 
dominated by G. vaginalis, and Corynebacterium tuberculostearicum.  
 Participant ProFUM03 identified as Asian, with regular menses, used an IUD for birth 
control, and had one or more previous vaginal deliveries. Her data (Figure 16C) represented the 
only participant without Lactobacillus identified as part of her longitudinal MSU microbiota or 
microbiome. The MSU microbiota of ProFUM03 was a somewhat equal mix of S. agalactiae (i.e., 
Group B Streptococcus), Staphylococcus epidermidis (light blue), and a variety of 
Corynebacterium species. During three separate, roughly one-week periods at the beginning, 
middle, and end of specimen collection, there was an appearance of Actinomyces neuii (brown).  
 Participant ProFUM04 identified as White/Caucasian, with regular menses, and used a 
daily oral birth control pill. Her data (Figure 16D) had almost exclusively Lactobacillus-dominant 
MSU specimens, which were comprised of an equal abundance of L. jensenii and L. iners. Most 
specimens also had low abundances of a variety of other microorganisms, including anaerobes 
such as Finegoldia magna (yellow), and Anaerococcus species (bright red), facultative anaerobes 
like A. neuii and Corynebacterium species, and aerobes such as Staphylococcus. In the majority 
of the MSU specimens, these various microorganisms (i.e., non-Lactobacillus) did not exceed 50% 
relative abundance. 
 Participant ProFUM05 identified as White/Caucasian, with no menses, and used an IUD 
for birth control. Her data (Figure 16E), like ProFUM01, alternated between Lactobacillus and 
Gardnerella-dominant MSU specimens. The Lactobacillus was a mix of L. jensenii and L. crispatus, 
with higher abundances of L. jensenii, while the Gardnerella was exclusively G. vaginalis. The MSU 
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microbiota also had periodic, but seemingly random instances of the appearance and/or 
dominance of Streptococcus, which was primarily identified as S. mitis. 
 Participant ProFUM06 identified as White/Caucasian, with regular menses, and cited 
condom use as the only form of birth control. Her MSU specimens were analyzed by 16S rRNA 
gene sequencing exclusively. Figure 16F shows the relative abundance of the 20 most abundant 
genera. The remaining taxa were grouped into the “other” category (grey), which represents 
<20% relative abundance for all MSU specimens. Lactobacillus was the most abundant genus for 
most MSU specimens. Levels of Corynebacterium and Prevotella (dark green) fluctuated over 
time. Low abundances of various anaerobic genera [e.g., Anaerococcus, Finegoldia, Dialister 
(bright blue), Peptoniphilus (light pink), Veillonella (dark pink)] were found in most specimens. 
 Participant ProFUM07 identified as Asian, with irregular menses, and used an IUD for birth 
control. Her MSU specimens were analyzed by both 16S rRNA gene sequencing (Figure 16H) and 
modified EQUC (Figure 16G). The two methods show similar results, where most MSU specimens 
were dominated by Lactobacillus. Modified EQUC showed that the Lactobacillus was primarily L. 
jensenii. Similar to ProFUM03, three separate one-to-two week-long periods at the beginning, 
middle, and end of specimen collection were not dominated by the typical pattern of 
microorganisms (i.e., Lactobacillus). Instead, modified EQUC showed the appearance of a mix of 
Corynebacterium species, Actinomyces radingae, and various Staphylococcus and Streptococcus 
species, while 16S rRNA gene sequencing showed elevated abundances of Corynebacterium and 
Streptococcus and various anaerobes including Prevotella, Peptoniphilus, Anaerococcus, and  
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D       ProFUM04 
E       ProFUM05 
F       ProFUM06 (16S rRNA gene sequencing) 
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G       ProFUM07 
I        ProFUM08 
H      ProFUM07 (16S rRNA gene sequencing) 
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Dialister. Furthermore, there were periodic, but seemingly random instances of the appearance 
and very high abundances of Streptococcus, which included a variety of species.  
 Participant ProFUM08 identified as Black/African American, with regular menses, and 
used an IUD as well as a daily oral birth control pill. Her data (Figure 16I) had almost exclusively 
Lactobacillus-dominant MSU specimens, which were comprised of an equal abundance of L. 
jensenii and L. crispatus. Most specimens also had low abundances (<20% relative abundance) of 
G. vaginalis. The exceptions were three separate periods within the first month of specimen 
collection, where the relative abundance of Lactobacillus and Gardnerella decreased while 
various amounts of Streptococcus and Staphylococcus species appeared. 
 
J 
Figure 16. Microbiota Profiles of MSU Specimens from all ProFUM Participants. Microbiota 
profiles are shown as stacked bar graphs depicting the relative abundance (y-axes) of various 
genera over time in chronological order (x-axes) from MSU specimens. Bars that appear ‘white’ 
refer to days where no specimen was collected, received, or stored. A legend containing the 
most common genera is found in panel J. ‘Other’ refers to the combined relative abundance for 
all taxa not included in the 20 most abundance taxa. Data were generated using modified EQUC 
(panels A, B, C, D, E, G, and I) or 16S rRNA gene sequencing (panels F and H). *Other: only used 
for panels F and H 
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 Overall, the data show that the MSU microbiota and microbiome are fairly stable, or 
unchanging, over time. Qualitatively, there are periods of disruption from the ‘normal’ 
compositional state for most participants. These periods seem to be consistent within a 
participant, but not consistent among participants. Therefore, trends appear to be highly 
individualized, which is consistent with other microbiome research findings. 
Measuring the Overall Stability of the LUT Microbiota 
 JSD values were calculated as the primary measure of microbiota and microbiome 
stability for both MSU and peri-urethral specimens. Essentially, JSD quantifies how 
distinguishable two distributions are from one another. This can be interpreted as stability when 
applied to a longitudinal dataset. JSD values were obtained as previously described272, by first 
calculating a representative microbiota distribution for each participant. This was done by 
averaging the abundance data for the microbiota across all collection days. JSD values were then 
calculated between each day’s microbiota and the average microbiota (e.g., MSU microbiota of 
Day 1 and average microbiota for participant ProFUM01). Values range from 0 to 1, where higher 
values indicate less similarity, or instability when viewed longitudinally. Thus, I obtained values 
unique for each specimen type and specimen collection day that quantitatively reflect how 
distinct the microbiota was in comparison to an average for each participant. These values can 
be graphed to view periods of stability and instability or they can be applied to metadata, such 
as lifestyle questionnaire results, to determine if a statistical relationship exists between the 
stability of the microbiota and lifestyle factors. 
123 
 
 
 
 Figure 17 shows the distributions of JSD values for MSU (Figure 17A) and peri-urethral 
(Figure 17B) microbiota for all participants. The boxplots show that the median JSD values (i.e., 
solid line of each box) of the MSU microbiota for all participants are low (<0.2) (Figure 17A). The 
median JSD values are significantly (p<0.001) higher for the peri-urethral microbiota (Figure 17B); 
Figure 17. Distribution of Jensen-Shannon Divergence Values for MSU and Peri-urethral 
Microbiota from all ProFUM Participants. Box plots depict the range of JSD values of microbiota 
(EQUC of ProFUM 1-5, 7-8) and microbiome (16S rRNA gene sequencing of ProFUM06 and 
ProFUM07) data of MSU (A) and peri-urethral (B) specimens from all applicable ProFUM 
participants. Median scores are depicted by the solid lines in each box. The distribution of raw 
values are depicted by the overlaid circles. 
 
124 
 
 
 
only two participants had median JSD values <0.2 (i.e., ProFUM02 and ProFUM03). These data 
show that, overall, the peri-urethral microbiota are more variable within an individual than the 
MSU microbiota. Nonetheless, the range of JSD values for the MSU microbiota is large, indicating 
that periods of microbiota variability exist. 
 Microbiota stability was assessed by visualizing the JSD values over time. An example is 
shown in Figure 18. The solid line graph shows the change in JSD values for the MSU microbiota 
of participant ProFUM07 over time. In general, JSD values are low (i.e., nearing 0). On days with 
low values, the microbiota show little variability from the microbiota of all other days, meaning 
high stability. The exceptions are JSD values for the microbiota of roughly Days 1-4, 21-33, and 
46-61. On these days, the JSD values are higher, meaning that the microbiota were more distinct 
from the microbiota of all other days (i.e., higher instability). These data are complementary to 
Figure 18. JSD Values for MSU Microbiota of Participant ProFUM07 Obtained using Culture and 
Sequencing. JSD values were calculated for MSU microbiota of participant ProFUM07. 
Microbiota data was obtained using modified EQUC (solid line) and 16S rRNA gene sequencing 
(dashed line). Data are plotted over time in days. 
 
125 
 
 
 
the qualitative description of the MSU microbiota of ProFUM07 (Figure 16G), where one can 
visualize three separate one-to-two weeklong periods at the beginning, middle, and end of 
specimen collection that were not dominated by the typical pattern of microorganisms (i.e., 
Lactobacillus). These periods line-up well to the periods of higher JSD values in Figure 18, thus 
providing a level of confidence in the JSD values. 
 Figure 18 also highlights the complementarity of modified EQUC and 16S rRNA gene 
sequencing. Despite some compositional differences between the microbiota characterized by 
the two methods (Figure 16G & H), the JSD values for the modified EQUC (solid line) and the 16S 
rRNA gene sequencing (dashed line) techniques are almost identical (Figure 18). 
Menstruation and LUT Microbiota Variability 
 I sought to determine if lifestyle factors are correlated to temporal changes in the 
microbiota of the LUT. These changes, if any, could be related to stability, microbial composition, 
or microbial diversity. 
 I hypothesized that menstruation relates to variable MSU microbiota possibly due to the 
alteration of the LUT microenvironment or the introduction of exogenous organisms through 
feminine hygiene product use (e.g., tampon, pad use). Menstruation was reported by all eight 
participants. Three participants reported having irregular menstrual cycles, while five reported 
having regular cycles defined as once every 20-40 days (Table 5). Furthermore, five participants 
reported using a form of contraception/birth control other than condom use (Table 5). Due to 
the small sample size, it is difficult to discern the impact of these demographic data on the 
relationship between menstruation and MSU microbiota variability. 
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Figure 19. Relationship Between Jensen-Shannon Divergence Values and Menstruation. JSD 
values were calculated for MSU (solid lines) and peri-urethral (dashed lines) microbiota of 
participants ProFUM07 (A), ProFUM08 (B), and ProFUM02 (C). Data are plotted over time in 
days. Participant-reported menstruation is depicted by the grey bars. 
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 I first assessed whether menstruation is associated with MSU microbiota stability. Figure 
19 plots the JSD values of the MSU and peri-urethral microbiota, as assessed by modified EQUC, 
over time for participants ProFUM07 (Figure 19A), ProFUM08 (Figure 19B), and ProFUM02 
(Figure 19C). Days shaded in grey reflect participant-reported menstruation. Qualitatively, many 
peaks in the values exist, meaning higher levels of instability. A visual trend exists in which many 
of these peaks occur during menstruation for the MSU microbiota data, suggesting that 
menstruation is associated with MSU microbiota variability. This trend was not apparent for the 
peri-urethral microbiota JSD values, except for participant ProFUM02 (Figure 19C). 
Quantitatively, JSD values were significantly higher for the MSU microbiota during menstruation 
for most participants (Table 7). JSD values for the peri-urethral microbiota were not significantly 
Menstruation 
Participants 
MSU Microbiota 
(Median JSD Values) 
Peri-urethral Microbiota 
(Median JSD Values) 
“Yes” (n) “No” (n) p-value “Yes” (n) “No” (n) p-value 
ProFUM01 0.200 (15) 0.145 (52) 0.109 0.355 (15) 0.324 (50) 0.729 
ProFUM02 0.316 (7) 0.127 (59) 0.039 0.377 (7) 0.172 (55) <0.001 
ProFUM03 0.137 (18) 0.100 (53) 0.041 0.127 (16) 0.112 (47) 0.313 
ProFUM04 0.122 (12) 0.059 (60) 0.023 0.320 (10) 0.253 (56) 0.088 
ProFUM05 0.101 (3) 0.129 (64) 0.989 0.240 (3) 0.252 (57) 0.873 
ProFUM06 (16S) 0.094 (7) 0.072 (59) 0.540 - - - 
ProFUM07 0.078 (41) 0.052 (28) 0.014 0.246 (41) 0.322 (28) 0.095 
ProFUM07 (16S) 0.070 (43) 0.048 (29) <0.001 - - - 
ProFUM08 0.098 (19) 0.068 (48) 0.047 0.227 (19) 0.297 (47) 0.051 
Table 7. Association between Jensen-Shannon Divergence Values for MSU and Peri-urethral 
Microbiota and Participant-reported Menstruation. 
 
Median JSD values shown for MSU (left) and peri-urethral (right) microbiota on days when the 
participant reported (“Yes”) or did not report (“No”) menstruation. Mann-Whitney U test used 
to determine significance. p-value < 0.05 is significant (green). 
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higher during menstruation, except for participant ProFUM02 (Table 7). These data show that a 
significant association exists between menstruation and variable MSU, but not peri-urethral 
microbiota. 
 To determine the nature of the MSU microbiota instability during menstruation, I 
assessed for differences in microbiota composition and diversity. Two measures of alpha-
diversity were calculated for each MSU microbiota: Shannon and Simpson’s diversity indices. 
These values were assessed for a statistical association with menstruation (Table 8). Generally, I 
found higher median alpha-diversity measures during menstruation. These values were  
Menstruation 
Participants 
MSU Microbiota 
(Median Shannon Diversity Values) 
MSU Microbiota 
(Median Simpson’s Diversity Values) 
“Yes” “No” p-value “Yes” “No” p-value 
ProFUM01 0.970 0.675 0.035 0.500 0.429 0.040 
ProFUM02 1.153 0.547 0.012 0.557 0.307 0.021 
ProFUM03 1.418 1.186 <0.001 0.714 0.642 <0.001 
ProFUM04 1.072 0.757 0.026 0.584 0.489 0.064 
ProFUM05 0.624 0.917 0.168 0.338 0.509 0.187 
ProFUM06 (16S) 2.838 2.655 0.148 0.841 0.796 0.057 
ProFUM07 0.675 0.019 <0.001 0.362 0.005 <0.001 
ProFUM07 (16S) 1.444 1.010 <0.001 0.552 0.447 0.008 
ProFUM08 0.883 0.778 0.037 0.526 0.486 0.049 
Table 8. Association between Alpha-Diversity Values for MSU Microbiota and Participant-
reported Menstruation. 
 
Median Shannon Diversity (left) and Simpson’s Diversity (right) values shown for MSU 
microbiota on days when the participant reported (“Yes”) or did not report (“No”) menstruation. 
Mann-Whitney U test used to determine significance. p-value < 0.05 is significant (green). 
Menstruation reported: ProFUM01 (15/67 days), ProFUM02 (7/66 days), ProFUM03 (18/71 
days), ProFUM04 (12/72 days), ProFUM05 (3/67 days), ProFUM06 (7/66 days), ProFUM07 
(41/69 days), ProFUM08 (19/67 days). 
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Participants Significant Taxa Frequency of Detection during Menstruation 
ProFUM01 
Species “Yes” (n=15) “No” (n=52) p-value 
Corynebacterium lipophile group F1 6 (40%) 4 (8%) 0.006a 
Corynebacterium tuberculostearicum 7 (47%) 3 (6%) <0.001a 
Staphylococcus epidermidis 13 (87%) 30 (58%) 0.038a 
Streptococcus agalactiae 12 (80%) 17 (33%) 0.002a 
ProFUM02 
Species “Yes” (n=7) “No” (n=59) p-value 
Actinomyces neuii 4 (57%) 5 (8%) 0.005a 
Alloscardovia omnicolens 2 (29%) 0 (0%) 0.010a 
Corynebacterium amycolatum 2 (29%) 0 (0%) 0.010a 
Corynebacterium tuberculostearicum 5 (71%) 11 (19%) 0.007a 
Gardnerella vaginalis 4 (57%) 10 (17%) 0.032a 
Staphylococcus epidermidis 7 (100%) 17 (29%) <0.001a 
Streptococcus anginosus 6 (86%) 9 (15%) <0.001a 
ProFUM03 
Species “Yes” (n=18) “No” (n=53) p-value 
Actinomyces neuii 17 (89%) 23 (43%) <0.001a 
Corynebacterium amycolatum 16 (84%) 28 (53%) 0.027a 
Finegoldia magna 7 (37%) 3 (6%) 0.002a 
ProFUM04 Species “Yes” (n=12) “No” (n=60) p-value 
Corynebacterium glucuronolyticum 3 (25%) 2 (3%) 0.030a 
ProFUM05 Species “Yes” (n=3) “No” (n=64) p-value 
ProFUM06 (16S) Genera “Yes” (n=7) “No” (n=59) p-value 
ProFUM07 
Species “Yes” (n=41) “No” (n=28) p-value 
Actinomyces radingae 14 (34%) 1 (4%) 0.003a 
Corynebacterium amycolatum 19 (46%) 0 (0%) <0.001a 
Corynebacterium aurimucosum 17 (41%) 2 (7%) 0.002a 
Corynebacterium tuberculostearicum 13 (32%) 2 (7%) 0.018a 
Finegoldia magna 8 (20%) 0 (0%) 0.018a 
Staphylococcus epidermidis 35 (85%) 9 (32%) <0.001 
Staphylococcus hominis 12 (29%) 2 (7%) 0.033a 
Staphylococcus pettenkoferi 12 (29%) 2 (7%) 0.033a 
ProFUM07(16S) Genera “Yes” (n=43) “No” (n=29) p-value 
Finegoldia 7 (16%) 0 (0%) 0.037a 
ProFUM08 Species “Yes” (n=19) “No” (n=48) p-value 
 
Table 9. List of MSU Taxa with Significantly different Frequencies of Detection during 
Participant-reported Menstruation. 
 
MSU microbiota listed, had significantly different (p<0.05) frequencies of detection between 
menstruation and non-menstruation. Yellow cells indicate higher frequency. Chi-square used 
unless otherwise indicated. a: Fisher’s exact test 
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Figure 20. Fold Change of Average CFU/mL of MSU Microbiota for Participant ProFUM03 
between Reporting of “Menstruation” and “No Menstruation”. Average CFUs of each species 
found in the MSU specimens of Participant ProFUM03 were calculated. The fold change 
between the values obtained on days after the participant reported “menstruation” versus “no 
menstruation” were then measured. Species with red dots were found at higher CFUs following 
menstruation. Bars indicate that the species was only found in one group. Average total CFU/mL 
is in green and shows no difference. Species underlined had significantly (p<0.05) different 
mean abundances between groups (Student’s t-test). 
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significantly higher for most participants (Table 8), particularly those participants who previously 
showed high MSU microbiota instability during menstruation (Table 7).  
 In addition to elevated alpha-diversity values, I observed numerous differences in the 
frequency of detected taxa during menstruation. Table 9 lists the bacterial taxa that had 
significantly different frequencies of detection between menstruation and non-menstruation 
days. Five participants (ProFUM01, ProFUM02, ProFUM03, ProFUM04 and ProFUM07) had at 
least one bacterial taxon that was statistically significant; three participants (ProFUM08, 
ProFUM05, and ProFUM06) did not; the latter two previously showed no difference in alpha-
diversity (Table 8) or JSD values (Table 7) during menstruation. Interestingly, all of the statistically 
significant bacterial taxa listed in Table 9 had higher frequencies of detection during 
menstruation. These data suggest that the elevated alpha-diversity values during menstruation 
(Table 8) may be a result of the increased detection of particular taxa. However, further analyses 
show that this trend is more complex. Comparisons of the mean bacterial abundances between 
menstruation and non-menstruation days show that many of the significant taxa in Table 9 are 
also found at higher abundance during menstruation. An example of these findings is shown in 
Figure 20. Figure 20 shows the fold change in mean bacterial abundance for each taxon between 
menstruation and non-menstruation days for participant ProFUM03. F. magna, A. neuii, and 
Corynebacterium amycolatum were found at significantly higher mean abundances during 
menstruation; all three of which were also found to be more frequently detected during 
menstruation (Table 9). These additional data now suggest that the elevated alpha-diversity 
values during menstruation (Table 8) are likely a result of both more frequent detection and  
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Participants 
Mean Total Bacterial  
Abundance during Menstruation 
“Yes” “No” p-value 
ProFUM01 62600 83700 0.239 
ProFUM02 40400 48800 0.672 
ProFUM03 90000 74300 0.217 
ProFUM04 28800 73900 0.002 
ProFUM05 31700 55000 0.401 
ProFUM06 (16S) 41300 43000 0.269 
ProFUM07 85300 71300 0.765 
ProFUM07 (16S) 47000 45600 0.748 
ProFUM08 54800 46600 0.243 
increased abundance of particular taxa. Yet, the mean total abundance of all detected bacteria 
was not significantly different between menstruation and non-menstruation days for participant 
ProFUM03 (Figure 20), or any of the other participants, with exception of ProFUM04 (Table 10). 
Thus, while certain taxa tended to increase in abundance during menstruation, the abundance 
of other taxa tended to decrease (though not significantly); thus, keeping the total bacterial 
abundance relatively unchanged. This suggests that certain taxa replaced other taxa during 
menstruation. Visually, this can be seen in Figure 16. For example, participant ProFUM03 has 
increased relative abundance of Actinomyces during menstruation which co-occurs with 
decreased relative abundance of Corynebacterium, Staphylococcus, and Streptococcus (Figure  
Table 10. Mean Total MSU Bacterial Abundance during Participant-reported Menstruation. 
Mean total bacteria detected in MSU specimens between menstruation and non-menstruation. 
Total bacterial abundance was calculated from CFUs or OTUs (if indicated by “16S”). Student’s 
t-test (two-tailed) used. p-values <0.05 were significant. Menstruation reported: ProFUM01 
(15/67 days), ProFUM02 (7/66 days), ProFUM03 (18/71 days), ProFUM04 (12/72 days), 
ProFUM05 (3/67 days), ProFUM06 (7/66 days), ProFUM07 (41/69 days), ProFUM08 (19/67 
days). 
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Participants 
Median Bray-Curtis Dissimilarity between 
Microbiota of Paired Specimens during Menstruation 
“Yes” “No” p-value 
ProFUM01 0.930 0.995 <0.001 
ProFUM02 0.887 0.886 0.944 
ProFUM03 0.821 0.794 0.106 
ProFUM04 0.976 0.831 0.004 
ProFUM05 0.908 0.845 0.507 
ProFUM06 - - - 
ProFUM07 0.900 0.695 0.037 
ProFUM08 0.778 0.844 0.625 
 16C). Overall, I conclude that the influence of menstruation on the MSU microbiota is both 
complex and dynamic. 
 Finally, I sought to determine if menstruation altered the dissimilarity of the microbiota 
of paired MSU and peri-urethral specimens. This is important to know because if the microbiota 
of the paired specimens are more similar during menstruation, this may suggest increased 
microbial sharing, which could provide vital insight into the mechanism by which these trends 
are occurring. Therefore, I calculated Bray-Curtis Dissimilarity values between microbiota of all 
paired specimens for each participant. The median values are shown in Table 11. In general, 
paired specimens had microbiota that were more dissimilar (i.e., higher median Bray-Curtis   
Table 11. Median Bray-Curtis Dissimilarity Values between Microbiota of Paired Specimens 
during Participant-reported Menstruation. 
 
Median Bray-Curtis Dissimilarity values shown for paired MSU and peri-urethral microbiota on 
days when the participant reported (“Yes”) or did not report (“No”) menstruation. Mann-
Whitney U test used to determine significance. p-value < 0.05 is significant (green). Yellow cells 
indicate higher Bray-Curtis Dissimilarity. Menstruation reported: ProFUM01 (15/67 days), 
ProFUM02 (7/66 days), ProFUM03 (18/71 days), ProFUM04 (12/72 days), ProFUM05 (3/67 
days), ProFUM06 (7/66 days), ProFUM07 (41/69 days), ProFUM08 (19/67 days). 
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Dissimilarity values) during menstruation, but the trend was not always statistically significant. 
Only participants ProFUM04, ProFUM07, and ProFUM01 had significantly different values 
between menstruation and non-menstruation days, the latter of which was one of only two   
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ProFUM01 0.532 (10/40) 
1.000a 
(0/1) 
<0.001a 
(15/15) 
<0.001a 
(14/14) - - 
1.000a 
(15/66) 
1.000a 
(0/3) 0.918
b 
ProFUM02 <0.001
a 
(0/39) 
0.617a 
(2/13) 
<0.001a 
(6/6) 
0.106a 
(1/1) 
1.000a 
(0/2) 
1.000a 
(0/1) 
0.442a 
(2/30) 
1.000a 
(0/2) 0.623
b 
ProFUM03 0.105 (6/37) - - 
<0.001a 
(18/18) - - 
0.789 
(9/36) 
1.000a 
(3/11) 0.136
b 
ProFUM04 0.139 (4/38) 
0.671 
(6/32) 
<0.001a 
(12/12) - 
0.025a 
(1/27) - 
0.047a 
(11/47) - 0.026
b 
ProFUM05 1.000
a 
(2/34) 
1.000a 
(1/27) - - 
0.547a 
(0/21) 
1.000a 
(0/4) 
1.000a 
(3/63) 
1.000a 
(0/4) 0.977
b 
ProFUM06 1.000
a 
(4/39) 
0.426a 
(5/32) - - 
1.000a 
(0/1) 
1.000a 
(0/2) 
0.584a 
(7/54) - 0.032
b 
ProFUM07 <0.001 (29/37) 
1.000a 
(1/1) - 
<0.001a 
(39/40) 
0.642a 
(3/4) 
1.000a 
(2/4) 
1.000a 
(41/69) 
0.058a 
(0/3) 0.057
b 
ProFUM08 0.081 (7/36) 
0.411 
(7/30) 
<0.001a 
(6/6) - 
1.000a 
(1/3) 
1.000a 
(1/3) 
0.850 
(8/27) 
1.000a 
(0/1) 0.036
b 
Table 12. Significance of Reporting Menstruation with Confounding Lifestyle Factors. 
 
Frequency of participant-reported lifestyle factors was assessed for an association with 
participant-reported menstruation. p-values are shown in the table. Chi-square test used unless 
otherwise indicated. p-value < 0.05 is significant (green). Cells in gray are interpreted as lifestyle 
factors that were not reported by the corresponding participant. Significant p-values that are 
underlined represent lifestyle factors reported at higher frequencies (or means) during 
menstruation. Number of times each lifestyle factor was co-reported with menstruation out of 
total is indicated in parentheses in each cell. Menstruation reported: ProFUM01 (15/67 days), 
ProFUM02 (7/66 days), ProFUM03 (18/71 days), ProFUM04 (12/72 days), ProFUM05 (3/67 
days), ProFUM06 (7/66 days), ProFUM07 (41/69 days), ProFUM08 (19/67 days). 
a: Fisher’s exact test 
b: Wilcoxon rank sum test 
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Participants 
(mean number of 
bowel movements) 
Significance of Various Microbiota and Microbiome Measures 
and Participant-reported Number of Bowel Movements 
JSD Values 
Alpha-diversity Values 
(MSU) 
Bray-Curtis 
Dissimilarity 
between Paired 
Specimens MSU Peri-urethra 
Shannon 
Index 
Simpson’s 
Index 
ProFUM01 (3) 0.923 0.404 0.040 0.054 0.585 
ProFUM02 (2) 0.804 0.427 0.526 0.321 0.560 
ProFUM03 (2) 0.389 0.038 0.544 0.504 0.605 
ProFUM04 (2) 0.808 0.943 0.452 0.629 0.108 
ProFUM05 (2) 0.510 0.818 0.718 0.574 0.637 
ProFUM06 (16S) (1) 0.333 - 0.307 0.328 - 
ProFUM07 (1) 0.174 0.210 0.718 0.697 0.016 
ProFUM07 (16S) (1) 0.643 - 0.643 0.544 - 
ProFUM08 (1) 0.659 0.580 0.942 0.896 0.803 
 participants with lower dissimilarity during menstruation (Table 11). These trends did not align 
with any previous trends I observed with stability, diversity, or composition, suggesting that the 
clinical significance is negligible. 
 As later discussed in Chapter V, other lifestyle factors show similar trends with the 
microbiota as described above for menstruation. Therefore, I determined whether reporting of 
other lifestyle factors could have confounded the menstruation data. Table 12 lists p-values 
assessing the association between participant-reported menstruation and other lifestyle factors. 
Table 13. Significance of JSD, Alpha-Diversity, and Bray-Curtis Dissimilarity Values of MSU and 
Peri-urethral Microbiota and Participant-reported Number of Bowel Movements. 
 
Mean JSD, Alpha-diversity, and Bray-Curtis Dissimilarity values of the MSU and/or peri-urethral 
(if indicated) microbiota or microbiome (indicated by “16S”) were assessed for an association 
with participant-reported number of bowel movements. p-values are shown in the table. One-
way ANOVA was used to determine significance. p-value < 0.05 is significant (green). Cells in 
gray are not applicable. 
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Most lifestyle factors were not statistically associated with reporting of menstruation, but some 
were. As expected, reporting of tampon and or pad use nearly always co-occurred with 
menstruation (Table 12). Additionally, two participants had an association between 
menstruation and probiotic/placebo use (Table 12). However, the two participants were in 
separate treatment groups (ProFUM02 was in the placebo group; ProFUM07 was in the probiotic 
group), suggesting that these data are not specifically related to the probiotic. Furthermore, 
three participants (ProFUM04, ProFUM06, and ProFUM08) had associations between 
menstruation and number of bowel movements reported, with all three participants reporting 
higher mean number of bowel movements during menstruation (Table 12). 
 To determine if the association between number of bowel movements and menstruation 
served as a significant confounder for the conclusions regarding the effects of menstruation on 
MSU microbiota variability, I assessed whether number of bowel movements was also related to 
MSU microbiota variability. Using an ANOVA, I determined if there was a statistical association 
between number of bowel movements and JSD values for MSU and peri-urethral microbiota 
(Table 13). I also assessed for an association between number of bowel movements and MSU 
microbiota alpha-diversity indices, as well as Bray-Curtis Dissimilarity values between microbiota 
of paired specimens (Table 13). Overall, very few statistical tests showed significance (i.e., 
p<0.05), suggesting that the influence of number of bowel movements does not contribute to 
the findings on menstruation and MSU microbiota variability. 
 Finally, to better understand the mechanistic relationship between menstruation and 
MSU microbiota variability, I determined whether urine properties and constituents, as 
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ProFUM01 1.000
a 
(3/15) 
0.164a 
(1/14) 0.020
b <0.001
a 
(13/16) 0.046
b - - 0.400
a 
(1/2) 
0.181a 
(3/7) 
ProFUM02 0.407
a 
(1/24) 
1.000a 
(1/9) 0.647
b 0.005
a 
(4/8) 0.965
b 0.665
a 
(1/19) 
1.000a 
(0/1) 
1.000a 
(0/1) - 
ProFUM03 0.532 (5/24) 
1.000a 
(1/1) 0.939
b <0.001
a 
(17/40) 0.648
b 0.166
a 
(3/9) - - - 
ProFUM04 0.722
a 
(3/16) - 0.144
b 0.705
a 
(3/15) 0.583
b 1.000
a 
(0/4) - 
1.000a 
(0/1) 
0.581a 
(0/6) 
ProFUM05 1.000
a 
(3/52) 
1.000a 
(0/3) 0.772
b 1.000
a 
(0/5) 0.667
b 0.452
a 
(1/12) - 
1.000a 
(1/2) 
1.000a 
(0/2) 
ProFUM06 0.696
a 
(5/41) 
1.000a 
(0/1) 0.135
b 0.003
a 
(3/8) 0.510
b - - 1.000
a 
(0/1) 
0.208a 
(1/2) 
ProFUM07 0.075
a 
(5/5) 
1.000a 
(1/2) 0.325
b <0.001
a 
(26/29) 0.512
b 0.141
a 
(4/4) - 
1.000a 
(1/1) 
0.678 
(9/14) 
ProFUM08 0.850 (11/40) 
0.318a 
(2/14) 0.862
b 0.030 (10/22) 0.856
b 0.741
a 
(3/14) - - 
0.320a 
(2/14) 
  
Table 14. Significance of Participant-reported Menstruation with Urine Property and 
Constituent Results. 
 
Frequency of urine property and constituent results was assessed for an association with 
participant-reported menstruation. Positive urine test results were considered as any outcome 
other than “negative”, except for Specific Gravity and pH which do not have “negative” 
outcomes. p-values are shown in the table. Chi-square test used unless otherwise indicated. p-
value < 0.05 is significant (green). Urine properties and constituents for a given participant that 
were always negative, or baseline, are gray. Significant p-values that are underlined represent 
urine properties and constituents with “positive” results found at higher frequencies (or higher 
mean values) during menstruation. Number of times each “positive” categorical test result was 
co-reported with menstruation out of total is indicated in parentheses in each applicable cell. 
Menstruation reported: ProFUM01 (15/67 days), ProFUM02 (7/66 days), ProFUM03 (18/71 
days), ProFUM04 (12/72 days), ProFUM05 (3/67 days), ProFUM06 (7/66 days), ProFUM07 
(41/69 days), ProFUM08 (19/67 days). 
a: Fisher’s exact test 
b: Wilcoxon rank sum test 
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assessed by urine dipsticks, were significantly different during menstruation. Not surprisingly, 
with few exceptions, the only characteristic found to be significantly altered (i.e., frequency of 
positive outcomes) was blood (Table 14). In all cases of statistical significance, the frequency of 
positive blood results was higher during menstruation. No other urine property or constituent 
was found to be related to menstruation among the participants (Table 14). 
Urine Properties and Constituents and LUT Microbiota Variability 
 Urine dipsticks are colorimetric urine tests used clinically as indicators of disease. 
However, useful information regarding the various properties and constituents of the urine are 
provided by these tests. I performed urine dipstick tests on all MSU specimens. The daily 
variability in the results was dramatic and, to my knowledge, has not been described in the 
literature. An example is shown in Table 15, which documents the urine dipstick results for just 
the first 10 days of MSU specimens provided by participant ProFUM01. The data, which are 
variable, reflect the variability in the LUT environment on a daily basis. Therefore, I hypothesized 
that these daily changes would correlate to MSU microbiota variability, thus providing a potential 
mechanism to explain the trends with menstruation, for example. 
 I assessed for associations between urine properties and constituents, and microbiota 
stability and alpha-diversity values. Measures of glucose were negative for all MSU specimens of 
all participants and were thus excluded from the analysis. Urobilinogen measures were at 
baseline levels (i.e., 0.2 mg/dL) for all MSU specimens of all participants, with the exception of 
one day (Day 16) of participant ProFUM02 and were thus also excluded from the analysis. Of the 
remaining tests, positive results for Bilirubin, Ketones, Blood, Protein, Nitrites, and Leukocytes  
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 Variation of Urine Properties and Constituents in ProFUM01 over Time 
Time (Days) 1 2 3 4 5 6 7 8 9 10 
Glucose - - - - - - - - - - 
Bilirubin + + - - - - - - - + 
Ketones - - - - - - - 5 5 - 
Specific Gravity 
(Osmolarity) 1.005 1.015 1.005 1.000 1.000 1.000 1.005 1.020 1.015 1.020 
Blood - H+++ H+++ H-Tr H-Tr H+ NH+ - - - 
pH 8.0 6.5 8.0 8.5 8.5 8.5 8.0 6.5 6.5 7.5 
Protein - - - - - - - - - - 
Urobilinogen 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 
Nitrites - - - - - - - - - - 
Leukocytes - - - - - - ++ - - - 
 
  
Table 15. Variation of Urine Properties and Constituents over Time.  
 
Glucose: Quantitative - range of 100mg/dL to 2000mg/dL; reaction with glucose oxidase and 
peroxidase 
Bilirubin: Qualitative - relative levels detected as erythrocyte breakdown; reaction with a 
diazonium salt 
Ketones: Detection of Acetoacetic acid; Quantitative - range of 5mg/dL to 160mg/dL; reaction 
with sodium nitroprusside 
Specific Gravity: Measurement of osmolarity; Quantitative – range of 1.000 to 1.030; reaction 
with an anionic polyelectrolyte and detection by bromothymol blue 
Blood: Detection of hemolyzed (H) or non-hemolyzed (NH) erythrocytes; Qualitative; reaction 
with peroxidase and tetramethylbenzidine blue 
pH: Quantitative – range of 5.0 to 8.5; detected by indicators (methyl red and bromothymol blue) 
Protein: Quantitative – range of 30mg/dL to 2000mg/dL; detection by tetrabromphenol blue 
Urobilinogen: Quantitative – range of 0.2mg/dL to 8mg/dL; reaction with Ehrlich’s reagent 
Nitrites: Semi-quantitative – Negative (<0.075mg/dL), Positive (>0.075mg/dL); reaction with 
para-arsanilic acid and a diazonium salt 
Leukocytes: Detection of Leukocyte esterase; Qualitative – relative levels of leukocyte esterase 
detected from catalysis of indolecarboxylic acid 
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Participants 
(Number of Specimens) 
Significance of Urine Properties and Constituents and  
MSU JSD Values 
Bilirubin 
(n) 
Ketones 
(n) Blood (n) Protein (n) 
Nitrites 
(n) 
Leukocytes 
(n) 
ProFUM01 (n=67) 0.949 (15) 0.911 (14) 0.189 (16) - 1.000 (2) 0.391 (7) 
ProFUM02 (n=66) 0.145 (24) 0.484 (9) 0.378 (8) 0.726 (19) 0.242 (1) - 
ProFUM03 (n=71) 0.722 (24) 0.901 (1) 0.156 (40) 0.501 (9) - - 
ProFUM04 (n=72) 0.233 (16) - 0.225 (15) 0.045 (4) 0.500 (1) 0.302 (6) 
ProFUM05 (n=67) 0.618 (52) 0.875 (3) 0.538 (5) 0.452 (12) 0.039 (2) 0.521 (2) 
ProFUM06 (16S) (n=66) 0.632 (39) 0.156 (1) 0.727 (8) - 0.750 (1) 0.671 (2) 
ProFUM07 (n=69) 0.198 (5) 0.145 (2) 0.011 (29) 0.558 (4) 0.377 (1) 0.903 (14) 
ProFUM07 (16S) (n=69) 0.477 (5) 0.692 (2) 0.890 (29) 0.093 (4) 0.551 (1) 0.492 (14) 
ProFUM08 (n=67) 0.671 (40) 0.118 (14) 0.214 (22) 0.909 (14) - 0.011 (14) 
Participants 
(Number of Specimens) 
Significance of Urine Properties and Constituents and  
Peri-urethral JSD Values 
Bilirubin 
(n) 
Ketones 
(n) Blood (n) Protein (n) 
Nitrites 
(n) 
Leukocytes 
(n) 
ProFUM01 (n=65) 0.231 (14) 0.425 (14) 0.511 (16) - 0.809 (2) 0.138 (7) 
ProFUM02 (n=62) 0.331 (22) 0.227 (9) 0.011 (8) 0.554 (18) 0.903 (1) - 
ProFUM03 (n=63) 0.985 (20) 0.889 (1) 0.646 (36) 0.002 (9) - - 
ProFUM04 (n=66) 0.046 (15) - 0.406 (14) 0.806 (4) 0.303 (1) 0.394 (5) 
ProFUM05 (n=60) 0.999 (47) 0.975 (3) 0.736 (5) 0.211 (10) 0.854 (2) 0.734 (2) 
ProFUM07 (n=69) 0.347 (5) 0.692 (2) 0.599 (29) 0.795 (4) 0.638 (1) 0.751 (14) 
ProFUM08 (n=66) 0.430 (40) 0.323 (14) 0.241 (22) 0.056 (14) - 0.221 (14) 
 
  
Table 16. Significance of JSD Values of MSU and Peri-urethral Microbiota and Selected Urine 
Properties and Constituents. 
Median JSD values of the MSU (top) and peri-urethral (bottom) microbiota or microbiome 
(indicated by “16S”) were assessed for an association with selected urine properties and 
constituents. p-values are shown in the tables. Mann-Whitney U test used to determine 
significance. p-value < 0.05 is significant (green). Cells in gray are not applicable. Significant p-
values that are underlined had higher median JSD values when the corresponding urine test 
result was “positive”. Number of “positive” results is indicated in parentheses in each cell. 
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Participants 
(Number of Specimens) 
Significance of Urine Properties and Constituents and  
Shannon Diversity Values of MSU Microbiota 
Bilirubin 
(n) 
Ketones 
(n) Blood (n) Protein (n) 
Nitrites 
(n) 
Leukocytes 
(n) 
ProFUM01 (n=67) 0.415 (15) 0.718 (14) 0.011 (16) - 0.023 (2) 0.205 (7) 
ProFUM02 (n=66) 0.645 (24) 0.152 (9) 0.033 (8) 0.323 (19) 0.909 (1) - 
ProFUM03 (n=71) 0.795 (24) 0.028 (1) 0.096 (40) 0.953 (9) - - 
ProFUM04 (n=72) 0.273 (16) - 0.721 (15) 0.859 (4) 0.528 (1) 0.517 (6) 
ProFUM05 (n=67) 0.947 (52) 0.066 (3) 0.049 (5) 0.904 (12) 0.023 (2) 0.418 (2) 
ProFUM06 (16S) (n=66) 0.743 (39) 0.188 (1) 0.530 (8) - 0.125 (1) 0.131 (2) 
ProFUM07 (n=69) 0.495 (5) 0.402 (2) <0.001 (29) 0.122 (4) 0.609 (1) 0.809 (14) 
ProFUM07 (16S) (n=69) 0.223 (5) 0.308 (2) 0.011 (29) 0.419 (4) 0.464 (1) 0.429 (14) 
ProFUM08 (n=67) 0.925 (40) 0.377 (14) 0.945 (22) 0.377 (14) - 0.188 (14) 
Participants 
(Number of Specimens) 
Significance of Urine Properties and Constituents and  
Simpson’s Diversity Values of MSU Microbiota 
Bilirubin 
(n) 
Ketones 
(n) Blood (n) Protein (n) 
Nitrites 
(n) 
Leukocytes 
(n) 
ProFUM01 (n=67) 0.515 (15) 0.629 (14) 0.098 (16) - 0.153 (2) 0.252 (7) 
ProFUM02 (n=66) 0.576 (24) 0.250 (9) 0.040 (8) 0.344 (19) 0.909 (1) - 
ProFUM03 (n=71) 0.695 (24) 0.028 (1) 0.241 (40) 0.858 (9) - - 
ProFUM04 (n=72) 0.559 (16) - 0.602 (15) 0.454 (4) 0.694 (1) 0.209 (6) 
ProFUM05 (n=67) 0.715 (52) 0.124 (3) 0.079 (5) 0.765 (12) 0.018 (2) 0.479 (2) 
ProFUM06 (16S) (n=66) 0.913 (39) 0.313 (1) 0.373 (8) - 0.219 (1) 0.080 (2) 
ProFUM07 (n=69) 0.495 (5) 0.384 (2) <0.001 (29) 0.136 (4) 0.609 (1) 0.844 (14) 
ProFUM07 (16S) (n=69) 0.206 (5) 0.491 (2) 0.033 (29) 0.404 (4) 0.696 (1) 0.263 (14) 
ProFUM08 (n=67) 0.687 (40) 0.585 (14) 0.209 (22) 0.265 (14) - 0.361 (14) 
 
Table 17. Significance of Alpha-Diversity Values of MSU Microbiota and Selected Urine 
Properties and Constituents. 
 
Median Shannon (top) and Simpson’s (bottom) alpha-diversity values of the MSU microbiota or 
microbiome (indicated by “16S”) were assessed for an association with selected urine properties 
and constituents. p-values are shown in the tables. Mann-Whitney U test used to determine 
significance. p-value < 0.05 is significant (green). Cells in gray are not applicable. Significant p-
values that are underlined had higher median alpha-diversity values when the corresponding 
urine test result was “positive”. Number of “positive” results is indicated in parentheses in each 
cell. 
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Significance of Urine Properties and Constituents and JSD Values 
MSU Microbiota Peri-urethral Microbiota 
Participants 
(Number of Specimens) 
Specific 
Gravity pH 
Participants 
(Number of Specimens) 
Specific 
Gravity pH 
ProFUM01 (n=67) 0.457 0.605 ProFUM01 (N=65) 0.249 0.240 
ProFUM02 (n=66) 0.606 0.841 ProFUM02 (N=62) 0.376 0.739 
ProFUM03 (n=71) 0.997 0.135 ProFUM03 (N=63) 0.053 0.556 
ProFUM04 (n=72) 0.441 0.405 ProFUM04 (N=66) 0.342 0.181 
ProFUM05 (n=67) 0.611 0.030 ProFUM05 (N=60) 0.626 0.032 
ProFUM06 (16S) (n=66) 0.702 0.731    
ProFUM07 (n=69) 0.334 0.689 ProFUM07 (N=69) 0.238 0.536 
ProFUM07 (16S) (n=69) 0.168 0.740    
ProFUM08 (n=67) 0.459 0.779 ProFUM08 (N=66) 0.376 0.963 
  
Participants 
(Number of Specimens) 
Significance of Urine Properties and Constituents and  
Alpha-Diversity Values of MSU Microbiota 
Shannon Diversity Values Simpson’s Diversity Values 
Specific Gravity pH Specific Gravity pH 
ProFUM01 (n=67) 0.858 0.472 0.837 0.406 
ProFUM02 (n=66) 0.302 0.403 0.267 0.444 
ProFUM03 (n=71) 0.736 0.815 0.536 0.906 
ProFUM04 (n=72) 0.033 0.901 0.083 0.806 
ProFUM05 (n=67) 0.062 0.096 0.171 0.138 
ProFUM06 (16S) (n=66) 0.418 0.245 0.539 0.381 
ProFUM07 (n=69) 0.221 0.791 0.259 0.800 
ProFUM07 (16S) (n=69) 0.052 0.993 0.130 0.915 
ProFUM08 (n=67) 0.448 0.425 0.627 0.178 
Table 18. Significance of JDS and Alpha-Diversity Values of MSU and Peri-urethral Microbiota 
and Categorical Urine Properties and Constituents. 
 
Mean JSD (A) values of MSU (left) and peri-urethral (right) microbiota or microbiome (indicated 
by “16S”) were assessed for an association with categorical urine properties and constituents. 
Alpha-diversity values (B) including Shannon (left) and Simpson’s (right) diversity values of the 
MSU microbiota or microbiome are also shown. p-values are shown in the tables. One-way 
ANOVA tests used to determine significance. p-value < 0.05 is significant (green). 
A. 
B. 
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were grouped into one category (e.g., all Ketone results ranging from 5 mg/dL to 160 mg/dL were 
considered positive) and compared to negative results. Specific gravity and pH were treated as 
categorical variables and a one-way ANOVA was performed to determine if microbiota 
differences existed amongst the categories.  
 Table 16 shows the p-values for the statistical tests measuring associations between 
microbiota JSD values and non-categorical urine properties and constituents. I found that median 
JSD values for MSU and peri-urethral microbiota were not significantly different between positive 
and negative urine dipstick test results (Table 16). Some tests showed statistical significance, but 
overall no trends were observed. The exception was in Table 17, which showed that a positive 
blood test result was generally associated with higher mean alpha-diversity values for MSU 
microbiota (Table 17). For the categorical variables (i.e., specific gravity and pH), I also observed 
very few statistically significant trends between test results and microbiota stability (Table 18A) 
or alpha-diversity values (Table 18B). Altogether, these data show that the MSU microbiota is 
generally unaffected by the chemical environment of the LUT, at least relating to the urine 
properties assessed here. This could also be interpreted to mean that the microbiota do not alter 
the chemical environment of the LUT. 
Summary 
 Using the findings from Chapter III, I measured specimen collection compliance by using 
a pre-study Screening Phase. Of the 12 participants screened, I excluded four based on the use 
of Bray-Curtis Dissimilarity between microbiota of paired specimens. This approach provided us 
with quality specimens (i.e., distinct MSU and peri-urethral microbiota) in the primary study. I 
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found that all eight enrolled participants had median Bray-Curtis Dissimilarity values above 0.8 
(Table 6), though the scores varied dramatically over time for some participants (Figure 14). 
Nonetheless, the participants provided specimens with distinct microbiota (Figure 15). Use of a 
specific standard measure allowed us to make stronger comparisons and conclusions among the 
data and allowed us to make statements exclusively related to the LUT rather than the peri-
urethral environment regarding microbiota stability and change. 
 The temporal variability in the MSU microbiota of the participants is graphically depicted 
in Figure 16. I used JSD as the primary measure of longitudinal microbiota stability. I found that 
the peri-urethral microbiota were, overall, more unstable than the microbiota of the MSU 
specimens. The median JSD values for all participants were higher for the peri-urethral 
microbiota compared to the MSU microbiota, indicating greater instability over time (Figure 17). 
Physiologically, this is not surprising, as the peri-urethral area is exposed to the genital and 
external environments, while MSU specimens and the majority of the LUT are not. Therefore, 
exogenous introduction of microorganisms as well as movement of the normal flora of the peri-
urethra may occur more frequently than in the LUT. 
 For participant ProFUM07, I performed both modified EQUC and 16S rRNA gene 
sequencing. Qualitatively, the microbiota and microbiome of ProFUM07 were dominated by 
Lactobacillus (blue) except for three, one to two-week periods during the beginning (i.e., week 
1), middle (i.e., weeks 3 and 4), and end (i.e., weeks 7 and 8). During these non-Lactobacillus 
dominant periods, the two identification methods conflicted slightly. However, the deviation 
from Lactobacillus dominance occurred for the exact same specimens by both methods, and JSD 
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values were elevated for both methods during these periods (Figure 18). These data show that 
the two methods are complementary and validate the use of only one method to analyze the 
specimens of the other seven participants. 
 The primary aim of Chapter IV was to determine if intrinsic lifestyle factors relate to 
microbiota dynamics of the LUT. I found significant associations between microbial instability and 
participant-reported menstruation (Table 7). The associations were only significant for the MSU 
microbiota/microbiome data, suggesting that menstruation is associated with microbiota 
changes in the LUT, but not the peri-urethra (Figure 19). Compositional differences existed during 
menstruation, where higher frequencies and abundances of mainly Corynebacterium, 
Staphylococcus, and Actinomyces, which are common skin flora, were found in the MSU 
specimens of most participants (Table 9 and Figure 20). Median alpha-diversity values of the MSU 
microbiota were also significantly higher during menstruation (Table 8), despite the total 
bacterial abundance being largely unchanged (Table 10). Altogether, these data show that the 
association between MSU microbiota variability and menstruation is dynamic, meaning that 
several, likely related trends apply to the microbiota of the LUT. 
 As an assessment of confounding factors, I found that tampon and pad use were reported 
at significantly higher frequencies during reporting of menstruation for all participants, as 
expected (Table 12). The reported number of bowel movements was also significantly higher 
during menstruation for several participants (Table 12), but further analyses showed no 
association between number of bowel movements and MSU microbiota stability or alpha-
diversity measures (Table 13). Furthermore, I found that a positive blood result on the urine 
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dipstick test was the only result correlated with menstruation (Table 14). This last finding serves 
as an important positive control, because it suggests that the participants are reporting 
menstruation appropriately and provides a level of confidence that the remaining questionnaire 
was completed honestly. 
 I also used a urine dipstick test to determine if urine properties and constituents related 
to MSU microbiota variability. By assessing these characteristics on a daily basis, I was able to 
observe novel temporal variabilities in the data, an example of which is shown in Table 15. 
However, the variability in urine characteristics did not relate to microbiota variability (Tables 16, 
17, & 18). The exception was blood, which showed a similar pattern of trends as was seen with 
menstruation, as expected (Table 14).  
 Altogether, these data suggest that, mechanistically, the MSU microbiota variability 
associated with menstruation may relate to feminine hygiene product use, but likely not the 
chemical composition of the urine (i.e., LUT environment), at least none of the parameters that I 
assessed. The caveat to this hypothesis is that I did not observe a similar trend with the peri-
urethral microbiota suggesting that exogenous introduction of microorganisms into the LUT due 
to hygiene product use is unlikely. More research needs to be done exploring the peri-urethral 
microbiota to understand if this is a plausible conclusion.
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CHAPTER V 
EFFECT OF EXTRINSIC LIFESTYLE FACTORS ON LUT MICROBIOTA 
Sexual Activity and LUT Microbiota Variability 
 In this chapter, I sought to determine if extrinsic, or externally controlled, lifestyle factors 
are correlated to temporal changes in the microbiota of the LUT. Similar to Chapter IV, these 
changes could be related to MSU microbiota stability, composition, or alpha-diversity. 
 I hypothesized that sexual activity would alter the MSU microbiota, likely by introducing 
exogenous microorganisms. Participants were queried regarding sexual activity on the lifestyle 
questionnaire. If they reported sexual activity, they were then asked several follow-up questions 
including type of sexual activity (e.g., penetrative vaginal intercourse, receiving oral intercourse, 
other), condom use, and whether the partner was the same as the previous reported activity. 
These latter two follow-up questions were added to the questionnaire during the study and were 
therefore only completed by participants ProFUM06, ProFUM07, and ProFUM08. 
 Sexual activity was reported by six participants (Table 19). Of these six participants, 
penetrative vaginal intercourse was reported by all at least once, and was the main type of sexual 
activity for most. For the applicable participants (i.e., ProFUM06, ProFUM07, and ProFUM08), 
condom use was reported on 100% of the reported instances of vaginal intercourse. One 
participant, ProFUM07, reported being with the same male partner for all instances of vaginal 
intercourse (5/5, 100%), while ProFUM08 reported different male partners for each instance of  
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vaginal intercourse (0/3, 0%). Oral intercourse was reported by five of the six participants (Table 
19). 
 I first assessed whether sexual activity is broadly associated with MSU microbiota 
stability. Figure 21 plots the JSD values of the MSU and peri-urethral microbiota over time for 
participants ProFUM04 (Figure 21A), ProFUM05 (Figure 21B), and ProFUM08 (Figure 21C). Days 
shaded in grey reflect participant-reported sexual activity. Penetrative vaginal intercourse is 
depicted by the red triangles, and receiving oral intercourse is depicted by the blue circles. 
Qualitatively, participants ProFUM05 (Figure 21B) and ProFUM08 (Figure 21C) have a clear trend 
between reporting sexual activity and higher JSD values for the MSU microbiota. Visually, there 
also appears to be a slight trend for the peri-urethral microbiota of participant ProFUM05 (Figure 
21B), but this was determined to not be statistically significant (Table 20). Participant ProFUM04  
Participants 
Participant-reported Lifestyle Factors Relating to Sexual Activity 
Sexual 
Activity 
Penetrative 
Vaginal 
Intercourse 
Condom 
Use 
Same 
Partner – 
“Yes” 
Received 
Oral 
Intercourse 
“Other” 
Sexual 
Activity 
ProFUM01 0 N/A - - N/A N/A 
ProFUM02 3 2 (67%) - - 2 (67%) 1 (33%) 
ProFUM03 0 N/A - - N/A N/A 
ProFUM04 29 29 (100%) - - 0 (0%) 0 (0%) 
ProFUM05 22 22 (100%) - - 4 (18%) 0 (0%) 
ProFUM06 4 2 (50%) 2 (100%) 1 (50%) 3 (75%) 1 (25%) 
ProFUM07 15 5 (33%) 5 (100%) 5 (100%) 5 (33%) 15 (100%) 
ProFUM08 3 3 (100%) 3 (100%) 0 (0%) 3 (100%) 0 (0%) 
Table 19. Summary of Participant-reported Lifestyle Factors Relating to Sexual Activity. 
N/A (Not applicable) refers to participants who did not report the lifestyle factor (i.e. 
participants ProFUM01 and ProFUM03). Condom use and new partner were added to the 
lifestyle questionnaire following the completion of participant ProFUM05. 
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Figure 21. Relationship Between JSD Values and Sexual Activity. JSD values were calculated for 
MSU (solid lines) and peri-urethral (dashed lines) microbiota of participants ProFUM04 (A), 
ProFUM05 (B), and ProFUM08 (C). Data are plotted over time in days. Participant-reported 
sexual activity is depicted by the grey bars. Vaginal intercourse is depicted by the red triangles. 
Oral intercourse is depicted by the blue circles. 
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(Figure 21A) did not have a visual trend between JSD values and sexual activity for either 
specimen type; this was quantitatively confirmed in Table 20.  
 Significantly higher median JSD values of the MSU, but not peri-urethral, microbiota were 
associated with participant-reported sexual activity for three of the six applicable participants: 
ProFUM05, ProFUM06, and ProFUM08 (Table 20). Because sexual activity includes both/either 
penetrative vaginal intercourse and/or receiving oral intercourse, I next separated the responses 
by activity type and determined the relationship to microbiota stability. I found that four of the 
six applicable participants (ProFUM02, ProFUM05, ProFUM07, and ProFUM08) had significant 
associations between MSU microbiota JSD values and vaginal intercourse, while only two 
Sexual Activity 
Participants 
MSU Microbiota 
(Median JSD Values) 
Peri-urethral Microbiota 
(Median JSD Values) 
“Yes” (n) “No” (n) p-value “Yes” (n) “No” (n) p-value 
ProFUM01 N/A N/A - N/A N/A - 
ProFUM02 0.549 (3) 0.139 (63) 0.207 0.492 (3) 0.172 (59) 0.192 
ProFUM03 N/A N/A - N/A N/A - 
ProFUM04 0.057 (27) 0.063 (45) 0.373 0.303 (25) 0.256 (41) 0.162 
ProFUM05 0.200 (21) 0.108 (46) 0.036 0.267 (20) 0.249 (40) 0.441 
ProFUM06 (16S) 0.172 (3) 0.122 (63) 0.042 - - - 
ProFUM07 0.057 (13) 0.057 (56) 0.707 0.215 (13) 0.272 (56) 0.140 
ProFUM07 (16S) 0.063 (13) 0.053 (56) 0.136 - - - 
ProFUM08 0.279 (3) 0.071 (64) <0.001 0.198 (3) 0.279 (63) 0.080 
Table 20. Association between JSD Values for MSU and Peri-urethral Microbiota and 
Participant-reported Sexual Activity. 
Median Jensen-Shannon Divergence (JSD) values shown for MSU (left) and peri-urethral (right) 
microbiota on days when the participant reported (“Yes”) or did not report (“No”) sexual 
activity. Mann-Whitney U test used to determine significance. p-value < 0.05 is significant 
(green). N/A (Not applicable) refers to participants who did not report the lifestyle factor. 
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participants (ProFUM02 and ProFUM08) had an association with oral intercourse (Table 21). 
However, the two participants with significant associations between MSU microbiota JSD values 
and oral intercourse were the only two participants who always co-reported oral intercourse with 
vaginal intercourse, suggesting that the trend with sexual activity is due to vaginal intercourse. 
 To determine the nature of the MSU microbiota instability following vaginal intercourse, 
I assessed for differences in microbiota diversity and composition. Two measures of alpha-
diversity were calculated for each MSU microbiota: Shannon and Simpson’s diversity indices. 
These values were assessed for an association with participant-reported vaginal intercourse 
(Table 22). I found that median alpha-diversity measures were significantly higher following  
MSU Microbiota (Median JSD Values) 
Participants 
Penetrative Vaginal Intercourse Receiving Oral Intercourse 
“Yes” (n) “No” (n) p-value “Yes” (n) “No” (n) p-value 
ProFUM01 N/A N/A - N/A N/A - 
ProFUM02 0.559 (2) 0.136 (64) <0.001 0.559 (2) 0.136 (64) <0.001 
ProFUM03 N/A N/A - N/A N/A - 
ProFUM04 0.057 (27) 0.063 (45) 0.373 N/A N/A - 
ProFUM05 0.200 (21) 0.108 (46) 0.036 0.264 (4) 0.125 (63) 0.078 
ProFUM06 (16S) 0.173 (1) 0.123 (65) 0.152 0.150 (2) 0.123 (64) 0.183 
ProFUM07 0.242 (4) 0.057 (65) <0.001 0.163 (4) 0.057 (65) 0.094 
ProFUM07 (16S) 0.057 (4) 0.054 (65) 0.150 0.083 (4) 0.054 (65) 0.117 
ProFUM08 0.279 (3) 0.071 (64) <0.001 0.279 (3) 0.071 (64) <0.001 
Table 21. Association between Jensen-Shannon Divergence Values for MSU Microbiota and 
Participant-reported Vaginal and Oral Intercourse. 
Median JSD values shown for MSU microbiota on days when the participant reported (“Yes”) or 
did not report (“No”) vaginal intercourse (left) or oral intercourse (right). Mann-Whitney U test 
used to determine significance. p-value < 0.05 is significant (green). N/A (Not applicable) refers 
to participants who did not report the lifestyle factor. 
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vaginal intercourse for two of the participants (i.e., ProFUM07 and ProFUM08) who previously 
showed significant associations with MSU microbiota instability (Table 21). 
 In addition to elevated alpha-diversity values in some participants, I observed numerous 
differences in the frequency of detected taxa following vaginal intercourse. Table 23 lists the 
bacterial taxa that had significantly different frequencies of detection between reporting and not 
reporting vaginal intercourse.  
 Four participants had at least one bacterial taxon that was statistically significant (Table 
23). The exceptions were participants ProFUM02 and ProFUM06; however, these participants  
Vaginal Intercourse 
Participants 
MSU Microbiota 
(Median Shannon Diversity Values) 
MSU Microbiota 
(Median Simpson’s Diversity Values) 
“Yes” “No” p-value “Yes” “No” p-value 
ProFUM01 N/A N/A - N/A N/A - 
ProFUM02 1.247 0.567 0.242 0.642 0.318 0.303 
ProFUM03 N/A N/A - N/A N/A - 
ProFUM04 0.748 0.810 0.532 0.496 0.488 0.817 
ProFUM05 0.757 0.925 0.163 0.450 0.529 0.223 
ProFUM06 (16S) 1.809 2.675 0.212 0.682 0.800 0.333 
ProFUM07 1.643 0.249 <0.001 0.753 0.123 <0.001 
ProFUM07 (16S) 0.909 1.264 0.083 0.379 0.508 0.144 
ProFUM08 1.895 0.804 <0.001 0.820 0.488 <0.001 
Table 22. Association between Alpha-Diversity Values for MSU Microbiota and Participant-
reported Vaginal Intercourse. 
Median Shannon Diversity (left) and Simpson’s Diversity (right) values shown for MSU 
microbiota on days when the participant reported (“Yes”) or did not report (“No”) vaginal 
intercourse. Mann-Whitney U test used to determine significance. p-value < 0.05 is significant 
(green). N/A (Not applicable) refers to participants who did not report the lifestyle factor. 
Vaginal intercourse reported: ProFUM01 (0/67 days), ProFUM02 (2/66 days), ProFUM03 (0/71 
days), ProFUM04 (27/72 days), ProFUM05 (21/67 days), ProFUM06 (1/66 days), ProFUM07 
(4/69 days), ProFUM08 (3/67 days). 
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only reported vaginal intercourse on two and one day(s), respectively, thus making statistical 
significance difficult to obtain. Participants ProFUM04, ProFUM05, ProFUM07, and ProFUM08 all 
had significantly higher frequencies of detection of various Streptococcus and Staphylococcus 
species following vaginal intercourse. Participant ProFUM02 also had higher frequencies of  
Participants Significant Taxa Frequency of Detection following Vaginal Intercourse 
ProFUM02 Species “Yes” (n=2) “No” (n=64) p-value 
ProFUM04 Species “Yes” (n=27) “No” (n=45) p-value 
Staphylococcus epidermidis 22 (81%) 26 (58%) 0.039 
ProFUM05 
Species “Yes” (n=21) “No” (n=46) p-value 
Actinomyces neuii 4 (17%) 24 (52%) 0.016a 
Lactobacillus crispatus 9 (43%) 34 (74%) 0.014 
Streptococcus agalactiae 5 (24%) 2 (4%) 0.027a 
ProFUM06 (16S) Genera “Yes” (n=1) “No” (n=65) p-value 
ProFUM07 
Species “Yes” (n=4) “No” (n=65) p-value 
Staphylococcus hominis 4 (100%) 10 (15%) 0.001a 
Streptococcus mitis 3 (75%) 0 (0%) <0.001a 
Streptococcus salivarius 2 (50%) 0 (0%) 0.003a 
ProFUM07 (16S) Genera “Yes” (n=4) “No” (n=65) p-value 
Campylobacter 1 (25%) 51 (78%) 0.044a 
ProFUM08 
Species “Yes” (n=3) “No” (n=64) p-value 
Corynebacterium tuberculostearicum 2 (67%) 7 (11%) 0.045a 
Neisseria macacae 1 (33%) 0 (0%) 0.045a 
Staphylococcus hominis 3 (100%) 8 (13%) 0.003a 
Staphylococcus lugdunensis 2 (67%) 2 (3%) 0.008a 
Streptococcus gordonii 1 (33%) 0 (0%) 0.045a 
Streptococcus mitis 3 (100%) 2 (3%) <0.001a 
Streptococcus parasanguinis 2 (67%) 0 (0%) 0.001a 
Streptococcus salivarius 2 (67%) 0 (0%) 0.001a 
Streptococcus vestibularis 1 (33%) 0 (0%) 0.045a 
Table 23. List of MSU Taxa with Significantly different Frequencies of Detection following 
Participant-reported Vaginal Intercourse. 
MSU microbiota listed, had significantly different (p<0.05) frequencies of detection between 
vaginal intercourse and no vaginal intercourse. Yellow cells indicate higher frequency. Chi-
square used unless otherwise indicated. 
a: Fisher’s exact test 
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Figure 22. Fold Change of Average CFU/mL of MSU Microbiota for Participant ProFUM05 
between Reporting of “Vaginal Intercourse” and “No Vaginal Intercourse”. Average CFUs of 
each species found in the MSU specimens of Participant 05 were calculated. The fold change 
between the values obtained on days after the participant reported “vaginal intercourse” versus 
“no vaginal intercourse” were then measured. Species with red dots were found at higher CFUs 
following menstruation. Bars indicate that the species was only found in one group. Average 
total CFU/mL is in green and shows no difference. Species underlined had significantly (p<0.05) 
different mean abundances between groups (Student’s t-test). 
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Participants 
Mean Total Bacterial  
Abundance following Vaginal Intercourse 
“Yes” “No” p-value 
ProFUM01 N/A N/A - 
ProFUM02 115900 45800 0.044 
ProFUM03 N/A N/A - 
ProFUM04 85000 55200 0.010 
ProFUM05 59800 51300 0.496 
ProFUM06 (16S) 44600 47500 - 
ProFUM07 29300 42800 0.238 
ProFUM07 (16S) 32700 47200 0.118 
ProFUM08 24700 77600 0.042 
Streptococcus species, although the statistical tests only approached significance (p=0.081). 
Furthermore, the abundance of these significant species was generally elevated following vaginal 
intercourse; an example of which is shown in Figure 22, which shows that, for participant 
ProFUM05, S. mitis (p=0.002) and S. agalactiae (p=0.041) had significantly higher mean 
abundances in the MSU specimens following vaginal intercourse. 
 Table 23 also shows that some species, none of which belong to the Streptococcus or 
Staphylococcus genera, had significantly lower frequencies of detection following vaginal 
intercourse. These data may relate to the mixed results seen in Table 22 regarding alpha-diversity  
Table 24. Mean Total MSU Bacterial Abundance following Participant-reported Vaginal 
Intercourse. 
Mean total bacteria detected in MSU specimens between vaginal intercourse and no vaginal 
intercourse. Total bacterial abundance was calculated from CFUs or OTUs (if indicated by “16S”). 
Student’s t-test (two-tailed) used. p-value <0.05 were significant. N/A (Not applicable) refers to 
participants who did not report the lifestyle factor. Vaginal intercourse reported: ProFUM01 
(0/67 days), ProFUM02 (2/66 days), ProFUM03 (0/71 days), ProFUM04 (27/72 days), ProFUM05 
(21/67 days), ProFUM06 (1/66 days), ProFUM07 (4/69 days), ProFUM08 (3/67 days). 
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Significance of Reporting Vaginal Intercourse with Confounding Lifestyle 
Factors 
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ProFUM01 N/A N/A N/A N/A N/A N/A N/A N/A N/A 
ProFUM02 1.000
a 
(1/39) 
0.036a 
(2/13) 
1.000a 
(0/7) 
1.000a 
(0/6) 
1.000a 
(0/1) 
0.030a 
(1/1) 
0.203a 
(2/30) 
1.000a 
(0/2) 0.215
b 
ProFUM03 N/A N/A N/A N/A N/A N/A N/A N/A N/A 
ProFUM04 0.903 (14/38) 
0.142 
(9/32) 
0.025a 
(1/12) 
0.025a 
(1/12) - - 
0.749 
(17/47) - 0.673
b 
ProFUM05 0.479 (12/34) 
0.409 
(10/27) 
0.546a 
(0/3) - - 
0.008a 
(4/4) 
1.000a 
(20/63) 
0.584a 
(2/4) 0.473
b 
ProFUM06 0.418
a 
(0/39) 
0.478a 
(1/32) 
1.000a 
(0/7) - - 
0.030a 
(1/2) 
1.000a 
(1/54) - 1.000
b 
ProFUM07 0.618
a 
(3/37) 
1.000a 
(0/4) 
0.642a 
(3/41) - 
0.634a 
(3/40) 
0.015a 
(2/4) 
1.000a 
(4/69) 
1.000a 
(0/3) 0.399
b 
ProFUM08 1.000
a 
(2/36) 
0.583a 
(2/30) 
1.000a 
(1/19) 
0.249a 
(1/6) - 
<0.001a 
(3/3) 
0.226a 
(2/27) 
1.000a 
(0/1) 1.000
b 
values, as well as those in Table 24, which also showed varied results for differences in mean 
total bacterial abundance following vaginal intercourse. Altogether, these data suggest that the 
Table 25. Significance of Reporting Vaginal Intercourse with Confounding Lifestyle Factors. 
Frequency of participant-reported lifestyle factors was assessed for an association with 
participant-reported vaginal intercourse. p-values are shown in the table. Chi-square test used 
unless otherwise indicated. p-value < 0.05 is significant (green). Cells in gray are interpreted as 
lifestyle factors that were not reported by the corresponding participant. N/A (Not applicable) 
refers to participants who did not report vaginal intercourse. Significant p-values that are 
underlined represent lifestyle factors reported at higher frequencies (or means) following 
vaginal intercourse. Number of times each lifestyle factor was co-reported with vaginal 
intercourse out of total is indicated in parentheses in each cell.  Vaginal intercourse reported: 
ProFUM01 (0/67 days), ProFUM02 (2/66 days), ProFUM03 (0/71 days), ProFUM04 (27/72 days), 
ProFUM05 (21/67 days), ProFUM06 (1/66 days), ProFUM07 (4/69 days), ProFUM08 (3/67 days). 
a: Fisher’s exact test 
b: Wilcoxon rank sum test 
157 
 
 
 
variability of the MSU microbiota following vaginal intercourse is more complicated and 
individualized than the trends described in Chapter IV for menstruation. It is likely that related 
factors, such as co-reporting oral intercourse, condom use, and whether the partner was the 
same, play a large role in the discrepancies of the trends described here. However, because the 
latter two factors were only asked of participants ProFUM06, ProFUM07, and ProFUM08, one 
can only speculate. I did seek to determine whether reporting of other lifestyle factors could have 
confounded the data. The results in Table 25 confirm the significance between co-reporting oral 
intercourse with vaginal intercourse. Significant values were obtained for five of the six applicable 
participants; the remaining participant, ProFUM04, did not report oral intercourse (Table 25). 
However, I previously showed that oral intercourse is generally not significantly associated with 
MSU microbiota stability (Table 21). Participant ProFUM04 did show a trend with another 
lifestyle factor. I found that vaginal intercourse was significantly less likely to be co-reported with 
menstruation or tampon use (Table 25). Other relevant lifestyle factors such as condom use and 
new sexual partners were not analyzed due to the small sample size of participants (i.e., three 
participants). Furthermore, condom use was reported by all three applicable participants for all 
incidences of vaginal intercourse. Without this information for the remaining participants, I have 
no data to compare the results to. Participant ProFUM08 was the only applicable participant to 
report multiple sexual partners, again making conclusions difficult to draw from such a small 
sample size. 
 To better understand the mechanistic relationship between vaginal intercourse and MSU 
microbiota variability, I next determined whether urine properties and constituents were  
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ProFUM01 N/A N/A N/A N/A N/A N/A N/A N/A N/A 
ProFUM02 0.129
a 
(2/24) 
0.016a 
(2/9) 0.289
b 1.000
a 
(0/8) 0.638
b 0.484a 
(1/19) 
1.000a 
(0/1) 
1.000a 
(0/1) - 
ProFUM03 N/A N/A N/A N/A N/A N/A N/A N/A N/A 
ProFUM04 1.000 (6/16) - 0.542b 
0.822 
(6/15) 0.949
b 1.000
a 
(1/4) - 
1.000a 
(0/1) 
1.000a 
(2/6) 
ProFUM05 0.007 (12/52) 
0.546a 
(0/3) 0.054
b 0.315
a 
(3/5) 0.008
b 0.395 (5/12) - 
0.532a 
(1/2) 
1.000a 
(0/2) 
ProFUM06 1.000
a 
(1/41) 
0.015a 
(1/1) 0.125
b 1.000
a 
(0/8) 0.250
b - - 1.000
a 
(0/1) 
1.000a 
(0/2) 
ProFUM07 0.265
a 
(1/5) 
1.000a 
(0/2) 0.534
b 1.000a 
(2/29) 1.000
b 1.000
a 
(0/4) - 
1.000a 
(0/1) 
0.575a 
(0/14) 
ProFUM08 1.000
a 
(2/40) 
0.511a 
(1/14) 0.473
b 0.545
a 
(0/22) 0.953
b 1.000a 
(0/14) - - 
0.108a 
(2/14) 
  
Table 26. Significance of Participant-reported Vaginal Intercourse with Urine Property and 
Constituent Results. 
Frequency of urine property and constituent results was assessed for an association with 
participant-reported vaginal intercourse. Positive urine test results were considered as any 
outcome other than “negative”, except for Specific Gravity and pH which do not have “negative” 
outcomes. p-values are shown in the table. Chi-square test used unless otherwise indicated. p-
value < 0.05 is significant (green). Urine properties and constituents for a given participant that 
were always negative, or baseline are gray. N/A (Not applicable) refers to participants who did 
not report vaginal intercourse. Significant p-values that are underlined represent urine 
properties and constituents with “positive” results found at higher frequencies (or higher mean 
values) following vaginal intercourse. Number of times each “positive” categorical test result 
was co-reported with vaginal intercourse out of total is indicated in parentheses in each 
applicable cell. Vaginal intercourse reported: ProFUM01 (0/67 days), ProFUM02 (2/66 days), 
ProFUM03 (0/71 days), ProFUM04 (27/72 days), ProFUM05 (21/67 days), ProFUM06 (1/66 
days), ProFUM07 (4/69 days), ProFUM08 (3/67 days). 
a: Fisher’s exact test 
b: Wilcoxon rank sum test 
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significantly different following vaginal intercourse. In general, I found few significant 
associations between urine test results and participant-reported vaginal intercourse (Table 26). 
The exception was for participant ProFUM05, who had two urine test results with significant 
associations to vaginal intercourse. Frequency of positive bilirubin results and mean urine pH 
were significantly higher following vaginal intercourse for participant ProFUM05 (Table 26). The 
trend with pH, though it only applied to participant ProFUM05, may be relevant to data 
presented in Chapter VI where I found that bacterial supernatants of urinary isolates found at 
higher abundances following vaginal intercourse (i.e., Streptococcus) (Table 23) had higher pH 
levels than supernatants of other urinary isolates (e.g., Lactobacillus). 
 All in all, clear associations exist between MSU microbiota variability and vaginal 
intercourse. But these associations are complex and individualized, and it is likely that they 
cannot fully be explained by the data that was collected in this study.  
Hygiene and LUT Microbiota Variability 
 Participants were queried regarding hygiene practices on the lifestyle questionnaire. In 
this section, I discuss data relating to bathing and showering. Data relating to feminine hygiene 
product use is found in Chapter IV. 
 I hypothesized that bathing would alter the microbiota of the LUT possibly by physically 
removing certain organisms or inhibiting others with the use of bathing products. In the pre-study 
demographics questionnaire, participants reported a mean (SD) weekly number of showers as 6 
(±1) and baths as 1 (±1) (Table 5). These statistics more or less agreed with the data reported in  
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Participants 
(number of days 
bathing reported) 
Significance of Various Microbiota and Microbiome Measures 
and Participant-reported Bathing 
JSD Values 
Alpha-diversity Values 
(MSU) 
Bray-Curtis 
Dissimilarity 
between Paired 
Specimens MSU Peri-urethra 
Shannon 
Index 
Simpson’s 
Index 
ProFUM01 (66) 0.746 0.031 0.776 0.985 0.119 
ProFUM02 (30) 0.510 0.839 0.047 0.067 0.316 
ProFUM03 (36) 0.482 0.097 0.017 0.083 0.363 
ProFUM04 (47) 0.365 0.342 0.428 0.851 0.217 
ProFUM05 (63) 0.949 0.706 0.272 0.362 0.418 
ProFUM06 (16S) (54) 0.266 - 0.231 0.172 - 
ProFUM07 (69) N/A N/A N/A N/A N/A 
ProFUM07 (16S) (69) N/A - N/A N/A - 
ProFUM08 (27) 0.027 0.189 0.536 0.503 0.627 
the ProFUM study. However, the lifestyle questionnaire did not discriminate between showering 
and bathing (i.e., either activity was reported broadly as “bathing”), nor did it discriminate 
between number of bathing episodes per day. I also did not ask about time of day. The frequency 
of reported daily bathing ranged from 40% (i.e., participant ProFUM08; 27/67 days) to 100% (i.e., 
participant ProFUM07; 69/69 days). Despite this broad range, data regarding microbiota 
variability was generally not significantly associated to bathing frequencies (Table 27). 
Median JSD, Alpha-diversity, and Bray-Curtis Dissimilarity values of the MSU and/or peri-
urethral (if indicated) microbiota or microbiome (indicated by “16S”) were assessed for an 
association with participant-reported bathing. p-values are shown in the table. Mann-Whitney 
U test was used to determine significance. p-value < 0.05 is significant (green). Cells in gray are 
not applicable. N/A (Not applicable) refers to participants who always reported bathing. 
Table 27. Significance of JSD, Alpha-Diversity, and Bray-Curtis Dissimilarity Values of MSU and 
Peri-urethral Microbiota and Participant-reported Bathing. 
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 I assessed for associations between bathing and MSU and peri-urethral microbiota 
stability (i.e., JSD values), MSU microbiota alpha-diversity, and Bray-Curtis Dissimilarity between  
  
 
Significance of Reporting Bathing with Confounding Lifestyle Factors 
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ProFUM01 0.403
a 
(40/40) 
1.000a 
(1/1) 
1.000a 
(15/15) 
1.000a 
(15/15) 
1.000a 
(14/14) - - 
1.000a 
(3/3) 1.000
b 
ProFUM02 0.715 (17/39) 
0.498 
(7/13) 
0.442a 
(2/7) 
0.209a 
(1/6) 
0.455a 
(1/1) 
0.203a 
(2/2) 
0.455a 
(1/1) 
1.000a 
(1/2) 0.268
b 
ProFUM03 0.074 (15/37) - 
0.945 
(9/18) - 
0.945 
(9/18) - - 
0.705 
(5/11) 0.506
b 
ProFUM04 0.371 (23/38) 
0.293 
(23/32) 
0.047a 
(11/12) 
0.047a 
(11/12) - 
0.749 
(17/27) - - 0.147
b 
ProFUM05 1.000
a 
(32/34) 
0.643a 
(26/27) 
1.000a 
(3/3) - - 
1.000a 
(20/21) 
1.000a 
(4/4) 
0.223a 
(3/4) 0.239
b 
ProFUM06 0.748
a 
(31/39) 
0.110a 
(29/32) 
0.334a 
(7/7) - - 
1.000a 
(1/1) 
1.000a 
(2/2) - 0.060
b 
ProFUM07 N/A N/A N/A N/A N/A N/A N/A N/A N/A 
ProFUM08 0.800 (14/36) 
0.339 
(14/30) 
0.850 
(8/19) 
0.211a 
(4/6) - 
0.560a 
(2/3) 
0.560a 
(2/3) 
0.403a 
(1/1) 0.047
b 
Table 28. Significance of Reporting Bathing with Confounding Lifestyle Factors. 
Frequency of participant-reported lifestyle factors was assessed for an association with 
participant-reported bathing. p-values are shown in the table. Chi-square test used unless 
otherwise indicated. p-value < 0.05 is significant (green). Cells in gray are interpreted as lifestyle 
factors that were not reported by the corresponding participant. N/A (Not applicable) refers to 
participants who always reported bathing. Significant p-values that are underlined represent 
lifestyle factors reported at higher frequencies (or means) with bathing. Number of times each 
lifestyle factor was co-reported with bathing out of total is indicated in parentheses in each cell.  
Bathing reported: ProFUM01 (66/67 days), ProFUM02 (30/66 days), ProFUM03 (36/71 days), 
ProFUM04 (47/72 days), ProFUM05 (63/67 days), ProFUM06 (54/66 days), ProFUM07 (69/69 
days), ProFUM08 (27/67 days). 
a: Fisher’s exact test 
b: Wilcoxon rank sum test 
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paired specimens. Overall, some participants had significant associations for some of these 
statistical tests, but no general pattern was seen (Table 27). In an effort to explain these data, I 
then asked whether other lifestyle factors were confounding the results. I found that  
Figure 23. Principal Coordinate Analyses of MSU Microbiota of Select ProFUM Participants and 
Relation to Bathing Habits. Analysis was done using MSU microbiota data collected from four 
ProFUM participants: ProFUM02 (upper-left), ProFUM03 (upper-right), ProFUM04 (lower-left), 
and ProFUM08 (lower-right). Graphs plot the 1st and 2nd principal coordinates of the data. 
Percent of total variance explained by the principal coordinate is shown in the parentheses. 
Closed circles indicate microbiota of days when no bathing was reported. Open circles indicate 
bathing. 
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participant ProFUM04 had higher frequencies of reporting bathing during menstruation and 
tampon use (Table 28), but this finding is not likely related to the MSU microbiota as this 
participant showed no trends between bathing and MSU microbiota variability (Table 27). 
 Because the data were rather inconclusive, I then performed PCoA to broadly determine 
if the MSU microbiota clustered by bathing habits. For participants ProFUM02, ProFUM03, 
ProFUM04, and ProFUM08, all of whom had some significant associations described in Tables 27 
& 28, there was no visual relationship between MSU microbiota and bathing (Figure 23). 
Therefore, I concluded that bathing, as measured and defined in this study, was not related to 
MSU microbiota variability. 
Oral Probiotics and LUT Microbiota Variability 
Participants 
Overview of Participant Randomization and Follow-up Survey Results 
Cohort # Pills Remaining “Which cohort do you think you were in?” 
ProFUM01 Probiotic 0 Placebo 
ProFUM02 Placebo 20 Probiotic 
ProFUM03 Probiotic 7 Placebo 
ProFUM04 Probiotic 0 Probiotic 
ProFUM05 Placebo 6 Placebo 
ProFUM06 Probiotic 4 Probiotic 
ProFUM07 Probiotic 4 Placebo 
ProFUM08 Placebo 2 Probiotic 
Table 29. Summary of Randomization and Follow-up Survey Results. 
Results for “which cohort do you think you were in?” listed in green indicate that the participant 
was correct; results in red were incorrect. 3/8 participants correctly predicted the 
randomization. 
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 Participants were randomized in a 2:1 ratio to take an oral probiotic or placebo during 
Days 21-60 (i.e. Phase II) of the study. Five participants were in the probiotic cohort, and three 
were in the control/placebo cohort. All participants completed a short follow-up survey in which 
they were asked how many pills remained after study completion (participants took two pills per 
day for 40 days), and they were asked which cohort they thought they were in as a measure of 
the effectiveness of the study blinding. These results are listed in Table 29. Overall the data show 
high compliance with the given instructions and successful blinding of cohort placement. 
Participants 
Significance of Various Microbiota and Microbiome Measures 
and Probiotic or Placebo Use 
JSD Values 
Alpha-diversity Values 
(MSU) 
Bray-Curtis 
Dissimilarity 
between Paired 
Specimens MSU Peri-urethra 
Shannon 
Index 
Simpson’s 
Index 
ProFUM01 0.083 0.715 0.057 0.029 0.724 
ProFUM02 0.103 0.003 0.008 0.005 0.340 
ProFUM03 0.440 0.194 0.034 0.005 0.087 
ProFUM04 0.337 0.583 0.610 0.996 0.572 
ProFUM05 0.076 0.628 0.280 0.400 0.016 
ProFUM06 (16S) 0.969 - 0.015 0.037 - 
ProFUM07 0.159 0.219 0.004 <0.001 0.122 
ProFUM07 (16S) 0.335 - 0.029 0.089 - 
ProFUM08 0.906 0.360 0.878 0.615 0.055 
Median JSD, Alpha-diversity, and Bray-Curtis Dissimilarity values of the MSU and/or peri-
urethral (if indicated) microbiota or microbiome (indicated by “16S”) were assessed for an 
association with probiotic use. p-values are shown in the table. Mann-Whitney U test was used 
to determine significance. p-value < 0.05 is significant (green). Cells in gray are not applicable. 
Participants in the probiotic cohort are in blue. 
Table 30. Significance of JSD, Alpha-Diversity, and Bray-Curtis Dissimilarity Values of MSU and 
Peri-urethral Microbiota and Probiotic or Placebo Use. 
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 I hypothesized that oral Lactobacillus probiotic use would result in altered MSU 
microbiota as a potential explanation for the link between probiotic use and decreased UTI risk158 
159, as described in Chapter I. I asked whether probiotic use was associated with microbiota 
stability and alpha-diversity values. The results showed several statistically significant trends 
(most with alpha-diversity values), but the relation to probiotic use was not strong (Table 30). In 
particular, several participants had increased (i.e., ProFUM06 and ProFUM07) or decreased (i.e., 
ProFUM01, ProFUM02, and ProFUM03) alpha-diversity values during Days 21-40, but there were 
no general patterns between the cohorts (i.e., probiotic versus placebo). 
Summary 
 The primary aim of the study reported in Chapter V was to determine if extrinsic lifestyle 
factors relate to MSU microbiota variability. I found significant associations between microbial 
instability and participant-reported sexual activity (Table 20). The associations were only 
significant for the MSU microbiota/microbiome data, suggesting that sexual activity alters the 
microbiota of the LUT but not peri-urethra (Figure 20). I found that the variability of the MSU 
microbiota following sexual activity is complex and rather individualized. Some participants had 
differences in median alpha-diversity values of MSU microbiota (Table 22), while others had 
differences in microbiota composition, in particular an increase in the frequency and abundance 
of Streptococcus and Staphylococcus species (Table 23 & Figure 22). Overall, the pattern of these 
trends was very different from those seen in Chapter IV relating to menstruation. Therefore, it is 
likely that the mechanisms underlying the variable MSU microbiota in response to menstruation 
are separate from those relating to sexual activity. 
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 In an effort to understand the mechanism underlying the microbiota trends associated 
with sexual activity, I first assessed for confounding factors. Unsurprisingly, I found that oral 
intercourse was reported at significantly higher frequencies during vaginal intercourse for most 
participants (Table 25). This finding makes it difficult to make conclusions regarding an individual 
type of sexual activity. Interestingly though, participant ProFUM04, who only reported vaginal 
intercourse (27/72 days), was one of the only participants who did not have significantly different 
JSD values for the MSU microbiota following vaginal intercourse (Table 21). These data suggest 
that the microbiota variability seen when broadly reporting sexual activity is more related to oral 
intercourse. This conclusion is further supported by the fact that Streptococcus, one of the main 
genera to appear at higher frequencies and abundances following sexual intercourse, are 
commonly found as part of the oral flora273. However, if one considers the rest of the participants’ 
data, this conclusion does not withstand. For example, participant ProFUM05 reported sexual 
activity 21/67 days; 17/21 days she reported vaginal intercourse only, while the other 4/21 days 
she reported both vaginal and oral intercourse. Assessment of these four days alone shows no 
significant association with MSU microbiota stability, while assessment of all 21 days does (Table 
21). Similar findings are seen for other participants. Altogether, these data suggest that vaginal 
intercourse, rather than oral intercourse, is associated with MSU microbiota variability, but the 
inconsistencies in the trends suggest that other factors have a clear influence. 
 Besides oral intercourse, few lifestyle factors or urine properties and constituents were 
significantly co-reported with vaginal intercourse, and none were consistent among participants 
(Tables 25 & 26). Furthermore, condom use was reported 100% of the time when vaginal 
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intercourse was reported in the three participants who were asked (i.e. ProFUM06, ProFUM07, 
and ProFUM08) making it impossible to conclude how condom use contributes to the trends 
between MSU microbiota variability and vaginal intercourse. A likely explanation for the 
individualized-nature of the trends is sexual partner variability. However, these data were not 
collected for every participant and timepoints are too few to allow for strong conclusions. I 
explore this hypothesis further in Chapter VI by explicitly determining whether movement of 
bacterial strains between sexual partners following vaginal intercourse occurs. 
 I also determined if hygiene practices related to MSU microbiota variability, specifically 
frequency of showering and bathing. I observed no relationship between frequency of bathing 
and microbiota characteristics (Table 27). This was confirmed using PCoA, which showed no 
clustering of MSU microbiota based on bathing versus no bathing (Figure 23). I found no 
relationship between frequency of bathing and peri-urethral microbiota variability (Table 27), 
which was surprising considering that the peri-urethral environment would be directly affected 
by this. Clearly, more information regarding bathing practices is necessary to understand these 
data completely, and conclusions based on the findings alone should be cautioned. 
 Finally, I assessed for associations between probiotic use and MSU microbiota variability. 
Although several significant trends were found for alpha-diversity values (Table 30), these trends 
were not unique to the probiotic cohort, suggesting that the differences are unrelated to actual 
use of the probiotic. Therefore, it seems that data relating oral probiotic use to decreased UTI 
risk cannot be explained by changes to the microbiota of the LUT.
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CHAPTER VI 
MECHANISTIC DETERMINATION AND SIGNIFICANCE OF LUT MICROBIOTA VARIABILITY AND 
VAGINAL INTERCOURSE 
Introduction and Rationale 
 In Chapter V, I described a significant trend between MSU microbiota variability and 
participant-reported vaginal intercourse. Though most of the specifics of the microbiota 
variability varied among participants, one consistent finding was an increase in frequency and/or 
abundance of Streptococcus and Staphylococcus. In this chapter, I aim to determine the clinical 
and biological significances of these data. 
 In regard to the clinical significance, I hypothesized that the MSU microbiota variability 
following vaginal intercourse related to UTI risk. As described in Chapter I, vaginal intercourse is 
a major risk factor for UTI in women179 180 181 182. However, with some exceptions, it has been 
shown that the UTI-causing pathogens (e.g., UPEC) are not introduced during intercourse. 
Researchers have instead found other, mainly Gram-positive, non-pathogenic organisms in 
female urine specimens following vaginal intercourse including Corynebacterium, 
Staphylococcus, and Streptococcus181 . These findings are consistent with the data from Chapter 
V. Therefore, I wondered whether these findings were related to UTI risk. More specifically, I 
hypothesized that Streptococcus and Staphylococcus that appear in high frequency and/or 
abundance following vaginal intercourse are less inhibitory against UTI-causing pathogens in vitro 
  168 
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than microorganisms of the normal LUT flora. I defined the normal LUT flora as the predominant 
microorganisms present when vaginal intercourse and/or menstruation were not reported, as 
these were the two lifestyle factors found to have the greatest association with MSU microbiota 
variability. For all participants except ProFUM03, the normal LUT flora were dominated by 
Lactobacillus; some participants also had high abundance of Gardnerella. Lactobacillus is 
generally considered to be a health-associated genus. In the vagina, a variety of known probiotic 
characteristics are associated with this genus, including the production of lactic acid and 
hydrogen peroxide274, strong adhesion to epithelial cells275, ability to modulate the host immune 
response276 277, and the production of bacteriocins and other antimicrobials278 279 280 281 282. These 
characteristics not only apply to the vaginal environment, but also impact the LUT. Vaginal 
Lactobacillus strains have been shown to be inhibitory towards UTI-causing pathogens283 284 285. 
Recently, our group showed that Lactobacillus strains isolated from the urine and vagina are 
phylogenetically similar57. Therefore, it is reasonable to hypothesize that urinary isolates of 
Lactobacillus (i.e., the normal LUT flora) will have similar inhibitory activities against UTI-causing 
pathogens as reported for vaginal isolates. 
 In regard to the biological significance, I hypothesized that the LUT microbiota variability 
following vaginal intercourse originates from the male sexual partner. I designed a study in which 
participant ProFUM05, and her male sexual partner, provided urine and genital specimens for 
three additional weeks. I isolated multiple representative isolates of S. mitis and then performed 
WGS and subsequent genomic analyses to determine the relatedness of the isolates. I 
hypothesized that the S. mitis that appear in high abundance in MSU specimens of participant 
170 
 
 
 
ProFUM05 following vaginal intercourse are clonally related to S. mitis isolates isolated from her 
male sexual partner. 
 In the first half of Chapter VI, I described a series of in vitro experiments to assess the 
inhibitory properties of Streptococcus and Lactobacillus isolates against strains of UPEC. 
Specifically, I used isolates of S. mitis and L. jensenii isolated from MSU specimens of participant 
ProFUM05. In the second half of Chapter VI, I reported a follow-up study (i.e., PARTNER study) 
to determine if S. mitis isolates that appear in high abundance in MSU specimens of participant 
ProFUM05 following vaginal intercourse are clonally related to S. mitis isolates from her male 
sexual partner. A list of strains used and isolated are found in Table 3. 
Assessing the Clinical Significance of LUT Microbiota Variability Following Vaginal Intercourse 
 I hypothesized that S. mitis isolates that appear in high abundance in MSU specimens of 
participant ProFUM05 following vaginal intercourse are less inhibitory against UTI-causing 
pathogens in vitro than microorganisms of her normal LUT flora (e.g., L. jensenii). Positive findings 
would suggest that the microbiota of the LUT following vaginal intercourse are less protective 
against a UTI. I used isolates of S. mitis and L. jensenii isolated from MSU specimens of participant 
ProFUM05 during the ProFUM study. I assessed the in vitro phenotypes of these isolates on two 
previously characterized strains of UPEC: NU14 and UTI89. 
Effect of Urinary Isolates on UPEC Adherence to Urothelial Cells 
 I first asked whether the urinary bacterial isolates (i.e., S. mitis and L. jensenii) affect the 
ability of UPEC to adhere to urothelial cells. For a successful infection, UPEC must adhere to the 
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urothelial tissue of the bladder and form a biofilm to be protected from immune detection and 
allow for dissemination. A non-malignant urothelial cell line (HURO23A) established by Dr. Phong 
Le267 was used for these experiments. One strain of UPEC, NU14268, was grown in TSB overnight 
in aerobic conditions. The cells were diluted to an OD600 of 0.1, pelleted, washed with PBS and 
then resuspended in PBS. Cell free supernatants of S. mitis and L. jensenii were added to the 
NU14 cells in a 1:1 ratio and left for 1 hour. Briefly, the S. mitis cells were grown in BHI broth at 
Figure 24. Effect of Urinary Bacterial Supernatants on UPEC Adherence to Urothelial Cells. 
UPEC (i.e., NU14) cells were grown overnight in TSB. Cells were diluted to an OD600 of 0.1, 
pelleted, washed and resuspended in PBS. NU14 cells were pre-treated with supernatants from 
an isolate of S. mitis (SM34) or L. jensenii (LJ35) at a 1:1 volume ratio for 1 hour. NU14 cells 
were then pelleted, washed, and resuspended in DMEM/F-12 (approximately 108 CFU/mL 
DMEM/F-12). 1mL of the NU14 cultures were added to microtiter plates containing urothelial 
cell monolayers (approximately 104 cells/well) and incubated at 5% CO2 for 3 hours. Figure 
depicts the amount of NU14 recovered from Triton-X-treated urothelial cell cultures following 
the incubation. White bars indicate NU14 binding to empty wells (i.e., without urothelial cells); 
black bars indicate binding to wells containing urothelial cell monolayers. Experiment was 
performed in triplicate.  
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5% CO2 conditions for 48 hours. L. jensenii cells were grown in MRS broth at 5% CO2 conditions 
for 48 hours. Cells from both cultures were pelleted and the supernatants were filtered using a 
0.2-micron filter. In this experiment, I used one isolate of L. jensenii, LJ35 (isolated from an MSU 
specimen collected by participant ProFUM05 on Day 35; no vaginal intercourse reported) and 
one isolate of S. mitis, SM34 (isolated from an MSU specimen collected by participant ProFUM05 
on Day 34; vaginal intercourse reported). After the incubation with the urinary isolate 
supernatants, the NU14 cells were pelleted again, and resuspended in DMEM/F-12 (i.e., 
urothelial cell culture media). NU14 counts were approximately 108 CFU/mL DMEM/F-12. 1mL of 
cultures were added to a 24 well plate containing approximately 104 urothelial cells per well. The 
plates were incubated in 5% CO2 for 3 hours. The wells were then washed with PBS three times, 
500µL of Triton-X was added to each well, and then the contents were plated on BAP media and 
incubated aerobically for 24 hours to assess for NU14 CFUs.  
 Figure 24 shows the results of this experiment. I hypothesized that the L. jensenii 
supernatants would have an inhibitory effect on UPEC urothelial adherence, while the S. mitis 
supernatants would not. This finding would support the theory that the S. mitis increase in 
abundance following vaginal intercourse relates to elevated UTI risk. In Figure 24, the white bars 
(i.e., without urothelial cells) show the basal amount of NU14 binding to the plastic microtiter 
plate, while the black bars (i.e., with urothelial cells) show binding in the presence of urothelial 
cells. The data show no difference in adherence of NU14 alone (i.e., no pre-treatment) compared 
to pre-treatment with either urinary isolate supernatant (Figure 24). These data show that the 
bacterial supernatants did not affect the ability of UPEC to bind to urothelial cells in vitro. 
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Effect of Urinary Isolates on UPEC Biofilm Formation 
 I next asked whether the urinary bacterial isolates affect the ability of UPEC to form a 
biofilm in vitro. NU14, L. jensenii, and S. mitis cells were grown as previously described. An NU14 
strain with a deletion in the fimH gene was used as a negative control (i.e., NU14∆fimH)270. The 
FimH protein forms part of the fimbriae of E. coli that is used for surface attachment. Therefore, 
the fimH mutant adheres poorly to surfaces and subsequently forms a less robust biofilm286. The 
NU14 strains were grown in TSB overnight in aerobic conditions. The cells were diluted to an 
OD600 of 0.1 and 100uL were plated into a 96 well microtiter plate. At various timepoints (0, 0.5, 
1, 2, 4, and 6 hours) at or after addition of the NU14 strains, an equal volume (i.e., 100uL) of 
urinary bacterial supernatants were added. Two isolates of L. jensenii, LJ35 and LJ70 (isolated 
from an MSU specimen collected by participant ProFUM05 on Days 35 and 70, respectively; no 
vaginal intercourse reported on either day) and two isolates of S. mitis, SM34 and SM69 (isolated 
from an MSU specimen collected by participant ProFUM05 on Days 34 and 69, respectively; 
vaginal intercourse reported on both days) were used. Plates were incubated aerobically for 24 
hours total. NU14 biofilm formation was assessed using a standard crystal violet assay. Briefly, 
wells were decanted and washed with PBS three times, 200uL of crystal violet stain was added 
to each well and left for 10 minutes. The crystal violet stain was then decanted, and the plates 
were left to dry for 30 minutes before adding 200 µL of 70% ethanol to each well. OD600 
measurements were taken. 
 I hypothesized that the L. jensenii supernatants would have an inhibitory effect on UPEC 
biofilm formation, while the S. mitis supernatants would not. Again, this finding would relate S. 
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mitis to increased UTI risk. Figure 25 shows the 0-hour timepoint data. Data for other timepoints 
are not shown h ere but, in general, showed similar patterns. In Figure 25A, the y-axis shows the 
Figure 25. Effect of Urinary Bacterial Supernatants on UPEC Biofilm Formation in vitro. UPEC 
(i.e., NU14) cells were grown overnight in TSB. Cells were diluted to an OD600 of 0.1 and 100µL 
were plated into a 96 well microtiter plate. Plates were incubated at 5% CO2. An equal volume 
of bacterial supernatants or media controls were added to each well at 0, 0.5, 1, 2, 4, and 6 
hours after addition of the NU14. After 24 hours, biofilm formation was assessed using a 
standard crystal violet assay. OD600 values were collected. An NU14 mutant lacking the fimH 
gene (i.e. NU14∆fimH) was used as a negative control. Figures show the data for the 0-hour 
addition only. Supernatants from two L. jensenii (i.e., LJ35 and LJ70) and two S. mitis (i.e., SM34 
and SM69) isolates were used. (A) Depicts the OD600 values for WT NU14 over the ∆fimH mutant. 
T-tests were used to determine significance of data compared to media control (i.e., MRS or 
BHI). * p<0.05; ** p<0.01. (B) Depicts the OD600 values for the WT NU14 (black bars) and the 
NU14∆fimH (white bars). Experiments were performed in triplicate. 
A 
B 
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OD600 of the WT NU14 over the mutant (i.e., NU14∆fimH). In most conditions, the NU14 strain 
had OD600 values that were twice t hose of the mutant, meaning twice as much biomass. The 
exception was when the NU14 strains were grown in the presence of the L. jensenii supernatants 
(i.e., LJ35 and LJ70), which gave OD600 values that were significantly different from the MRS media 
control (Figure 25A). The S. mitis supernatants (i.e., SM34 and SM69) did not show the same 
effect (Figure 25A). These data show that the L. jensenii isolates have inhibitory effects on NU14 
biofilm formation in vitro, while the S. mitis isolates do not. Furthermore, the raw NU14∆fimH 
OD600 data for the L. jensenii conditions were lower than other conditions (Figure 25B). These 
data suggest that the L. jensenii supernatants are not affecting NU14 biofilm formation, but 
rather NU14 growth in general because they are affecting NU14 irrespective of the presence of 
fimH. 
Effect of Urinary Isolates on UPEC Growth 
 To determine if the L. jensenii isolates affect UPEC growth, I tested the supernatants 
inhibitory capacity on two UPEC strains: NU14 and UTI89269. UTI89 was grown similarly to NU14. 
UPEC cells from overnight cultures were diluted to an OD600 of 0.1 and then added in a 1:1 volume 
ratio with supernatants from six different S. mitis strains: SM34, SM43, SM54, SM65, SM68, and 
SM69 (isolated from an MSU specimen collected by participant ProFUM05 on Days 34, 43, 54, 
65, 68, and 69, respectively; vaginal intercourse reported on all days) and six different L. jensenii 
strains: LJ35, LJ44, LJ55, LJ66, LJ69, and LJ70 (isolated from an MSU specimen collected by 
participant ProFUM05 on Days 35, 44, 55, 66, 69, and 70, respectively; no vaginal intercourse 
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reported on all days). The cultures were incubated aerobically for 24 hours and OD600 
measurements were taken periodically. CFUs were measured at 0-hours and 24-hours.  
 I hypothesized that the L. jensenii supernatants would have an inhibitory effect on UPEC 
growth, while the S. mitis supernatants would not, which can be related to UTI risk. Figure 26 
shows the data for the SM34 and LJ35 supernatants. Similar results were seen for all other 
isolates tested. In the presence of the L. jensenii supernatants, both UPEC strains showed no 
Figure 26. Effect of Urinary Bacterial Supernatants on UPEC Growth. UPEC (i.e., NU14 or UTI89) 
cells were grown overnight in TSB. Cells were diluted to an OD600 of 0.1. Supernatants from 
bacterial isolates or media controls were added to UPEC cells in a 1:1 volume ratio. Two strains 
of UPEC were used: NU14 (A and C) and UTI89 (B and D). OD600 measurements of UPEC growth 
were taken at 0, 2, 4, 6, 8, and 24 hours (A and B). UPEC CFUs were measured at 0 (black bars) 
and 24 (white bars) hours (C and D). Figures show data using one L. jensenii (LJ35) and one S. 
mitis (SM34) isolate. Experiments were performed in triplicate. Supernatants from five 
additional L. jensenii (i.e., LJ44, LJ55, LJ66, LJ69, and LJ70) and five S. mitis (SM43, SM54, SM65, 
SM68, and SM69) isolates were also used. Data not shown. 
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additional growth, as measured by OD600, over 24 hours (Figure 26A & B). CFUs also remained 
steady (Figure 26C & D). However, in the presence of the S. mitis supernatants, both UPEC strains 
showed comparable growth to the BHI media control. The data were similar between both UPEC 
strains: NU14 (Figure 26A) and UTI89 (Figure 26B). These data show that the supernatants of L. 
jensenii are inhibitory towards UPEC growth, while supernatants of S. mitis are not. These 
findings could be interpreted to reflect differences in UTI risk or susceptibility.  
 From these data, I can also conclude that the L. jensenii supernatants are bacteriostatic, 
not bactericidal, meaning that they inhibit the growth of UPEC, but do not kill or lyse the cells. I 
can make this conclusion primarily from the CFU data of Figure 26, which shows that while the 
Figure 27. Effect of Diluted L. jensenii Supernatants on UPEC Growth. UPEC (i.e., NU14) cells 
were grown overnight in TSB. Cells were diluted to an OD600 of 0.1. Supernatants from one L. 
jensenii isolate (LJ35) were added undiluted or diluted with PBS in a 1:1 volume ratio with the 
NU14. Bars depict log CFU/mL of NU14 growth on BAP at 0 hours (black bars) and 24 hours 
(white bars) after incubation. Experiment was performed in triplicate. 
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CFUs of the UPEC strains did not increase over the 24 hours in the presence of the L. jensenii 
supernatants, they did not decrease either. This suggests that the cells remained viable but were 
not able to grow. This is supported by data from Figure 24, which showed that after 1 hour in the 
presence of the L. jensenii supernatants, the number of viable NU14 cells (i.e., black bars) was 
unaffected. 
 If the bacteriostatic activity is directly related to the L. jensenii supernatants, then I would 
expect a dose-dependent effect when the supernatant is diluted, which is what I observed in 
Figure 27. When I diluted the LJ35 supernatant with PBS and then added the mixtures in a 1:1 
volume ratio with NU14 (OD600 = 0.01), I found that the bacteriostatic effects were only applicable 
to the undiluted supernatants (Figure 27). The 1:1 dilution with PBS condition was not 
bacteriostatic against NU14 suggesting that the inhibitory compound(s) of the L. jensenii 
supernatant are at their minimum inhibitory concentration (MIC) in the undiluted supernatant. 
 In an effort to determine the mechanism underlying the inhibition of UPEC growth by the 
L. jensenii supernatants, I first assessed for differences in the properties of the supernatants. I 
found that the average pH of the supernatants of the six L. jensenii isolates used in the 
experiment in Figure 26 was 5.1, while the supernatants of the six S. mitis isolates was 7.5. This 
is potentially clinically relevant because I previously found a statistically significant trend between 
urine pH and reporting vaginal intercourse for participant ProFUM05 (Table 26). On days when 
vaginal intercourse was not reported, the average pH of the MSU specimens was 6.5. I found a 
significantly higher (p=0.013) average pH of 7.5 on days when vaginal intercourse was reported.  
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 It has been well described in the literature that Lactobacillus species create acidic 
environments through their production of lactic acid and hydrogen peroxide (H2O2)287 288. To 
determine if these compounds contribute to the bacteriostatic effect, I assessed UPEC growth in 
the presence of the L. jensenii supernatant with or without the addition of catalase288. I found 
that this reversed the inhibitory phenotype of the supernatant (Figure 28). These data suggest 
that H2O2 production by L. jensenii is involved in the bacteriostatic effects against UPEC. 
 To determine if H2O2 itself is causing the growth inhibition of UPEC, I first measured H2O2 
levels produced by the L. jensenii strains. I also measured levels in the S. mitis  
Figure 28. Effect of Addition of Catalase on Inhibition of UPEC Growth by L. jensenii 
Supernatants. UPEC (i.e., NU14) cells were grown overnight in TSB. Cells were diluted to an 
OD600 of 0.1. Supernatants from one L. jensenii isolate (LJ35) were added in a 1:1 volume ratio 
with the NU14. 0.5mg/mL of catalase were added to select cultures. MRS was used as a media 
control for the LJ35 supernatant. Bars depict log CFU/mL of NU14 growth on BAP at 0 hours 
(black bars) and 24 hours (white bars) after incubation. Experiment was performed in triplicate. 
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Bacterial Isolates H2O2 Concentration (mM) 
L. jensenii (LJ35) 2.12 ± 0.25 
L. jensenii (LJ70) 2.39 ± 0.34 
S. mitis (SM34) 0.12 ± 0.11 
S. mitis (SM69) 0.18 ± 0.07 
supernatants as a control. To measure H2O2 levels, I used a colorimetric assay involving 
horseradish peroxidase and tetramethylbenzidine (TMB), as previously described287. In the 
presence of H2O2, the peroxidase will oxidize the TMB, which acts as a chromophore that is 
measured by assessing absorbance at 620nm. By comparing the results of the bacterial 
supernatants to standard concentrations of H2O2, I was able to estimate the quantity of H2O2 in 
the supernatants. I found substantially higher concentrations of H2O2 in the supernatants of the 
L. jensenii isolates compared to the S. mitis isolates (Table 31).  
 I then asked whether addition of similar concentrations of H2O2, as seen in Table 31 for L. 
jensenii, result in the same bacteriostatic phenotype of UPEC. H2O2 concentrations similar to 
those produced by S. mitis isolates (i.e., 0.15 mM) had no effect on NU14 growth, while 
concentrations similar to those produced by L. jensenii isolates (i.e., 2 mM) had a bacteriostatic 
Table 31. Measured Concentrations of H2O2 in Supernatants of Bacterial Isolates. 
Supernatants from two L. jensenii (i.e., LJ35 and LJ70) and two S. mitis (i.e., SM34 and SM69) 
isolates were assessed for their H2O2 concentration using a colorimetric assay. Supernatants 
were diluted 1:10 in 100 mM piperazine-N,N′-bis(2-ethanesulfonic acid) (PIPES) buffer. 100µL 
were added to 100µL of 10mM 3,3′,5,5′-tetramethylbenzidine (TMB). 2µL of horseradish 
peroxidase (1 mg/mL) were added. Reaction mixtures were incubated at 14°C for 10 min. 
Absorbance readings were measured at 620nm. Measurements were compared to a standard 
curve made using known concentrations of H2O2. Table shows mean H2O2 concentrations for 
the bacterial supernatants. Experiment was done in triplicate. 
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effect on NU14 comparable to that of the L. jensenii supernatants (Figure 29). These data, 
together with the findings from Figure 28, strongly suggest that H2O2 production by L. jensenii 
isolates is bacteriostatic to UPEC.  
Assessing the Ability of Urinary Isolates to Adhere to Urothelial Cells 
 I hypothesized that the lack of an inhibitory phenotype against UPEC by S. mitis relates to 
elevated UTI risk when S. mitis is found in high abundance in the LUT. The high abundance of S. 
mitis in the LUT flora of participant ProFUM05 is transient, as is the heightened risk for UTI 
Figure 29. Effect of Addition of H2O2 on UPEC Growth. UPEC (i.e., NU14) cells were grown 
overnight in TSB. Cells were diluted to an OD600 of 0.1. Varying concentrations of H2O2 were 
added in a 1:1 volume ratio with the NU14. Bars depict log CFU/mL of NU14 growth on BAP at 
0 hours (black bars) and 24 hours (white bars) after incubation. Experiment was performed in 
triplicate. Data for TSB, LJ35 supernatant, and SM34 supernatant are shown for a comparison. 
These data come from Figure 26C. ND=Not Detectable (i.e., <103 CFU/mL). 
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following vaginal intercourse, according to literature136 179 180 181 182. This may suggest that the S. 
mitis is ill-adapted to the LUT environment compared to L. jensenii. 
 To determine whether S. mitis isolates are not adapted to persist in the LUT environment, 
I assessed whether the bacterial isolates could adhere to urothelial cells, in vitro. Using a similar 
experimental design as used in Figure 24, I tested the adherence of LJ35 and SM34 to urothelial 
Figure 30. Bacterial Isolate Adherence to Urothelial Cells. Bacterial isolates of S. mitis (SM34) 
and L. jensenii (LJ35) were grown for 48 hours in BHI or MRS broth, respectively. OD600 
measures were around 0.8. This corresponded to approximately 5x107 CFU/mL of SM34 and 
2x108 CFU/mL of LJ35. Cells were pelleted, washed, and resuspended in DMEM/F-12. 1mL of the 
bacterial cultures were added to microtiter plates containing urothelial cell monolayers 
(approximately 104 cells/well) and incubated at 5% CO2 for 3 hours. Figure depicts the number 
of cells recovered from Triton-X-treated urothelial cell cultures following the incubation. White 
bars indicate bacteria binding to empty wells (i.e., without urothelial cells); black bars indicate 
binding to wells containing urothelial cell monolayers. Experiment was performed in triplicate.  
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cells. I found that L. jensenii, but not S. mitis, could adhere to the urothelial monolayers (Figure 
30). These data support my hypothesis that the S. mitis isolates are not adapted to persist in the 
LUT environment. 
Assessing the Biological Significance of LUT Microbiota Variability Following Vaginal 
Intercourse 
 Significantly higher abundances of S. mitis are found in the MSU specimens of participant 
ProFUM05 following vaginal intercourse (Figure 22). In the first part of this chapter, I showed 
that these findings have clinical significance as they may relate to UTI risk due to the difference 
in phenotypes against UPEC compared to L. jensenii isolates. In the second part of this chapter, I 
will described experiments to determine the biological significance of these data by assessing the 
mechanism by which the S. mitis abundance is increased following vaginal intercourse. I 
hypothesize that the S. mitis cells are exogenously introduced during vaginal intercourse by the 
male sexual partner. I designed a follow-up study to test this. 
Overview of PARTNER Study 
 I enrolled one female participant and her male sexual partner in a follow-up study (i.e., 
PARTNER Study) to further investigate the effects of vaginal intercourse on the female MSU 
microbiota. The female participant was previously enrolled in the ProFUM Study as participant 
ProFUM05. As part of the study design (Figure 6), the male sexual partner of the female 
participant (PARTNER01) was also enrolled in the study (PARNTER02), following consent. I 
hypothesized that the S. mitis isolates that appear in the female MSU specimens in high 
abundance following vaginal intercourse originate from her male sexual partner. To test this, I 
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assessed for the presence of S. mitis in several specimen types collected from the male (i.e., MSU, 
peri-urethral/meatal swab, penile swab, oral swab). I isolated and stored several representative 
isolates of S. mitis identified from the specimens for genomic analyses. 
Description of Microbiota Findings 
 Figure 31 shows the relative abundance of the microbiota, as assessed by modified EQUC, 
over time for the two participants. The data are presented as stacked bar graphs, where each bar 
represents a specimen on a given day; each color represents a unique bacterial taxon (i.e., genus), 
and the relative amount of each color within each bar refers to the relative abundance of the 
taxon found in the specimen. The x-axes are in chronological order. White bars refer to specimen 
collection days in which the specimen was not collected, received, or stored. S. mitis CFUs are 
depicted on the secondary y-axes. Figures 31A-D represent the longitudinal MSU, peri-urethral, 
vaginal, and oral microbiota, respectively, for the female participant. Oral swabs were collected 
once per week. Vaginal intercourse was reported on Days 2, 9, and 17. Condom use was not 
reported on each instance. Lubricant use was also not reported. Oral intercourse was reported 
on Day 9 only. Figures 31E-H represent the microbiota of MSU, peri-urethral/meatal, penile, and 
oral specimens, respectively, for the male participant. The male participant’s specimens were 
collected once per week (e.g., WK1) <30 minutes before intercourse (e.g., WK1-B) and <30 
minutes after intercourse (e.g., WK1-A). The oral swabs were collected once per week. Figure 31I 
shows the legend for each graph and describes the genus-color correspondence. Below is a 
qualitative description of the data. 
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  A.    PARTNER01 (MSU) 
B.    PARTNER01 (Peri-urethral Swab) 
C.    PARTNER01 (Vaginal Swab) 
D.    PARTNER01 (Oral Swab) 
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  E.    PARTNER02 (MSU) 
F.    PARTNER02 (Peri-urethral/Meatal Swab) 
G.    PARTNER02 (Penile Swab) 
H.    PARTNER02 (Oral Swab) 
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 Consistent with data from the ProFUM study, PARTNER01 (i.e., ProFUM05) had visual 
trends in the microbiota associated with reporting of vaginal intercourse. Interestingly, these 
trends, which were a significant increase in Streptococcus, applied to both the MSU (Figure 31A)  
 
J I. 
Figure 31. S. mitis Abundance and Microbiota Profiles of Specimens from PARTNER 
Participants. Microbiota profiles are shown as stacked bar graphs depicting the relative 
abundance (y-axes) of various genera over time in chronological order (x-axes) from various 
specimens. Bars that appear ‘white’ refer to days where no specimen was collected, received, 
or stored. A legend containing the most common genera is found in panel I. ‘Other’ refers to the 
combined relative abundance for all taxa not included in the 20 most abundance taxa. Data were 
generated using modified EQUC. S. mitis levels, if applicable, are shown on the secondary y-axes. 
Participants were instructed to engage in vaginal intercourse only once per week. Vaginal 
intercourse was reported on Days 2, 9, and 17 in reference to the previous evening. Oral 
intercourse was reported on Day 9. Panels A, B, C, and D show data for participant PARTNER01 
(i.e., female participant). Specimens for PARTNER01 were collected daily for 21 days, except oral 
swabs which were collected once per week (i.e., Days 2, 8, and 15). Panels E, F, G, and H show 
data for participant PARTNER02 (i.e., male participant). Specimens for PARTNER02 were 
collected bi-weekly within 30 minutes of vaginal intercourse [before (e.g., WK1-B) and after 
(e.g., WK1-A)], except oral swabs which were collected once per week before vaginal 
intercourse. 
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Vaginal Intercourse 
Specimen Type 
Microbiota 
(Median JSD Values) 
“Yes” (n) “No” (n) p-value 
MSU 0.155 (3) 0.130 (16) 0.109 
Peri-Urethral Swab 0.252 (3) 0.165 (13) 0.296 
Vaginal Swab 0.067 (3) 0.068 (13) 1.000 
and vaginal (Figure 31B) microbiota. I did not observe an increase in Streptococcus following 
vaginal intercourse in the peri-urethral microbiota (Figure 31B) which was consistent with the 
findings from the ProFUM Study. However, the Streptococcus that appeared in the MSU and 
vaginal microbiota were different species. S. mitis was consistently found in the MSU microbiota  
(Figure 31A) in high abundances following vaginal intercourse but was only found once in the 
vaginal microbiota (Figure 31C). I primarily found S. agalactiae, or Group B Streptococcus, in the 
vaginal microbiota following vaginal intercourse. Fascinatingly, the S. mitis in the vaginal 
microbiota was found in very high abundance but was not in a specimen following vaginal 
intercourse. Instead, I found the S. mitis one day after vaginal intercourse was reported (i.e., Day 
3).  In contrast to the ProFUM study, I detected, although in very low abundance, S. mitis in the 
peri-urethral microbiota on Days 2 and 9, both of which were after participant-reported vaginal 
intercourse (Figure 31B). In the ProFUM study, S. mitis was detected in the peri-urethral 
microbiota of participant ProFUM05 on three days (i.e., Days 13, 21, and 64), two of which were 
Table 32. Association between JSD Values for Microbiota of PARTNER01 and Participant-
reported Vaginal Intercourse. 
Median JSD values shown for MSU, peri-urethral, and vaginal microbiota of participant 
PARTNER01 on days when the participant reported (“Yes”) or did not report (“No”) vaginal 
intercourse. Mann-Whitney U test used to determine significance. p-value < 0.05 is significant 
(green). 
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following vaginal intercourse (2/21 days). I also detected S. mitis in the oral swab of participant 
PARTNER01 on all three days (Figure 31D). Furthermore, I measured JSD values for the MSU, peri-
urethral, and vaginal microbiota of PARTNER01 and found a disruption in the stability of the MSU 
microbiota following vaginal intercourse that approached statistical significance (i.e., p=0.109) 
(Table 32). These data are consistent with the findings for participant ProFUM05 (Table 20) and 
additionally show that the vaginal microbiota is unaffected.  
 I hypothesized that the male sexual partner (i.e., PARTNER02) was providing the source 
of the S. mitis. However, I did not detect S. mitis in the MSU samples (Figure 31E) or genital swabs 
(Figure 31F&G) in those specimens collected prior to vaginal intercourse (e.g., WK1-B). I detected 
S. mitis in low abundance in the penile swab collected after intercourse during week 1 (Figure 
31G). The exception was the oral swabs which had high levels of S. mitis each week (Figure 31H). 
I detected other species of Streptococcus in the genital swab specimens (Figures 31G&H); these 
species were primarily S. agalactiae. Whether the isolates of S. agalactiae were clonally related 
to those isolates found in the vaginal swab of PARTNER01 (Figure 31C) are unclear from the data. 
 All in all, I can conclude from these data that the S. mitis species that appear in high 
abundance in the MSU microbiota of participant PARTNER01 (i.e., ProFUM05) following vaginal 
intercourse may originate (i.e., are clonally related to isolates) from the oral cavity of her male 
sexual partner (i.e., PARTNER02). 
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Measuring Clonal Relatedness of S. mitis Isolates 
  I collected a total of 54 isolates of S. mitis from the specimens of PARTNER01 and 
PARTNER02 (Table 3). These isolates are from a variety of specimens throughout the study period 
and, in several cases, include multiple isolates from a single specimen. Pure cultures of S. mitis 
isolates were grown, genomic DNA was extracted, and all 54 genomes were sequenced, as 
Figure 32. Dendrogram based on Average Nucleotide Identity of S. mitis Isolates. The genomes 
of six isolates of S. mitis isolated on Day 17 were compared using ANI. Three isolates were from 
the MSU specimen of PARTNER01 (red) and three isolates were from the oral swab specimen of 
PARTNER02 (blue). Hierarchical clustering was performed in R studio. Figure depicts 
dendrogram showing relatedness of isolates. 
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described in Chapter II. Annotations and genome relatedness analyses are currently (May, 2019) 
ongoing. However, early findings support my hypothesis. I measured the relatedness of the 
genomes of S. mitis isolates isolated on Day 17 from MSU specimens of PARTNER01 and oral 
swab specimens of PARTNER02. Figure 32 shows these data using hierarchical clustering based 
on the ANI between the six isolates analyzed. The genomes of the three isolates isolated from 
the MSU specimen of PARTNER01 on Day 17 (red) are highly similar to one another suggesting 
that the S. mitis bacteria in these specimens represent one clonal population. This is in contrast 
to the genomes of the three isolates isolated from the oral swab specimen of PARTNER02 (blue) 
which are different from one another suggesting that there are at least three genomically distinct 
populations of S. mitis in this specimen. Interestingly, one of these isolates, SM49, has a genome 
that is highly similar to the genomes of the MSU-isolated isolates from PARTNER01. These data 
show that some isolates of S. mitis found in the oral cavity of PARTNER02 are clonally related to 
isolates found in the LUT of PARTNER01. Therefore, I have strong evidence to support my 
hypothesis that the S. mitis is moving between sexual partners. However, these data alone are 
not sufficient to describe the direction of this movement (i.e., male to female, or vice versa). 
Summary 
 In Chapter VI, I sought to determine the clinical and biological significance of the trend 
between MSU microbiota variability and participant-reported vaginal intercourse described in 
Chapter V. 
 In regard to clinical significance, I hypothesized that the microbiota of the LUT facilitates 
the literature-described relationship between vaginal intercourse and UTI risk179 180 181 182. To 
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assess this, I used bacterial isolates isolated from MSU specimens of participant ProFUM05. 
These included S. mitis, which were found at higher abundance following vaginal intercourse, and 
L. jensenii, which were found in the microbiota of the LUT regardless of lifestyle data. To assess 
UTI risk in vitro, I measured various characteristics relating to UPEC pathogenesis in the presence 
of either bacterial isolate (i.e., S. mitis or L. jensenii). I found that supernatants of L. jensenii 
isolates were inhibitory towards UPEC biofilm formation, while supernatants of S. mitis isolates, 
isolated from MSU specimens collected on days following vaginal intercourse, were not (Figure 
25). Further assessment revealed that the L. jensenii supernatants were actually bacteriostatic 
towards UPEC strains (i.e., NU14 and UTI89) (Figure 26). In an effort to understand the 
mechanism underlying this clinically significant inhibition, I determined whether hydrogen 
peroxide or lactic acid production by the L. jensenii isolates were involved. I found that addition 
of catalase prevented the bacteriostatic phenotype (Figure 28) suggesting a role for hydrogen 
peroxide. I measured hydrogen peroxide production in the supernatants of the L. jensenii and S. 
mitis isolates and found significantly higher levels in the former (Table 31). I then assessed 
whether these concentrations of hydrogen peroxide were sufficient to cause the bacteriostatic 
phenotype against UPEC in the absence of the L. jensenii supernatants and found similar results 
(Figure 29). In the context of the microbiota data, these findings show that the normal LUT flora 
(i.e., L. jensenii) of participant ProFUM05 has inhibitory properties against UTI-causing pathogens 
(i.e., UPEC) while the MSU microbiota that appear following vaginal intercourse (i.e., S. mitis) 
does not. These data provide a novel explanation for the association between vaginal intercourse 
and increased UTI risk; one which is mediated by the microbiota of the LUT. 
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 I also asked about the biological significance of the association between vaginal 
intercourse and MSU microbiota variability. I hypothesized that S. mitis, which is found at 
significantly higher abundance in MSU specimens following vaginal intercourse, are exogenously 
introduced during vaginal intercourse by the male sexual partner. To test this, I designed a follow-
up study in which ProFUM05 (i.e., PARTNER01) and her male sexual partner (i.e. PARTNER02) 
provided additional specimens, allowing us to determine the relatedness of S. mitis isolates 
between the participants. The additional specimen types also allowed us to explore the trend 
with vaginal intercourse further. I found that median JSD values were different following vaginal 
intercourse for the MSU microbiota (Table 32). Furthermore, with few exceptions, S. mitis 
isolates were only identified in the female’s MSU specimens and the oral swab specimens of both 
participants (Figure 31). I asked whether the MSU isolates of S. mitis were clonally related to S. 
mitis isolates from the male’s oral swab. By comparing the isolates isolated from specimens on 
Day 17, I found that the genome of one isolate (i.e., SM49) from the male’s oral swab prior to 
vaginal intercourse was highly similar to the genomes of three isolates (i.e., SM45, SM46, and 
SM47) from the female’s MSU specimen collected the morning after vaginal intercourse (Figure 
32). These data show that the S. mitis is moving between sexual partners. Together with the in 
vitro clinical findings, these data show that it may be possible to reduce UTI risk by some manner 
of clinical interference to ensure maintenance of the female LUT flora and prevention of the 
transfer of non-protective Streptococcus strains. Whether this would involve targeted 
prophylactic antimicrobial treatments or simply using proper sexual protection, remains to be 
determined.
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CHAPTER VII 
DISCUSSION 
Brief Summary 
 In this thesis, I used three clinical studies to (1) define the feasibility and methodology of 
longitudinal urogenital specimens (i.e., MAGnUM Study), (2) characterize the temporal dynamics 
of the microbiota of the LUT and their relation to lifestyle (i.e., ProFUM Study), and (3) determine 
the biological mechanism for observed microbiota variability following reporting of one particular 
lifestyle factor, vaginal intercourse (i.e., PARTNER Study). Through these studies, I identified a 
novel method to collect and ensure quality of longitudinal urine specimens, provided the first 
characterization of the temporal dynamics of the microbiota of the LUT in pre-menopausal 
women, identified two potential causes of this microbiota variability (i.e., menstruation and 
vaginal intercourse), identified a mechanism to explain the association between microbiota 
variability and vaginal intercourse, and provided a novel hypothesis for the relationship between 
vaginal intercourse and UTI risk. 
Discussion of Chapter III 
 The primary aim of Chapter III was to determine if longitudinal urine specimen collection 
in community women and men for microbiota research analyses was feasible. The data show 
that both longitudinal urine and genital specimen collection in community participants is feasible. 
Only two participants withdrew from this study and these participants cited personal reasons as 
  194 
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the cause rather than complications or difficulties with the study. As this was the first effort to 
obtain and analyze longitudinal urine specimens for research purposes by our research group at 
Loyola University Chicago, the study design and clinical workflow will serve as a framework to 
guide future projects. 
 A large part of assessing the feasibility was to identify a method and subsequently apply 
that method to assess specimen collection accuracy. Literature suggests that the microorganisms 
of the peri-urethral area and MSU are distinct73 246 247. Therefore, I hypothesized that properly 
collected specimens would contain distinct or dissimilar microbiota. Using a Bray-Curtis 
Dissimilarity test, I quantified the level of dissimilarity of the microbiota between paired 
specimens of individual participants over time. I found that the median Bray-Curtis Dissimilarity 
values of the microbiota of paired specimens for all seven female participants was above 0.8. I 
then used this value as a threshold for determining whether a properly collected MSU specimen 
was obtained (i.e., the microbiota of the MSU specimen was dissimilar from the microbiota of 
the peri-urethral specimen). Bray-Curtis Dissimilarity values range from 0 to 1. Intuitively, it may 
seem appropriate to choose 0.5 (i.e., the middle value) as a proper threshold. However, this may 
not be biologically meaningful when applied to certain data. In this case, using 0.5 would not be 
appropriate because the basal median level of dissimilarity between the microbiota of the two 
specimen types in this particular participant population is well above 0.5. Therefore, an 
improperly collected specimen may be considered acceptable if a threshold of 0.5 was used. It is 
also important to consider that the level of dissimilarity of the microbiota between the specimen 
types may naturally vary over time, possibly correlating with certain lifestyle factors. By 
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measuring the median value over several time points, the impact of confounding factors is 
lessened, and the conclusion that a threshold of 0.8 should be used is strengthened. 
 The importance of obtaining distinct MSU and peri-urethral specimens should not be 
understated. A small number of studies have assessed the microbiota or microbiome of the 
urinary and LUT environment using MSU specimens, but none have properly controlled for 
specimen contamination and collection bias248 69 73 48 43 53 249. Without a proper understanding of 
the quality of the MSU specimen, the microbiota data generated from these specimens lose all 
interpretability. Therefore, my approach in this study (i.e., to quantify the differences in the 
microbiota of paired specimens) is a novel and innovative method that ensures proper specimen 
interpretability and should set the standard for future studies. Furthermore, collection of distinct 
MSU specimens allows one to make conclusions unique to the LUT. Physiologically, the LUT is 
very different from the peri-urethral area. Health and disease factors affect each site differently. 
Thus, to properly study the effects of the microbiota on the health and disease of the LUT, it is 
vital to specifically sample the microbiota of the LUT. 
 Few studies have directly compared the microbiota of male and female MSU specimens, 
and none have done so longitudinally. The data highlight differences between the microbiota of 
male and female MSU specimens. Male MSU specimens primarily contained species from the 
genera Streptococcus, Staphylococcus, and Corynebacterium, as well as several species from 
anaerobic genera, whereas female MSU specimens largely contained species from the genera 
Lactobacillus and Gardnerella. The total abundance of bacteria also was quite different between 
male and female MSU specimens, where males generally had 102-103 CFU/mL urine, while 
197 
 
 
 
females generally had 104-106 CFU/mL urine. Although these data come from a small sample size, 
the longitudinal aspect of this study shows that these findings are consistent within an individual 
over time and thus not the result of random sampling. The dramatic differences between the 
male and female data are likely reflective of fundamental differences in anatomy, where the 
bladder urine of males is not readily exposed to other microbiologic niches; whereas in females 
the bladder urine is exposed to other niches (e.g., vaginal microbiota, skin microbiota). Thus, it is 
surprising that the microbiota of MSU and peri-urethral specimens were, in general, more distinct 
(i.e., higher Bray-Curtis Dissimilarity values) in females than males. More research needs to be 
done to confirm these findings, but preliminarily these data could suggest that male MSU 
specimens sample the microbiota of the distal LUT rather than the bladder and thus more closely 
resemble the peri-urethral microbiota, while female MSU specimens more distinctly sample the 
microbiota of the LUT (if properly collected). 
 A secondary aim of Chapter III was to determine if short-term temporal dynamics of the 
MSU microbiota exist, and to determine the effects of one lifestyle factor, alcohol consumption, 
on the temporal dynamics. I found that daily variation in the MSU microbiota exists, but a level 
of constancy is also maintained. Several participants had MSU specimens in which the microbiota 
of a particular day did not resemble the microbiota of any of the other specimens collected during 
the study. Whether there is a biological or clinical significance behind these abrupt changes is 
unclear from these data alone. In general, these data are consistent with microbiota findings in 
other body sites. There is typically a baseline level of stability to the microbiota, but the bacterial 
populations are subject to change. These changes are usually brief and not maintained, meaning 
198 
 
 
 
that the populations readily return to a baseline state. Though I sampled a relatively short period 
of time, the data seem to follow a similar trend, which is not surprising. The human microbiota 
co-evolved with us and have thus adapted to each niche of our bodies2. For each niche, the 
microbiota that reside there are essentially in their optimal growth environment. While other 
microorganisms can colonize that niche, the resident microbiota are better adapted to the 
environment and ultimately will regain dominance over time, unless the environment itself is 
changing. Therefore, the temporary changes I observed in the MSU microbiota may be due to 
the introduction and subsequent decline of exogenous microorganisms, or due to a temporary 
change in the bladder or LUT environment that allows for differentially adapted microorganisms 
to thrive. 
 From a research perspective, these data show that single timepoint sampling of the MSU 
microbiota may not be reflective of the average state. This is an important conclusion because 
most research on the microbiota and microbiome of the bladder and LUT have been performed 
using single timepoint specimens. With larger sample sizes, the influence of this bias is less 
relevant, but for studies with smaller sample sizes, we must now interpret their conclusions with 
caution. As shown in later experiments, some lifestyle factors correlate to days with 
unrepresentative MSU microbiota. Therefore, it may be possible to use questionnaires about 
lifestyle as a screening tool to determine whether the MSU specimen should be excluded from 
analyses. Even more broadly, it may be relevant to screen patient urine specimens with a similar 
type of approach prior to urinalysis and culture in a clinical setting. The extent to which lifestyle 
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can alter the clinical, rather than research interpretability of MSU specimens is unclear from 
these data but is an important future direction to consider. 
Discussion of Chapter IV 
 One of the aims of Chapter IV was to measure the long-term temporal dynamics of the 
microbiota of the LUT in pre-menopausal non-symptomatic community women. To properly 
assess the long-term dynamics, I first had to apply my findings from Chapter III and measure MSU 
specimen accuracy. Due to the high cost and time necessary to measure the microbiota of daily 
specimens over approximately three months, ensuring that the specimens were obtained 
properly was essential. I measured specimen collection compliance by using a pre-study 
Screening Phase. During the Screening Phase, eligible participants collected MSU and peri-
urethral specimens, as instructed by video and verbal explanation from the clinical team, for 
three consecutive days. Of the 12 participants screened, I excluded four based on the use of Bray-
Curtis Dissimilarity between microbiota of paired specimens. The four excluded participants 
failed to provide specimens with Bray-Curtis Dissimilarity values above 0.8 for at least two of the 
three days of specimen collection. While this approach ultimately provided us with quality 
specimens (i.e., distinct MSU and peri-urethral microbiota) in the primary study (Table 6), it may 
have biased the participant population. Though literature suggests that the microorganisms of 
the peri-urethra and MSU are distinct73 246 247, rigorous and properly controlled studies assessing 
this distinction have yet to be performed. Therefore, excluding participants based on lack of 
distinct microbiota between paired specimens may not actually relate to specimen collection 
compliance. It is possible that some pre-menopausal women naturally have significant overlap in 
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the microbiota of properly collected peri-urethral and MSU specimens. To further complicate this 
issue, data from Chapter IV show that Bray-Curtis Dissimilarity values between microbiota of 
paired specimens are associated with lifestyle factors in some participants. Menstruation was the 
only lifestyle factor I assessed that showed significant trends with Bray-Curtis Dissimilarity values 
of microbiota of paired specimens. Though these values are usually higher (i.e., more dissimilar) 
during menstruation, this is not always the case (Table 11). Participants in the Screening Phase 
completed the daily lifestyle questionnaire each day. Two participants (SCREEN09 and SCREEN12) 
reported menstruation and feminine hygiene product use on all three and two of the three days, 
respectively. Despite this, only one of the two participants was excluded from the final study (i.e., 
SCREEN09). Though a sample size of two participants is small, these data suggest that reporting 
of menstruation did not affect the screening criteria. Nonetheless, whether exclusion of 
participants based on the criteria is biologically appropriate or not, use of a specific standard 
measure allowed us to make stronger comparisons and conclusions from the data that I collected 
on the microbiota from the final study population of participants. Furthermore, the criteria allows 
us to make statements regarding microbiota stability and change that exclusively relate to the 
LUT rather than the peri-urethral environment.  
 Using JSD, a common approach to measure longitudinal stability, I found that the peri-
urethral microbiota were more unstable than the microbiota of the MSU specimens. The median 
JSD values for all seven applicable participants were higher for the peri-urethral microbiota 
compared to the MSU microbiota, indicating greater instability over time (Figure 17). Biologically, 
these findings mean that the peri-urethral microbiota have greater daily variability than the MSU 
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microbiota. Physiologically, this is not surprising, as the peri-urethral area is exposed to the 
genital and external environment, while voided urine and the LUT are not. Therefore, 
introduction and movement of flora may occur more frequently in the peri-urethra than the LUT. 
Vaginal swabs were not collected from the participants in this study, so I cannot conclude 
whether bacterial interplay between the peri-urethra and vaginal tract occurred. The participants 
collected combination perineal and vaginal swabs once per week, but this was not frequent 
enough to make conclusions about temporal dynamics and bacterial interplay. As this is the first 
study to assess the peri-urethral microbiota temporal dynamics, I cannot compare these findings 
to others. It is also possible that the instability of the peri-urethral microbiota relate to specimen 
collection variability. Participants were instructed verbally and visually to collect the peri-urethral 
specimen by swabbing 1 cm around the urethral opening. Without clinical supervision, it is 
impossible to know whether variability resulted from the collection method used by the 
participants. The rigor of the force used on the swab, the number of rotations of the swab, and 
the area of swabbing could all affect the sampled microbiota, none of which are applicable to the 
collection of an MSU specimen. These variabilities of collection were no doubt different between 
individuals, but they may also apply to the same individual over time. However, one would expect 
that with repeated collection over three months, the personal technique used to collect the peri-
urethral specimen would become more standard and consistent by the participant. Therefore, if 
specimen collection variability relates to JSD values and microbiota instability, one would expect 
the JSD values to become lower (i.e., more stable) throughout the study. Qualitatively, this did 
202 
 
 
 
not occur (e.g., Figure 19). This suggests that the daily variability of the peri-urethral microbiota 
is biologically meaningful and not likely due to collection inconsistencies. 
 Modified EQUC was the primary method used to identify and characterize the microbiota 
in this study. However, 16S rRNA gene sequencing was used on the MSU specimens of 
participants ProFUM06 and ProFUM07. ProFUM07 was unique because both methods, culture 
and sequencing, were used to characterize the MSU microbiota over time. The microbiota 
profiles of the culture and sequencing results are shown in Figures 16G & H, respectively. 
Qualitatively, the microbiota and microbiome were dominated by Lactobacillus (blue) except for 
three, one to two-week periods during the beginning (i.e., week 1), middle (i.e., weeks 3 and 4), 
and end (i.e., weeks 7 and 8). During these non-Lactobacillus-dominant periods, the two 
identification methods conflicted slightly; modified EQUC showed increases in relative 
abundance of Staphylococcus (light blue), and Actinomyces (brown) (Figure 16G), while 16S rRNA 
gene sequencing showed increases in Prevotella (dark green), Dialister (bright blue), and 
Anaerococcus (bright red) (Figure 16H). These data are not surprising because we have previously 
seen that detection of obligate anaerobes by EQUC is significantly lower than 16S rRNA gene 
sequencing. Both methods showed increases in relative abundance of Streptococcus (green) and 
Corynebacterium (orange). Nonetheless, a deviation from Lactobacillus dominance occurred for 
the exact same specimens by both methods. Appropriately, JSD values were elevated for both 
methods during these periods. In fact, JSD values for the two methods followed an almost 
identical pattern over time (Figure 18). These data show that the two methods are 
complementary and validate the use of only one method to analyze the specimens of the other 
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seven participants. Despite the differences in composition, the two methods were consistent in 
their assessment of bacterial stability over time. Therefore, in future studies assessing MSU 
microbiota dynamics, it seems reasonable that either method can be used to make conclusions 
regarding stability. 
 The other aim of Chapter IV was to determine if intrinsic lifestyle factors relate to MSU 
microbiota dynamics. I found significant associations between microbial instability and 
participant-reported menstruation (Table 7). The associations were only significant for the MSU 
microbiota/microbiome data, suggesting that menstruation alters the microbiota of the LUT but 
not peri-urethra. Menstruation also alters the vaginal microbiota, as described by multiple 
research groups188 189 190 191. Therefore, the findings were surprising because the peri-urethral area 
is anatomically closer to the vaginal tract than is the LUT. Nonetheless, I observed trends in the 
microbiota of the LUT similar to what has been described in the vaginal microbiota during 
menstruation. The trends showed clear variability (i.e., JSD values), but were highly 
individualized. Median alpha-diversity values were significantly higher during menstruation 
(Table 8) for all participants who had significantly different MSU microbiota JSD values during 
menstruation (Table 7). Furthermore, compositional differences existed during menstruation, 
where higher frequencies and abundances of mainly Corynebacterium, Staphylococcus, and 
Actinomyces were found in the MSU specimens of most participants (Table 9 and Figure 20). 
Overall, I found that the microbiota of the LUT are more diverse and compositionally distinct 
during menstruation, but these trends differ slightly among participants. 
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 It is difficult to determine the mechanistic relationship between menstruation and MSU 
microbiota variability. The microorganisms found at higher frequencies and abundances during 
menstruation (e.g., Corynebacterium, Staphylococcus, Actinomyces) are primarily skin flora2. It is 
possible that these bacteria are introduced exogenously into the LUT during menstruation, 
perhaps via the use of feminine hygiene products. Tampon and pad use were reported at 
significantly higher frequencies during menstruation for all participants (Table 12). Whether use 
of these products alone is sufficient to induce MSU microbiota changes is unclear from the data. 
However, if the bacteria were introduced by the hygiene product, one would expect similar 
microbiologic changes to the peri-urethral area, as it is more readily exposed, but I observed no 
change in peri-urethral microbiota stability with menstruation, or hygiene product use. 
Furthermore, only a few participants had significant differences in the median Bray-Curtis 
Dissimilarity values between microbiota of paired specimens during menstruation (Table 11), and 
most of those participants had significantly higher dissimilarity during menstruation, whereas I 
would expect the opposite result. Thus, the data do not support a model in which the use of 
feminine hygiene products during menstruation results in the observed MSU microbiota 
variability during these times. An alternative explanation is that the LUT environment changes 
during menstruation, thus allowing for colonization and/or growth of different microorganisms. 
However, there were no significant changes in the frequency of positive urine property and 
constituent results during menstruation, except for blood (Table 14). The blood is likely a 
contaminant from the vaginal tract and thus not directly relevant to the LUT environment. I also 
determined that other reported lifestyle factors did not confound the data. Besides feminine 
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hygiene product use only reported number of bowel movements was found to have a significant 
association with menstruation, where three participants had significantly higher numbers of daily 
bowel movements during menstruation (Table 12). However, when I assessed for associations 
between number of bowel movements and microbiota characteristics, I found no significant 
trends, suggesting that this was not confounding the trends seen with menstruation. All in all, 
these data do not point to a clear mechanism to explain the association between menstruation 
and MSU microbiota variability. It is possible that other urine properties, not measured by the 
urine dipstick, were altered during menstruation to allow for microbiota alterations. For example, 
in pre-menopausal women, hormones associated with the menstrual cycle remain at low levels 
during menses followed by a spike in some during ovulation and an increase in others during the 
subsequent luteal phase. One of these cyclical hormones, estrogen, can have a profound effect 
on the LUT. Estrogen receptors are found throughout the LUT and researchers have found 
correlations between elevated estrogen levels and urodynamic variables and LUTS289. As a result, 
it is common for women to experience greater frequency of urination during menses. This 
increased urinary frequency could affect the microbiota of the LUT, where planktonic cells are 
more likely to be expelled from the bladder, while tissue-attached cells remain behind. If 
competition normally exists between these two bacterial cell types, the increased urination 
frequency would give a selective growth advantage to tissue-attached cells. This could explain 
the greater abundance of certain organisms seen during menstruation. Though it is not 
uncommon for Gram-positive bacteria, like those seen in elevated frequencies during 
menstruation (e.g., Corynebacterium, Staphylococcus, Actinomyces), to have molecular 
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mechanisms to promote surface attachment (e.g., pili, fimbriae), the strain variability is too high 
to make generalized conclusions regarding these particular urinary species. Furthermore, I did 
not query the participants regarding urination frequency. Therefore, this remains a likely 
mechanistic explanation for the findings, but the data are not sufficient to support or refute it. 
 Though the finding that positive blood results on the urine dipstick relate to menstruation 
is not likely relevant to the LUT environment, it serves as an important positive control. All 
lifestyle factors reported in this study are self-documented by the participant and, as such, are 
not validated by a clinical or research professional. Furthermore, there is no incentive to answer 
the questionnaire honestly. Menstruation serves as the only recorded lifestyle factor that can be 
validated, although indirectly, in a research setting. Six of the eight participants had statistically 
significant correlations between reporting menstruation and positive blood results on the urine 
dipstick (Table 14). These data suggest that the participants are reporting menstruation 
appropriately and provide a level of confidence that the remaining questionnaire was completed 
honestly. Of the two participants without statistical significance, participant ProFUM05 only 
reported menstruation on three total days. Participant ProFUM04 reported menstruation on 12 
total days, and although a positive blood result did not always co-occur with these days, a closer 
look at the data show that all positive blood results occurred within 5 days (before or after) of 
reported menstruation. 
 The finding presented above represents an important caveat to the analyses. In this 
thesis, I have limited the approach to assessing the relationship between lifestyle factors and the 
microbiota of the subsequent day. It is difficult to discern whether it would be biologically 
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appropriate to expand the analyses beyond just the following day’s microbiota. It is possible that 
some lifestyle factors take longer than one day to show significant impacts on the microbiota. To 
my knowledge, research has shown that for other body sites, lifestyle factors usually have an 
immediate impact on the microbiota. Whether this can be broadly applied to the LUT remains to 
be seen. The correlations between lifestyle factors and UTI risk for example, were studied across 
weeks, months, and even years, and thus do not provide relevant information regarding the 
timeliness of their effects. Though I did not assess this here, the dataset represents a novel means 
to determine this relationship and is an important future direction to consider. 
 In this chapter, I also determined if urine properties and constituents relate to MSU 
microbiota dynamics. I used a semi-quantitative urine dipstick test to measure 10 clinically 
important urine characteristics, most of which are applicable to disease diagnosis but 
nonetheless act to describe the urinary microenvironment. By assessing these characteristics on 
a daily basis, I was able to observe novel variabilities in the data. To my knowledge, no one has 
described urine dipstick test result variabilities over time in healthy people. The results, an 
example of which is shown in Table 15, are highly variable from day-to-day. These findings call 
into question the validity of this test for disease diagnosis, as it is possible that false-positive 
results could be part of the normal temporal variability in the urine. Interestingly, this variability 
in urine characteristics did not relate to microbiota variability. I determined that, in general, no 
relationship existed between urine properties and constituents and MSU or peri-urethral 
microbiota stability (Table 16 and Table 18A), or MSU microbiota alpha-diversity values (Table 
17 and Table 18B). The exception was blood, which showed a similar pattern of trends as was 
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seen with menstruation. Because these two factors co-occur (Table 14), these results are not 
surprising. The finding that urine properties and constituents do not relate to MSU microbiota 
variability is noteworthy because it shows that potential mechanisms underlying trends with 
lifestyle factors (e.g., menstruation) likely do not involve alterations to the urinary environment. 
Discussion of Chapter V 
 The primary aim of Chapter V was to determine if extrinsic lifestyle factors relate to MSU 
microbiota dynamics. I found significant associations between microbial instability and 
participant-reported sexual activity (Table 20). Sexual activity was reported by six of the eight 
participants. The associations were only significant for the MSU microbiota/microbiome data, 
suggesting that sexual activity alters the microbiota of the LUT but not the peri-urethra. 
Compared to menstruation, the other lifestyle factor to show trends with the MSU microbiota, 
the data for sexual activity were more complicated. During menstruation, the MSU microbiota 
had higher instability, were more diverse, and several taxa appeared more frequently in the 
specimens, whereas these trends were more variable among participants for sexual activity. For 
sexual activity, some participants only showed significantly altered microbiota stability for 
particular types (e.g., vaginal intercourse), some were actually more stable during sexual activity 
(e.g., ProFUM07 in Table 21), and some participants had significantly different alpha-diversity 
values (Table 22), whereas a separate group of participants had significantly different mean total 
bacterial abundances (Table 24). The only consistent finding among the participants was an 
elevated frequency and abundance of Streptococcus and Staphylococcus species following 
vaginal intercourse. Interestingly, this one consistency was the one trend that did not necessarily 
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apply to the menstruation data from Chapter IV, where the type of altered taxa varied among 
the participants. Nonetheless, it is clear from these comparisons that the mechanisms underlying 
the altered MSU microbiota in response to menstruation are separate from those relating to 
sexual activity. 
 Participants who responded “yes” to the question relating to sexual activity were then 
asked if they engaged in penetrative vaginal intercourse, received oral intercourse, or engaged 
in another (i.e., “other”) form of sexual activity (e.g., masturbation, anal intercourse). The 
lifestyle questionnaire prompted a written explanation if “other” was chosen. On the lifestyle 
questionnaire, the “sexual activity: other” category was not proceeded by examples of inclusive 
activities and is therefore possible that it was interpreted differently among the participants. 
Most participants, with the exception of ProFUM07, did not report “other” forms of sexual 
activity. Participant ProFUM07 reported masturbation on all 15 days she reported sexual activity. 
Initial assessments of microbiota stability and sexual activity showed no significance for 
participant ProFUM07 (Table 20). Only when I separated the data for vaginal intercourse (4/15) 
did I find significance (Table 21). These data suggest that masturbation did not affect MSU 
microbiota stability, although the sample size is only one participant. Of the remaining types of 
sexual activity recorded, all applicable participants, except for participant ProFUM04 who did not 
report oral intercourse, significantly co-reported vaginal and oral intercourse (Table 25). This 
finding makes it difficult to make conclusions regarding an individual type of sexual activity. 
Interestingly though, participant ProFUM04 who only reported vaginal intercourse (27/72 days), 
did not have significantly different JSD values for either MSU or peri-urethral microbiota (Table 
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21), suggesting that the microbiota variability seen when broadly reporting sexual activity might 
be more related to oral intercourse. This conclusion is further supported by the fact that species 
of Streptococcus, one of the main genera to appear at higher frequencies and abundances 
following sexual intercourse, are commonly found as part of the oral flora273. However, if one 
considers the rest of the participants’ data, this conclusion does not hold up. For example, 
participant ProFUM05 reported sexual activity 21/67 days; 17/21 days she reported vaginal 
intercourse only, while the other 4/21 days she reported both vaginal and oral intercourse. 
Assessment of these four days alone shows no significant association with MSU microbiota 
stability, while assessment of all 21 days does (Table 21). Furthermore, participant ProFUM07 
reported sexual activity 6/69 days; 2/6 days she reported only vaginal intercourse, 2/6 only oral 
intercourse, and 2/6 both. Again, only an assessment of days including vaginal intercourse (4/6) 
showed significant associations with MSU microbiota stability (Table 21). The microbiota of the 
MSU specimens collected on the two days that she reported only oral intercourse (i.e., Days 11 
and 18) contained only L. jensenii. Altogether, these data suggest that vaginal intercourse, rather 
than oral intercourse, are associated with MSU microbiota variability, but other factors clearly 
influence the trend. 
 From the data alone, it is difficult to determine what other factors influence the trend 
between vaginal intercourse and the variability of the microbiota of the LUT. I sought to 
determine this by asking which lifestyle factors and urine properties co-occurred with vaginal 
intercourse. Besides oral intercourse, which was reported significantly more frequently during 
vaginal intercourse for all participants, except ProFUM04 who did not report oral intercourse 
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(Table 25), few factors showed significant trends, and none were consistent among participants 
(Tables 25 & 26). Follow-up work revealed that at least one of these significant trends may be 
biologically meaningful. The significantly higher mean pH of the MSU specimens of participant 
ProFUM05 following vaginal intercourse likely relate to data shown in Chapter VI. The in vitro pH 
of culture supernatants of S. mitis strains isolated from the MSU specimens of participant 
ProFUM05 have higher pH levels than those of L. jensenii isolates. This could relate to vaginal 
intercourse because S. mitis was detected at higher abundances (p=0.018) following vaginal 
intercourse. Interestingly, I did not find higher frequencies of detection of S. mitis. These data 
suggest that the act of vaginal intercourse causes increased abundance of S. mitis, which 
subsequently decrease, but remain present, over time. One possible explanation for this is that 
the environment of the LUT changes following vaginal intercourse. However, aside from pH, 
which seems to be a result of the bacteria and not the cause of its increase, the only other urine 
property for participant ProFUM05 found to be significantly more positive following vaginal 
intercourse was bilirubin (Table 26). Bilirubin in the urine relates to liver function and has not 
been linked to UTI risk. Another possibility for the increased abundance, but not frequency, of S. 
mitis is that it is physically introduced during vaginal intercourse. Though basal levels of S. mitis 
exist in the LUT, the abundance could increase following the exogenous introduction of more 
bacterial cells. The levels of S. mitis then appear to decrease in the LUT, either because it is not 
adapted to the environment or it is being actively inhibited in some way. This is the case until the 
next incidence of vaginal intercourse when more cells are introduced, and levels increase again. 
However, if the S. mitis are introduced during vaginal intercourse, one would expect to see it 
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appear in the peri-urethra as well. S. mitis was only identified in the peri-urethral specimens of 
participant ProFUM05 on three days (i.e., Days 13, 21, and 64); vaginal intercourse was reported 
(i.e., the day before) for two of those days. It is possible that in the time between vaginal 
intercourse and collection of specimens the following morning, S. mitis cells in the peri-urethral 
area were disrupted in some way. Anatomically, this makes logical sense as the peri-urethra is 
more subject to environmental influence than the LUT. Bathing could be an explanation, but as I 
showed later in Chapter V, frequency of bathing did not relate to peri-urethral microbiota 
instability (Table 27). Furthermore, bathing was reported on both days (i.e., Days 13 and 64) 
when S. mitis appeared in the peri-urethral specimens of participant ProFUM05 following vaginal 
intercourse. It is possible that the timing of the bathing is relevant, as are other factors such as 
urination frequency and factors relating directly to the vaginal intercourse. These are explored in 
Chapter VI as part of the PARTNER study. Unfortunately, for participant ProFUM05 in the ProFUM 
study, I did not collect information relating to condom use or new sexual partners; this 
information may have provided crucial details to explain the S. mitis trends observed. 
 In the three participants who were asked (i.e., ProFUM06, ProFUM07, and ProFUM08), 
condom use was reported 100% of the time when vaginal intercourse was reported. Therefore, 
it is impossible from these data alone to make a conclusion regarding the influence of condom 
use on the relationship between MSU microbiota variability and vaginal intercourse. Sexual 
partner variability was different among the applicable participants. Whereas participant 
ProFUM07 reported the same male sexual partner for each instance of vaginal intercourse (N=4), 
participant ProFUM08 reported different male partners (N=3). Qualitatively, one could 
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tentatively conclude from the raw data that the pattern of Streptococcus species that appear 
following vaginal intercourse are more consistent for participant ProFUM07 than participant 
ProFUM08, thus suggesting a role by the sexual partner, but the timepoints are too few, and 
there are other confounding factors (e.g., oral intercourse) that interfere with my ability to make 
strong conclusions. To conclusively show a role for the male sexual partner in the MSU microbiota 
variability of the female, it would be necessary to show movement of genomically related isolates 
between the partners following vaginal intercourse. I attempted this in the PARTNER study of 
Chapter VI. These data and their implications on a potential mechanism to explain the association 
between vaginal intercourse and MSU microbiota variability are discussed in the section below. 
 Interestingly, the findings on the variability of the MSU microbiota following vaginal 
intercourse are quite different from data on the vaginal microbiota. Using only 16S rRNA gene 
sequencing, researchers have found that disruptions to the stability of the vaginal microbiome 
occur with vaginal intercourse188. The changes to the vaginal microbiome are consistently shown 
to be an increase in Gardnerella188 290 291 292 and this is sometimes accompanied by a decrease in 
Lactobacillus, particularly L. iners290  and L. crispatus292. These changes are not seen when condom 
use is reported290 . The current theory of the mechanism behind these changes is that the altered 
microbiome comes from the male ejaculate. The microbiome of semen has been very recently 
characterized and found to contain low but detectable abundances of bacteria, many of which 
are part of the vaginal microbiome (e.g., Lactobacillus, Veillonella, Streptococcus, 
Porphyromonas, Atopobium), including Gardnerella292. The alpha-diversity of the semen 
microbiome is higher than the vaginal microbiome292. Mandar et al. recently showed that in 23 
214 
 
 
 
heterosexual couples, the semen microbiome, collected several days prior to intercourse, was 
more similar to the partner’s vaginal microbiome after vaginal intercourse292. However, they did 
not analyze the data further using metagenomics or WGS of cultured strains to verify the clonal 
relatedness of taxa found between the male and female specimens. Nonetheless, when 
comparing these data to the findings in the LUT, several differences are seen. I did not observe 
increases in Gardnerella in the MSU specimens following vaginal intercourse, even by 16S rRNA 
gene sequencing. The trends I found were with Streptococcus and Staphylococcus. Streptococcus 
is a predominant taxon in the semen microbiome; Staphylococcus is present but not as often292. 
However, I observed these trends even when condom use was reported (e.g., ProFUM07 and 
ProFUM08) and therefore the bacteria are not likely from the male ejaculate. I also generally did 
not observe a decrease in abundance of Lactobacillus following vaginal intercourse. Overall, the 
only comparable finding is that both the vaginal and MSU microbiota have decreased stability 
following vaginal intercourse, but the mechanisms underlying these changes may be very 
different, which is surprising considering the anatomical proximity. 
 Another lifestyle factor that I assessed in Chapter V was hygiene – specifically bathing. As 
this was largely an exploratory study, I defined bathing rather broadly and without additional 
details. The lifestyle questionnaire did not discriminate between showering and bathing. In 
hindsight, this may have biased the data, as bathing (e.g., tub bath) but not showering has been 
shown to relate to UTI risk131. This was possibly reflected in the results, which showed somewhat 
inconsistent trends among participants (Table 27). It is possible that the type of bathing, number 
of bathing times per day, and time of day may have influenced the association between bathing 
215 
 
 
 
and the MSU microbiota. Time of day would be most relevant. Bathing in the morning prior to 
specimen collection could result in vastly different specimens than those collected from someone 
who only bathed the night before. For example, if bathing and particularly soap use act to inhibit 
bacterial growth, then one would expect specimens collected immediately after use to have 
lower biomass and lower overall alpha-diversity of the microbiota. Nonetheless, I used PCoA to 
broadly analyze MSU microbiota based on the limited bathing-related data that I collected and 
found no observable trends. 
Discussion of Chapter VI 
 In Chapter VI, I sought to determine the clinical and biological significance of the trend 
between MSU microbiota variability and participant-reported vaginal intercourse described in 
Chapter V. 
 With respect to the clinical significance, I hypothesized that the microbiota of the LUT 
facilitates the relationship between vaginal intercourse and UTI risk179 180 181 182. To assess this, I 
used bacterial isolates from MSU specimens of participant ProFUM05, including S. mitis, which 
were found at higher abundance following vaginal intercourse, and L. jensenii, which were found 
in the microbiota of the LUT regardless of lifestyle data. I found that supernatants of L. jensenii 
isolates exhibited a bacteriostatic phenotype on UPEC biofilm formation and growth, in vitro. 
Furthermore, I determined that hydrogen peroxide production by L. jensenii was likely 
responsible for this because addition of exogenous catalase prevented the phenotype. 
Interestingly, both strains of UPEC that were used (i.e., NU14268  and UTI89269) have annotated 
genomes that contain catalase-peroxidase-like genes293 269. NU14 has two genes with predicted 
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protein structures suggestive of catalase activity293, while UTI89 has one gene269 with high 
sequence homology to the katG gene (i.e., encodes KatG catalase enzyme) of Mycobacterium 
tuberculosis294. Furthermore, in data not shown, I performed a simple qualitative bacterial 
catalase test in which one drop of 30% hydrogen peroxide was added to UPEC cells on a glass 
slide. I observed production of bubbles for both UPEC strains, which is suggestive of the release 
of oxygen from the catalysis of hydrogen peroxide by a catalase enzyme. These data suggest that 
the UPEC strains used in the in vitro experiments are able to produce functional catalase 
enzymes. These findings seem to conflict with the findings from Chapter VI. Why is hydrogen 
peroxide production by L. jensenii bacteriostatic towards UPEC if these strains can produce an 
enzyme to prevent the oxidative damage caused by the chemical? It is possible that the 
concentrations of hydrogen peroxide produced by the L. jensenii (Table 31), are too high for the 
catalase to reduce completely. However, the hydrogen peroxide levels in the supernatant are 
static, so there should be a point in time when the levels are completely reduced. It is possible 
that that point in time was beyond the time assayed in the experiments. I only measured UPEC 
growth in the presence of the supernatants for 24 hours. It is also possible that the enzymatic 
activity of the catalase enzyme is diminished in the presence of the L. jensenii supernatants. It 
has been demonstrated that catalase activity towards hydrogen peroxide is greatly diminished at 
pH levels below 4295. I measured the pH of all of the L. jensenii supernatants used in the 
experiments and none had pH levels below 5 suggesting that the enzymatic activity should not 
be affected (by the pH alone). It could also be possible that the production rather than the activity 
of the catalase enzyme is reduced in the presence of the L. jensenii supernatants. It is possible 
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that some component or property of the supernatant prevents the transcription or translation 
of the catalase genes or mRNA. In concordance with this theory, I did not observe bubble 
formation in the cultures of UPEC with the supernatants (data not shown) suggesting that the 
breakdown of hydrogen peroxide and release of oxygen was not occurring. Regardless of the 
precise explanation, these findings are complementary to previous findings in literature. For 
example, Gupta et al. reported an inverse association between the presence of hydrogen 
peroxide-producing vaginal strains of Lactobacillus and UPEC vaginal colonization and UTI 
recurrence222. Furthermore, several groups have shown bacteriostatic effects of vaginal 
Lactobacillus strains against UPEC296 297. Cadieux et al. found reduced UPEC growth and increased 
promoter activity of outer membrane stress response proteins in the presence of Lactobacillus 
supernatants, and the phenotype was reversed by the addition of catalase296. Interestingly, this 
group used the two Lactobacillus strains that make up the oral probiotic (i.e., L. rhamnosus GR-1 
and L. reuteri RC-14) that I used in the ProFUM study296. Similarly, Atassi et al. found bacteriostatic 
effects on UPEC in response to hydrogen peroxide production by vaginal Lactobacillus strains, 
but also found that the additional presence of lactic acid in the supernatants resulted in a more 
severe phenotype where the UPEC cells were no longer viable297. This finding suggests that the 
urinary L. jensenii strains did not produce lactic acid, as I did not observe a bactericidal affect on 
UPEC in the experiments. Lactic acid concentrations need to be measured in these supernatants 
to confirm. All in all, these findings are unique because they show that these bacteriostatic 
phenotypes are applicable to urinary strains of Lactobacillus as well as vaginal strains, which have 
been described in literature. Furthermore, in combination with the longitudinal microbiota data 
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and lifestyle data, I can form a novel hypothesis in that the MSU microbiota changes following 
vaginal intercourse (e.g., reduction in L. jensenii and an increase in S. mitis) are clinically related 
to UTI risk, due to differences in protective phenotypes from UPEC growth and colonization. 
Clearly more needs to be done to further understand these phenotypes, to determine if they are 
broadly applicable to urinary Lactobacillus strains, and to determine if these phenotypes can be 
reproduced in an in vivo system. 
 I also asked about the biological significance of the association between vaginal 
intercourse and MSU microbiota variability. I hypothesized that S. mitis, which is found at 
significantly higher abundance in MSU specimens following vaginal intercourse, are exogenously 
introduced during vaginal intercourse by the male sexual partner. To test this, I designed a follow-
up study in which ProFUM05 (i.e., PARTNER01) and her male sexual partner (i.e. PARTNER02) 
provided additional specimens, allowing us to determine the relatedness of S. mitis isolates 
between the participants. I found similar temporal dynamics of the female microbiota as in the 
ProFUM study in relation to vaginal intercourse. However, in the PARTNER study I obtained 
additional relevant data. I found increases in Streptococcus in the vaginal swabs following 
intercourse, but the species were primarily S. agalactiae, not S. mitis. Interestingly, S. agalactiae 
but not S. mitis were found on the penile swab of the male, and I know from the questionnaires 
that condom use was not reported for any of the three instances of vaginal intercourse. 
Therefore, it is possible that the vaginal Streptococcus was directly transferred from the male 
during vaginal intercourse through direct skin contact. In literature, vaginal microbiota changes 
appear to originate from the male ejaculate292, but these data, like mine, are only correlative. 
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Nonetheless, these data show that the S. mitis in the LUT of the female are not originating from 
the male’s genitals (at least not from an area that I assessed). This suggests that two distinct 
mechanisms are responsible for the microbiota changes between the LUT and vagina of the 
female following vaginal intercourse. 
 S. mitis is a commensal member of the oral flora298, although outside of the oral cavity, it 
can behave as a pathogen causing infective endocarditis, bacteremia, and septicemia299. Because 
of this, I included the collection of oral/buccal swabs in the PARTNER study. I detected high 
abundance of S. mitis from all oral swabs obtained by both participants (i.e., swabs were obtained 
once per week for three weeks). Therefore, it seemed likely that the S. mitis in the LUT of the 
female may have originated from the oral cavity of the male. This agrees with the findings from 
Chapter V which showed that vaginal and oral intercourse were frequently co-reported by the 
ProFUM participants. However, I also determined in Chapter V that vaginal intercourse, rather 
than oral intercourse, was related to the MSU microbiota trends. In the PARTNER study, oral 
intercourse was reported on only one of the three instances of vaginal intercourse (i.e., Day 9), 
despite clear increases in S. mitis abundance in the MSU specimens following all three instances 
of vaginal intercourse (i.e., Days 2, 9, and 17). These data show that the S. mitis elevated 
abundance, as well as the higher microbiota instability on these days, is related to vaginal 
intercourse, not oral intercourse. Thus, it seems like the S. mitis from the female MSU specimens 
did not originate from the oral cavity. However, I used ANI to compare the genomes of S. mitis 
isolates isolated from female MSU specimens following vaginal intercourse (i.e., Day 17) to 
isolates from the male oral swab collected before intercourse that day. I found that one oral 
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isolate had high genome similarity to all three urinary isolates, suggesting that the S. mitis is 
moving between the oral cavity of the male and the LUT of the female following vaginal 
intercourse. This is difficult to explain without more details regarding the practices or behaviors 
of the participants during and following vaginal intercourse. The most likely explanation is that 
saliva from the male was used as a lubricant source and thus introduced the oral S. mitis isolates 
in this manner. Lubricant use was not reported by the participants. However, this does not 
necessarily disprove my hypothesis, as it is possible that saliva was simply not reported as a 
lubricant by the participants. This would need to be explicitly asked in future studies. If saliva was 
the source, it remains to be seen why the S. mitis isolates did not appear in the vagina or peri-
urethra of the female. Similarly confounding data was previously discussed in this chapter and 
several possible explanations were described, including hygiene and bathing practices following 
the lifestyle factor in question. Hygiene and bathing practices may affect the peri-urethral and 
vaginal environments more than the LUT, thus creating an opportunity for microorganism (e.g., 
S. mitis) to be physically removed or inhibited from these areas while remining in the LUT. 
Furthermore, the findings fail to describe the direction of S. mitis movement between the 
participants. Further genomic comparisons of other S. mitis isolates are needed, and these 
analyses are currently ongoing. 
Significance and Implications 
 The discovery of the urinary microbiota and microbiome occurred barely a decade ago. In 
the short period of time that has followed, we have learned an immense amount of information 
about these microbiota, ranging from their associations with diseases to differences among 
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demographics. It is becoming clear that the way we identify and diagnose urinary infections as 
well as the way we treat LUT diseases, is on the verge of dramatic change. However, before these 
much-needed changes can be implemented, a few more questions need to be answered. For 
example, mechanistic links between the microbiota and disease need to be demonstrated. These 
mechanisms may be directly connected to the bacteria, possibly through proteins or other 
molecules produced by the microorganism, or they may involve indirect and complex pathways 
incorporating the host immune cells or tissue. But most importantly, we need to understand why 
these associations with disease occurred to begin with. If the bacteria really are mechanistically 
involved in the etiologies, then how did they come to colonize the bladder and LUT? In other 
words, can the urinary microbiota change over time? And if temporal changes do exist, as they 
do for other human microbiota, what is driving those changes? These are the questions that I 
sought to address in this thesis and have been thoroughly described above. In this section, I 
highlight some key findings and expound upon their significance. 
 I found that in pre-menopausal healthy women, temporal changes in the microbiota of 
the LUT exist and relate to lifestyle factors. This is an incredibly significant and novel finding that 
has many implications. First, it provides merit to the idea that the urinary microbiota can cause 
LUT diseases because it shows that the microbiota can transition from one state to another (e.g., 
a healthy state to a disease-associated state). If this were not true, then the associations between 
disease and the urinary microbiota would have to involve alterations to the host’s response to 
the bacteria rather than alterations to the bacteria themselves. Second, it raises questions about 
methodologies. Can one accurately characterize the urinary microbiota through the use of a 
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single timepoint specimen? And how do we incorporate this natural variability in the microbiota 
into power analyses and study design when designing clinical studies? Third, it verifies that the 
bladder and LUT environments are dynamic and subject to external influence. This has been 
suggested by data relating lifestyle factors to UTI risk. My data further support these claims. 
Fourth, it shows that we have influence on the ability of the urinary microbiota to change. Should 
women with a history of UTI avoid unprotected heterosexual vaginal intercourse? Should they 
avoid using certain types of feminine hygiene products for menstrual care? I found that these 
types of lifestyle factors significantly altered the urinary microbiota and thus may be clinically 
relevant for disease or infection prevention. Lastly, it provides us with new insight into 
understanding UTIs. Bacteria naturally compete for space and resources. This is relevant for an 
infectious microorganism as it has to compete against the resident microbiota for these features. 
If these resident microbiota are subject to change, that would affect the infectious 
microorganism’s efficacy at colonizing. If we can understand this relationship better, then we can 
use the type of lifestyle data described here as means to prevent or decrease risk for UTI. 
 One of the reasons why the work presented in this thesis had not been done before is 
because of urine specimen interpretability. As I described in Chapter I, the less invasive the urine 
collection method is, and subsequently the easier it is to acquire these specimens from 
participants and patients, the less interpretable the urine specimen will be. Longitudinal studies 
requiring repeated specimen collection cannot rely on invasive methods. My approach to 
handling this problem is unique and provides a novel tool for the field. By pairing a less invasive 
and interpretable urine specimen (i.e., MSU) with a more interpretable genital specimen (i.e., 
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peri-urethral swab) and then measuring the concordance of the microbiota between the paired 
specimens, I was able to provide a measure of quality for the MSU specimen, thus increasing its’ 
interpretability. This allows for stronger conclusions regarding the microbiota of the LUT from 
MSU specimens and reduces the risk of specimen variability over time. 
 I also found a novel link between the microbiota of the LUT and UTI risk. In an effort to 
understand the mechanistic basis for one of the observed trends between lifestyle and 
microbiota variability, I found that certain members of the MSU microbiota are differentially 
protective from UTI-causing pathogens, in vitro. Moreover, the difference in isolate phenotypes 
relate to lifestyle (i.e., vaginal intercourse). Culture supernatants of S. mitis isolates isolated from 
participant ProFUM05, which are found at higher mean abundance following vaginal intercourse, 
have no observed inhibitory capacity towards UPEC strains. This is in contrast to L. jensenii 
isolates, whose supernatants are bacteriostatic towards UPEC, likely through production of 
hydrogen peroxide. These findings are intriguing because they provide an alternate hypothesis 
to explain why vaginal intercourse is related to UTI risk179 180 181 182. Rather than directly 
introducing the UTI-causing pathogen, which is not entirely supported by literature, I hypothesize 
that vaginal intercourse alters the microbiota of the LUT to a less protective state. This less 
protective state is less capable of preventing colonization by an exogenous uropathogen. The 
clinical implication of this alternative mechanism would be that methods should be explored 
aimed at maintaining the protective normal flora of the LUT (e.g., Lactobacillus) following vaginal 
intercourse rather than using preventative measures aimed at the UTI-causing pathogen. The 
data showed that these Streptococcus species (i.e., S. mitis) likely originated from the oral cavity 
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of the male sexual partner due to a high genomic relatedness of female MSU isolates. However, 
I have yet to determine which direction the bacteria are moving. Considering that a spike in 
Streptococcus is consistently seen in the MSU microbiota of the female following vaginal 
intercourse, it seems reasonable to hypothesize that the Streptococcus is moving to the female, 
thus increasing the abundance. Though the exact mechanism of transfer to the female LUT 
remains unclear (i.e., was not related to oral intercourse), this creates an opportunity for some 
manner of clinical interference to ensure maintenance of the female LUT flora regardless. What 
exactly that entails requires more insight into the mechanism of Streptococcus strain transfer 
between sexual partners but may be as simple as using protective measures such as condoms. 
Future Directions 
 The findings presented in this thesis represent a novel description of the temporal 
dynamics of the microbiota of the LUT in pre-menopausal healthy women. Researchers should 
use these findings to guide the design, methodology, and interpretation of future studies 
assessing this topic. 
 The data obtained in the studies described in this thesis are vast and contain incredible 
detail. The analyses that were done are not by any means all-encompassing. I limited the analyses 
of these data to what I believed to be the most clinically important questions.  Nonetheless, more 
questions can certainly be addressed using these data. I restricted the approach to assessing the 
relationship between lifestyle factors and the microbiota of the subsequent day. Whether it is 
biologically appropriate to expand the analyses beyond just the following day’s microbiota is 
arguable. This should be done more for the sake of scientific curiosity rather than necessity. I also 
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did not assess the relationship between diet and MSU microbiota variability. Diet would 
ultimately impact the microbiota of the LUT by altering the composition of the urine, which I 
measured using the urine dipstick. I assessed for associations between urine dipstick results and 
MSU microbiota variability in Chapter IV, and therefore felt it was unnecessary to evaluate diet 
as well. I also did not assess for changes in peri-urethral microbiota composition and diversity. In 
this dissertation, the peri-urethral microbiota data served as a control. If lifestyle factors altered 
the microbiota stability of the MSU specimens but not the peri-urethral specimens, then I could 
make conclusions regarding the LUT specifically. This was the case for most lifestyle factors 
discussed in Chapters IV & V. However, subtle but significant changes in the peri-urethral 
microbiota could still have occurred and should be explored further.  
 Future studies assessing the urinary microbiota longitudinally should include more 
rigorous and detailed lifestyle questionnaires. In regard to sexual activity, it would be important 
to collect information on condom use, including brand, whether it contains spermicide, and 
whether it was removed prior to ejaculation. Information on hygiene practices (e.g., urination 
habits and bathing habits) during the time between sexual activity and specimen collection 
should be obtained. Information on the sexual partner should be included. It may be interesting 
to compare the MSU microbiota variability between male and female (i.e. heterosexual and 
homosexual) partners, as this could provide more insight into the mechanism(s) behind the 
trends described here. In regard to bathing, showering and baths should be reported separately. 
Number of bathing episodes and time(s) of day should be recorded. Use and type of soap may 
also be useful information to collect. Finally, it would be important to record overall frequency 
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of urination each day. It is likely that this will relate to total bacterial abundance and alpha-
diversity, but additional trends may be found. It is also possible that this will relate to 
menstruation and menstrual hormone levels289. These future studies should focus initially on a 
similar participant population to confirm the trends described here. It would be useful to 
eventually assess a more clinically relevant participant population such as post-menopausal 
women who have higher incidences of LUTS. A subsequent comparison of this population with 
these data would also be revealing. 
 Whether performed on the samples collected here, or on newly collected longitudinal 
samples, it would be fascinating to assess the microbiome of the LUT using a metagenomic 
approach. This would go beyond taxonomic classification and provide us with insight into 
genomic content and genomic variations over time. I have described strong associations between 
MSU microbiota variability and lifestyle, but, with the exception of the in vitro experiments in 
Chapter VI relating the microbiota, vaginal intercourse, and UTI risk, we have no idea if these 
trends are clinically or biologically relevant. For example, it may be the case that the MSU 
microbiota during menstruation has a similar genotype to the normal microbiota. If this were the 
case, then the microbiota variability during menstruation may not be clinically meaningful at all. 
Another benefit of taking a metagenomic approach is the ability to observe strain-specific change 
over time. In this thesis I limited the approach to measuring changes in genera and species. It is 
likely the case that individual strains of the LUT flora are evolving over time and this may relate 
to lifestyle. Many of the lifestyle factors and urine properties that I assessed showed no 
association with MSU microbiota variability, but this does not mean that the lifestyle factor did 
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not have an influence on the bacteria. It is entirely possible that an altered LUT environment 
creates a selective pressure for certain adaptive bacterial traits. The ongoing analyses of the S. 
mitis genomes may provide some important insight into strain variability over time. 
 Continued assessment of MSU urine specimens is also necessary. In these studies, I 
compared the microbiota of MSU specimens to peri-urethral specimens and enrolled participants 
based on the dissimilarity of the two. Though this provided us with a comparable participant 
population, it may have also introduced bias. I do not currently know how much overlap there 
normally is in the microbiota of MSU and peri-urethral specimens. It is crucial to understand this 
so the field can move away from the use of catheterized urine specimens which greatly limit the 
study of the urinary microbiota in community women and men. A comprehensive study 
comparing the microbiota of several urogenital specimen types in pre-menopausal and post-
menopausal women is greatly needed. 
 Eventually, we need to develop an appropriate animal model to study the urinary 
microbiota in more relevant context. In this thesis, I showed associations between the MSU 
microbiota and several lifestyle factors, but it is incredibly difficult to determine how and why 
these associations exist. Without the ability to study the lifestyle factor and the microbiota in an 
in vivo model, I can only speculate as to the causes and relevance of these trends. 
 The two lifestyle factors that showed the greatest variability in the microbiota of the LUT 
were menstruation and vaginal intercourse. More should be done to understand the 
mechanism(s) underlying these trends; much of which can be done without an animal model. 
Regarding menstruation, the mechanism underlying the MSU microbiota variability likely lies 
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with feminine hygiene product use or hormone fluctuations. A case-controlled study should be 
performed comparing the MSU microbiota over time during menstruation in populations of 
women who do and do not use feminine hygiene products. In my data, I could not separate 
menstruation from hygiene product use because of the high frequency of co-reporting the two. 
Hygiene products have not been shown to alter the vaginal microbiota164 165 166, and I found that 
they did not alter the peri-urethral microbiota stability which suggests that the variability in the 
MSU microbiota during menstruation may not relate to hygiene products. An alternate 
mechanism could relate to hormone fluctuations, specifically estrogen which has been shown to 
relate to increased urination frequency289. Menstrual hormone levels could be measured using 
commercially available enzyme-linked immunosorbent assay (ELISA) kits and assessed for an 
association with MSU microbiota variability over time. Furthermore, as mentioned above, it is 
essential that in future longitudinal studies of the MSU microbiota, urination frequency needs to 
be measured. This could relate to menstruation and may provide vital insight into a mechanism 
for the MSU microbiota variability. 
 Vaginal intercourse was the other lifestyle factor that showed significant associations with 
MSU microbiota variability. I was able to show that the variable microbiota (i.e., Streptococcus) 
may have clinical relevance for UTI risk. I found contrasting phenotypes for UPEC growth 
inhibition between S. mitis, part of the variable MSU microbiota, and L. jensenii, a likely member 
of the normal LUT flora. This is interesting from the perspective of either bacteria. From the S. 
mitis perspective, it would be interesting to ask whether prophylactic antibiotic use against 
Streptococcus following vaginal intercourse results in reduced UTI risk. Similar studies have been 
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performed using antibiotics targeting typical Gram-negative uropathogens, and the results have 
been somewhat mixed150 151 235. From the L. jensenii perspective, I found that hydrogen peroxide 
was the cause of the UPEC inhibition. Because hydrogen peroxide is a common byproduct of 
Lactobacillus species, it would be important to know if other urinary species of Lactobacillus have 
similar phenotypes. Furthermore, it is important to understand how these findings relate to the 
in vivo environment of the bladder. High concentrations of hydrogen peroxide production in 
bacterial cultures may not relate to high concentrations in the bladder. Additionally, hydrogen 
peroxide production only occurs when Lactobacillus are in low oxygen environments. We 
recently showed that oxygen levels in the bladder vary greatly300, and therefore it is important to 
understand how this relates to the data.  
 Ultimately, the goal is to figure out how to take the findings described here and improve 
clinical care. As a whole, these data suggest that alterations to the LUT microbiota relate to 
lifestyle factors and may affect UTI risk. Clearly more research needs to be performed to greater 
understand the relationship among these findings. Nonetheless, they provide support for novel 
preventative and therapeutic measures aimed at maintaining the protective normal LUT flora. 
Whether this is achieved through alteration of lifestyle factors or microbiologic-focused means, 
such as pre/probiotic therapies, remains to be determined. All in all, the urinary microbiota is an 
intriguing and novel therapeutic target that has the potential to improve the health of millions of 
women.
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 This appendix provides the texts of most current and in-process publications that are not 
directly related to this dissertation. At the beginning of each appendix section, the manuscript 
citation will be listed, followed by a short summary of the work. The full manuscript text, all 
figures and tables, both primary and supplementary, as well as complete methods are included. 
Additional work not included in the publication will be listed in the addendum following each 
appendix. Some appendices provide topic-specific data that are not published, but again are not 
directly related to topics in this dissertation.
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Overview of Appendix B 
 
This abstract assesses the relationship between the urinary microbiota and UI symptom 
severity. We found that UI symptom severity increased with species richness values of the urinary 
microbiota. Thus, symptom severity appears to relate to the identity and number of urinary 
species. Whether these microbiologic differences are a potential cause of UI or are a result of it, 
is unclear. 
My contributions to these data include project development and study design, data 
acquisition, data interpretation and analysis, and manuscript writing. This work was done from 
2014 to 2019. As of Spring 2019, this manuscript is currently in progress. 
Abstract Text 
Objective 
 To identify relationships between the bladder microbiome and urinary incontinence (UI) 
symptom severity in a urogynecologic population. 
Methods 
 With IRB oversight, transurethral catheterized urine specimens were collected from 309 
adult women categorized into 3 groups using response to the Pelvic Floor Distress Inventory 
(PFDI): Urgency Urinary Incontinence (UUI), Stress Urinary Incontinence (SUI), and continent 
controls. Symptom severity was assessed with the Urinary Distress Inventory (UDI) subscale 
score. Bacterial presence was assessed using an Expanded Quantitative Urine Culture (EQUC) 
protocol and 16S rRNA gene sequencing. 
 Results 
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 Participant mean age was 53 (range 22-90); most were Caucasian (65%). Women with UI 
were older (Control= 47, SUI=54, UUI=61). UDI symptom scores were as follows: control = 
8.43(10.1), SUI = 97.95(55.36) and UUI = 93.71(49.12) and the differences were significant 
(p<0.001). Bacteria were detected by EQUC (216 [70%]) and sequencing (111 [36%]); 96 (31%) 
urine specimens were positive by both methods. The mean abundance of numerous taxa was 
significantly associated with UDI score. Multiple alpha diversity indices of species richness (i.e. 
number of unique taxa) strongly associated with symptom severity (increased diversity 
associated with increased symptoms); species evenness (i.e. distribution of taxa) did not differ 
significantly (Figure B.1). 
Conclusions 
 Composition and species richness of the urinary microbiome relates to both the presence 
of UI and symptom severity, regardless of UI subtype. Symptom severity increased with species 
richness but not evenness. Thus, symptom severity appears to relate the identity and number of 
bladder species, but not the distribution of those species. The potential etiologic role of these 
findings warrants further study.  
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Figure B.1. Correlation between Alpha Diversity and UDI Scores. Scatter plots depict the 
distribution of various alpha diversity scores calculated from EQUC data (x-axes) versus the 
distribution of UDI Scores (y-axes). Fitted regression lines are in yellow. The area between the 
confidence bands is shaded in grey. Each data point is colored according to cohort, where red 
is Control, green is SUI, and blue is UUI. Alpha diversity measures tested include Chao1 (A), ACE 
(B), Shannon (C), Simpson (D), and Pielou (E). Pearson, Kendall, and Spearman correlation tests 
were used to determine the statistical significance between UDI score and alpha diversity 
measure for each scatter plot. P-values (not shown) were significant (p<0.05) or approached 
significance for all alpha diversity measures except Pielou, which is the only index that 
measures only evenness (E). 
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FEMALE LOWER URINARY TRACT MICROBIOTA DO NOT ASSOCIATE WITH IC/PBS SYMPTOMS: A 
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Overview of Appendix C 
 
This paper assesses the urinary and vaginal microbiota of women with and without 
IC/PBS. IC/PBS is a complex and poorly understood disease with multiple etiologies. Several 
groups have assessed the urinary microbiota in this patient population but found generally 
conflicting results. Our data, which is case-controlled, includes vaginal swab specimens, and uses 
two complementary methods (i.e. EQUC and 16S rRNA gene sequencing) to characterize the 
microbiota, shows that there is no difference in the composition or diversity of the urinary 
microbiota between women with and without IC/PBS. Therefore, a microbial etiology to IC/PBS 
seems unlikely. 
My contributions to these data include project development and study design, data 
acquisition, data interpretation and analysis, and manuscript writing. This work was done from 
2015 to 2019. 
Abstract 
Objective 
 Current etiology of interstitial cystitis/painful bladder syndrome (IC/PBS) is poorly 
understood and multifactorial. Recent studies suggest the female urinary microbiota (FUM) 
contribute to IC/PBS symptoms. This study was designed to determine if the FUM, analyzed using 
mid-stream voided urine samples, differs between IC/PBS patients and controls. 
Materials and Methods 
 This prospective case-controlled study compared the voided FUM of women with 
symptoms of urinary frequency, urgency, and bladder pain for greater than 6 months to the 
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voided FUM of healthy female controls without pain.  Bacterial identification was performed 
using 16S rRNA gene sequencing and EQUC, a validated enhanced urine culture approach. 
Urotype was defined by a genus present at >50% relative abundance. If no genus was present 
above this threshold, the urotype was classified as ‘mixed’. Group comparisons were performed 
for urotype and diversity measures.  
Results 
 A mid-stream voided specimen was collected from 21 IC/PBS patients and 20 
asymptomatic controls. The two groups had similar demographics. Urotypes did not differ 
between cohorts as assessed by either EQUC or 16S rRNA gene sequencing. We detected no 
significant differences between cohorts by alpha-diversity. Cohorts also were not distinct using 
Principle Component Analysis or hierarchical clustering. Detection by EQUC of bacterial species 
considered uropathogenic was high in both cohorts, but detection of these uropathogenic 
species did not differ between groups (p=0.10).  
Conclusions 
 Enhanced culture and DNA sequencing methods provide evidence that IC/PBS symptoms 
may not be related to differences in the FUM, at least not its bacterial components. Future larger 
studies are needed to confirm this preliminary findings. 
Introduction 
 Interstitial Cystitis/Painful Bladder Syndrome (IC/PBS) affects nearly 7.9 million US adult 
women301. The AUA and SUFU define IC/PBS as “an unpleasant sensation (pain, pressure, 
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discomfort) perceived to be related to the urinary bladder, associated with lower urinary tract 
symptoms of more than six weeks duration, in the absence of infection or other identifiable 
causes”302.  
 The etiology of IC/PBS is multifactorial, poorly understood, and assumes that the female 
urinary tract is sterile in the absence of clinical infection. However, our research team and others 
have shown that the female urinary tract is not sterile; it possesses communities of microbes 
called the female urinary microbiota (FUM)29 30 32 34. Furthermore, the FUM is associated with 
various lower urinary tract symptoms15 37 31 35 56 303. These findings present a new avenue for 
studying the etiologies of IC/PBS. 
 Few groups have reported on the FUM of IC/PBS patients. The few existing studies used 
various urine collection methods and bacterial detection methods, in general had small sample 
sizes and, therefore, the data conflict36 42 33. Our prospective case-controlled study sought to 
determine if the FUM of women with and without IC/PBS differs using mid-stream voided urine 
specimens to avoid pain provocation and analyzed them with expanded techniques. Secondarily, 
we sought to describe the vaginal microbiota of the IC/PBS cohort. 
Materials and Methods 
Study Design and Patient Population 
 Following Institutional Review Board (IRB) approval, we enrolled 41 female patients; 21 
with IC/PBS (i.e., IC Cohort) and 20 without (i.e., Control Cohort). Women in the IC Cohort 
experienced symptoms of urinary frequency, urgency, and bladder pain for greater than 6 
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months, meeting the AUA IC/PBS definition. For both cohorts, basic demographics were 
collected. The members of the IC cohort completed validated questionnaires including the-Beck 
Anxiety Inventory, Beck Depression Inventory, the Pain Disability Index, the Female Genitourinary 
Pain Index, the Pain Catastrophizing Scale, the IC Symptom Index Score and the IC Problem Index 
Score. 
Sample Collection 
Midstream voided urine specimens were collected from both cohorts. A vaginal swab 
specimen was collected from the IC Cohort. A portion of each urine sample was placed in a BD 
Vacutainer® Plus C&S Preservative Tube for culturing. A separate portion for 16S rRNA gene 
sequencing was placed at 4°C for less than 4 hours following collection; 10% AssayAssure (Sierra 
Molecular, Incline Village, NV) was added before storage at -80°C. Puritan Opti-Tranz® Liquid 
Stuart Swabs were used to collect two aerobic vaginal swab specimens. Each swab was vortexed 
and diluted in 1ml phosphate buffered saline (PBS). One aliquot was used for culture and one 
was stored for 16S rRNA gene sequencing, as described above. 
Urine Culture Protocols 
A variation of the Expanded Quantitative Urine Culture (EQUC) protocol34 was used to 
culture the biological specimens. 10µL of urine sample or vaginal swab aliquot was spread 
quantitatively onto BAP, Chocolate, and Colistin Naladixic Acid (CNA) agars (BD BBL™ Prepared 
Plated Media) and incubated in 5% CO2 at 35°C for 48 hours; onto BAP incubated aerobically at 
35°C for 48 hours; and onto CDC Anaerobic 5% sheep blood (Anaerobic BAP) agar (BD BBL™ 
Prepared Plated Media) incubated anaerobically at 35°C for 48 hours. The vaginal swab aliquots 
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were also plated on Thayer-Martin media and incubated in 5% CO2 at 35°C for 48 hours. Each 
distinct colony morphology was sub-cultured at 48 hours to obtain pure culture for microbial 
identification. Microbial identification was determined using a Matrix-Assisted Laser 
Desorption/Ionization-Time-of-Flight Mass Spectrometer (MALDI-TOF MS, Bruker Daltonics, 
Billerica, MA). 
DNA Isolation and 16S Sequencing 
DNA isolation, polymerase chain reaction (PCR) amplification, and 16S rRNA gene 
sequencing of urine cultures have been described previously15. Genomic DNA was extracted from 
1 ml of urine or 500ul of the vaginal swab aliquot, using previously validated protocols developed 
for the Human Microbiome Project251 34 15. To isolate genomic DNA from these samples, this 
protocol includes the addition of mutanolysin and lysozyme to ensure robust lysis of Gram-
positive and Gram-negative species251. 
The hyper-variable region 4 (V4) of the bacterial 16S rRNA gene was amplified via a two-
step PCR protocol, as described previously34 15. Extraction negative controls (no urine or swab 
suspension) and PCR-negative controls (no template) were included to assess the contribution of 
extraneous DNA from reagents. Ten-microliter aliquots of each reaction mixture were run on a 
1% agarose gel. Samples containing a band of approximately 360 bp were considered PCR-
positive and subjected to further library preparation. Samples with no visible amplified product 
were considered PCR-negative and not processed further. The PCR-positive reaction mixtures 
were diluted 1:50 and amplified for an additional 10 cycles, using primers encoding the required 
adapter sequences for Illumina MiSeq sequencing and an 8-nucleotide sample index. The PCR 
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reaction was purified, and size selected using Agencourt AMPure XP-PCR magnetic beads 
(Beckman Coulter, Pasadena, CA). Each sample was quantified using the Qubit fluorometeric 
system (Thermo-Fisher, Waltham, MA). The samples were pooled, quantified to a standard 
volume, and placed in the 2 X 250 bp sequencing reagent cartridge, according to the 
manufacturer’s instructions (Illumina, San Diego, CA).  
Sample barcodes and sequencing primers were removed using the Illumina proprietary 
MiSeq post-sequencing software. The mothur program (v1.37.4) was used to process the raw 
sequences by following the recommended MiSeq standard operating procedure252. Briefly, 
mothur produced 16S contigs by combining the paired end reads based on overlapping 
nucleotides in the sequence reads; contigs of incorrect length for the V4 region (<290 bp, >300 
bp) and/or contigs containing ambiguous bases were removed. Chimeric sequences were 
removed using UCHIME within the mothur package253. Subsampling at a depth of 5000 sequences 
was performed to correct for different sequencing depth of each sample. The sequences were 
clustered into species-level operational taxonomic units (OTUs) with identity cutoff at 97%254. The 
OTUs were classified using RDP classifier (v2.11) at the genus level254. Specimens designated as 
“undetectable” had <1000 total sequence reads. 
Statistical Analyses 
Continuous variables were reported as means with standard deviations (SD); categorical 
variables were reported as frequencies and percentages. Pearson Chi-square tests or Fisher’s 
Exact Tests and 2-sample t-tests or Wilcoxon Rank Sum tests were used to compare categorical 
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and continuous demographics and culture results, respectively. Data were plotted using R  
(version 3.4.3). Cluster analysis was performed using hierarchical clustering. All statistical 
analyses were conducted using SAS software v9.4 (SAS Institute, Cary, NC) or SYSTAT software 
version 13.1 (SYSTAT Software Inc., Chicago, IL). 
Results 
Demographics 
 Table C.1 displays the demographic characteristics of the two cohorts (IC and Control). 
The entire population had a mean age of 49 ± 13 years and was predominately White/Caucasian 
Table C.1. Demographic and Clinical Variables for the IC and Control Cohorts. 
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(70%) consistent with our clinical patient’s population. The two groups had similar demographics 
and percentage of EQUC and 16S sequence-positive specimens (p>0.05 for all comparisons 
except vaginal parity).  
Description of the Lower Urinary Tract and Vaginal Microbiomes in IC Patients 
 16S rRNA gene sequencing was performed on all (21) IC voided urine and vaginal swab 
specimens. The majority of voided urine specimens of IC patients had a Lactobacillus (11/21; 
53%) or Mixed (6/21; 29%) urotype, a measure of bacterial community structure as determined 
Table C.2. Demographic, Clinical Variables, and Symptom Questionnaire Results for IC 
Patients with Lactobacillus and non-Lactobacillus Urotypes determined by 16S rRNA Gene 
Sequencing. 
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by 16S rRNA gene sequencing (Supplemental Figure C.S1). For most IC patients, the urotype 
matched the dominant taxa present in the paired vaginal swab specimen (19/21; 90%) 
(Supplemental Figure C.S1). The specimen types (IC vaginal swab, IC urine, control urine) did not 
significantly differ by several mean alpha diversity measures that report on the richness, 
evenness and abundance of community members (Supplemental Figure C.S2).  
Table C.2 displays the demographics and validated questionnaire results of the IC cohort 
stratified by Lactobacillus versus non-Lactobacillus urotype. IC Patients with a Lactobacillus 
urotype were younger (p=0.01) and more likely to be pre-menopausal (p=0.03) than IC patients 
with a non-Lactobacillus urotype, which were more likely to be post-menopausal (p=0.009); 
neither the Lactobacillus urotype nor the non-Lactobacillus urotypes had significantly different 
mean scores for any of the validated clinical questionnaires. 
Figure C.1. Principle Component Analysis of Mid-Stream Voided Urine Specimens from IC and 
Control Patients. Principle component analysis comparing 16S rRNA gene sequence data 
between IC patients (21), blue, and Control patients (C patients) (19), red. 
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Figure C.2. Heatmap of Relative Abundance Values for Common Bacterial OTUs among 
Cohorts and Specimen Types. Heatmap of the relative abundance of 16S rRNA gene sequence 
data classified by otu's. The y-axis lists common bacterial otu classifications in alphabetical 
order. The x-axis describes the specimen type and patient cohort of the corresponding sample. 
Specimens listed in red are mid-stream voided urine specimens from IC patients, orange are 
vaginal swab specimens from IC patients, and black are mid-stream voided urine specimens 
from Control (C) patients. Data are grouped by hierarchical clustering using the corresponding 
dendogram. 
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Comparison of Lower Urinary Tract Microbiome of IC and Control Patients 
 16S rRNA gene sequencing was performed on voided urines from 19 of 20 Control 
specimens. Consistent with the IC Cohort, the Control patients had predominately Lactobacillus 
(9/19; 47%) or Mixed (6/19; 32%) urotypes by 16S rRNA gene sequencing. Mean alpha diversity 
measures did not differ between the voided urine specimens of the IC and Control cohorts 
(Supplemental Figure C.S2). When plotted, principal component analysis did not show visual 
separation between the cohorts (Figure C.1). A hierarchical cluster analysis of specimens 
classified at the OTU-level from both cohorts is shown in Figure C.2, which does not reveal any 
clear apparent clustering of specimen types or cohort-specific specimens. 
Detection of Uropathogenic Bacteria between Cohorts 
Table C.3. List of Uropathogenic Bacterial Taxa Identified in Mid-Stream Voided Urine 
Specimens of IC and Control patients using EQUC. 
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 EQUC was performed on all Control (20) and 18 of the 21 IC urine specimens. Using EQUC, 
we detected 39 and 51 unique species in the IC (N=18) and Control (N=20) cohorts, respectively. 
Frequency of detection of Staphylococcus lugdunensis (0% IC versus 25% control, p=0.04) and 
Streptococcus agalactiae (i.e. Group B Streptococcus) (6% IC versus 35% control, p=0.04) differed 
by group (Table C.3). Detection of Escherichia coli was higher in the IC cohort (28% IC versus 5% 
control, p=0.08). Detection of bacterial species typically considered uropathogenic was high in 
both groups (IC=15/18, 83%; C=20/20, 100%, p=0.10) (Table C.3).  
Discussion 
This study failed to detect significant differences in the voided FUM of women with and 
without IC/PBS. Despite the study limitation of small sample size, our data suggest that 
microbiota of the lower urinary tract may not contribute to the symptoms in women meeting the 
clinical definition of IC/PBS. This contradicts recent work by others, who have argued for a link 
between clinical symptoms of IC/PBS and the FUM36 42 33. Abernathy et al. hypothesized a 
protective role of a more diverse and Lactobacillus-dominant microbiome. Catheterized urine of 
women with IC were found to have fewer OTUs and less likely to contain Lactobacillus species, 
particularly L. acidophilus.  Furthermore, Abernathy et al. found that the presence of 
Lactobacillus was associated with improved scores on two IC-specific symptom severity indices, 
suggesting that the urinary microbiome may influence lower urinary tract symptoms. Although 
our collection techniques differed and our expanded culture technique additive, these findings 
were not reproduced in our study nor were the differences in Lactobacillus dominance indicative 
of symptom burden. Siddiqui et al. found that Lactobacillus predominance was associated with 
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IC/PBS patients (i.e., the opposite trend) using clean catch voided urine specimens. Finally, Nickel 
et al. analyzed a larger cohort of IC/PBS participants (n=233) using clean catch urine during flare 
vs non-flare pain states and showed no difference in species composition. However, this study 
did indicate that the IC group had a higher prevalence of fungi. Fungi were not directly analyzed 
in our cohort. However, we did detect Candida species in both cohorts using EQUC. 
Strengths of this study were the use of two complementary identification methods: 
sequencing and culture, as well as the use of vaginal swabs as a comparative specimen to voided 
urine in the IC cohort. Voided specimens were chosen intentionally so as not to create an IC pain 
flare by obtaining a catheterized specimen. Furthermore, contemporary urological guidelines do 
not require a catheterized urine specimen as a part of the diagnostic IC work up (AUA guideline) 
and not routinely performed in this patient population due to catheterization discomfort and 
poor patient’s compliance302. Limitations include small sample size for both cohorts, lack of 
vaginal swabs in the controls, and lack of other clinical data in the control group. Although, we 
did not have an a priori sample size estimation, our cohort sizes were similar to those of the 
Abernethy et al. study, which did show differences in the urinary microbiome between groups, 
so we felt our sample size was adequate for this preliminary analysis. We agree with Nickel et al. 
that the voided urine does not represent the bladder microbiome in our study, but rather the 
genitourinary tract. Additionally, we also recognize that we did not control antibiotic exposure, 
similar to Abernethy et al.  
This case-control study of the FUM in predominantly middle-aged women with IC/PBS 
compared to controls without pain showed no significant differences in the voided FUM between 
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groups. These findings suggest that microbes may not directly contribute to IC/PBS unlike 
previously reported literature. Larger scale studies using complementary microbial detection 
techniques similar to ours and assessing multiple urine collection methods (voided and 
catheterized) would contribute to deeper understanding of the FUM as a potential etiology in 
IC/PBS.  
Supplemental Materials 
  
Supplemental Figure C.S1. Histogram of Paired Voided Urine and Vaginal Swab Specimens 
from IC Patients. Histogram depicts the genus or family-level taxonomic classification of 16S 
rRNA gene sequence reads from voided urine (left bar) and vaginal swab (right bar) specimens 
collected from IC patients (N=21). Data are presented as relative abundance values. Taxa 
present at <10% relative abundance in all specimens were grouped into “other”. Specimens 
designated as “undetectable” had <1000 total 16S rRNA gene sequence reads. 
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Supplemental Figure C.S2. Alpha Diversity Values among Patient Cohort and Specimen Types. 
Boxplots depict the distribution of various alpha diversity indices measured from 16S rRNA gene 
sequencing data for the control patients (orange) and the IC patients (blue – voided urine; green 
– vaginal swab). Values for the Shannon Index (A), Simpson’s Index (B), and Pielou’s Evenness 
(C) are shown. Tables below each plot show the P-values comparing data between each group. 
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Overview of Appendix D 
 
This abstract assesses the urinary microbiota of women with and without IC/PBS. Unlike 
the data presented in Appendix C, these data were obtained from catheterized urine specimens. 
In this case-controlled study, we found very few differences between patients with and without 
IC/PBS, consistent with the conclusions made in Appendix C. Therefore, a microbial etiology to 
IC/PBS seems unlikely. 
My contributions to these data include data acquisition, data interpretation and analysis, 
and manuscript writing. This work was done from 2017 to 2019. As of Spring 2019, this 
manuscript is currently in progress. 
Abstract Text 
Objective 
 Interstitial cystitis (IC)/Painful Bladder Syndrome (PBS) is a diagnosis of exclusion 
predicated on a negative standard urine culture. Studies into the urinary microbiome, utilizing 
expanded quantitative urine culture (EQUC), demonstrate that most women in the general 
population have cultivatable bacteria in their urine. The existence of these bacteria challenges 
the diagnosis of IC/PBS, which presumes a sterile bladder. No data are available regarding 
cultivatable bacteria in the IC/PBS population utilizing the comprehensive EQUC technique. The 
objectives of this study were: (1) to use EQUC to compare the female urinary microbiome (FUM) 
in women with IC/PBS to controls and (2) to correlate baseline FUM composition with IC/PBS 
symptoms. 
Methods 
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 In this cross-sectional study, we enrolled 89 women 49 IC/PBS and 40 unaffected controls; 
all provided catheterized urine specimens and completed validated questionnaires. Women were 
excluded if they were less than 18 years old, had received antibiotics or undergone bladder 
instrumentation in the 28 days prior to enrollment, or had known bladder anomalies. We 
assessed the FUM of both cohorts using EQUC and compared the resultant data. Statistical 
comparisons were performed using Fisher’s exact test, Ttest, and ANOVA. 
Results 
 Mean age (yrs) of the IC/PBS cohort was 50.5 (SD 15.9) and 44.5 (SD 12.8) for the controls 
(p=0.062). The average score on the Genitourinary Pain Index (GUPI) was 26.1 (SD 11.3) for the 
IC/PBS cohort versus 3.0 (SD 4.9) for the controls (p<0.0001). Of the 89 women, only 40 had 
detectable FUM by EQUC. For the IC/PBS cohort, the primary detectable urotypes were 
Lactobacillus (11/49), Streptococcus (8/49), and Escherichia (2/49); 25/49 were undetectable. For 
the control cohort, the primary detectable urotypes were Lactobacillus (8/40) and Gardnerella 
(2/40); 24/40 were undetectable. The overall distribution of urotypes was significantly different 
(p=0.029), with Streptococcus found in 16% of the IC/PBS cohort versus 0% of controls (p=0.007). 
For the IC/PBS cohort, the mean GUPI score varied by urotype with scores of 31.1 (SD 6.7) for the 
Lactobacillus urotype, 29.3 (SD 9.6) for the undetectable urotype, and 15.2 (SD 12.7) for the 
Streptococcus urotype; this was statistically significant (p=0.0013). 
Conclusions 
 For both cohorts of women, when bacteria were detected, the most common urotype 
was Lactobacillus. Streptococcus was only present in the IC/PBS cohort and was the only urotype 
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that differed with statistical significance; however, interestingly, it was associated with lower 
GUPI scores. More research is needed to address EQUC findings in women with IC/PBS and its 
impact on symptom severity.
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APPENDIX E 
THE CLINICAL URINE CULTURE: ENHANCED TECHNIQUES IMPROVE DETECTION OF CLINICALLY 
RELEVANT MICROORGANISMS 
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Overview of Appendix E 
 
This paper compares the use of EQUC and SUC for the detection of uropathogens in 
women with and without acute UTI symptoms as assessed by a validated symptom 
questionnaire. EQUC detected uropathogens in 84% of women who thought they had a UTI, while 
SUC only detected uropathogens in 33% of those women. A streamlined version of EQUC is 
recommended by this paper and a current clinical trial, described in the Addendum, is ongoing 
to determine the clinical efficacy of its use. 
Abstract 
 
 Enhanced quantitative urine culture (EQUC) detects live microorganisms in the vast 
majority of urine specimens reported as “no growth” by the standard urine culture protocol. 
Here, we evaluated an expanded set of EQUC conditions (expanded-spectrum EQUC) to identify 
an optimal version that provides a more complete description of uropathogens in women 
experiencing urinary tract infection (UTI)-like symptoms. One hundred fifty adult urogynecology 
patient-participants were characterized using a self-completed validated UTI symptom 
assessment (UTISA) questionnaire and asked, “Do you feel you have a UTI?” Women responding 
negatively were recruited into the no-UTI cohort, while women responding affirmatively were 
recruited into the UTI cohort; the latter cohort was reassessed with the UTISA questionnaire 3 to 
7 days later. Baseline catheterized urine samples were plated using both standard urine culture 
and expanded-spectrum EQUC protocols: standard urine culture inoculated at 1μl onto 2 agars 
incubated aerobically; expanded-spectrum EQUC inoculated at three different volumes of urine 
onto 7 combinations of agars and environments. Compared to expanded-spectrum EQUC, 
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standard urine culture missed 67% of uropathogens overall and 50% in participants with severe 
urinary symptoms. Thirty-six percent of participants with missed uropathogens reported no 
symptom resolution after treatment by standard urine culture results. Optimal detection of 
uropathogens could be achieved using the following: 100 μl of urine plated onto blood (blood 
agar plate [BAP]), colistin-nalidixic acid (CNA), and MacConkey agars in 5% CO2 for 48 h. This 
streamlined EQUC protocol achieved 84% uropathogen detection relative to 33% detection by 
standard urine culture. The streamlined EQUC protocol improves detection of uropathogens that 
are likely relevant for symptomatic women, giving clinicians the opportunity to receive additional 
information not currently reported using standard urine culture techniques. 
Introduction 
The diagnostic gold standard for clinically relevant urinary tract infection (UTI) continues 
to be questioned for both clinical and research purposes. Since the 1950s, clinical practice has 
relied on detecting ≥105 CFU/ml of a known uropathogen using the standard clinical urine culture 
protocol18. The standard urine culture was initially described for detection of patients at risk for 
pyelonephritis19; interpretation has been generalized to diagnose lower urinary tract infection 
despite studies reporting limitations of the ≥105 CFU/ml threshold25 304 305 26. While the clinical 
focus has centered on various cutoff thresholds, the basic uropathogen detection method 
remains unchanged. 
Given emerging evidence that documents the presence of urinary microbiota in many 
adult women29 35 34 32 30 249 37 306 50 15, it is clear that the mere presence of an organism should 
not prompt antibiotic treatment. However, clinicians are likely to benefit from a more complete 
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report of organisms present within a symptomatic patient's urine. Recent evidence reports 
bacteria in ∼90% of “no-growth” standard urine cultures34 15. We hypothesized that, in women 
experiencing UTI-like symptoms, an improved culture protocol would provide a more complete 
description of potentially treatable, clinically relevant uropathogens. This study evaluated 
various combinations of urine volumes, media, atmospheric environments, and incubation 
durations to determine conditions that optimally balance uropathogen detection with feasibility. 
Materials and Methods 
Study Design and Patient Population 
Following institutional review board (IRB) approval, we enrolled 75 women who reported 
UTI symptoms and 75 who did not based on their yes/no response to the question “Do you feel 
you have a UTI?” Participants were seeking clinical care at Loyola University Medical Center's 
Female Pelvic Medicine and Reconstructive Surgery center between June 2014 and August 2015. 
Participants gave verbal and written research consent and provided permission for 
abstraction of their demographic and clinical information from the electronic medical record. At 
baseline, urinary symptoms were characterized using a self-completed, validated UTI symptom 
assessment (UTISA) questionnaire, completed by both cohorts307. Participants were 
dichotomized based on their yes/no response to the question “Do you feel you have a UTI?” 
Those who responded affirmatively (UTI cohort) completed the UTISA questionnaire again by 
phone 3 to 7 days post enrollment and were queried about the magnitude of symptom 
resolution, if any. All clinical treatment was individually based on physician assessment of patient 
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symptoms and standard urine culture results. Exclusion criteria included age of <18 years, 
pregnancy, catheterization (indwelling or intermittent), or insufficient English skills to complete 
study measures. 
Sample Collection and Analysis 
Consistent with patient care clinical protocol, urine was collected via transurethral 
catheter and then placed into two BD Vacutainer Plus C&S preservative tubes: one sent to the 
clinical microbiology laboratory for diagnostic purposes and one sent to the researchers for 
testing. 
Table E.1 displays all culture protocols used by the clinical microbiology laboratory staff 
and the researchers. The standard urine culture protocol used 1 μl of urine, spread quantitatively 
(i.e., pinwheel streak) onto 5% sheep blood (blood agar plate [BAP]) and MacConkey agars (BD 
BBL Prepared Plated Media; Cockeysville, MD) and incubated aerobically at 35°C for 24 h. The 
modified standard urine culture used the same agars and temperature but changed the 
incubation condition to 5% CO2; if pinpoint growth was seen at 24 h, the agars were held for 
Table E.1. Summary of Urine Cultivation Protocols for Catheterized Urine Specimens.  
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another 24 h under the same conditions. Unrelated to this study, the clinical microbiology 
laboratory adopted the modified standard urine culture for diagnosis during patient recruitment 
for this study. Thus, diagnostic testing for patients 1 to 107 was the standard urine culture, while 
the modified standard urine culture was used for patients 108 to 150. However, this change did 
not impact data presented in this study, as standard urine culture data for patients 108 to 150 
were obtained by analyzing the corresponding subset of expanded enhanced quantitative urine 
culture (EQUC) conditions (i.e., 1 μl BAP and MacConkey agars; aerobic, 35°C; 24 h). 
The conditions of the original enhanced quantitative urine culture (EQUC) protocol were 
described previously34. In this study, we expanded those conditions (i.e., expanded-spectrum 
EQUC protocol), using three urine volumes (1 μl, 10 μl, and 100 μl) and additional plating 
conditions (Table E.1). Each urine sample was spread quantitatively onto BAP, chocolate, and 
colistin-nalidixic acid (CNA) agars (BD BBL Prepared Plated Media) and incubated in 5% CO2 at at 
35°C for 48 h; BAP and MacConkey agars were incubated aerobically at 35°C for 48 h; two CDC 
anaerobic 5% sheep blood (anaerobic BAP) agars (BD BBL Prepared Plated Media) were incubated 
either in microaerophilic Campy gas mixture (5% O2, 10% CO2, 85% N) or anaerobically at 35°C 
for 48 h. 
Three sets of these conditions were used for each urine sample, each using one of the 
urine volumes, for a total of 21 agars per sample. All agars were documented for growth (i.e., for 
morphologies and CFU per milliliter) at 24 and 48 h, except the two anaerobic BAP conditions. 
Each distinct colony morphology was sub-cultured at 48 h to obtain pure culture for microbial 
identification. 
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Microbial identification was determined using a matrix-assisted laser desorption 
ionization–time of flight mass spectrometer (MALDI-TOF MS; Bruker Daltonics, Billerica, MA) as 
described previously34. Only clinically relevant microbes (i.e., known and emerging 
uropathogens) were used to calculate uropathogen detection. These uropathogens were 
selected based on previously published case reports of UTI. 
UTISA Questionnaire 
This questionnaire asks the participant to rate the degree of severity and bother for seven 
common UTI symptoms: frequency of urination, urgency of urination, incomplete bladder 
emptying (urinary retention), pain or burning during urination (dysuria), lower abdominal 
discomfort or pelvic pain/pressure, lower back pain, and blood in the urine (hematuria). Scores 
for each symptom range from 0 to 3; a 0 corresponds to no symptom present, whereas a 3 
indicates highest severity or bother. The seven symptoms can be clustered into four symptom 
domains: urination regularity (frequency and urgency), problems with urination (incomplete 
bladder emptying and pain or burning), pain associated with the UTI (abdominal or pelvic pain 
and lower back pain), and blood in the urine307. 
Statistical Analyses 
Continuous variables were reported as means and standard deviations (SDs) or medians 
and interquartile ranges (IQRs); categorical variables were reported as frequencies and 
percentages. Pearson chi-square tests (or Fisher's exact tests, when necessary) and 2-sample t 
tests (or Wilcoxon rank sum tests, when appropriate) were used to compare demographics and 
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culture results (e.g., abundance and diversity) between cohorts. Measures of alpha diversity 
(diversity within a population) were represented as Shannon diversity indices and/or graphically 
by species accumulation curves (which plot accumulation of unique species per group for each 
additional sample included). All statistical analyses were conducted using SAS software v9.4 (SAS 
Institute, Cary, NC) or Systat software version 13.1 (Systat Software Inc., Chicago, IL). 
Table E.2. Demographic Characteristics and Symptoms.  
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Results 
Participant Demographic and Symptoms 
Table E.2 describes demographics of the two cohorts (75 no-UTI and 75 UTI patients). 
Most participants were white (81%) and overweight (mean body mass index [BMI] = 29.3 kg/m2). 
Most participants (92%, 138/150) reported at least one urinary symptom; as expected, women 
in the UTI cohort had higher UTISA questionnaire scores. 
Expanded-Spectrum EQUC: Urinary Microbiota Characteristics 
Nearly all (93% [139/150]) catheterized urine samples grew bacterial colonies with at 
least one combination of the expanded-spectrum EQUC protocol's conditions (Table E.1). The 
no-UTI and UTI cohorts had similar proportions of cultivatable urine samples (89% [67/75] versus 
96% [72/75]; P = 0.12), similar numbers of total unique species detected per cohort (75 versus 
66), and similar median numbers of species detected per urine sample (3 [IQR = 1 to 5] versus 2 
[IQR = 1 to 4]; P = 0.12) (see Table S1 in the supplemental material). However, the cohorts differed 
in organism diversity, genus-level composition, and species-level composition. The no-UTI cohort 
had more diversity with greater species richness as depicted by species accumulation curves (see 
Figure E.S1 in the supplemental material) and greater alpha diversity as measured by the 
Shannon diversity index (no-UTI = 3.89 versus UTI = 3.49). The genera Streptococcus (P = 0.003) 
and Gardnerella (P = 0.04) were more prevalent in the no-UTI cohort, while the genus Escherichia 
(P < 0.001) was detected more often in the UTI cohort (see Figure E.S2). Five species, namely, 
Gardnerella vaginalis (P = 0.4), Streptococcus mitis/oralis/pneumoniae (P = 0.01), Streptococcus 
parasanguinis (P = 0.02), Streptococcus salivarius (P = 0.05), and Streptococcus sanguinis (P = 
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0.01), were detected more often in the no-UTI cohort; in contrast, the species Escherichia coli (P 
< 0.001) was more prevalent in the UTI cohort (see Figure E.S3). 
The genera Streptococcus (P = 0.003) and Gardnerella (P = 0.04) were more prevalent in 
the no-UTI cohort, while the genus Escherichia (P < 0.001) was detected more often in the UTI 
cohort (see Figure E.S2). Five species, namely, Gardnerella vaginalis (P = 0.4), Streptococcus 
mitis/oralis/pneumoniae (P = 0.01), Streptococcus parasanguinis (P = 0.02), Streptococcus 
salivarius (P = 0.05), and Streptococcus sanguinis (P = 0.01), were detected more often in the no-
UTI cohort; in contrast, the species Escherichia coli (P < 0.001) was more prevalent in the UTI 
cohort (see Figure E.S3). 
Uropathogen Detection 
We next modeled our evaluation to uropathogen detection by the expanded-spectrum 
EQUC protocol with regard to the following parameters: detection compared to standard urine 
culture, detection with different urine volumes, and detection using different plating conditions. 
With these findings, we then identified an optimal subset of expanded-spectrum EQUC 
conditions for improved detection of uropathogens, which we call the streamlined EQUC 
protocol. 
Expanded-Spectrum EQUC Versus Standard Urine Culture 
The expanded-spectrum EQUC protocol detected a total of 182 uropathogens in all the 
catheterized urine samples, 110 uropathogens in the UTI cohort urine samples, and 72 
uropathogens in in the non-UTI cohort urine samples. Whereas the expanded-spectrum EQUC 
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did not miss any uropathogen detected by standard urine culture, the standard urine culture 
protocol detected 33% (60/182) of all detected uropathogens, 50% (55/110) of those detected 
Figure E.1. Average CFU per milliliter of uropathogens between the UTI and no-UTI cohorts. 
Depicted are the average CFU per milliliter with which the various uropathogens were cultured 
for both cohorts: UTI (blue bars) and no-UTI (red bars). Average CFU of Klebsiella pneumoniae 
(P = 0.04) and Streptococcus agalactiae (P = 0.02) are significantly higher in the UTI cohort (*). 
Several uropathogens had substantially lower average CFU-per-milliliter values in the no-UTI 
cohort than in the UTI cohort: Aerococcus urinae (P = 0.12), Enterococcus faecalis (P = 0.09), 
Escherichia coli (P = 0.08), Staphylococcus aureus (P = 0.06), and Streptococcus anginosus (P = 
0.08). Independent t test (*, P < 0.05). Black bars depict common UTI thresholds (≥105 CFU/ml 
and ≥103 CFU/ml). 
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in the UTI cohort, and only 7% (5/72) of those detected in the non-UTI cohort. 
 The expanded-spectrum EQUC protocol detected all uropathogens at a higher average 
CFU per milliliter in the UTI cohort than in the no-UTI cohort (Figure E.1). This protocol detected 
E. coli in a total of 50 samples obtained from both cohorts; of these, standard urine culture 
detected E. coli in 88% (44/50). From the UTI cohort alone, expanded-spectrum EQUC detected 
E. coli in 43 samples; of these, standard urine culture detected E. coli in 91% (39/43). In contrast, 
standard urine culture detected a strikingly low fraction (12% [16/132]) of the non- E. coli 
Table E.3. Optimal Detection of Specific Uropathogens by the Expanded-Spectrum EQUC 
Protocol.  
 
aListed are the uropathogens and the number of times that each was cultured under each 
expanded-spectrum EQUC plating condition. The condition(s) that best detected each 
uropathogen is shaded. 
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uropathogens detected in the two cohorts by the expanded-spectrum EQUC protocol. This 
percentage was only slightly better in the UTI cohort alone, where standard urine culture 
detected 24% (16/67) of the non-E. coli uropathogens detected by the expanded-spectrum EQUC 
protocol. Therefore, standard urine culture's capacity to detect E. coli dramatically skewed its 
overall uropathogen detection value. 
Expanded-Spectrum EQUC: Urine Volumes 
 Uropathogen detection differed greatly based on expanded-spectrum EQUC urine 
volumes: for 100 μl, 96% detection (174/182); for 10 μl, 65% detection (118/182); and for 1 μl, 
52% detection (95/182) versus standard urine culture (33% [60/182]). Some uropathogens were 
detected equally by all volumes (e.g., E. coli and Pseudomonas aeruginosa); others most often 
required 100 μl for detection (e.g., Aerococcus urinae, Alloscardovia omnicolens, Enterococcus 
faecalis, and Streptococcus anginosus) (see Figure E.S4).  
Expanded-Spectrum EQUC: Plating Conditions 
Table E.3 displays uropathogens and the number of times that each was cultured under 
the various expanded-spectrum EQUC plating conditions. After 48 h incubation, CDC anaerobic 
BAP incubated anaerobically detected the most uropathogens (63% [115/182]), followed by BAP 
in 5% CO2 (62% [112/182]), CDC anaerobic BAP incubated microaerophilically (54% [98/182]), 
chocolate agar in 5% CO2 (53% [96/182]), BAP incubated aerobically (52% [94/182]), CNA agar in 
5% CO2 (43% [79/182]), and MacConkey agar incubated aerobically (34% [62/182]). Although the 
CNA agar condition detected fewer uropathogens, it ideally detected Gram- positive 
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uropathogens when Gram-negative bacteria overwhelmed other agars. For example, of the 47 
samples where a Gram-negative uropathogen was present at ≥50,000 CFU/ml, the CNA agar 
condition detected 27 underlying Gram-positive uropathogens, all of which were missed by 
standard urine culture (see Table S2A in the supplemental material). Conversely, of the seven 
samples where a Gram-positive uropathogen was present at ≥50,000 CFU/ml, the MacConkey 
condition detected two underlying Gram-negative uropathogens (see Table E.S2B).  
Streamlined EQUC Protocol 
One hundred microliters of urine plated on a combination of BAP and CNA agars in 5% 
CO2 and MacConkey agar under aerobic conditions would have detected 84% (152/182) of all 
Table E.4. Detection of Uropathogens in UTI Cohort without Symptom Improvement. 
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uropathogens detected by the expanded-spectrum EQUC protocol. This is vastly superior to the 
33% (60/182) uropathogen detection by standard urine culture. In the UTI cohort alone, the 
streamlined EQUC protocol (Table E.1) would have detected 91% (100/110) of uropathogens, 
compared to only 52% (57/110) by standard urine culture. 
Symptom Resolution 
Seventy-nine percent (59/75) of the participants in the UTI cohort completed the follow- 
up UTISA questionnaire. Following clinically selected treatment based on standard urine culture 
(or modified standard urine culture), 59% (35/59) of participants reported symptom 
improvement, while 41% (24/59) reported no improvement (same or worse) (Table E.4). Half 
(12/24) of the 24 participants who did not improve had at least one uropathogen detected only 
by the expanded-spectrum EQUC protocol, and 13 (54%) had microorganisms of unknown 
pathogenicity, which were detected only by the expanded-spectrum EQUC protocol (see Table 
S3 in the supplemental material). Importantly, all of these missed uropathogens would have also 
been detected using the streamlined EQUC protocol. Ten of the 24 patients who did not improve 
had been clinically treated with antibiotics based on the finding of a standard urine culture-
detected uropathogen. However, in 3 (30%) of these 10 patients, the expanded-spectrum EQUC 
(as well as streamlined EQUC) detected an additional Gram-positive uropathogen (Aerococcus 
urinae, Corynebacterium riegelii, or Streptococcus anginosus). 
Discussion 
Accurate diagnosis for women with UTI symptoms is critical, both to target appropriate 
therapy and to limit inappropriate antibiotic use. Our study demonstrates deficiencies in the 
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standard urine culture protocol that limit potentially important information that should be 
provided to clinicians. Our findings suggest that improved detection of clinically relevant urinary 
microbes can be achieved in all diagnostic clinical laboratories using the following conditions: a 
100-μl urine sample obtained by transurethral catheter plated onto BAP, CNA, and MacConkey 
agars, with incubation of all agars in 5% CO2 for 48 h. While incubation of MacConkey agar in 5% 
CO2 may not improve Gram-negative bacillus recovery, we recommend that all agars be 
incubated in 5% CO2 for the convenience of using a single incubator. All detected uropathogens 
will grow under the conditions described in the streamlined EQUC protocol. 
Our findings support the use of the streamlined EQUC protocol to more fully describe 
uropathogens. We also recommend that 1μl of the catheterized urine be plated onto BAP and 
MacConkey agars and incubated in 5% CO2 for 24 h with an option to incubate for 48 h (modified 
standard urine culture). The streamlined EQUC protocol provides the most thorough detection 
of uropathogens, while the modified standard urine culture ensures accurate colony count 
assessment and is beneficial for species detection of underlying uropathogens when bacterial 
colony counts of a predominant uropathogen exceed 105 CFU/ml. The need for modified 
standard urine culture inclusion is apparent from the observation that the expanded- spectrum 
EQUC (and the streamlined EQUC) protocols were not 100% sensitive. In the expanded-spectrum 
EQUC protocol, the use of 100 μl urine detected the most microbes and the most uropathogens. 
However, a small number of uropathogens were detected only with the use of a smaller urine 
volume (10 μl). This apparent paradox likely results from microbial overcrowding in samples 
containing high numbers of CFU; in these circumstances, 100 μl was not ideal for distinguishing 
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morphologies. While addition of selective media (i.e., CNA and MacConkey agars) helped detect 
underlying uropathogens, some samples contained both Gram-positive and Gram-negative 
bacteria at high CFU numbers, likely making the 100-μl expanded-spectrum EQUC volume less 
efficient. 
Streamlined EQUC would provide more information to clinicians who are considering the 
clinical need for uropathogen(s) treatment; many of these are currently missed by the standard 
urine culture protocol. Until better information is available concerning the relationship between 
clinically important UTI and CFU per milliliter, we recommend that these testing conditions (i.e., 
streamlined EQUC) be used for patients with recurrent UTIs or patients with clear UTI-like 
symptoms despite a negative standard urine culture result. Nonetheless, it is clear that treatment 
based on standard urine culture results limits diagnostic information that may be useful for 
symptom resolution. This study did not assess symptom relief in patients whose uropathogens 
were detected only with the streamlined EQUC protocol. Such studies are clearly needed. 
Compared to the expanded-spectrum EQUC, the standard urine culture missed 67% 
(122/182) of all detected uropathogens and 88% (116/132) of non-E. coli uropathogens. 
Detection of uropathogens by the standard urine culture was slightly better for the UTI cohort 
alone (50% total missed [55/110]; 76% non-E. coli missed [51/67]). This improvement may result 
from the higher average uropathogen CFU per milliliter in the UTI cohort (Figure E.1), making 
detection by standard urine culture more likely. The data in Table E.1 also reveal that the use of 
one threshold for UTI diagnosis is likely incorrect. Use of the ≥105-CFU/ml threshold would result 
in untreated uropathogens in the UTI cohort (Figure E.1). Lowering the threshold to ≥103 CFU/ml, 
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however, creates other concerns. While use of the ≥103-CFU/ml threshold would leave fewer 
uropathogens in the UTI cohort untreated, it would detect some uropathogens in the no-UTI 
cohort. Since individuals in the no-UTI cohort presumably do not have an infection (i.e., no/low 
severity of urinary symptoms), it is unlikely that they would benefit from antibiotic use. This 
creates a problem in diagnosis and treatment of UTIs and is likely the reason for the current 
ambiguity surrounding urine cultures. From these data, we suggest the possibility that, for UTI 
diagnosis, each uropathogen may have its own unique threshold (e.g., ≥102 CFU/ml for 
Aerococcus urinae, ≥103 CFU/ml for Streptococcus agalactiae, and ≥104 CFU/ml for Klebsiella 
pneumoniae). 
Our findings in a selected, health care-seeking population of women should be 
generalized with caution to community-dwelling women who may or may not have similar 
microbial profiles in health or during UTI. Microbial characterization of women longitudinally may 
provide additional context for interpretation of standard and streamlined culture results. 
It appears that simple changes to the commonly performed standard urine culture 
protocol have the capacity to provide potentially useful clinical information. Importantly, the 
urine must be collected by catheter, as we have previously shown that vulvovaginal 
contamination renders clean-catch voided specimens obsolete4. At this time, we suggest that 
the recommended culture conditions (i.e., streamlined EQUC) be considered both as a 
supplemental test when individuals with UTI-like symptoms have “no growth” via standard urine 
culture and for use with individuals with persistent UTI-like symptoms (i.e., recurrent UTI). 
Supplementary Materials 
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Figure E.S1. Species accumulation curves of UTI and No-UTI Cohorts. Species accumulation data 
depicts the number of unique species cultured (using the Expanded Spectrum EQUC) with each 
new patient sampled. When the curve plateaus, it indicates that the community is fully sampled 
and few, if any, new species will be identified. Therefore, it also measures the overall diversity 
of the population in terms of species richness. The UTI cohort (blue line) is comprised of 66 
species. The No-UTI cohort (red line) is comprised of 75 species. 
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Figure E.S2. Frequency of detection of genera in the UTI and No-UTI cohorts. Depicts the 
frequency (i.e., percentage) of detection (using the Expanded Spectrum EQUC) of the urine 
samples containing each genus between the UTI (blue bars) and No-UTI (red bars) cohorts. 
Streptococcus (p=0.003), Gardnerella (p=0.04), and Escherichia (p<0.001). 
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Figure E.S3. Species significantly different between the UTI and No-UTI cohorts. Depicts the 
frequency (i.e., percentage) of detection (using the Expanded Spectrum EQUC) of the species 
that are statistically associated with either the UTI (blue bars) and No-UTI (red bars) cohorts. 
Gardnerella vaginalis (p=0.04), Streptococcus mitis/oralis/pneumoniae (p=0.01), Streptococcus 
parasanguinis (p=0.02), Streptococcus salivarius (p=0.05) and Streptococcus sanguinis (p=0.01) 
are associated with the No-UTI cohort. Escherichia coli (p<0.001) is associated with the UTI 
cohort. Pearson chi-square and Fisher’s exact test (* p<0,05; **p<0.01,*** p<0.001). The species 
S. mitis, S. oralis, and S. pneumoniae were grouped together because they cannot accurately be 
distinguished using MALDI-TOF MS. 
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Figure E.S4. Detection of Uropathogens by each expanded spectrum EQUC urine volume. 
Depicts the total number of times each uropathogen was identified by each of the urine volumes 
(1 µL, 10 µL, 100 µL) in the Expanded Spectrum EQUC protocol as well as the Standard Urine 
Culture protocol: Standard Urine Culture (blue bars), 1µL Expanded Spectrum EQUC (purple 
bars), 10 µL Expanded Spectrum EQUC (green bars), and 100 µL Expanded Spectrum EQUC (red 
bars). 
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 UTI 
(n=75) 
No-UTI 
(n=75) 
p-value 
Cultivatable Urine Samples 72 (96%) 6 (89%) 0.12* 
Total number of unique species 66 75  
Median number of unique specie per isolate, mdn (IQR) 2 (1-4) 3 (1-5) 0.12 ** 
Shannon Diversity index 3.49 3.89  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table E.S1. Urinary Microbiota Characteristics. 
IQR = Interquartile Range. Mdn = median 
* Chi-Square Test 
**Wilcoxon Rank Sum Test 
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Addendum 
 Data collected from this project was used as a rationale and to power a clinical trial 
designed to determine if the recommended, “Optimal EQUC”, protocol results in improved 
patient care. We are currently recruiting patients at the Loyola University Medical Center 
Urogynecology Clinic for this trial. Our goal is to recruit 225 women, who respond “yes” when 
asked, “Do you feel you have a urinary tract infection today?”. TUC specimens are being collected 
from these patients, and symptoms are characterized using the UTISA questionnaire. The 
questionnaire was slightly modified to include an additional question asking the patient to choose 
which symptom is most severe/bothersome. Participants are randomized, doubled-blinded, in a 
2:1 ratio to receiving SUC or Optimal EQUC, performed by the hospital clinical microbiology 
laboratory. A treatment algorithm in which all uropathogens, regardless of CFU/mL, are 
considered for symptom etiology. Clinical treatment is provided (clinicians are blinded to method 
used). A post-treatment questionnaire is sent to all participants; this includes the UTISA 
questionnaire, and a series of questions to determine if the patient feels “better”. Patients who 
do not report feeling “better” are asked to return to the clinic, a follow-up TUC specimen is 
collected, and Optimal EQUC is performed regardless of starting cohort. Clinical treatment is 
provided again, if prompted. A second post-treatment questionnaire is sent to the follow-up 
participants.  
 This study will help us determine if use of Optimal EQUC improves patient care. We 
predict that some patients who originally receive SUC will report no symptom resolution 
following treatment (if any). They will return, receive Optimal EQUC and then symptoms will 
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resolve following a more appropriate treatment. This study is a registered clinical trial 
(NCT03190421). More information can be found at the following link: 
https://clinicaltrials.gov/ct2/show/NCT03190421?cond=UTI&cntry=US&state=US%3AIL&draw=
1.
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APPENDIX F 
URINARY SYMPTOMS AND THEIR ASSOCIATIONS WITH URINARY TRACT INFECTIONS IN 
UROGYNECOLOGIC PATIENTS 
 
Dune T., Price T.K., Hilt E.E., Thomas-White K.J., Kliethermes S., Brincat C., Brubaker L., 
Schreckenberger P., Wolfe A.J., Mueller E.R. Urinary Symptoms and their Associations with 
Urinary Tract Infections in Urogynecologic Patients. Obstet. Gynecol. 2017 Oct;130(4):718-725. 
doi: 10.1097/AOG.0000000000002239. 
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Overview of Appendix F 
This paper compares three methods for UTI diagnosis and the relationship of each to 
urinary symptoms, as characterized by the use of the UTISA questionnaire307. These three 
methods are: self-report (a non-culture-based UTI diagnosis) which was defined by the Yes/No 
response to the query “Do you think you have a UTI?”, and two culture-based UTI diagnoses, 
including the Standard Urine Culture (≥104 CFU/mL of any uropathogen) and the Enhanced 
Quantitative Urine Culture (≥10 CFU/mL of any uropathogen). We found that the presence of 
frequency and urgency did not differ between “UTI-positive” and “UTI-negative” women defined 
by any of the three methods used. Conversely, the presence of dysuria (pain during urination) 
was significantly more common in the “UTI-positive” women by all three methods used. 
Abstract 
Objective 
 The goal of this study was to assess urinary symptoms associated with urinary tract 
infection (UTI) in a urogynecologic population of women. The primary measure (i.e. UTI diagnosis) 
was defined in three ways: self-report, Standard Urine Culture and Enhanced Quantitative Urine 
Culture. 
Methods 
 We enrolled 150 urogynecologic patients, who completed the validated UTI Symptom 
Assessment questionnaire and contributed transurethral catheterized urine samples. Three 
methods for diagnosis of UTI were compared to symptoms. Self-report (a non-culture-based UTI 
diagnosis) was defined by the Yes/No response to the query “Do you think you have a UTI?” Two 
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culture-based UTI diagnoses also were analyzed: Standard Urine Culture (≥104 CFU/mL) and 
Enhanced Quantitative Urine Culture (≥10 CFU/mL) of any uropathogen. Statistical analyses were 
performed on patient demographics and urinary symptom prevalence among patient groups.  
Results 
 The presence of the urinary symptoms of frequency and urgency did not differ between 
‘UTI-positive’ and ‘UTI-negative’ women, regardless of the UTI diagnosis method (self-report, 
Standard Urine Culture, or Enhanced Quantitative Urine Culture).  However, the presence of 
dysuria during urination was significantly more prevalent in ‘UTI-positive’ women for all UTI 
definitions. Furthermore, women reporting dysuria had statistically higher severity and bother 
scores for all other urinary symptoms assessed by the UTI Symptom Assessment questionnaire, 
compared to women not reporting dysuria. 
Conclusion 
 Our findings show that in women seeking urogynecologic care, presence of frequency and 
urgency of urination do not confirm a culture-based UTI diagnosis. Instead, clinicians can more 
readily detect UTI using the presence of dysuria, which more effectively discriminates UTI-
positive and UTI-negative individuals, regardless of the culture-based method used to diagnose 
UTI.  
Introduction 
 Clinicians typically rely on patient-reported symptoms to diagnose UTI in ambulatory 
adult women. Seven classic UTI symptoms, including frequency and urgency of urination are 
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included in the only validated UTI symptom survey307. Yet many clinicians accept that frequency 
and urgency are non-specific for a culture-based UTI diagnosis and frequency and urgency may 
add little or nothing to a UTI diagnosis in a urogynecologic population.  
Clinicians face a dilemma when assessing UTI in urogynecologic patients with chronic 
frequency and/or urgency. In this population, Fitzgerald et al. found that chronic frequency and 
incontinence of urine were unlikely to be symptoms reliably associated with UTI308. Thus, despite 
scant evidence, patients and clinicians may rely on changes in baseline symptoms to detect UTI 
(e.g., worsened urgency and/or frequency, dysuria). In the urogynecologic population, clinicians 
typically assume a non-bacteriologic etiology for urgency and/or frequency when standard UTI 
testing is negative. However, recent advances in understanding the female urinary microbiota29 
32 30 50 306 37 35 34 44 demonstrate that most women have detectable bacteria present using an 
Enhanced Quantitative Urine Culture protocol despite a negative Standard Urine Culture34 44. This 
new knowledge complicates our understanding of bladder health and disease, including UTIs.  
We assessed the proportion of patients with symptoms using three different definitions 
of UTI (self-report, Standard Urine Culture, and Enhanced Quantitative Urine Culture). Our goal 
was to determine if urinary symptoms differ among the diagnosis methods, as well as to identify 
symptoms that are the strongest indicators of UTI regardless of diagnosis method. 
Materials and Methods 
Our a priori sample size of 150 urogynecologic patients was enrolled following 
Institutional Review Board (IRB) approval. Participants were volunteers from consecutively 
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approached adult women seeking clinical urogynecologic care at Loyola University Medical 
Center’s Female Pelvic Medicine and Reconstructive Surgery center between June 2014 and 
August 2015. Exclusion criteria included age <18, pregnancy, catheterization (indwelling or 
intermittent) or insufficient English skills to complete study measures. Participants contributed 
demographic and questionnaire data, as well as a single transurethral catheterized urine sample. 
Two cohorts, each with 75 women, were formed based on their self-report of UTI presence using 
the query: “Do you feel you have a UTI?” (Yes/No). All participants completed the validated UTI 
Symptom Assessment questionnaire307, in which the participant rates the severity and bother for 
seven common UTI symptoms (frequency and urgency of urination, dysuria, difficulty urinating, 
lower abdominal/pelvic pain or pressure, low back pain, blood in urine); the UTI Symptom 
Assessment questionnaire further groups the 7 symptoms into four domains. Scores for each 
symptom range from 0 (no symptom) to 3 (highest severity or bother). Participants who reported 
UTI symptoms (Yes cohort) were also asked to qualitatively document any UTI-related symptoms.  
Participants were clinically characterized using standard urogynecologic history and 
physical assessments. Consistent with the patient care clinical protocol, each patient-
participant’s urine was collected aseptically via transurethral catheterization and placed into BD 
Vacutainer Plus C&S preservative tubes. Each specimen was processed by two clinical laboratory 
methods: The Standard Urine Culture method and an expanded spectrum version of the 
Enhanced Quantitative Urine Culture method. The Enhanced Quantitative Urine Culture method 
was developed by our team and has been previously described34 44. Table F.1 displays the 
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parameters of these two culture-based methods. The Standard Urine Culture protocol used 1µL 
of urine, spread quantitatively (i.e., pinwheel streak) onto 5% sheep blood (BAP) and MacConkey 
agars (BD BBL™ Prepared Plated Media, Cockeysville, MD) and incubated aerobically at 35°C for 
24 hours. The limit of microbial detection for standard urine culture is 103 CFU/mL. The UTI 
diagnosis definition for Standard Urine Culture was ≥104 CFU/mL of a uropathogen. The 
Expanded Spectrum Enhanced Quantitative Urine Culture protocol used 1, 10, and 100µL of 
urine, spread quantitatively (i.e., pinwheel streak) onto 5% sheep blood (BAP), MacConkey, 
Chocolate, CNA, and CDC Anaerobic BAP (BD BBL™ Prepared Plated Media, Cockeysville, MD) and 
incubated aerobically, in 5% CO2, anaerobically, or in microaerophilic conditions at 35°C for 48 
hours, although some plates were documented for growth at 24 hours. The limit of microbial 
Table F.1. Summary of Urine Cultivation Protocols and Urinary Tract Infection Diagnosis 
Definitions. 
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detection for the enhanced quantitative urine culture is 10 CFU/mL. The UTI diagnosis definition 
for Enhanced Quantitative Urine Culture was ≥10 CFU/mL of a uropathogen. 
Continuous variables were reported as means with standard deviations (SD) or medians 
with ranges; categorical variables were reported as frequencies and percentages. Pearson Chi-
square tests (or Fisher’s Exact Tests, when necessary) and 2-sample t-tests (or Wilcoxon Rank 
Sum tests, when appropriate) were used to compare demographics and culture results (e.g., 
Table F.2. Patient Demographics and Symptoms by Self-Report or Dysuria. 
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abundance and diversity) between cohorts. All statistical analyses were conducted using SAS 
software v9.4 (SAS Institute, Cary, NC) or SYSTAT software version 13.1 (SYSTAT Software Inc., 
Chicago, IL). 
Results 
The study population (150 participants) had an average age of 62.3 years ± 14.9 years; 
most were Caucasian (81%) and overweight (mean body mass index 29.3 kg/m2 ± 6.3 kg/m2) 
Table F.3. List of Uropathogens. 
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(Table F.2). Nearly all participants (92% [138/150]) endorsed symptoms on the UTI Symptom 
Assessment questionnaire. Additional patient and clinical demographics were previously 
published44.  
Using Standard Urine Culture, only 38% (57/150) of samples grew microbial colonies (11 
different species from 10 different genera, median number of 1 microbial species per urine 
sample). Using the Expanded Spectrum Enhanced Quantitative Urine Culture, nearly all samples 
[139/150 (93%)] grew microbial colonies (98 different species from 36 different genera, median 
number of 2 microbial species per urine sample). Consistent with the current clinical uropathogen 
literature, we classified all 11 species detected by Standard Urine Culture and 23 of the species 
detected by the Expanded Spectrum Enhanced Quantitative Urine Culture as uropathogens 
(Table F.3).  
Of the 150 participants, by our a priori study design, 75 were in each self-reported cohort 
(Yes/No); these two groups were similar demographically (Table F.2). We did not detect 
significant differences in the proportions of urine samples with detected bacteria [No self-
reported UTI=89% (67/75) vs. self-reported UTI=96% (72/75); p=0.12] or total unique species per 
urine sample (75 vs. 66; p=0.31). Although the no self-reported UTI cohort had a larger median 
number of detected species per urine sample when compared to the self-reported UTI group, 
the difference was not statistically significant [3 (IQR=1-5) vs. 2 (IQR=1-4); p=0.12].  
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Table F.2 also displays the percentage of patients reporting each UTI symptom. Symptoms 
were endorsed by all women who self-reported UTI (100%, 75/75) and most women in the no 
self-reported UTI population (84%; 63/75). However, women who self-reported UTI had higher 
average scores (severity and bother scores combined) for the seven symptoms and four domains 
of the UTI Symptom Assessment questionnaire. In addition to the UTI symptom assessment 
Table F.4a. Patient Demographics and Symptoms Defined by Standard or Expanded Spectrum 
Enhanced Quantitative Urine Culture. 
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questionnaire-measured symptoms, 64/75 women in the self-reported UTI population 
qualitatively reported their UTI symptoms and 19% (12/64) indicated the presence of malodorous 
urine. The presence of frequency and urgency of urination did not differ between the cohorts; 
however, dysuria was significantly more prevalent in the self-reported UTI population. 
Fifty-seven individuals (38%) met the criterion for UTI using Standard Urine Culture, most 
(91%) of whom also self-reported UTI (Table F.4). Except for age, the Standard Urine Culture 
defined UTI-positive population did not differ demographically from the UTI-negative population.  
Table F.4 displays the proportion of patients reporting UTI symptoms and dichotomized 
by culture-based UTI diagnoses. Nearly all (98%) of the Standard Urine Culture defined UTI-
positive and a majority [88% (82/93)] of the UTI-negative population endorsed symptoms on the 
UTI Symptom Assessment questionnaire. Similar to results by self-reported UTI (Table F.2), the 
presence of frequency and urgency of urination did not differ largely between the cohorts, while 
Table F.4b. Patient Demographics and Symptoms Defined by Standard or Expanded Spectrum 
Enhanced Quantitative Urine Culture (continued). 
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dysuria was significantly more prevalent in the Standard Urine Culture defined UTI-positive 
population. Twenty percent (9/44) of women who were both Standard Urine Culture defined UTI-
positive and self-reported UTI reported malodorous urine. 
One hundred and ten (73%) women met the criterion for UTI as defined by the Enhanced 
Quantitative Urine Culture (Table F.4); most also self-reported UTI (63%, 69/110). The Enhanced 
Quantitative Urine Culture defined UTI-positive population did not differ demographically from 
the UTI-negative population (Table F.4). Most of the Enhanced Quantitative Urine Culture 
defined UTI-positive and UTI-negative women endorsed symptoms on the UTI Symptom 
Assessment questionnaire [92% (101/110) and 93% (37/40), respectively]. The presence of 
frequency and urgency of urination did not differ largely between the cohorts, while dysuria was 
significantly more prevalent in the Enhanced Quantitative Urine Culture defined UTI-positive 
population. Nineteen percent (11/57) of women who were both Enhanced Quantitative Urine 
Culture defined UTI-positive and self-reported UTI reported malodorous urine.  
Discussion 
 Our findings suggest that, in urogynecologic patients, dysuria is a better clinical clue to 
UTI than urinary frequency or urgency or both. While clinicians and validated UTI measures that 
include urinary urgency and frequency have utilized the Standard Urine Culture as the current 
standard for UTI diagnosis, this approach has not been evaluated in urogynecologic patients. In 
our participants, urgency and frequency correlated poorly with culture-based UTI diagnostic tests 
and did not contribute to a correct UTI diagnosis. Dysuria, however, appeared relevant and more 
specific; therefore, the use of dysuria as a key UTI symptom warrants further assessment. 
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 Abnormal urinary odor is not included in the currently validated UTI assessment tool, yet 
participants often reported this symptom as a sign of UTI; this correlates with our clinical 
experience. We suggest that odor be included in a modified tool, at least for urogynecologic 
populations. Conversely, hematuria was rarely reported and may have less importance as a UTI-
related symptom in this population. 
 It is critical that we improve current UTI detection methods. In response to patient-
reported symptoms, clinicians consider it proper to empirically treat acute uncomplicated UTIs 
in pre-menopausal women who experience infrequent episodes of UTI with typical symptoms, 
e.g. urgency and frequency20 309 310. In urogynecologic populations, however, the chronic presence 
of these symptoms complicates UTI diagnosis. Clinicians often rely on Standard Urine Culture, 
which requires growth of at least one uropathogen above a certain threshold. However, our 
group has found that this method misses most non-E. coli uropathogens44. This and other 
emerging knowledge about urinary microbiota may provide information about the absence of 
good bacteria, as well as the presence (or overabundance) of bad bacteria. In a companion to 
this study44, we reported that urine samples from women who did not self-report UTI were likely 
to be predominated by Lactobacillus, Streptococcus, and Gardnerella, an observation that is 
consistent with previous reports37 35 15. In contrast, the urine of women with UTI were more likely 
to contain traditional uropathogens at the expense of Gardnerella, Streptococcus and 
Lactobacillus44, which may be a clue to the composition of healthy microbiota, consistent in part 
with previous observations35 15. Given its beneficial role in the genito-urinary tract162 311 199 312, 
Lactobacillus in the bladder may prevent UTI or facilitate microbial restoration following UTI 
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treatment. Thus, clinicians must balance appropriate, selective UTI testing with the risk of 
antibiotic overuse. Given the beneficial protective role of certain bacteria in the bladder50 37, 
improved UTI testing and treatment algorithms in urogynecologic patients may improve patient 
care. 
 The colony count threshold has been debated extensively. In this study, we tested a 
traditional threshold with the standard method, as well as a lower threshold with an enhanced 
culture protocol. The former was chosen because it is the most widely used threshold and 
method for UTI diagnosis in this patient population. We chose the latter to detect as many 
potential pathogens as possible. 
 Strengths of our study include various definitions of UTI, including simple self-report, two 
different thresholds for culture methods and the Enhanced Quantitative Urine Culture technique. 
Our study also benefits from an enhanced means of describing patient symptoms through the 
validated UTI Symptom Assessment questionnaire. Finally, we reduced vulvo-vaginal 
contamination through standardized urethral catheterization collection techniques. 
 Limitations of this study include a lack of ethnic diversity of the study population. We 
recommend caution in generalizing our findings beyond this subspecialty population. In addition, 
we did not complete an a priori power calculation due to a lack of effect size estimates in the 
literature. We hope our findings will inform these aspects of future studies. 
 Clinicians may wish to include microbial assessment using the streamlined version of the 
Enhanced Quantitative Urine Culture, which we recently recommended for patients with 
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negative Standard Urine Culture results and persistent or refractory urinary symptoms44. Good 
antibiotic stewardship in this population may need to incorporate a more personalized approach 
to antibiotics use that aligns more closely with specific symptoms. Such techniques will help 
clinicians and patients move away from the simplistic approach of kill the uropathogen and better 
understand the role of good and bad bacteria that inhabit the female bladder. Also, certain 
women may benefit from an approach that ensures restoration of a healthy urinary microbiota 
following UTI treatment. Further research into these compelling areas of women’s urinary health 
may reduce the morbidity and costs associated with poorly controlled bladder symptoms and 
improve diagnostic precision and treatment.
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APPENDIX G 
URINE TROUBLE: SHOULD WE THINK DIFFERENTLY ABOUT UTI? 
 
Price T.K., Hilt E.E., Dune J., Mueller E.R., Wolfe A.J., Brubaker L. Urine Trouble: Should we think 
Differently about UTI? Int. Urogynecol. J. 2018 Feb;29(2):205-210. doi: 10.1007/s00192-017-
3528-8. Epub 2017 Dec 26. 
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Overview of Appendix G 
This in an opinion paper, primarily describing the works from Appendix E and Appendix 
F. The goal of this paper is to question the current methods and understanding of UTI in the 
context of more recently presented research (e.g. the urinary microbiome). 
Abstract 
 Urinary tract infection (UTI) is clinically important, given that it is one of the most common 
bacterial infections in adult women. However, the current understanding of UTI remains based 
on a now disproven concept that the urinary bladder is sterile. Thus, current standards for UTI 
diagnosis have significant limitations that may reduce the opportunity to improve patient care. 
Using data from our work and numerous other peer-reviewed studies, we identified four major 
limitations to the contemporary UTI description: the language of UTI, UTI diagnostic testing, the 
Escherichia coli-centric view of UTI, and the colony-forming units (CFU) threshold-based 
diagnosis. Contemporary methods and technology combined with continued rigorous clinical 
research can be used to correct these limitations. 
Introduction 
 Urinary tract infection (UTI) is the most common bacterial infection in adult women, with 
50% of women experiencing at least one UTI in their lifetime and as many as 10% having at least 
one UTI annually. UTI is among the most common reasons for antibiotic treatment20 229. The 
nomenclature and concepts of UTI, based on the now disproven dogma that the lower urinary 
tract is a sterile environment, have remained stagnant over many decades. This older dogma has 
been informed with scientific evidence that some bacteria are present in the absence of urinary 
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symptoms or a positive result of traditional UTI tests (urinalysis or standard urine culture). 
Although discovery of the urinary microbiota should clearly affect the care of women with UTI, 
specific clinical changes occur slowly. It is already clear that the widely used standard urine 
culture methods for detecting urinary bacteria have significant limitations compared with 16S 
rRNA gene sequencing29 30 15 and more sensitive enhanced culture techniques15 35 32 34. These 
more sensitive assays have demonstrated that the female urinary bladder contains its own 
community of microbes, or microbiota. It is increasingly evident that alterations to the microbiota 
throughout the human body can have an impact on health.  
 We believe that it is time to advance UTI diagnosis and treatment. The first step in this 
process is a clear discussion of the limitations of the current standards in the context of the new 
knowledge about the female urinary microbiota. Although empiric treatment is currently 
pragmatic and highly effective for symptom resolution in uncomplicated, infrequent UTI, we 
anticipate that increasing recognition of the collateral effects of this regimen may cause a change 
in this practice. Our therapeutic goal should be to provide an optimal treatment, with high 
efficacy and few, if any, undesired effects. We highlight four major limitations in current UTI 
thinking: the language of UTI, UTI diagnostic testing, the Escherichia coli-centric view of UTI, and 
the colony-forming units (CFU) threshold-based diagnosis. Future research to overcome these 
limitations using rigorous clinical testing is paramount. 
The Limitations of the Language of UTI 
 The widely used UTI nomenclature is based on a dichotomous clinical scenario—infected 
or not (with the odd exception of asymptomatic bacteriuria). The traditional view of UTI envisions 
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uropathogens invading a previously sterile environment (the bladder) to cause infection. 
Antibiotics come to the rescue to rid the person of the invading microbes and the bladder returns 
to the previously uninfected state. This language is grossly inconsistent with our current scientific 
knowledge about UTI. More importantly, this language does not recognize changes in the 
community of microbes that reside in the bladder. This microbial community can have beneficial 
functions in warding off infection. Furthermore, disruption to the resident microbial community 
(i.e., dysbiosis) could plausibly result in UTI symptoms, as is the case with several other disorders 
(see below). In adult women, such dysbioses could result from an invading microbe in the urinary 
system, an antimicrobial treatment, or some change to the host’s metabolism or immune system. 
Nonetheless, our current language does not place the “UTI-causative microbe invades” concept 
in the context of non-causative microbes. The goal of UTI treatment should not be to eradicate 
every microbe in the bladder, especially given the evidence that some members of the urinary 
microbiota are beneficial and/or protective15. 
The Limitations of UTI Testing 
 The Standard Urine Culture (SUC) is currently the diagnostic gold standard for confirming 
the presence of bacteriuria for UTI diagnosis. Unfortunately, SUC has significant limitations that 
have resulted in a profound detection bias. This bias has caused fundamental misunderstandings 
of the bacterial contributions to urinary health and disease. 
 Typically, SUC is performed in a clinical laboratory by plating 1 μL of urine onto Blood and 
MacConkey agar plates and incubating aerobically at 35 °C for 24 h. Since the original description 
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of this technique in the 1950s19, this protocol has been adopted as the standard diagnostic tool 
for the detection of UTIs, despite numerous limitations reported by many different 
investigators25 26 305. These limitations include: the inability to detect slow-growing 
microorganisms, the inability to grow fastidious and non-aerobic microorganisms, the inability to 
detect microorganisms present at less than 103 CFU/mL, and the difficulty of detecting underlying 
Gram-positive bacteria due to a lack of selective media.  
 More sensitive culture techniques, such as Expanded Quantitative Urine Culture (EQUC), 
have repeatedly shown that SUC possesses a 90% false-negative rate15 35 34. Relative to SUC, this 
enhanced urine culture protocol uses 100x more urine plated onto several different media and 
environmental conditions with twice the incubation time34. EQUC has provided compelling 
evidence that almost every adult female studied to date is bacteriuric229. 
Figure G.1. Patient Schematic of Price et al, 2016. (Price et al, 2016).    
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 In 2016, we demonstrated that SUC even fails to detect “clinically relevant 
microorganisms” in symptomatic patients44. We prospectively enrolled 150 urogynecology 
patients and dichotomized the group based on their UTI perception by asking,  
“Do you feel you have a UTI?” (Figure G.1) Transurethral catheterized urine specimens were 
collected and urinary symptoms were documented using the validated UTI Symptoms 
Assessment (UTISA) questionnaire307.  
 We assessed the microbiota using both SUC and EQUC. In the catheterized urine sample 
of most women in the UTI cohort (69 out of 75), EQUC detected one or more bacteria that the 
literature classifies as uropathogens. In these 69 urine samples, EQUC identified a total of 110 
uropathogens. In contrast, SUC only detected 50% (55 out of 110) of these uropathogens. 
Seventy-nine percent (59 out of 75) of the participants in the UTI cohort completed the follow-
up UTISA questionnaire. Following clinically selected treatment based on SUC, 59% (35 out of 59) 
of participants reported symptom improvement, while 41% (24 out of 59) reported no 
improvement. Half (12 out of 24) of the 24 participants who did not improve had at least one 
uropathogen detected by EQUC, but not SUC. Collectively, these data show that SUC fails to 
detect microorganisms that may be contributing to UTI symptoms. Thus, sole reliance on SUC in 
these patients could lead to a suboptimal clinical outcome. It is reasonable to test whether the 
use of EQUC would have led to improved symptom resolution.  
 Other commonly used diagnostic tests are also severely limited. Dipstick and urinalysis 
tests are commonly used in the replacement of or in conjunction with SUC, but the efficacy of 
these rapid tests has been questioned, especially for Gram-positive infections313. Current studies 
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continue to highlight the limitations of these tests; our own unpublished data reveal a lack of 
utility for these tests. For example, we collected transurethral catheterized urine samples from a 
population of urogynecologically treated women (N = 199) with and without lower urinary tract 
symptoms (LUTS). In this population, 17 out of 199 (8.5%) had a positive dipstick result (i.e., the 
presence of white blood cells, nitrates, and/or red blood cells). Of these, one (5.9%) had bacteria 
detected by SUC whereas 13 (76.5%) had bacteria detected by EQUC. In the 182 (91.5%) with a 
negative dipstick, SUC detected bacteria in 17 samples (9.3%), whereas EQUC detected bacteria 
in 122 (67.0%). The percentage of bacteriuric samples diagnosed by SUC (p = 0.23) or EQUC (p = 
0.63) were not statistically different in the dipstick-positive or dipstick-negative groups, showing 
that a positive urine dipstick test has no association with the presence of microorganisms, in this 
patient population (Price, unpublished data). 
The Limitations of an Escherichia coli-centric View of UTI 
 Standard Urine Culture was used to establish that E. coli is the most common cause of 
uncomplicated UTI20  314. Yet, other Gram-negative bacteria such as Pseudomonas aeruginosa 
and several species within the Enterobacteriaceae family (e.g., species of the genera Proteus and 
Klebsiella) also can cause UTIs314 315. In addition, a few Gram-positive bacteria, like 
Staphylococcus saprophyticus and Enterococcus faecalis, as well as some fungi, such as Candida 
sp., have been linked to UTIs314 315. In some patients with complicating factors, the commonality 
of these organisms depends on other comorbidities and demographics315. The list of 
uropathogens has grown longer with the availability of more sophisticated identification tools. 
Several additional microorganisms have now been classified as “emerging uropathogens”316 317. 
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These microorganisms have been found in high colony counts in patients with UTI symptoms 
and/or acute cystitis, but knowledge regarding their pathophysiology is unavailable.  
 Given that SUC was designed to detect E. coli, its results affect broad epidemiological 
statements concerning UTI. For example, it is commonly stated that E. coli accounts for 80– 95% 
of all uncomplicated UTIs20 314. Indeed, in the Price et al. study (Figure G.1), we showed that most 
(71%) of the SUC identified pathogens were E. coli (39 out of 55). However, the biases of SUC 
showed through; it identified only 24% (16 out of 67) of the non-E. coli uropathogens in this group 
of women44. Furthermore, although EQUC detected E coli in 57% (43 out of 75) of women in the 
UTI cohort, rarely (8 out of 43) was E. coli the only microorganism detected in these samples44. 
Most patients with E. coli also had other species (35 out of 43), and frequently these additional 
species were uropathogens (24 out of 35). Similarly, Wolfe et al. detailed a case study of a woman 
with a positive SUC of >105 CFU/ mL of E. coli. However, 16S rRNA sequencing showed that 
sequence reads of Actinobaculum and Aerococcus far exceeded those of E. coli29. Traditionally, 
bacteriuria caused by multiple species (i.e., a polymicrobial UTI) has been identified at a higher 
incidence in the elderly and children under the age of 10 years318. These tend to co-occur with 
multispecies bacteremia318. The new data described above suggest that polymicrobial UTI might 
be both common and frequently overlooked.  
 The presence of polymicrobial UTIs has been greatly underestimated because the 
presence of multiple colony morphologies on an SUC typically prompts clinical laboratories to 
dismiss these as “contamination”316. This common practice, combined with the clear screening 
inadequacies of SUC, has resulted in a flawed, one-species perspective of UTIs. Although it is 
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unlikely that all bacteria associated with a polymicrobial UTI are causative agents of the patient’s 
symptoms, this has not been explicitly tested. It is possible that a bacterial dysbiosis is present. 
Bacterial dysbioses have been associated with several other health disparities such as bacterial 
vaginosis (BV) in the vagina, and inflammatory bowel disease (IBD) in the gut. Whether urinary 
dysbiosis can cause UTI symptoms or results in colonization of the UTI causative organism(s) 
requires further study. 
The Limitations of a CFU Threshold-Based Diagnosis 
 Current research calls into question the utility of thresholds in UTI diagnosis and 
treatment. With the incorporation of SUC in the 1950s, physicians have relied on a threshold of 
≥105 CFU/mL of urine to distinguish between significant bacteriuria and bacterial contamination. 
This threshold was set to identify women with pyelonephritis19. That diagnostic threshold was 
subsequently applied to women with acute cystitis. Yet, multiple investigators have 
demonstrated that 30– 50% of women do not meet this threshold, despite symptoms of dysuria 
and urgency and frequency of urination319. Numerous recommendations have since been made 
to alter this threshold44 319. Stamm demonstrated that for women with acute cystitis, use of ≥105 
CFU/mL resulted in high specificity, but low sensitivity in detecting bacteriuria, whereas a lower 
threshold, such as ≥102 CFU/mL, had a much higher sensitivity25. UTI symptoms and pyuria often 
persist when bacteriuria at <105 CFU/mL is left untreated319 and, in catheterized patients, the 
presence of bacteria between 102 and 104 CFU/mL is reported to increase to ≥105 CFU/mL if left 
untreated25. All this work, however, predated the newly discovered urinary microbiota.  
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 In a population of women seeking urogynecological care (Figure G.1), we found that a 
single overall threshold did not distinguish between women who self-reported UTI and those 
who did not. EQUC demonstrated that significant differences in CFU/mL exist between 
uropathogens identified in women and that the mean CFU/mL for E. coli was near 105 CFU/mL 
for both patient cohorts (Figure G.2)44. Collectively, these data suggest that not only is the ≥105 
CFU/mL threshold insufficient to detect most uropathogens but lowering this threshold does not 
solve the problem either and may lead to unnecessary treatment. Importantly, the presence of 
uropathogens at levels that exceed the threshold, as with E. coli, does not necessarily result in 
symptoms.  
 Figure G.3 shows a schematic of the uropathogen composition and patient symptom 
resolution of the women in the self-report UTI cohort, grouped by CFU threshold. Ninety-two 
percent of women (69 out of 75) had a common or emerging uropathogen present. Forty-two 
percent of these women had a polymicrobial infection (defined here as at least one Gram-positive 
Figure G.2. Average CFU/mL of Common and Emerging Uropathogens. (Price et al, 2016).  
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and one Gram-negative bacterium), whereas 38% had a single Gram-negative bacterium present. 
Uropathogens were present at ≥105 CFU/mL in only 61% of women (46 out of 75). Of the women 
with at least one uropathogen present at ≥105 CFU/mL, 83% had a single Gram-negative 
bacterium present. Thirty-seven out of 46 of these women were treated with antibiotics and 1 
week later, 62% reported feeling “better”. 23 women had uropathogens present at <105 CFU/mL. 
Fifteen of these 23 women were not given antibiotics, and 1 week later, only 33% reported feeling 
Figure G.3. Schematic of the uropathogen composition and patient symptom resolution of the 
women in the self-report UTI cohort. Abx. antibiotics. (Price et al, 2016).  
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“better”. This finding is certainly possible and entirely consistent with our thoughts about urinary 
dysbioses. Like other human microbial niches, we expect an individual to be able to restore a 
dysbiotic niche—i.e., some women may be able to resolve “UTI” without antibiotic treatment. 
Yet, these data demonstrate that use of the ≥105 CFU/mL threshold for UTI diagnosis and 
treatment is not appropriate for all women; specifically, those with polymicrobial or Gram-
positive bacterial infections. Importantly, by not treating these patients, their clinical outcome is 
suboptimal (i.e., fewer reports feeling “better”). 
Next Steps 
 Research efforts to improve diagnosis are expanding as the limitations of SUC become 
more apparent. Clinical laboratories can immediately incorporate the EQUC technique; however, 
clinicians may be challenged to interpret EQUC findings. Clinical trials to develop treatment 
algorithms based on EQUC findings are needed to promote good antibiotic stewardship to 
safeguard the overall health and well-being of patients being treated for UTI. 
 In recent years, other nonculture-based screening assays have been and are being 
developed. Immunology-based diagnostics, such as the RapidBac, rely on antibody-based 
detection of common uropathogens at ≥103 CFU/mL with high specificity and sensitivity320. PCR 
assays, such as SeptiFast, have been assessed for use on urine samples with mild success320. And, 
several kits using fluorescence in situ hybridization (FISH) previously developed for blood and 
other specimens are being considered for use on urine for identification of pathogens320.  
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 Ongoing research will help to evaluate new treatment algorithms that incorporate the 
presence of previously undetected bacteria in UTI patients. Meanwhile, the role of the SUC must 
move away from the “gold standard” status. We believe that we will transition away from SUC 
to more sensitive testing that balances detection of organisms with appropriate therapies, 
designed to restore and maintain healthy microbial communities. 
Conclusion 
 Should we think differently about UTI? Absolutely. We are entering a new age in UTI 
diagnosis and treatment. No longer can we define a UTI microbiologically as uropathogens 
invading a sterile environment. We must now acknowledge that previously ignored populations 
of bacteria are contributing to urinary health, both positively and negatively. How these findings 
ultimately change our precise definition of UTI remains to be seen but will certainly be profound. 
 The status quo clearly needs to change so that patients benefit from this updated 
understanding of UTI. Improved treatment algorithms should be able to offer a spectrum of 
treatment with clear goals that reduce bothersome symptoms, the risk of serious infections and 
systemic illness, and unwanted collateral effects of UTI therapy. With appropriate adoption of 
evidence-based research, patients should benefit from more precise diagnosis and targeted 
treatment with limited deleterious collateral effects. Future research should advance our 
understanding of the role of the urinary microbiota in the context of both health and disease, 
and among women of differing demographics. 
 As with every major transition in clinical care, old habits are slow to fade away and 
adjustments will be needed as we enter this new era of UTI care. Clinicians need to learn new 
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methods of interpretation of UTI testing, such as EQUC. No single study will provide guidance for 
all clinical situations and clinical judgment will remain a valued tool in patient care. Although 
stepping away from long-held clinical patterns of care takes time, our patients deserve better 
and it is time to improve care for these patients. 
Addendum 
 This manuscript was originally intended to be a review of the literature surrounding the 
misconceptions of UTIs and modern interpretations. However, it was later changed to be an 
opinion paper. As a result, large portions of the paper were removed, including a section 
discussing “emerging uropathogens” that included a table of relevant literature citations. This is 
described below. 
 Emerging uropathogens are microorganisms that can be isolated and identified from 
urine specimens of patients with UTI symptoms. Unlike typical urine pathogens, these are usually 
but not always Gram-positive, found in lower counts, and are harder to identify. Because of the 
recent advancement and availability of microbial identification technologies such as MALDI-TOF 
MS, these emerging uropathogens are now being identified more frequently, despite an overall 
lack of knowledge surrounding their pathogenesis317. We also frequently identify these 
organisms as part of the urinary microbiota in patients with urinary symptoms44. 
 Common causes of UTI include Escherichia coli, Klebsiella pneumoniae, Pseudomonas 
aeruginosa, Proteus sp., Enterobacter sp., Staphylococcus aureus, Staphylococcus lugdunensis, 
Staphylococcus saprophyticus, and Streptococcus agalactiae (i.e. Group B Streptococcus). These 
are not included in the following discussion of emerging uropathogens. 
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 Acinetobacter is genus of Gram-negative bacteria that have been attributed to hospital-
acquired infections, particularly Acinetobacter baumannii. A comprehensive review of 
nosocomial infections with Gram-negative bacilli list Acinetobacter sp. as responsible for about 
1% of UTIs out of over 16,000 nosocomial UTI cases examined in the United States321. Gospodarek 
et al. describe 39 isolates of Acinetobacter sp. isolated from patients with UTI, using analytical 
profile index (API) strips322, and Solak et al. describes a case of a UTI with community-acquired 
carbapenem-resistant A. baumannii following a renal transplant323. 
 Actinotignum schaalii (formerly called Actinobaculum schaalii) is Gram-positive 
facultative anaerobe that was first described in the 1990s and has now been linked to UTIs 
primarily in the elderly (i.e. >60 years old) and patients with underlying urological conditions324. 
Only a few dozen cases of A. schaalii UTI have been described; most of these required growth 
conditions, or diagnostic testing beyond the standard clinical practices325, suggesting that the 
frequency of A. schaalii infection may be dramatically underrepresented. For example, Tavassoli 
et al. describe a case of an A. schaalii UTI in an elderly man where the urine culture was negative, 
despite evidence of Gram-positive bacilli on the Gram stain; this prompted further workup and 
eventual identification and treatment of the infection326. 
 Aerococcus is a genus of Gram-positive alpha-hemolytic cocci that include species such as 
Aerococcus urinae, Aerococcus sangunicola, and Aerococcus viridans. Morphologically, these 
organisms resemble Streptococcus on BAP and are frequently mis-identified327. A study by Cattoir 
et al. found 30 strains of Aerococcus sp. isolated from elderly UTI patients (average age of 73 
years old), several of whom had underlying urological (31%) or systemic (48%) diseases328. Other 
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case reports327 329 have shown that Aerococcus UTIs are primarily found in an elderly population. 
Clinically, Aerococcus is significant, as it frequently can progress to urosepsis and infectious 
endocarditis if left untreated327. 
 Alloscardovia omnicolens are Gram-positive bacilli, closely related to Bifidobacterium sp. 
Typically, A. omnicolens are commensal members of the GI tract and mouth, but more recent 
data show that they may be clinically significant in the context of the bladder and LUT. 
Morphologically, A. omnicolens are similar to Actinomyces and are frequently mis-identified330. 
When properly identified, studies have found A. omnicolens present at high abundance in 
patients with UTI symptoms330 and, in one case, failure to initially identify and treat the organism 
resulted in bacteremia in an elderly patient with uterine cancer331. 
 Candida is a genus of yeast, and is a common cause of fungal infections, including those 
in the urinary tract. In fact, one study from the 1990s found that it was the fourth most common 
cause of nosocomial UTIs in the United States332. Unlike most of the other emerging 
uropathogens, Candida UTIs are not mostly limited to the elderly population333. However, 
Candida sp. are not frequently grown using standard microbiologic practices and require longer 
incubation times. Therefore, the Candida UTI commonly goes unnoticed and leads to 
complications, such as fungal sepsis334. 
 Citrobacter is a genus of Gram-negative bacteria that belongs to the Enterobacteriaceae 
family, which includes several common UTI-causing organisms like E. coli and K. pneumoniae. 
Citrobacter includes several clinically relevant species including: Citrobacter koseri, Citrobacter 
freundii, and Citrobacter braakii. Although these organisms can cause a variety of infections in 
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humans, one study found that UTIs were the most common type of infection with Citrobacter sp. 
(53%)335. Citrobacter should grow well under the normal laboratory conditions, but failure to 
treat the organism can lead to severe complications including kidney abscesses336. 
 Corynebacterium riegelii is a Gram-positive aerobic bacilli that is considered to be part of 
the human microbiota but can be associated with UTIs. Coryneform bacteria have traditionally 
been ignored in a clinical setting (other than Corynebacterium diptheriae) and are thus not 
routinely identified on clinical cultures. However, numerous case reports and studies now exist337 
338 showing high abundance of C. riegelli in a range of patient demographics, some of which have 
led to fatal urosepsis339. Corynebacterium urealyticum is closely related to C. riegelii and is also 
associated with UTIs340 341. C. urealyticum secretes the urease enzyme to breakdown the urea in 
urine, thus making the urine more alkaline. As such, it is also associated with kidney stone 
formation342. 
 Enterococcus faecalis is a Gram-positive cocci, formerly classified as a species of 
Streptococcus. E. faecalis is a common cause of nosocomial infections, including UTIs343. Unlike 
most of the other emerging uropathogens, some aspects of Enterococcus pathogenesis is known, 
including the presence of several virulence factors, such as cytolysin (a type of hemolysin toxin) 
and adhesins for tissue attachment344. Additionally, Enterococcus sp. are clinically important due 
to the presence of Vancomycin-resistant Enterococcus (VRE), which are intrinsically resistant to 
several common antibiotics used to treat UTIs. 
 Morganella morganii is a Gram-negative rod and is usually considered a commensal 
organism of the GI tract but is also associated with post-operative nosocomial infections including 
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UTIs. Like C. urealyticum, M. morganii can produce urease resulting in a more alkaline urine 
environment, and also the consequent production of ammonia. In one case study, this led to 
hyperammonemia in an elderly patient where M. morganii was ultimately found in the urine345. 
 Oligella urethralis (formerly known as Moraxella urethralis) is a Gram-negative aerobic 
coccobacilli that commonly presents as urosepsis in immunocompromised patients346 347. 
 Raoultella is a genus of Gram-negative facultative anaerobic rods that are part of the 
Enterobacteriaceae family. Clinically relevant species include: Raoultella planticola and 
Raoultella ornithinolytica. Like most of the emerging uropathogens, Raoultella is not normally 
identified in biological specimens, but use of more advanced diagnostic instruments, like MALDI-
TOF MS have increased detection. Resultantly, Raoultella has been found to be the causative 
agent of not only UTIs, but also GI infections, skin infections, and sepsis348. These cases are 
typically in immunocompromised patients, or are acquired post-operatively, and have been 
found in elderly349 and pediatric patients350. 
 Serratia marcescens is also a member of the Enterobacteriaceae family, and it a rod-
shaped Gram-negative aerobic species. Morphologically, S. marcescens appears strikingly reddish 
due to production of a pigment called prodigiosin. S. marcescens is a common cause of 
nosocomial infections, including catheter-associated bacteremia, wound, respiratory, GI, and 
urinary infections351. 
 Streptococcus anginosus is a Gram-positive cocci that is naturally part of the oral flora but 
has been attributed to abscess formation throughout the body. Although rare, it has been 
associated with UTIs in a few reported cases352 353. 
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 This list of emerging uropathogens is not exhaustive and will likely change as our 
understanding of the pathogenesis of these organisms increases, as well as our comprehension 
of the urinary microbiota becomes more complete.
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Overview of Appendix H 
The following papers present data collected from WGS of several urinary bacterial isolates 
that were isolated from the female urinary microbiota. The first paper compares the genomic 
content of two E. coli isolates, one from a patient with UTI symptoms (E78) and one from a 
patient without (E75). Both were isolated from TUC specimens using EQUC. E78 most closely 
resembled UTI-associated strains of E. coli, while E75 was related to an avian strain. The second 
and third papers are genome announcements of Nosocomiicoccus ampullae and Lactobacillus 
crispatus, both isolated from TUC specimens using EQUC. N. ampullae could not be identified by 
MALDI-TOF MS, and prior attempts to characterize it genomically showed the possibility of a 
novel species. However, WGS analysis revealed that the isolate belonged to the taxon N. 
ampullae. L. crispatus was isolated from a healthy control patient. Prior work shows that L. 
crispatus is more abundant in healthy women compared to women with UUI15 . Therefore, this 
strain has been used in several in vitro laboratory experiments aimed at understanding its 
beneficial properties. 
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Appendix H1: Genome Sequences and Annotation of Two Urinary Isolates of E. coli. 
Abstract 
 The genus Escherichia includes pathogens and commensals. Bladder infections (cystitis) 
result most often from colonization of the bladder by uropathogenic E. coli strains. In contrast, a 
poorly defined condition called asymptomatic bacteriuria results from colonization of the bladder 
with E. coli strains without symptoms. As part of an on-going attempt to identify and characterize 
the newly discovered female urinary microbiota, we report the genome sequences and 
annotation of two urinary isolates of E. coli: one (E78) was isolated from a female patient who 
self-reported cystitis; the other (E75) was isolated from a female patient who reported that she 
did not have symptoms of cystitis. Whereas strain E75 is most closely related to an avian 
extraintestinal pathogen, strain E78 is a member of a clade that includes extraintestinal strains 
often found in the human bladder. Both genomes are uncommonly rich in prophages. 
Introduction 
 Clinicians typically equate the presence of bacteria in urine with infection, or, less 
commonly, an ill-defined phenomenon termed “asymptomatic bacteriuria.” These and other 
existing concepts are based on the long-held “sterile urine” paradigm. Recently, however, 
bacterial communities (microbiota) have been discovered in the female bladder50 306 30 34 32 69 15 248 
29. Thus, the “sterile urine” paradigm is no longer valid.  
 In an effort to provide a comprehensive view of the newly discovered female urinary 
microbiota, we have established an Enhanced Quantitative Urine Culture protocol. This enhanced 
culture protocol isolates bacteria from 75 to 90 % of urine samples deemed ‘no growth’ by the 
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standard clinical microbiology urine culture method34 15 44. We have begun to the sequence and 
annotate the genomes of these isolated bacteria.  
 Here, we report the full genome sequences and annotations of two of those bacteria, 
Escherichia coli strains E75 and E78 isolated from female patients pursuing urogynecologic clinical 
care. Strain E75 was isolated from a patient who thought that she did not have a urinary tract 
infection, while E78 was isolated from a patient who thought that she did. The strains were sub-
cultured to purity and then identified as E. coli by Matrix-Assisted Laser Desorption/Ionization-
Time-of-Flight Mass Spectrometry44. Strain E75 is most closely related to APEC O1, an avian 
extraintestinal pathogen. In contrast, strain E78 is a member of a clade that includes 
extraintestinal strains often associated with the human bladder, including uropathogenic strains 
UTI89 and J89 and asymptomatic bacteriuric strain ABU83972. Both genomes are uncommonly 
rich in prophages. 
Organism Information 
Classification and Features 
 Escherichia coli is a non-sporulating, Gram-negative, rod shaped bacterium. It is a 
facultative anaerobe found commonly in the environment and the lower intestines of mammals 
and other endotherms. Extra-intestinal strains can colonize other organs, including the urinary 
bladder. Most E. coli strains are harmless constituents of the normal microbiota, but others cause 
disease. For example, uropathogenic E. coli is the major case of urinary tract infections in 
humans; other E. coli strains colonize the bladder without causing symptoms, a condition called 
asymptomatic bacteriuria.  
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 Transmission electron microscopy images were generated for both E75 and E78 (Figure 
H1.1). Cell pellets were fixed with 0.1 % Ruthenium Red en bloc with sequential glutaraldehyde 
and osmium tetroxide fixation steps. These fixed samples were dehydrated with Ethanol and 
embedded in Resin. Ultrathin sections of 80 nm were mounted on copper grids, post-stained with 
uranyl acetate and lead citrate and observed in a Hitachi H-600 transmission electron microscope 
at 75 kV. Films were taken, negatives developed and scanned via a Microtek i800 film scanner. 
PhotoShop was used to convert negatives to positive images and adjust for brightness and 
contrast. The transmission electron micrographs revealed the typical E. coli rod-shape 
morphology. Strain E75 tended to possess electron poor intracellular inclusions (Figure H1.1b, 
black arrow). The general features of E. coli strains E75 and E78 are presented in Table H1.1.  
Figure H1.1. Transmission Electron Microscopy Images of E78 (A) and E75 (B). E75 tended to 
have electron poor intracellular inclusions (black arrow). 
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 E. coli strains E75 and E78 were isolated from patients who sought clinical care at Loyola 
University Medical Center’s Female Pelvic Medicine and Reconstructive Surgery center in 
September 2014. Patients were asked the question: Do you feel that you have a urinary tract 
infection? E75 was isolated from a patient who answered ‘no,’ whereas E78 was isolated from a 
patient who answered ‘yes.’ Both patients were white, post-menopausal women seeking care for 
Pelvic Organ Prolapse. Neither patient was taking antibiotics; both were using daily vaginal 
estrogen supplement. The UTI Symptoms Assessment Questionnaire was used to characterize 
the degree of severity and bother of the patients’ symptoms307. Both E. coli strains were identified 
at >100,000 colony forming units per milliliter, using an Expanded Spectrum version of the 
Table H1.1. Classification and general features of E. coli strains E75 and E78. 
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Enhanced Quantitative Urine Culture protocol44. After they were sub-cultured to purity, Matrix-
Assisted Laser Desorption/Ionization-Time-of- Flight Mass Spectrometry was used to confidently 
identify them as E. coli. For E75, the identification score was 2.530; for E78, the score was 2.265. 
No other microbes were detected in the urine sample containing strain E75. In the urine sample 
containing strain E78, Alloscardovia omnicolens (10 colony forming units per milliliter) and 
Lactobacillus rhamnosus (10 colony forming units per milliliter) were also detected. Figure H1.2 
shows a phylogenetic tree of the 16S rRNA sequences. 16S rRNA gene sequences include Yersinia 
enterocolitica (NR_104903), E. coli IAI39 (NC_011750), E. coli O157:H7 str. Sakai (NR_074891), E. 
coli K-12 substr. MG1655 (NR_102804), E. coli O157:H7 str. EDL933 (AE005174), E. coli CFT073 
(AE014075), E. coli VR50 (CP011134), E. coli UMN026 (NC_011751), E. coli RRL-36 (JQ398845), E. 
coli NBRC 102203 (NR_114042), E. coli U 5/41 (NR_024570), E. coli B str. REL606 (CP000819), E. 
coli O104:H4 str. 2011C-3493 (NC_018658), E. coli XA04 (KR080744), E. coli APEC O1 (CP000468), 
E. coli E75, E. coli E78, E. coli J96 (ALIN02000018), E. coli TOP379 149 (AOQB01000139), E. coli 
UMEA 3314-1 (AWDE010000004), E. coli UTI89 (CP000243), E. coli ABU 83972 (CP001671), and 
E. coli UM146 (CP002167). E. coli genome sequences typically include seven copies354. 
Genome Sequencing Information 
Genome Project History 
 The sequencing and quality assurance was performed at the Loyola Genome Facility at 
Loyola University Chicago, Maywood, IL, USA. The assemblies and finishing were done at the 
Lakeshore Campus of Loyola University Chicago, Chicago, IL, USA. Functional annotation was 
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produced by the RAST service355 and in-house scripts for COG classification356. Table H1.2 presents 
the project information and its association with MIGSversion2.0- compliance357.  
Growth Conditions and Genomic DNA Preparation 
 E. coli strains E75 and E78 were isolated from transurethral catheterized urine specimens 
of adult women with urinary symptoms44 using an Expanded Spectrum version of the previously 
described Enhanced Quantitative Urine Culture protocol34. Three urine volumes (1 μL, 10 μL, and 
100 μL) of each urine sample was spread quantitatively (i.e., pinwheel streak) onto 5% sheep 
blood (BD BBL™ Prepared Plated Media, Cockeysville, MD), Chocolate, and Colistin Naladixic Acid 
Figure H1.2. Phylogenetic tree based on 16S rRNA sequences. The alignment length was 1189 
bp. Sequences were retrieved from NCBI and aligned using Muscle. The tree was generated by 
FastTree using the GTR model. Support values are shown for branches leading to the placement 
of the two bladder isolates presented here. 
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agars (BD BBL™ Prepared Plated Media) and incubated in 5 % CO2 at 35 °C for 48 h; 5 % sheep 
blood and MacConkey (BD BBL™ Prepared Plated Media) agars incubated aerobically at 35 °C for 
48 h; two CDC Anaerobic 5 % sheep blood agars (BD BBL™ Prepared Plated Media) incubated in 
either Microaerophilic Campy gas mixture (5 % O2, 10 % CO2, 85 % N), or anaerobically at 35 °C 
for 48 h. All agars were documented for growth (i.e., for morphologies and colony forming units 
per milliliter) at 24 and 48 h. Each distinct colony morphology was sub-cultured at 48 h to obtain 
pure culture for microbial identification.  
 Microbial identification was determined using a Matrix-Assisted Laser 
Desorption/Ionization-Time-of-Flight Mass Spectrometer (Bruker Daltonics, Billerica, MA) as 
described34. Pure cultures were stored at -80 °C in a 2 ml CryoSaver Brucella Broth with 10 % 
Glycerol, no beads, Cryovial, for preservation (Hardy Diagnostics). For genome extraction and 
sequencing, the preserved pure culture isolates were grown on 5 % sheep blood agar under 
aerobic conditions at 35 °C for 24 h.   
 Genomic DNA extraction was performed using a phenol-chloroform extraction protocol. 
Briefly, cells were resuspended in 0.5 mL DNA Extraction Buffer (20 mMTris-Cl, 2 mM EDTA, 1.2 
% Triton X-100 [pH 8]) followed by addition of 50uL Lysozyme (20 mg/mL), 30uL Mutanolysin, 
and 5uL RNase (10 mg/mL). After a 1 h incubation at 37 °C, 80uL 10 % SDS, and 20µL Proteinase 
K were added followed by a 2 h incubation at 55 °C. 210µL of 6 M NaCl and 700µL phenol-
chloroform were then added. After a 30-min incubation with rotation, the solutions were 
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centrifuged at 13,500 RPM for 10 min, and the aqueous phase was extracted. An equivalent 
volume of Isopropanol was then added, and solution was centrifuged at 13,500 RPM for 10 min 
after a 10-min incubation. The supernatant was decanted, and the DNA pellet was precipitated 
using 600µL 70 % Ethanol. Following ethanol evaporation, the DNA pellet was resuspended in 
Tris-EDTA and stored at -20 °C.  
Genome Sequencing and Assembly 
 DNA samples were diluted in water to a concentration of 0.2 ng/µl as measured by a 
fluorometric-based method (Life Technologies, Carlsbad, CA) and 5 ul was used to obtain a total 
of 1 ng of input DNA. Library preparation was performed using the Nextera XT DNA Library 
Preparation Kit (Illumina, San Diego, CA) according to manufacturer’s instructions. The isolates 
were barcoded, pooled and each isolate was sequenced twice, on two separate runs, using the 
Illumina MiSeq platform and the MiSeq Reagent Kit v2 (300-cycles) to produce 150 bp paired-end 
Table H1.2. Project information. 
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reads. Sequencing reads were parsed into individual folders according to the respective 
barcodes. 
 Sequence assembly was conducted using Velvet358 (Table H1.2). The tool VelvetOptimiser 
was used to determine the best hash length; 99 was used in the two assemblies performed here. 
The scaffolding software SSPACE258 was utilized for scaffold finishing. The genome of strain E75 
was assembled into 463 contigs. The genome of strain E78 was assembled into 62 contigs. To 
confirm that the contigs were Enterobacteriaceae (i.e. not the result of contamination), each 
contig was BLASTed locally against all publicly available bacterial genomes (obtained from NCBI). 
Coverage across all contigs was on average 50.95-431.17X (for E75) and 52.59-30,723.61X (for 
E78). The high coverage observed within the E78 sequencing is the result of two contigs, one 
4083 bp in length (coverage 72,734X) and the other 2113 bp in length (99,530X). Assembly was 
repeated using the SPAdes assembler260, given its recent success in producing full plasmid 
sequences359. Two plasmids were identified by the SPAdes assembler with high coverage. 
Querying these two contigs against the Gen-Bank nr/nt database revealed sequence homology 
to the annotated E. coli plasmids p2PCN033 (GenBank: CP006634) and pVR50G (GenBank: 
CP011141) (among other E. coli plasmids), respectively. These two plasmids are listed in Table 3 
as Plasmid pE78.1 and Plasmid pE78.2, respectively. All 62 E78 contigs were also assessed for 
putative plasmid sequences using Plasmid-Finder360. While PlasmidFinder recognized pE78.2, it 
did not detect pE78.1. The complete genome of the E78 chromosome is thus represented within 
60 contigs (mean coverage 272X). 
Genome Annotation 
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 Genes were identified using GLIMMER using the g3-from-scratch.csh script included in 
the package361. The predicted CDSs were translated using the transeq script within the EMBOSS 
suite362. rRNA genes were identified by RNAmmer363 using the parameter set to identify bacterial 
rRNA sequences. The program tRNA-Scan364 identified tRNA sequences, using the parameter for 
bacterial tRNAs. Trans-membrane proteins were identified using TMHMM with standard 
parameters365. SignalP366 predicted signal peptides. All CDSs were queried (blastp) locally against 
the COG sequence dataset356  and assigned based upon their sequence homologies. CRISPR 
elements were detected through CRISPR-db367. Genes with Pfam domains were ascertained via 
searches of the Pfam database (E-value threshold 1.0)368. 
Genome Properties 
 Tables H1.4 and Table H1.5 include the summaries of the properties and statistics of each 
genome. Sequencing of the E78 isolate identified two plasmids (Table H1.3); the E75 isolate did 
not contain any identifiable plasmid sequences. The E75 and E78 chromosomes are similar in 
length and GC content: E75 is 5,032,328 bp (GC content 50.4 %), while E78 is 5,021,201 bp (GC 
content 50.3 %). The genomes for E75 and E78 are predicted to include 4587 and 4743 protein 
coding genes, respectively. A similar coding density is observed within the two genomes. The 85 
Table H1.3. Summary of genomes: two chromosomes and two plasmids. 
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RNA genes identified within the E75 genome include 78 tRNAs and 7 rRNAs. The E78 genome 
encodes for more RNA genes: 83 tRNAs and 13 rRNAs. The scaffolds of E75 and E78 are only 
annotated as having a single 16S rRNA gene, an underestimation due to recognized challenges of 
assembling sequences containing genes with multiple copies such as the rRNA genes369. Thus, we 
fully expect that the E75 and E78 genomes harbor rRNA gene numbers on par with the genus. 
Insights from the Genome Sequence 
 Although E75 was isolated from a woman who reported that she did not have symptoms 
of cystitis, its genome encodes proteins associated with E. coli pathogenesis, including the P pilus, 
RTX toxin, and α-fimbriae. These genes were not found in E78. While the E75 strain did not 
include plasmid sequences, genome sequencing of the E78 isolate contained two. Plasmid pE78.2 
Table H1.4. Genome statistics. 
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was nearly identical (one mismatch) to the E. coli plasmid pVR50G, collected from urine obtained 
from an individual with asymptomatic bacteriuria370. 
 Both genomes included a number of prophages. Each prophage sequence within the 
genomes was BLASTed (blastx) to the nr/nt database revealing numerous hits to phage 
sequences annotated as infecting Escherichia spp. Annotations within the genomes of the 
temperate phages Lambda and P4 were identified most frequently within the E75 and E78 
genomes, respectively. Table H1.6 lists the statistics of this search. The vast majority of the hits 
were to phages annotated as infectious for Escherichia, Salmonella, and/or Shigella spp. 
Nevertheless, prophage sequences for both temperate as well as lytic phages were identified. 
Table H1.5. Number of genes associated with general COG functional categories. 
 
 
 
 
329 
 
 
 
The abundance of prophage sequences within these two genomes exceeds that previously 
identified in E. coli genomes. 
Conclusions 
 The genome of E75, isolated from a woman who reported no symptoms of cystitis, is more 
closely related to the avian extraintestinal pathogen APEC 01. The genome of E75, isolated from 
a woman who reported cystitis symptoms, resides in a clade populated by human extra-intestinal 
strains that are either uropathogenic or asymptomatic bacteriuric. Both genomes contain an 
unusually large number of prophage sequences. 
 
 
 
 
 
 
Table H1.6. Predicted sequences of phage origin and putative origin. 
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Appendix H2: Draft Genome Sequence for a Urinary Isolate of Nosocomiicoccus ampullae 
Abstract 
 A draft genome sequence for a urinary isolate of Nosocomiicoccus ampullae (UMB0853) 
was investigated. The size of the genome was 1,578,043 bp, with an observed G+C content of 
36.1%. Annotation revealed 10 rRNA sequences, 40 tRNA genes, and 1,532 protein-coding 
sequences. Genome coverage was 727X and consisted of 32 contigs, with an N50 of 109,831 bp. 
Manuscript 
 As part of an attempt to characterize the newly discovered female urinary microbiota50 
306 30 34 32 69 15 248 29, we report here the genome sequence and annotation of a strain of 
Nosocomiicoccus ampullae isolated from a female pursuing urogynecologic clinical care. This is 
the first report of a human isolate of N. ampullae, a species that has not been associated with 
pathogenesis.  
 N. ampullae strain UMB0853 was isolated from urine obtained by transurethral 
catheterization of an adult woman with urinary symptoms, using the described enhanced 
quantitative urine culture protocol34. Strain UMB0853 was sub-cultured to purity and analyzed 
by matrix-assisted laser desorption ionization time of flight mass spectrometry44, which could not 
provide an assignment. In contrast, 16S rRNA gene sequence analysis identified the isolate as N. 
ampullae. A pure culture was stored at -80°C in a 2-ml CryoSaver brucella broth with 10% glycerol, 
and no beads (Hardy Diagnostics). For genome extraction and sequencing, the preserved pure 
culture isolate was grown on 5% sheep blood agar (BD BBL prepared plated medium) under 5% 
CO2 at 35°C for 48 h.  
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 To extract genomic DNA, cells were resuspended in 0.5 ml of DNA extraction buffer (20 
mM Tris HCl, 2 mM EDTA, 1.2% Triton X-100 [pH 8]), followed by the addition of 50 µl of lysozyme 
(20 mg/ml), 30 µl of mutanolysin, and 5 µl of RNase (10 mg/ml). After a 1-h incubation at 37°C, 
80 µl of 10% SDS and 20 µl proteinase K were added, followed by a 2-h incubation at 55°C. Two 
hundred ten microliters of 6 M NaCl and 700 µl of phenol-chloroform were added. After a 30-
min incubation with rotation, the solutions were centrifuged at 13,500 rpm for 10 min, and the 
aqueous phase was extracted. An equivalent volume of isopropanol was added, and the solution 
was centrifuged at 13,500 rpm for 10 min after a 10-min incubation. The supernatant was 
decanted, and the DNA pellet precipitated using 600µl of 70% ethanol. Following ethanol 
evaporation, the DNA pellet was resuspended in Tris-EDTA (TE) and stored at -20°C.  
 Genomic DNA was diluted in water to a concentration of 0.2 ng/µl, as measured by a 
fluorometric-based method (Life Technologies); 5 µl was used to obtain a total of 1 ng of input 
DNA. Library preparation of the isolated DNA was performed using the Nextera XT DNA library 
preparation kit. Two libraries were prepared and sequenced during separate runs on the MiSeq 
sequencer (Illumina) using the MiSeq reagent kit version 2 (300 cycles). The two runs produced 
11,221,884 reads in total. Assembly was performed using Velvet358 (k = 99), followed by SSPACE258 
for scaffolding, producing 32 contigs, which varied from 2,642 bp to 337,531 bp (N50, 109,831 
bp), with an average coverage of 727X. The NCBI Prokaryotic Genome Annotation Pipeline355 
detected 10 rRNA genes, 40 tRNA genes, 1,532 protein-coding sequences, and 35 pseudogenes. 
Six clustered regularly interspaced short palindromic repeat sequences (CRISPRs) were found367. 
The genome size was 1,578,043 bp, with an observed G+C content of 36.1%. 
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Accession Number(s) 
 The draft whole-genome project for N. ampullae strain UMB0853 has been deposited at 
DDBJ/EMBL/ GenBank under accession number MBFG00000000. Raw sequence reads are 
deposited at DDBJ/EMBL/GenBank under accession number SRR3828836. 
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Appendix H3: Draft Genome Sequence of a Urinary Isolate of Lactobacillus crispatus 
Abstract 
 While Lactobacillus crispatus contributes to the stability of normal vaginal microbiota, its 
role in urinary health remains unclear. As part of an on-going attempt to characterize the female 
urinary microbiota, we report the genome sequence of an L. crispatus strain isolated from a 
woman displaying no lower urinary tract symptoms. 
Manuscript 
 As part of an attempt to characterize the newly discovered female urinary microbiota30 34 
32 69 306 248 29 15 we report the genome sequence and annotation of a strain of Lactobacillus crispatus 
isolated from the bladder of an adult female. This is the first genome report of a urinary isolate 
of L. crispatus, a species associated with bladder health15.  
 Using the expanded spectrum version44 of the enhanced quantitative urine culture 
protocol34, L. crispatus strain C037 was isolated from a healthy female not displaying any urinary 
symptoms. The strain was sub-cultured to purity, analyzed by matrix-assisted laser 
desorption/ionization-time-of-flight mass spectrometry, and pure cultures were stored at -80°C 
in 2 mL CryoSaver Brucella broth with 10% glycerol, no beads, cryovials (Hardy Diagnostics). For 
genome extraction, the preserved pure culture isolate was grown on 5% sheep blood agar 
(BDBBL™ prepared plated media) under 5% CO2 at 35°C for 24 h.  
 To extract genomic DNA, cells were resuspended in 0.5 mL DNA extraction buffer 
(20mMtris-Cl, 2mMEDTA, 1.2% Triton X-100 [pH8]) followed by addition of 50µL lysozyme (20 
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mg/mL), 30 µL mutanolysin, and 5 µL RNase (10 mg/mL). After a 1-h incubation at 37°C, 80 µL 
10% SDS and 20 µL proteinase K were added followed by a 2-h incubation at 55°C. Then, 210 µL 
of 6M NaCl and 700 µL phenol-chloroform were added. After a 30-min incubation with rotation, 
the solution was centrifuged at 13,500 rpm for 10 min, and the aqueous phase extracted. An 
equivalent volume of isopropanol was added; after a 10-min incubation, the solution was 
centrifuged at 13,500 rpm for 10 min. The supernatant was decanted, and the DNA pellet 
precipitated using 600 µL 70% ethanol. Following ethanol evaporation, the DNA pellet was 
resuspended in tris-EDTA and stored at -20°C.  
 Genomic DNA was diluted in water to a concentration of 0.2 ng/µl. Library preparation 
was performed using the Nextera XTDNA library preparation kit (Illumina) according to 
manufacturer’s instructions with 1 ng of input DNA. The isolate was sequenced twice, on two 
separate runs, using the Illumina MiSeq platform and the MiSeq reagent kit v2 (300-cycles). 
Sequence assembly was performed using Velvet257 (k = 99) followed by SSPACE258 for scaffolding. 
L. crispatus C037 was assembled into 96 scaffolds with a genome coverage of 113X. The scaffolds 
include 2.147 Mbp of sequence with a G+C content of 36.6%. Gene annotations were performed 
using GLIMMER361 and tRNAScan364 identifying 2,096 protein coding genes, 65 RNA (tRNA and 
rRNA) genes, and four clustered regularly interspaced short palindromic repeats (CRISPR)367. The 
16S rRNA gene sequence of the urinary isolate C037 was identical to that of the species’ type 
strain L. crispatus ST1 (NR_074986), an avian enteric strain. One scaffold (10,704 bp in length) 
produced a hit to the 16,663 bp L. crispatus plasmid pLc17 (KR052811); while a significant 
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proportion of the plasmid sequence was detected, a complete, circularized assembly was not 
possible. 
Accession Number(s) 
 The draft whole-genome project for L. crispatus C037 has been deposited at 
DDBJ/EMBL/GenBank under accession number MAKH00000000.
336 
 
 
 
 
 
 
 
 
 
 
APPENDIX I 
GENOMES OF GARDERELLA STRAINS REVEAL AN ABUNDANCE OF PROPHAGES WITHIN THE 
BLADDER MICROBIOME 
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Zilliox M.J., Wolfe A.J., Putonti C. Genomes of Gardnerella Strains Uncover an Abundance of 
Prophages within the Bladder Microbiome. PloS one 2016;11:e0166757, PMID: 27861551. 
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Overview of Appendix I 
This paper assessed the genomic content of four Gardnerella isolates from the female 
urinary microbiota and compared the data to other available genomes. The data show high 
abundance of prophage-like sequences within these genomes. Some of the phage sequences are 
unique to certain Gardnerella genomes suggesting that phages may be involved in the evolution 
of urinary bacteria. 
Abstract 
Bacterial surveys of the vaginal and bladder human microbiota have revealed an 
abundance of many similar bacterial taxa. As the bladder was once thought to be sterile, the 
complex interactions between microbes within the bladder have yet to be characterized. To 
initiate this process, we have begun sequencing isolates, including the clinically relevant genus 
Gardnerella. Herein, we present the genomic sequences of four Gardnerella strains isolated from 
the bladders of women with symptoms of urgency urinary incontinence; these are the first 
Gardnerella genomes produced from this niche. Congruent to genomic characterization of 
Gardnerella isolates from the reproductive tract, isolates from the bladder reveal a large 
pangenome, as well as evidence of high frequency horizontal gene transfer. 
 Prophage gene sequences were found to be abundant amongst the strains isolated from 
the bladder, as well as amongst publicly available Gardnerella genomes from the vagina and 
endometrium, motivating an in-depth examination of these sequences. Amongst the 39 
Gardnerella strains examined here, there were more than 400 annotated prophage gene 
sequences that we could cluster into 95 homologous groups; 49 of these groups were unique to 
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a single strain. While many of these prophages exhibited no sequence similarity to any lytic phage 
genome, estimation of the rate of phage acquisition suggests both vertical and horizontal 
acquisition. Furthermore, bioinformatic evidence indicates that prophage acquisition is ongoing 
within both vaginal and bladder Gardnerella populations. The abundance of prophage sequences 
within the strains examined here suggests that phages could play an important role in the species’ 
evolutionary history and in its interactions within the complex communities found in the female 
urinary and reproductive tracts. 
Background 
Gardnerella, a member of the Bifidobacteriaceae family, is a genus of facultative 
anaerobes within the vaginal microbiota of both healthy women and those diagnosed with 
bacterial vaginosis (BV)371 372 373 374. Similarly, our group found Gardnerella in urine collected from 
adult female bladders by transurethral catheter29 35 34 37. This corresponds with microbiome 
studies of voided urine: Gardnerella was present regardless of sex or symptom status69 30 67 248 
375. Furthermore, the bladders of healthy individuals include other bacterial taxa also detected 
within the vaginal microbiota29 35 34 69 32 30 37 248 375. To date, thirty-nine G. vaginalis isolates from 
the vagina or endometrium have been sequenced376 377 378 379 380, including four complete 
genomes; the remaining genomes are represented as scaffolds or contigs. Analysis of G. vaginalis 
genomes found evidence of a large pangenome that consists of a modestly sized core genome in 
addition to strain-specific genes376 381. 
Prior investigations of G. vaginalis genomes from the reproductive tract have uncovered 
indications of substantial horizontal gene transfer (HGT), including the acquisition of genes from 
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other human-associated taxa376 381 382. In addition to natural competence, G. vaginalis may also 
include phage-mediated gene transfer, as coding regions of bacteriophage (phage) origin are 
ubiquitous within these genomes381. Similarly, genomic sequences from other bacterial taxa 
within the vaginal microbiota also contain parts of or entire temperate phage genomes383 384. 
 Prior studies have posited that lysogenic lactobacilli phages could contribute to a shift in 
the vaginal microbiota leading to BV (for a review, see Turovskiy et al 2011374). Phages have been 
found to play a crucial role in the structuring of microbial communities, including those residing 
within the human body385, driving bacterial genetic diversity386 and adaptation to changes in the 
environment387. Although several phages induced from vaginal lactobacilli have been 
identified388 389, currently no phages have been characterized for Gardnerella. While evidence 
suggests that phages are likely contributors to HGT in commensal communities383 387 390, the 
extent of their effect on the human microbiome is just now being explored391 392 393. Within many 
other microbiota, including the bladder, the virome remains largely unexplored. 
Herein, we present the genomic sequences of four Gardnerella strains isolated from the 
bladders of adult women with symptoms of urgency urinary incontinence (UUI). Comparative 
genomics between these strains and publicly available isolates revealed a highly conserved core 
genome across the bladder and vaginal isolates. Analogous to prior observations for this species, 
the Gardnerella strains isolated from the bladder also contain a large number of prophage gene 
sequences. The pervasiveness of prophage sequences in Gardnerella genomes from both the 
female urinary and reproductive tracts motivated our thorough bioinformatic investigation. A 
comprehensive interrogation of the over 400 annotated prophage gene sequences identified 
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here provides insight into the adaptive ability of Gardnerella, as well as the larger community of 
phages within the female urinary community. 
Materials and Methods 
Strain Isolation and DNA Extraction 
The Gardnerella and Gardnerella vaginalis isolates were isolated from transurethral 
catheterized urine specimens of adult women with UUI35 using the previously described 
Enhanced Quantitative Urine Culture (EQUC) protocol34. Microbial identification was determined 
using a Matrix-Assisted Laser Desorption/Ionization-Time-of-Flight Mass Spectrometer (MALDI- 
TOF MS, Bruker Daltonics, Billerica, MA) as described34. Pure cultures were stored at -80°C in a 2 
ml CryoSaver Brucella Broth with 10% Glycerol, no beads, Cryovial, for preservation (Hardy 
Diagnostics). 
The preserved pure culture isolates were grown on CDC Anaerobic 5% sheep blood 
(Anaerobic BAP) agar (BD BBL™ Prepared Plated Media) under anaerobic conditions at 35°C for 
48 hours. MALDI-TOF MS was performed for species/genus verification. An isolated colony was 
transferred to 5mL tryptic soy broth (TSB) supplemented with 10% fetal bovine serum (FBS) and 
grown under anaerobic conditions at 35°C for 48 hours. 1 mL of culture was collected, and cells 
were resuspended in 1 mL of buffered saline peptone (PBS). 
Genomic DNA extraction was performed using a phenol-chloroform extraction protocol. 
Briefly, cells were resuspended in 0.5 mL DNA Extraction Buffer (20 mM Tris-Cl, 2 mM EDTA, 1.2% 
Triton X-100, pH 8) followed by addition of 50 μL Lysozyme (20mg/mL), 30 μL Mutanolysin, and 
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5 μL RNase (10 mg/mL). After a 1-hour incubation at 37°C, 80 μL 10% SDS, and 20 μL Proteinase 
K were added followed by a 2-hour incubation at 55°C. 210 μL of 6 M NaCl and 700 μL phenol-
chloroform were then added. After a 30-minute incubation with rotation, the solutions were 
centrifuged at 13,500 RPM for 10 minutes, and the aqueous phase was extracted. An equivalent 
volume of Isopropanol was then added, and solution was centrifuged at 13,500 RPM for 10 
minutes after a 10-minute incubation. The supernatant was decanted, and the DNA pellet was 
precipitated using 600 μL 70% Ethanol. 
Genome Sequencing, Assembly, and Annotation 
DNA samples were diluted in water to a concentration of 0.2 ng/μl as measured by a 
fluorometric-based method (Life Technologies) and 5 μl was used to obtain a total of 1 ng of input 
DNA. Library preparation was performed using the Nextera XT DNA Library Preparation Kit 
(Illumina) according to manufacturer’s instructions. The isolates were barcoded, pooled and each 
isolate was sequenced twice, on two separate runs, using the Illumina MiSeq platform and the 
MiSeq Reagent Kit v2 (300-cycles) to produce 150 bp paired-end reads. Sequencing reads were 
parsed into individual folders according to the respective barcodes. 
Table I.1. Genomic characteristics of four Gardnerella strains isolated from female bladders. 
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The following protocol produced an assembly with the least number of scaffolds and the 
highest overall coverage (Table I.1). Reads were paired using Geneious (Biomatters Ltd., 
Auckland, New Zealand) for each isolate for each sequencing run. De novo assembly was 
performed, combining the two runs per isolate, using the Geneious plug-in for Velvet257 (k = 99). 
Sequence contigs were then extended and scaffolds were constructed using the tool SSPACE258. 
Resulting contigs were again assembled using the Geneious de novo assembler at the Medium-
Low sensitivity setting. Annotations were performed for each of the contigs using the RAST 
annotation pipeline394, as well as the BASys bacterial annotation system395. CRISPR arrays were 
predicted using CRISPRdb396. A local nucleotide database was created for each strain using the 
protein coding regions predicted by RAST. Each predicted coding region was then reciprocally 
BLASTed (blastn). Genes were determined to be homologs if the query coverage and the 
sequence identity were both greater than 70%. 
Raw sequencing reads as well as assembled contigs are available through NCBI: Gv18-4 
(SRA: SRX1688291, WGS: LWSP00000000), Gv23-12 (SRA: SRX1688198, WGS: LWSQ00000000), 
G26-12 (SRA: SRX1688301, WGS: LWSR00000000), and G30-4 (SRA: SRX1688300, WGS: 
LXJL00000000). Table I.S1 lists the annotated protein functionalities within the four strains; 
annotations are available and can be queried through NCBI. 
Phylogenetic Analysis 
Single Gene Trees: 16S rRNA gene sequence analysis was performed by excising the full 
length 16S sequence from the assembled genomes and querying each against the NCBI nr/nt 
database via blastn. Sequences producing full-length hits were collected and aligned using 
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MUSCLE253. The phylogenetic tree was constructed using RAxML265 and visualized using 
PhyloWidget397. Phylogenetic analysis of the VLY gene sequences was aligned using ClustalW398. 
As before, RAxML and PhyloWidget were used to derive and visualize the tree, respectively. 
Core Genome Tree. While 43 strains are presently publicly available through NCBI for G. 
vaginalis, this study considered only those that were (1) isolated from the vagina or endometrium 
and (2) are documented within the literature399 376 377 378 379 380. Table I.S3 lists the 35 publicly 
available strains meeting these criteria. The species tree was derived by first identifying the core 
set of genes within the 39 Gardnerella strain sequences (genome, scaffold, or contig collections). 
Incomplete genomes (scaffold or contig status) were retrieved from NCBI. Their sequences were 
individually submitted to the RAST server and annotated394. For the three complete genomes, G. 
vaginalis 409–05 (NC_013721), 14019 (NC_014644), and HMP9231 (NC_017456), the ffn format 
files were retrieved from NCBI’s FTP site. The core gene set was determined by first creating a 
local nucleotide BLAST database with the coding regions annotated for the G. vaginalis 14019 
strain. Annotated coding regions in other sequences were BLASTed locally (using BLASTn, e-
value<10-5), returning the top hit only. Genes producing hits in all other 38 genomes were 
identified as members of the core genome. The core gene set contains 183 genes (Table I.S4), a 
significantly smaller group than previously used when considering smaller numbers of strains376 
381. Each core gene and its orthologs were aligned using ClustalW398. Alignments were 
concatenated producing a concatenated gene alignment (super-gene alignment) using an in-
house script in R (available upon request). The Maximum-likelihood tree was derived using 
RAxML265. Trees were visualized using PhyloWidget397. 
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Assessing Presence/Absence of Coding Regions of Interest 
The absence of coding regions identified with key carbohydrate metabolism 
functionalities within the G26-12 and G30-4 genome analyses was experimentally verified via 
PCR. Coding regions within the Gv18-4 genomic sequence with the following functional 
annotations were retrieved: (1) chitin and N-acetylglucosamine utilization, (2) deoxyribose and 
deoxynucleoside catabolism, (3) D-gluconate and ketogluconates metabolism, (4) formaldehyde 
assimilation, (5) lactose and galactose uptake and utilization, (6) trehalose biosynthesis, uptake 
and utilization, and (7) xylose utilization. In total, 22 genes were identified. Each was BLASTed 
against the nr/nt database, specifying the genus Gardnerella, to retrieve orthologs from other 
strains. All annotations within the GenBank files retrieved were manually inspected verifying 
similar confirmed/predicted protein functions. Primers were designed for each gene, targeting 
conserved regions amongst all orthologs, and obtained from Eurofins MWG Operon (Huntsville, 
AL). In total, 66 PCR reactions were conducted, testing each of the primer pairs against: Gv18-4 
(serving as a positive control), G30-4, and nuclease-free water (serving as a negative control). All 
Gv18-4 reactions produced amplicons of the expected sizes. G30-4 and the negative controls did 
not produce amplicons. Primer sequences are listed in Table I.S6. 
Prophage Identification 
Genes annotated as phage or viral in origin were extracted from each of the genome 
sequence annotations. Local BLAST databases were used for both identifying the orthologous 
clusters of prophage sequences, as well as the putative origin of prophage clusters. First, a local 
nucleotide database was created, including all of the sequences predicted as phage from all 39 
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Gardnerella strains. Each individual putative phage coding region sequence was then BLASTed 
(blastn) against this local database (maximum 100 results), detecting identity to itself, as well as 
similarity to other sequences. Each hit was further qualified; hits with a sequence identity and 
query coverage greater than or equal to 80% were considered homologous. Once clusters were 
identified, the sequences within the cluster were aligned using ClustalW and manually inspected 
to guarantee correct clustering (File S1 [not included here due to size]). 
 Identification for the origin of each cluster was performed similar to above; the local 
database used for conducting blastn searches was the complete collection of viral RefSeq coding 
regions. The all.fna.tar.gz file was retrieved from ftp://ftp.ncbi.nlm.nih.gov/genomes/Viruses/. 
Homologs were called when query coverage was ≥80%. The sequence identity threshold was 
considerably lower ≥35%. A cluster was considered to show no homology to any RefSeq coding 
region if it did not meet both of these conditions. 
Estimating Rates of Phage Acquisition 
Rates of phage acquisition were estimated using the R package corHMM400, which 
implements a Hidden Markov Model to estimate the rate of evolution of traits occurring across 
a phylogeny. Each phage was encoded as a binary trait according to its presence/absence as 
visualized in Figure I.3. Using this method to estimate the “rate of evolution,” therefore, provides 
a meaningful proxy for the rate of phage acquisition across the tree. For any given phage, the 
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rate of acquisition is expected to scale with its total number of occurrences in the tree, and 
horizontally transmitted phages are expected to have faster relative rates than vertically 
transmitted phages (as seen in Figure I.4).  
Results 
Figure I.1. Characterization of predicted coding regions. (A) Homology and (B) annotated 
frequency within the four bladder Gardnerella strains. (**p value <0.05 between the two 
predicted Gardnerella strains and the two predicted G. vaginalis strains; *p value <0.1). Strains 
are represented using the same colors in both panels. 
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Genome Features 
Four Gardnerella strains were previously isolated from the bladders of four different 
female patients with symptoms of urgency urinary incontinence15 35. While MALDI-TOF identified 
two of these strains as G. vaginalis (henceforth denoted as Gv18-4 and Gv23-12), it did not 
resolve the other two strains to the species level (G26-12 and G30-4). 16S rRNA gene sequencing 
Figure I.2. Phylogenetic analysis of Gardnerella strains. Maximum Likelihood species tree of 
Gardnerella strains based upon sequence homology within the core gene set. (A) Phylogenetic 
tree listing branch supports and distinction of the four clades within the tree. Numbers within 
black circles indicate the number of homologous genes within each clade and the core 
Gardnerella genome. (B) Maximum Likelihood tree including branch lengths and isolation 
information with respect to location and diagnosed symptom. Strains isolated from the bladder 
and sequenced in this study are labeled in red; strains listed in green were isolated from the 
vagina/endometrium of BV+ patients; strains in light blue were isolated the 
vagina/endometrium of STD+ patients. All remaining strains (indicated in black font) were 
isolated from the vagina or endometrium. 
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for each isolate confirmed the strains belong to the genus Gardnerella (Figure I.S1). All four 
isolates were sequenced, assembled, and annotated and are publicly available via NCBI. The 
genomic sequences varied slightly in size from 1.48 to 1.62 Mbp (Table I.1). 
Homologs, as well as strain-specific coding regions, were identified within the genomes 
of these bladder Gardnerella strains (Figure I.1A). Although Gv18-4 and Gv23-12 were 
indistinguishable on the basis of their 16S rRNA sequences (Figure I.S1), instances of both strain-
specific gene acquisition and loss within their genomes were detected (Table S1 [Not included 
here due to size]). Annotation also revealed the type I CRISPR/Cas system in all four genomes, 
with multiple CRISPR loci per genome (Table I.1). 
Comparison between the two strains identified by MALDI-TOF analysis to the species level 
(Gv18-4 and Gv23-12) and those identified to the genus level (G26-12 and G30-4) revealed 
disparity in the number of genes with the annotated functionalities of carbohydrate metabolism, 
membrane transport, and cell wall and capsule synthesis (Figure I.1B); however, the genetic 
variation observed between the Gv and G strains is statistically significant only for loci that 
regulate carbohydrate metabolism. Consistent with previous studies that illustrated the ability of 
different Gardnerella strains to ferment and use different carbohydrates399, annotation of the 
genome for G26-12 and G30-4 suggest that they lack coding regions with the following 
functionalities: chitin and N-acetylglucosamine utilization, trehalose biosynthesis, trehalose 
uptake and utilization, lactose and galactose uptake and utilization, lactose utilization, 
formaldehyde assimilation, xylose utilization, deoxyribose and deoxynucleoside catabolism, D-
gluconate and ketogluconates metabolism. The absence of these coding regions within the G26-
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12 and G30-4 genome sequences was confirmed experimentally via PCR. 
The genomes of these bladder strains were further examined with respect to the 
presence/absence of coding regions associated with virulence, as previously defined by Yeoman 
et al.381 (Table I.S2). Genes associated with biofilm formation (glycosylases and 
glycosyltransferases) and epithelial adhesion (fimbria/pili) were identified in all four genomes; 
however, type-1 fimbrial precursors were found only within the genomes of G26-12 and G30-4. 
Genes associated with antibiotic/antimicrobial resistance, including those that encode the ABC- 
type multidrug transport system and the DedA protein (which has been shown to be required for 
drug resistance in E. coli)401 were present within all four genomes. However, tetracycline 
resistance proteins were encoded within the Gv18-4, Gv23-12, and G26-12 strains, but not in the 
G30-4 strain. Genes associated with protection or evasion from the immune response (alkyl 
hydroperoxide reductase and Rib-family surface protein) were found within all four of the 
bladder strains. Furthermore, the coding region for the vaginolysin (VLY) gene, which is selective 
for human cells381 402, was highly conserved within all four strains, in spite of the two amino acid 
substitutions that separate the Gv18-4 strain from the type strain for the genus ATCC 14019 
(Figure I.S2). Finally, the Gardnerella strains G26-12 and G30-4 contained an annotated rRNA 
methyltransferase associated with Gardnerella cytotoxicity381 and with hemolytic activity in other 
bacterial species403. Interestingly, only the Gv18-4 and Gv23-12 strains contained genes that 
encode sialidase, which has been experimentally proven to contribute to mucin degradation in 
BV377, although presence of the gene is not predictive of actual sialidase activity404 and thus 
warrants further investigation. 
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Phylogenetic Analysis and the Gardnerella Pangenome 
In an effort to assess the similarity/difference between Gardnerella strains isolated from 
the female bladder and those isolated from the female reproductive system, all publicly available 
sequenced strains isolated from the vagina or endometrium were retrieved from NCBI (Table 
I.S3). This set includes 35 complete, scaffold, or contig genome sequences. Extending beyond the 
16S rRNA gene marker, the evolutionary history of this genus was considered by investigating 
sequence homologies within the “core” Gardnerella genome (Methods; Table I.S4. In total, 183 
genes were identified as belonging to this core gene set, less than identified in prior studies of 
far fewer genomes376 381. As shown in Figure I.2, the strains isolated from the bladder are not 
monophyletic, establishing that the Gardnerella core genome does not correlate with a single 
isolation location. Examination of all coding sequences for all 39 investigated genomes revealed 
no gene(s) exclusive to the bladder strains. While the vast majority of the genes within the core 
set demonstrated an evolutionary history identical to that of the species tree (Figure I.2), genes 
indicative of intragenic recombination, such as VLY (Figure I.S2), were also identified. 
Nevertheless, the species tree (Figure I.2) we derived largely concurs with the tree produced by 
Ahmed et al376. In comparison to the phylogeny of Ahmed et al., which included 17 genomes and 
a core genome of 473 genes, their Group 3 and 4 are both contained within Clade A in Figure I.2. 
Our Clade B corresponds to their Group 2 and our Clade C is within their Group 1; only two of the 
genomes within Clade C were included in the prior analysis of Ahmed et al. As expected, each 
clade had significantly more homologous genes (404, 799, 762 and 635 for Clades A through D, 
respectively) (Figure I.2A), a likely residual of under sampling, biased sampling, and/or clade-
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specific functional conservation. 
The bladder strains G26-12 and G30-4 were determined to belong to Clade A, which also 
includes three strains isolated from BV+ patients (Figure I.2B). While the phylogeny based upon 
the core gene set does not correspond with isolation location, some clades appear to have a 
higher incidence of strains isolated from patients diagnosed as BV+. Because genes associated 
with virulence are not exclusively present within genomes isolated from symptomatic patients376 
381, it is not surprising that several are included within the core gene set identified here. The lack 
of correspondence between phylogenetic history and symptoms is supported by prior studies, 
which hypothesized that gene expression variation within G. vaginalis strains may trigger BV 
development405 and single point mutations may result in greater potential for cytotoxicity399. 
Thus, there appears to be no single gene that correlates with BV symptoms. This is, however, not 
surprising given that G. vaginalis strains are present within both the BV- and BV+ vagina406, and 
it is but one of the taxa that coincides with BV symptoms373. 
Mobile Elements 
The four bladder Gardnerella genomes varied in their number of ORFs predicted to be 
viral (bacteriophage) in origin. The number of prophage gene sequences per genome had no 
correspondence to evolutionary history (Figure I.2). This is true for the four Gardnerella strains 
isolated from the bladder, as well as for the 35 strains isolated from the reproductive system. For 
example, the G. vaginalis strain JCP8522, a vaginal BV+ strain377, has only one ORF annotated as 
a phage gene. In contrast, the Gv18-4 strain sequenced as part of this study contains the most, 
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33, phage-like gene sequences within a Gardnerella genome to date. Table I.S5 (not included due 
to size) lists the 442 annotated prophage genes within the 39 genomes examined. Due to the 
incomplete (scaffold/contig) status of the majority of the genomes included in the analysis here, 
Figure I.3. Presence/absence of prophage gene sequences from larger clusters. Clusters of 
orthologous prophage genes found within five or more of the 39 Gardnerella genomes are 
shown using a distinct color. Open circles indicate that the prophage sequences belonging to the 
particular cluster show no/poor sequence homology to characterized lytic phages. Closed circles 
indicate moderate (query coverage ≥80%, nucleotide sequence identity ≥35%) to high homology 
to a phage genome sequence record in NCBI. Nucleotide sequence identity for the prophage 
genes in each cluster is indicated by the bar chart at the top of the figure. 
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we evaluated predicted prophage genes (median length 939 bp) individually. 
To identify homologs, the nucleotide sequences for all annotated prophage genes across 
all Gardnerella genomes were examined. Based upon the combination of sequence identity and 
query coverage, 104 clusters of orthologous prophage genes were identified. Within larger 
clusters, prophage homolog sequences were highly conserved between genomes. Forty-nine 
clusters, however, included only a single prophage gene sequence, indicative of frequent 
independent acquisition of viral sequences. This is further supported by the variation in prophage 
genes identified within strains isolated from the same patient. While the genomes of JCP8481A 
and JCP8481B (both isolated from a single patient as denoted by A and B377) contain the same 
set of prophage gene sequences, the genomes of JCP8151A/B and JCP8017A/B do not (Figure I.3, 
Table I.S5); this captures the likely prevalence of lysogenic phage excision, as well as gene loss, 
events. Likewise, the genomes of 00703Bmash, 00703C2mash, and 00703Dmash, which are from 
sequential isolates from the same patient376, vary in their prophage gene content (Figure I.3, 
Table I.S5). This diversity, even within a single patient, suggests intra-host prophage gene 
gain/loss. 
Examination of the 37 largest prophage gene clusters suggested that prophage 
introduction within the Gardnerella genus has occurred by both vertical and lateral inheritance. 
These larger clusters include orthologous prophage gene sequences present within five or more 
Gardnerella genomes; the most pervasive prophage gene sequences were present within 21 of 
the 39 Gardnerella genomes examined here. As shown in Figure I.3, several of the larger 
prophage gene clusters have representatives across the entire phylogenetic tree and some sets 
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of clusters appeared to have been lost within particular lineages. Half of the 104 prophage gene 
clusters identified exhibit little to no resemblance to any sequence within the current GenBank 
nr/nt nucleotide database of characterized phage sequences; this includes several of the 
prophage genes within the larger clusters (represented as open circles in Figure I.3). For those 
prophage gene sequences that exhibit homology to characterized phage genes, hits were 
frequently identified to the genomes of Bacillus-, Mycobacterium-, and Staphylococcus- infecting 
phages. Previous targeted gene surveys of the bladder have routinely found Staphylococcus 
within the community34 37 15. 
Although Gardnerella-infecting phages have yet to be isolated, the abundance of 
prophage gene sequences in the genomes (Table I.S5) and the presence of the CRISPR/Cas- 
system (Table I.1) suggests that phages capable of infecting Gardnerella spp. exist. This 
assumption is corroborated by prior analyses of spacer sequences within 21 G. vaginalis 
genomes, in which 70.7% of the spacers showed no homology to sequences within the GenBank 
database382. While many of the clusters exhibiting homology to sequences in GenBank identified 
lytic phages annotated as infecting an array of different bacterial genera, analysis of eleven of 
the 104 clusters resulted in the description of phages thought to infect a single taxon. These 
included several of the larger clusters shown in Figure I.3: clusters 12, 15, and 30 were found to 
have homology to Bacillus-infecting phages; clusters 22 and 35 were determined to be similar to 
phages infecting Mycobacterium species; while cluster 29 exhibited a likeness to Staphylococcus-
infecting phages (Table I.S5). Yet, all of these phages are of the family Siphoviridae. Homologies 
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identified for these prophage sequences provide a foundation for future work in the isolation of 
Gardnerella-specific phages. More broadly, these prophage gene sequences provide insight into 
the phage community within the human microbiota. 
Lateral gene acquisition is ubiquitous; however, there is a strong discordance between 
the evolutionary tree (Figure I.2; Figure I.S1) and trees derived from strain:prophage gene 
presence/absence profiles (results not shown). To distinguish clusters acquired via HGT from 
those linearly inherited from a common ancestor, the genomes of 39 Gardnerella strains were 
examined. Clusters were compared given the number of occurrences and the rate of evolution 
of viral infection (Figure I.4). From this analysis, two groups can be observed. The phage gene 
clusters in the top right quadrant appear to have evolved quickly relative to their prevalence 
across strains and have likely been integrated into the Gardnerella genomes via HGT. In contrast, 
Figure I.4. Determining mechanisms of prophage gene acquisition. Colors correspond with the 
cluster colors in Figure L.3. Dashed lines are the mean value for each axis. 
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the four clusters in the bottom right quadrant appear to have been acquired by vertical 
transmission. Thus, we hypothesize that prophage integration has been occurring over a long, 
time scale. 
Given this evidence of phage-host interactions and the results of recent studies 
illuminating the vital contributions of viruses within other human microbiota407 392 393, one can 
surmise that phages are playing a significant role within both the bladder and reproductive 
system communities. 
As the bladder microbiota have only recently been discovered and subsequently 
surveyed29 35 34 32 30 37 50 15, their microbiome remains largely uncharacterized. The presence of 
the CRISPR/Cas system within the four Gardnerella strains sequenced here suggest phages are 
present and prolific within the bladder. Given the existence of both Gardnerella and Lactobacillus 
within both the female bladder29 35 34 37 15 and the vaginal226 408 409 microbiota, some insight can 
be gleaned from the latter. It is likely that phages play an important role in bacterial genome 
evolution and potentially disease in both niches. Evidence of phages has previously been found 
within the vaginal microbiota388 410. The incidence of Lactobacilli phages may have medical 
significance, as vaginal lactobacilli may be culled or repressed by phages within the microbiota 
leading to BV388 374. Increased prophage numbers within L. crispatus genomes from the human 
vagina relative to avian isolates suggests high frequency of phage within the human 
microbiota384. Phage-like sequences within both the bladder and vaginal bacterial microbiomes–
prophage sequences as well as CRISPR spacer sequences–often show little to no homology to 
characterized sequenced phage species, insinuating that numerous genetically diverse phages 
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have yet to be discovered. 
Conclusion 
Comparison of four new bladder-associated Gardnerella genomes to genomes from the 
reproductive system identifies strain-specific and lineage-specific genes, suggesting a large 
Gardnerella pangenome may exist. There is, however, no distinct difference between strains 
isolated from a particular niche. Of particular interest is the high incidence of prophages within 
the Gardnerella genomes and the variability in the number per strain, as well as their putative 
origin. While prior studies into the prophages of vaginal lactobacilli propose that phage may play 
a significant role in community dynamics within the vagina, this proposal has yet to be empirically 
tested. The Gardnerella genome analyses conducted here find evidence of ancient, as well as 
contemporary, phage infection; the fact that isolates from the same individual vary in their 
prophage gene sequences supports the latter. Bioinformatic inspections of prophage and CRISPR 
spacer sequences find little to no correspondence with characterized phage sequences, 
suggesting that Gardnerella-infecting phages exist, although they have yet to be isolated in the 
laboratory.  
Nonetheless, evidence presented here suggests that phages play a role within the 
complex microbial communities of both the reproductive tract and the bladder, warranting 
future exploration of their viromes. The continued isolation and empirical characterization of 
Gardnerella species from the human microbiota is necessary to learn whether microbiome- 
virome interactions help to establish and maintain ones’ bladder health and, if so, how 
perturbations of this equilibrium result in bladder pathologies. 
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Figure I.S1. Phylogenetic tree based on the 16S rRNA gene. 
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Table I.S2. Presence/absence of virulence genes within the four bladder isolates. 
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Figure I.S2. Phylogenetic analysis of VLY gene. (A) Amino acid sequence alignment of four 
bladder Gardnerella isolates and representatives from other clades; clades are indicated to the 
left of each strain/isolate name. Mismatches within the alignment are highlighted (red/blue 
text). (B) Maximum likelihood phylogenetic tree for the VLY gene. Bran supports are indicated. 
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Table I.S3. List of 35 genomes retrieved from NCBI for genome comparisons. 
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Overview of Appendix J 
 This paper assessed the efficacy of the Peezy midstream urine collection device. MSU 
specimens are the simplest type of urine specimen to obtain, but unlike TUC specimens, the 
contribution of the bacteria are less clear, and the level of standardization is low. Therefore, use 
of a device like Peezy could provide an improved and standardized MSU specimen. Use of Peezy 
to study the urinary microbiota or provide more accurate specimens for UTI diagnosis is 
promising. Our data show that MSU specimens collected by use of Peezy have lower bacterial 
abundance, similar to TUC specimens. These findings suggest that use of Peezy provides a more 
bladder-centric urine specimen compared to regular MSU specimens. 
Abstract 
Objectives 
 An expanded quantitative urine culture (EQUC) protocol was used to compare the 
microbial abundance and diversity of voided urines obtained using a standard urine collection 
and using the Peezy midstream device.  
Methods 
 62 female participants were assigned to 1 of 3 cohorts. One cohort used a standard clean-
catch mid-stream urine protocol that included a castile soap wipe, the second cohort used a 
Peezy mid-stream collection device with castile soap wipe and the third used the Peezy device 
without a castile soap wipe. Each participant watched a video that detailed the collection 
method. Prior to using the castile soap wipe, a peri-urethral swab was obtained to measure peri-
urethral microbe abundance. Demographics and pelvic floor symptoms were assessed by 
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validated questionnaires. Microbes were detected using EQUC. Diversity within each sample was 
analyzed using alpha diversity measures. 
Results 
 Paired peri-urethral and urine samples for each woman were analyzed and compared for 
species abundance, richness, and diversity.  Bacterial abundance in voided urine was significantly 
lower in both Peezy cohorts compared to standard clean catch. Bacterial profiles of Peezy-
collected urines differed significantly in diversity indices and had significantly reduced colony-
forming units. In contrast, within the standard clean-catch cohort, the urine and peri-urethral 
profiles only differed significantly by abundance and species richness with higher abundance and 
richness in voided urine.  
Conclusions 
 Compared to standard clean catch method, the Peezy urine collection device with and 
without the castile soap wipe resulted in urine with lower bacterial abundance. Voided urine 
collected by Peezy may reduce post-bladder microbial contribution. 
Introduction 
Contrary to long-held dogma, the bladder is not sterile; instead, it contains communities 
of microbes commonly referred to as the bladder microbiota. 16S ribosomal RNA gene 
sequencing provided DNA evidence of bacteria in transurethral catheterized urine specimens 
that were deemed “negative” by standard urine culture in women with and without urinary tract 
symptoms29. An enhanced urine culture method called EQUC (expanded quantitative urine 
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culture) showed that these bacteria were alive34. This is not surprising because standard urine 
culture methods preferentially grow Escherichia coli and fail to reproducibly grow many microbes 
that were identified using 16S ribosomal gene sequencing15 44.  In contrast, EQUC involves plating 
larger amounts of urine onto various culture media and incubating samples in multiple conditions 
for a longer length of time. As such, EQUC reproducibly cultures more diverse organisms than 
standard urine culture, making it a more suitable culture technique to use when studying the 
lower urinary tract microbiota34. Analyzing urine samples obtained by transurethral 
catheterization by 16S ribosomal RNA sequencing and EQUC, our team and others have defined 
the bladder microbiota and associations of microbes with specific lower urinary tract symptoms32 
30 15 35 37 31 63 303.  
Because transurethral catheterization for urine collection is invasive, it has limitations as 
a universal collection method for research of the microbiota of the lower urinary tract, especially 
for longitudinal studies involving community populations. Although voided urine samples are 
more practical, the typical “clean catch” method has been shown to contain high amounts of 
microbes associated with the vagina, vulva, and surrounding skin411 243 412. The presence of these 
contaminants can complicate the accurate depiction of lower urinary tract microbiota57.  
The standard clean catch (SCC) method involves using a cleansing castile soap wipe, 
urinating the initial urine stream into the toilet, and then collecting midstream urine into a sterile 
cup243. Typically, there is no standard instruction for how much urine should be voided before 
midstream collection. The lack of standardization of the standard clean catch procedure and the 
varying physical characteristics of women may contribute to the contamination of these urine 
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samples with the microbes residing in the urethra, the vagina, vulva and surrounding skin. Before 
microbiome researchers can use voided urine, we need to develop or identify a “cleaner” catch 
voided urine sample. Forte Medical has developed a device (Peezy) that discards ~10 mL of urine 
prior to collection into a sterile container. Previous studies of Peezy’s efficacy have produced 
conflicting results using standard urine culture techniques413  244.  
In this study, we used EQUC to compare microbial abundance and diversity of voided 
urines obtained by a standard urine collection method to the microbial abundance and diversity 
of voided urines collected using the Peezy midstream device. We hypothesized that voided urines 
obtained using Peezy have less “contamination” from the urethra, peri-urethra, vulva and vagina 
than voided samples obtained by typical clean catch techniques.  
Methods 
This is a cross-sectional pilot cohort study of participants from 2 randomized trials with 
Loyola IRB-approval. The first trial randomized 40 women into one of two arms of a voided urine 
collection study (standard clean catch technique using a castile soap wipe versus a “modified 
clean catch” approach that did not involve a castile soap wipe).  Only the 20 women enrolled into 
the standard clean catch method using a castile soap wipe were included in this analysis because 
our “modified technique” demonstrated no superiority over the standard clean catch technique. 
The second trial randomized 42 women to use the Peezy device with a castile soap wipe versus 
using the Peezy device without the castile soap wipe. 
 Recruitment 
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 Adult women 18 or older who were employees or students of the Loyola University 
Hospital System and/or Loyola University Health Sciences Campus were invited to participate in 
these IRB approved trials. Women were included if they could speak fluent English, were 
ambulatory, could view a video-based instruction for the collection method, and answered yes 
to the query “do you feel your bladder is full enough to void.” Women were excluded if they had 
a history of recurrent UTI (3 or more UTI in the last year or 2 in the last six months), pelvic organ 
prolapse, urinary urgency incontinence or urinary stress incontinence. Other exclusion criteria 
included current use of antibiotics, post-menopausal status, pregnancy, current menstruation or 
the use of intermittent self-catheterization. Following a signed informed consent, participants 
completed three forms: 1. Demographic information 2. the Pelvic Floor Distress Inventory-20414 
and 3. the UTISA questionnaire307 in which the participant rates the severity and bother for seven 
common UTI symptoms. All participants were enrolled by the first author, all samples were 
collected at the Loyola University Outpatient Urogynecology clinic and the Clinical Research 
Office, and all bacterial detection was performed by members of the Wolfe lab. Participants 
received a $5 gift card. 
Sample Collection 
 After watching a video detailing proper sample collection, each participant provided a 
peri-urethral swab and voided urine specimen. For women in the standard clean catch cohort, 
participants washed their hands with soap and water before collecting a peri-urethral sample 
with the provided swab. Participants then used a castile soap wipe to cleanse the peri-urethral 
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area by wiping from front to back before partially voiding into the toilet, then collecting 
midstream urine in a sterile cup. For women in the two Peezy cohorts, participants washed their 
hands with soap and water before collecting a peri-urethral sample with the provided swab. Half 
of the participants, randomized to the castile soap wipe, then used the castile soap wipe to 
cleanse the peri-urethral area by wiping from front to back before voiding into the device (Peezy 
with wipe, PZW). The other half voided into the device without using a castile soap wipe (Peezy 
without wipe, PZ). The Peezy device was held below the perineum and the participants urinated 
into the device, which allows the initial stream (~10 milliliters of urine) to pass through into the 
toilet (Figure J.1). This initial stream causes the expansion of a cellulose sponge that, when 
Figure J.1. Peezy midstream urine collection device. 
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engaged, forces the midstream urine into a sterile urine collection tube through a one-way valve. 
Once finished voiding, participants held the Peezy device over the toilet for 10 seconds to allow 
excess urine to flow through the device. Participants then unscrewed the collection tube from 
the device and placed the provided cap onto the tube. 
Culture Method and Identification of Bacterial Isolates 
 Paired urine and peri-urethral samples were cultured using EQUC, which consists of 
inoculation of 0.1mL urine onto diverse types of media (BAP, chocolate agar, colistin and nalidixic 
acid (CNA) agar, CDC anaerobe 5% BAP) with incubation in diverse environments (5% CO2, 
aerobic conditions, Campy gas mixture (5% O2, 10% CO2, 85% N) or anaerobic conditions) all at 
35°C for 48 hours. The level of detection for EQUC is 10 CFU/mL, represented by 1 colony of 
growth on any of the plates. EQUC is designed to isolate a broad array of Gram-negative and 
Gram-positive bacteria, including anaerobes and fastidious bacteria that grow slowly. Each 
morphologically distinct colony type was counted and isolated on a fresh plate of the same media 
to prepare a pure culture that was used for identification with Matrix-Assisted Laser 
Desorption/Ionization Time-of Flight (MALDI-TOF) mass spectroscopy.  
Statistical Analysis 
 REDCap (Research Electronic Data Capture) was utilized for the implementation of the 
random allocation sequence, which was only revealed upon participant enrollment just prior to 
sample collection. At the conclusion of recruitment, bacterial compositions of voided urines and 
peri-urethral swabs were analyzed using alpha diversity measures. Richness, or the number of 
microbial species present, was calculated by comparing the number of observed species for each 
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cohort and by each method of collection. Evenness, or the distribution of microbial species within 
the sample, was calculated with Pielou’s Index. This index ranks samples from 0 to 1, with 1 being 
completely even. A sample with a Pielou index score close to 1 contains all species present in 
nearly equal abundance, while a lower index score indicates that certain species are more 
abundant than others. Abundance, or the number of organisms, was calculated with Fisher’s 
alpha diversity Index. Communities with higher Fisher’s Index values indicate multiple species are 
present in low quantities. Combined interactions were calculated with the Shannon (richness and 
evenness) and Simpson (richness and abundance) indices. Communities with a large number of 
species that are present in similar amounts will have higher Shannon diversity values. A sample 
with high Simpson diversity has similar numbers of individuals in each species present, regardless 
of the number of species present. In all cases, higher index values describe more diverse samples. 
Patient demographics and clinical characteristics were compared using Wilcoxon rank-sum tests 
for continuous variables and chi-square or Fisher’s exact tests for nominal variables.  Wilcoxon 
signed rank tests were used to assess for statistical significance of within-group diversity 
differences in colony forming units and diversity measures. Kruskal-Wallis tests on swab 
measures were used to assess the statistical significance of differences in colony forming units 
between groups. P-values < 0.05 were considered statistically significant.  Analyses were 
performed using RStudio 1.1.423 (Boston, MA).  
Results 
 The 62 female participants were predominantly Caucasian, had a mean age of 28.8 years 
(range 22 -52) and a mean BMI of 25.7 kg/m2 (17.2-47.2 kg/m2).  There were 20 participants in 
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the standard clean catch cohort (SCC), 21 participants in the Peezy with periuretheral wipe cohort 
(PZW) and 21 participants in the Peezy without periurethral wipe cohort (PZ). The cohorts did not 
differ significantly in their demographics, PFDI-20, or UTISA symptoms scores (Table J.1).  The 
cohorts also represent healthy participants with no urinary tract symptoms and minimal pelvic 
floor symptoms.  
Microbiota Abundance 
 We investigated the abundance data by comparing the distribution of CFU/ml of voided 
urines to the mean CFU/ml of the paired peri-urethral swabs (that were obtained prior to the 
periurethral wipe). For both Peezy cohorts, the voided urines had significantly lower CFU/ml than 
their paired peri-urethral swabs (Table J.2). In contrast, there was no difference in CFU/ml of 
SCC-obtained urines and their paired peri-urethral swabs. 
Table J.1. Participant Demographics, UTISA, and PFDI-20. 
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PZW Versus PZ Microbiome Diversity 
 Microbiota of voided urines from both Peezy cohorts had significantly lower diversity 
values than those of paired peri-urethral swabs in Pielou (evenness), Shannon (richness and 
evenness), and Simpson (richness and abundance) indices (Figure J.2A-C, Supplemental Table 
J.1). Voided urines from both Peezy cohorts did not differ significantly from paired peri-urethral 
microbiota in species richness or abundance (Fisher’s Index).  
SCC Microbiome Diversity 
 Microbiota from the paired SCC urine and peri-urethral swabs did not differ significantly 
in diversity values for Pielou, Shannon, or Simpson indices. The only diversity measures in which 
the microbiota from the paired SCC voided urine and peri-urethral swab significantly differed 
were Fisher’s Index (Figure J.2D, Supplemental Table J.1) and species richness, with the 
microbiota of the voided urine obtained by SCC having significantly greater relative abundance 
and richness than the paired peri-urethral microbiota. 
Discussion 
Table J.2. Abundance Data Show the Peezy Device Reduces CFUs in Voided Urine Compared 
with Internal Control. 
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The aim of this study was to better understand the use of voided urine in microbiome 
studies. Obtaining catheterized urine is a rate limiting step for many researchers who want to do 
large community-based studies. Urine in the bladder has a low biomass and as urine from the 
bladder traverses the urethra, the urethral meatus, peri-urethra and vulvovaginal skin, the 
biomass increases. This has been previously demonstrated by the greater relative abundance of 
voided urine compared to catheterized urine44 246. Therefore, voided urine that has a higher 
relative abundance than its matched peri-urethral swabs (which were obtained prior to urination 
Figure J.2. Comparison of diversity between Peezy and SCC cohorts. Diversity measures for 
voided urines were compared to the paired periurethral swab. Median values are marked with 
black lines. Significant differences are denoted with underlined P values 
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and the castile wipe) is suggestive of a higher post-bladder contribution to the voided urine. The 
microbiota abundance data in this study demonstrates that standard clean catch urines produced 
similar CFU/ml to paired peri-urethral specimens. In contrast, however, Peezy urines yielded 
significantly lower CFU/ml than peri-urethral specimens. This contrast suggests that the Peezy 
device, used with or without peri-urethral cleansing, is more capable of reducing post bladder 
contributions to voided urines than the standard clean catch method. 
One of the challenges of this study was how to measure “better” voided urine collection. 
Previous studies have clearly demonstrated that voided and catheterized urine are distinct247. 
Since each woman has her own bacterial community, we needed to compare voided urine 
specimens to possible contamination from the urethra, peri-urethra, vulva and vagina.  We used 
diversity indices to compare the microbial communities between each participants voided urine 
and peri-urethra. These indices are used to describe environmental and bacterial communities. 
The periurethral vs. voided urine Shannon, Simpson and Pielou indices were significantly 
different for Peezy but not for standard clean catch participants. This indicates that the peri-
urethral and voided urine microbial communities were not distinct for standard clean catch but 
were distinct for Peezy. 
Bladder urine microbiota composition has been shown to have a lower biomass than the 
peri-urethral skin and vagina. As a result, a voided urine obtained by a “cleaner” catch should 
yield lower bacterial abundance which is measured by The Fischer alpha diversity index. The 
Fischer diversity index was significantly higher for the clean catch voided urine compared to the 
periurethral representing microbial contributions from the post bladder structures such as 
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urethra, vulva and vagina. Significant differences in Fischer diversity indices were not seen for 
the Peezy cohort. Likewise, the castile soap wipe does not appear to reduce peri-urethral 
contribution to urine, therefore it may prove to be an unnecessary and possible confounding step 
to voided urine collection. 
Our study includes some important strengths. The first is the use of EQUC. While other 
studies have examined the efficacy of Peezy, this is the first to utilize EQUC for sample analysis. 
Standard urine culture method, utilized in previous studies, preferentially cultures Escherichia 
coli, whereas EQUC has been shown to capture a wider range of bacterial species34 44. A sensitive 
assay, such as EQUC, is necessary to assess a novel urine collection since the bladder and vaginal 
microbiome have considerable overlap. In this study, the use of EQUC for analysis of the samples 
enabled us to identify a broader and more accurate range of bacteria, thus providing a better 
understanding of bacterial profiles both from the peri-urethra and LUT. 
Another strength was our standardized protocol. Urine collection directions are given in 
a variety of ways to patients; verbally, with written instructions, or sometimes no instruction at 
all. In this study, the content and delivery of directions for each protocol was controlled through 
the use of a pre-recorded video lasting approximately 2 minutes with both written and visual 
instruction of the collection protocol. Participants were then given an opportunity to ask 
clarifying questions before sample collection. The Peezy packaging contains visual and written 
instructions. Because one possible source of vaginal and skin bacterial contribution to standard 
urine collection may be inappropriate collection technique due to lack of standardized directions, 
this study sought to minimize this confounding factor through consistent delivery of directions. 
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Additionally, by utilizing written, visual, and verbal communication of directions, the diverse 
learning needs of participants was addressed. The use of standardized directions does mean that 
the results of this study may not be generalizable to studies where women are not given specific 
directions on how to collect their voided urine sample. The Peezy device may provide an 
additional level of standardization to the urine collection process by controlling the amount of 
initial voided urine (~10ml) discarded prior to collection. Rather than the requirement to start 
and stop one’s stream of urine, the device allows for one continuous void. This may be the 
mechanism by which Peezy provides urine with lower bacterial abundance. 
Finally, we used a peri-urethral swab as an internal control for vulvo-vaginal flora. Voided 
urine not obtained by a clean catch has been shown to include microbiota that reside outside of 
the LUT, most often due to vulvo-vaginal contribution, which cannot be easily distinguished from 
bladder microbiota. To better ascertain the origin of bacterial species, we utilized paired peri-
urethral swabs as a control for each individual. By understanding the bacterial profile of the peri-
urethral area, we could then compare this sample to the voided urine sample. Through this 
method we assessed the bacterial contribution of post-urethral bacteria to a given voided urine 
sample. This allowed us to evaluate methods of collection for reduction in post-urethral 
contribution. The Peezy device showed a significant reduction in post-urethral contribution. 
 We acknowledge that our study also had limitations. This study was limited by the number 
of participants and the use of a “healthy” control population as clearly demonstrated by the low 
UTISA and PFDI-20 subscales of the participants. Because this was a pilot study, future research 
should focus on increasing the number and diversity of participants. Because the participants 
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were young and relatively fit (avg. BMI: 24.7 kg/m2), they may have presented few issues with 
urine collection which is not the case in older urogynecologic patients. The generalizability of 
Peezy for future LUT microbiome research still needs to be assessed.  
 Our hope is that, as a research community, we can develop methods that allow us to 
obtain voided urines with a little post-bladder contamination as possible. We recommend that 
EQUC be utilized in future research studies due to its increased sensitivity and ability to capture 
a broad range of bacteria. We found in this small study that the use of the PEEZY device suggests 
a step towards a “cleaner catch”. We also found the peri-urethral wipe was not a necessary step. 
Additional studies and methods will validate or refute our findings and build on the current 
research of using voided urines to study the microbiome of the lower urinary tract.  
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